ID   ANDR_HUMAN              Reviewed;         919 AA.
AC   P10275; A2RUN2; B1AKD7; Q9UD95;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   06-FEB-2013, entry version 202.
DE   RecName: Full=Androgen receptor;
DE   AltName: Full=Dihydrotestosterone receptor;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 4;
GN   Name=AR; Synonyms=DHTR, NR3C4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=89112208; PubMed=3216866;
RA   Lubahn D.B., Joseph D.R., Sar M., Tan J., Higgs H.N., Larson R.E.,
RA   French F.S., Wilson E.M.;
RT   "The human androgen receptor: complementary deoxyribonucleic acid
RT   cloning, sequence analysis and gene expression in prostate.";
RL   Mol. Endocrinol. 2:1265-1275(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   MEDLINE=89017168; PubMed=3174628; DOI=10.1073/pnas.85.19.7211;
RA   Chang C., Kokontis J., Liao S.;
RT   "Structural analysis of complementary DNA and amino acid sequences of
RT   human and rat androgen receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:7211-7215(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   MEDLINE=89098909; PubMed=2911578; DOI=10.1073/pnas.86.1.327;
RA   Tilley W.D., Marcelli M., Wilson J.D., McPhaul M.J.;
RT   "Characterization and expression of a cDNA encoding the human androgen
RT   receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:327-331(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT AIS MET-866.
RX   MEDLINE=90083302; PubMed=2594783; DOI=10.1073/pnas.86.23.9534;
RA   Lubahn D.B., Brown T.R., Simental J.A., Higgs H.N., Migeon C.J.,
RA   Wilson E.M., French F.S.;
RT   "Sequence of the intron/exon junctions of the coding region of the
RT   human androgen receptor gene and identification of a point mutation in
RT   a family with complete androgen insensitivity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:9534-9538(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT DEL
RP   GLY-465--472-GLY.
RX   MEDLINE=90258935; PubMed=2342476;
RA   Govindan M.V.;
RT   "Specific region in hormone binding domain is essential for hormone
RT   binding and trans-activation by human androgen receptor.";
RL   Mol. Endocrinol. 4:417-427(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND NUCLEOTIDE SEQUENCE [MRNA]
RP   (ISOFORM 1).
RC   TISSUE=Prostate;
RX   MEDLINE=91155943; PubMed=2293020;
RA   Marcelli M., Tilley W.D., Wilson C.M., Griffin J.E., Wilson J.D.,
RA   McPhaul M.J.;
RT   "Definition of the human androgen receptor gene structure permits the
RT   identification of mutations that cause androgen resistance: premature
RT   termination of the receptor protein at amino acid residue 588 causes
RT   complete androgen resistance.";
RL   Mol. Endocrinol. 4:1105-1116(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 2),
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15634333; DOI=10.1111/j.1432-1033.2004.04395.x;
RA   Ahrens-Fath I., Politz O., Geserick C., Haendler B.;
RT   "Androgen receptor function is modulated by the tissue-specific AR45
RT   variant.";
RL   FEBS J. 272:74-84(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND POLYMORPHISM
RP   OF POLY-GLY REGION.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-538.
RX   MEDLINE=89137730; PubMed=2917688; DOI=10.1016/0303-7207(89)90137-8;
RA   Faber P.W., Kuiper G.G.J.M., van Rooij H.C.J.,
RA   van der Korput J.A.G.M., Brinkmann A.O., Trapman J.;
RT   "The N-terminal domain of the human androgen receptor is encoded by
RT   one, large exon.";
RL   Mol. Cell. Endocrinol. 61:257-262(1989).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-919 (ISOFORM 1).
RX   MEDLINE=88178111; PubMed=3353726; DOI=10.1126/science.3353726;
RA   Chang C., Kokontis J., Liao S.;
RT   "Molecular cloning of human and rat complementary DNA encoding
RT   androgen receptors.";
RL   Science 240:324-326(1988).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 446-475, AND POLYMORPHISM OF
RP   POLY-GLY REGION.
RC   TISSUE=Blood;
RA   Lu J., Danielsen M.;
RL   Submitted (FEB-1995) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 468-919 (ISOFORM 1).
RX   MEDLINE=88240407; PubMed=3377788; DOI=10.1016/S0006-291X(88)81214-2;
RA   Trapman J., Klaassen P., Kuiper G.G.J.M., van der Korput J.A.G.M.,
RA   Faber P.W., van Rooij H.C.J., Geurts van Kessel A., Voorhorst M.M.,
RA   Mulder E., Brinkmann A.O.;
RT   "Cloning, structure and expression of a cDNA encoding the human
RT   androgen receptor.";
RL   Biochem. Biophys. Res. Commun. 153:241-248(1988).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 536-540; 587-591; 626-630;
RP   722-726; 770-774; 814-817 AND 866-870.
RX   MEDLINE=89322749; PubMed=2546571;
RA   Kuiper G.G., Faber P.W., van Rooij H.C., van der Korput J.A.,
RA   Ris-Stalpers C., Klaassen P., Trapman J., Brinkmann A.O.;
RT   "Structural organization of the human androgen receptor gene.";
RL   J. Mol. Endocrinol. 2:R1-R4(1989).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 557-624 (ISOFORMS 1/2), AND VARIANT AIS
RP   HIS-615.
RC   TISSUE=Fibroblast;
RX   MEDLINE=94019395; PubMed=8413310; DOI=10.1210/me.7.7.861;
RA   Mowszowicz I., Lee H.-J., Chen H.-T., Mestayer C., Portois M.-C.,
RA   Cabrol S., Mauvais-Jarvis P., Chang C.;
RT   "A point mutation in the second zinc finger of the DNA-binding domain
RT   of the androgen receptor gene causes complete androgen insensitivity
RT   in two siblings with receptor-positive androgen resistance.";
RL   Mol. Endocrinol. 7:861-869(1993).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 559-624 (ISOFORMS 1/2).
RX   MEDLINE=88178112; PubMed=3353727; DOI=10.1126/science.3353727;
RA   Lubahn D.B., Joseph D.R., Sullivan P.M., Willard H.F., French F.S.,
RA   Wilson E.M.;
RT   "Cloning of human androgen receptor complementary DNA and localization
RT   to the X chromosome.";
RL   Science 240:327-330(1988).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 629-723, AND VARIANTS AIS ASN-695
RP   AND HIS-695.
RX   MEDLINE=92131007; PubMed=1775137;
RA   Ris-Stalpers C., Trifiro M.A., Kuiper G.G.J.M., Jenster G., Romalo G.,
RA   Sai T., van Rooij H.C.J., Kaufman M., Rosenfield R.L., Liao S.,
RA   Schweikert H.-U., Trapman J., Pinsky L., Brinkmann A.O.;
RT   "Substitution of aspartic acid-686 by histidine or asparagine in the
RT   human androgen receptor leads to a functionally inactive protein with
RT   altered hormone-binding characteristics.";
RL   Mol. Endocrinol. 5:1562-1569(1991).
RN   [19]
RP   POLYMORPHISM OF POLY-GLN REGION.
RX   MEDLINE=92220629; PubMed=1561105; DOI=10.1093/nar/20.6.1427-a;
RA   Sleddens H.F.B.M., Oostra B.A., Brinkmann A.O., Trapman J.;
RT   "Trinucleotide repeat polymorphism in the androgen receptor gene
RT   (AR).";
RL   Nucleic Acids Res. 20:1427-1427(1992).
RN   [20]
RP   POLYMORPHISM OF POLY-GLN REGION.
RX   MEDLINE=97250535; PubMed=9096391; DOI=10.1073/pnas.94.7.3320;
RA   Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D.,
RA   Brufsky A., Talcott J., Hennekens C.H., Kantoff P.W.;
RT   "The CAG repeat within the androgen receptor gene and its relationship
RT   to prostate cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:3320-3323(1997).
RN   [21]
RP   ERRATUM.
RA   Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D.,
RA   Brufsky A., Talcott J., Hennekens C.H., Kantoff P.W.;
RL   Proc. Natl. Acad. Sci. U.S.A. 94:8272-8272(1997).
RN   [22]
RP   INTERACTION WITH PQBP1.
RC   TISSUE=Brain;
RX   MEDLINE=99265913; PubMed=10332029; DOI=10.1093/hmg/8.6.977;
RA   Waragai M., Lammers C.-H., Takeuchi S., Imafuku I., Udagawa Y.,
RA   Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H.;
RT   "PQBP-1, a novel polyglutamine tract binding protein, inhibits
RT   transcription activation by Brn-2 and affects cell survival.";
RL   Hum. Mol. Genet. 8:977-987(1999).
RN   [23]
RP   INTERACTION WITH TGFB1I1.
RX   MEDLINE=99175218; PubMed=10075738; DOI=10.1074/jbc.274.12.8316;
RA   Fujimoto N., Yeh S., Kang H.-Y., Inui S., Chang H.-C., Mizokami A.,
RA   Chang C.;
RT   "Cloning and characterization of androgen receptor coactivator, ARA55,
RT   in human prostate.";
RL   J. Biol. Chem. 274:8316-8321(1999).
RN   [24]
RP   INTERACTION WITH UBE2I.
RX   PubMed=10383460; DOI=10.1074/jbc.274.27.19441;
RA   Poukka H., Aarnisalo P., Karvonen U., Palvimo J.J., Jaenne O.A.;
RT   "Ubc9 interacts with the androgen receptor and activates receptor-
RT   dependent transcription.";
RL   J. Biol. Chem. 274:19441-19446(1999).
RN   [25]
RP   INTERACTION WITH RAN.
RX   MEDLINE=99329028; PubMed=10400640; DOI=10.1074/jbc.274.29.20229;
RA   Hsiao P.-W., Lin D.-L., Nakao R., Chang C.;
RT   "The linkage of Kennedy's neuron disease to ARA24, the first
RT   identified androgen receptor polyglutamine region-associated
RT   coactivator.";
RL   J. Biol. Chem. 274:20229-20234(1999).
RN   [26]
RP   INTERACTION WITH SPDEF.
RX   MEDLINE=20092894; PubMed=10625666; DOI=10.1074/jbc.275.2.1216;
RA   Oettgen P., Finger E., Sun Z., Akbarali Y., Thamrongsak U., Boltax J.,
RA   Grall F., Dube A., Weiss A., Brown L., Quinn G., Kas K., Endress G.,
RA   Kunsch C., Libermann T.A.;
RT   "PDEF, a novel prostate epithelium-specific ets transcription factor,
RT   interacts with the androgen receptor and activates prostate-specific
RT   antigen gene expression.";
RL   J. Biol. Chem. 275:1216-1225(2000).
RN   [27]
RP   INTERACTION WITH KAT7.
RX   MEDLINE=20519613; PubMed=10930412; DOI=10.1074/jbc.M004838200;
RA   Sharma M., Zarnegar M., Li X., Lim B., Sun Z.;
RT   "Androgen receptor interacts with a novel MYST protein, HBO1.";
RL   J. Biol. Chem. 275:35200-35208(2000).
RN   [28]
RP   SUMOYLATION AT LYS-386 AND LYS-520.
RX   PubMed=11121022; DOI=10.1073/pnas.97.26.14145;
RA   Poukka H., Karvonen U., Jaenne O.A., Palvimo J.J.;
RT   "Covalent modification of the androgen receptor by small ubiquitin-
RT   like modifier 1 (SUMO-1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14145-14150(2000).
RN   [29]
RP   INTERACTION WITH RANBP9.
RX   MEDLINE=22359010; PubMed=12361945; DOI=10.1074/jbc.M209741200;
RA   Rao M.A., Cheng H., Quayle A.N., Nishitani H., Nelson C.C.,
RA   Rennie P.S.;
RT   "RanBPM, a nuclear protein that interacts with and regulates
RT   transcriptional activity of androgen receptor and glucocorticoid
RT   receptor.";
RL   J. Biol. Chem. 277:48020-48027(2002).
RN   [30]
RP   INTERACTION WITH PRPF6.
RX   PubMed=12039962; DOI=10.1074/jbc.M203811200;
RA   Zhao Y., Goto K., Saitoh M., Yanase T., Nomura M., Okabe T.,
RA   Takayanagi R., Nawata H.;
RT   "Activation function-1 domain of androgen receptor contributes to the
RT   interaction between subnuclear splicing factor compartment and nuclear
RT   receptor compartment. Identification of the p102 U5 small nuclear
RT   ribonucleoprotein particle-binding protein as a coactivator for the
RT   receptor.";
RL   J. Biol. Chem. 277:30031-30039(2002).
RN   [31]
RP   INTERACTION WITH PELP1.
RX   MEDLINE=22317447; PubMed=12415108; DOI=10.1073/pnas.192569699;
RA   Wong C.-W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J.;
RT   "Estrogen receptor-interacting protein that modulates its nongenomic
RT   activity-crosstalk with Src/Erk phosphorylation cascade.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14783-14788(2002).
RN   [32]
RP   INTERACTION WITH ZMIZ1.
RX   PubMed=14609956; DOI=10.1093/emboj/cdg585;
RA   Sharma M., Li X., Wang Y., Zarnegar M., Huang C.-Y., Palvimo J.J.,
RA   Lim B., Sun Z.;
RT   "hZimp10 is an androgen receptor co-activator and forms a complex with
RT   SUMO-1 at replication foci.";
RL   EMBO J. 22:6101-6114(2003).
RN   [33]
RP   INTERACTION WITH GNB2L1, AND SUBCELLULAR LOCATION.
RX   PubMed=12958311; DOI=10.1074/jbc.M306219200;
RA   Rigas A.C., Ozanne D.M., Neal D.E., Robson C.N.;
RT   "The scaffolding protein RACK1 interacts with androgen receptor and
RT   promotes cross-talk through a protein kinase C signaling pathway.";
RL   J. Biol. Chem. 278:46087-46093(2003).
RN   [34]
RP   FUNCTION, AND INTERACTION WITH RBAK.
RX   PubMed=14664718; DOI=10.1677/jme.0.0310583;
RA   Hofman K., Swinnen J.V., Claessens F., Verhoeven G., Heyns W.;
RT   "The retinoblastoma protein-associated transcription repressor RBaK
RT   interacts with the androgen receptor and enhances its transcriptional
RT   activity.";
RL   J. Mol. Endocrinol. 31:583-596(2003).
RN   [35]
RP   INTERACTION WITH EFCAB6.
RX   MEDLINE=22499918; PubMed=12612053;
RA   Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S.M.M., Ariga H.;
RT   "DJBP: a novel DJ-1-binding protein, negatively regulates the androgen
RT   receptor by recruiting histone deacetylase complex, and DJ-1
RT   antagonizes this inhibition by abrogation of this complex.";
RL   Mol. Cancer Res. 1:247-261(2003).
RN   [36]
RP   PHOSPHORYLATION BY PAK6.
RX   PubMed=14573606; DOI=10.1074/jbc.M311145200;
RA   Schrantz N., da Silva Correia J., Fowler B., Ge Q., Sun Z.,
RA   Bokoch G.M.;
RT   "Mechanism of p21-activated kinase 6-mediated inhibition of androgen
RT   receptor signaling.";
RL   J. Biol. Chem. 279:1922-1931(2004).
RN   [37]
RP   INTERACTION WITH HIP1.
RX   PubMed=16027218; DOI=10.1083/jcb.200503106;
RA   Mills I.G., Gaughan L., Robson C., Ross T., McCracken S., Kelly J.,
RA   Neal D.E.;
RT   "Huntingtin interacting protein 1 modulates the transcriptional
RT   activity of nuclear hormone receptors.";
RL   J. Cell Biol. 170:191-200(2005).
RN   [38]
RP   INTERACTION WITH ZMIZ2.
RX   PubMed=16051670; DOI=10.1210/me.2005-0097;
RA   Huang C.-Y., Beliakoff J., Li X., Lee J., Li X., Sharma M., Lim B.,
RA   Sun Z.;
RT   "hZimp7, a novel PIAS-like protein, enhances androgen receptor-
RT   mediated transcription and interacts with SWI/SNF-like BAF
RT   complexes.";
RL   Mol. Endocrinol. 19:2915-2929(2005).
RN   [39]
RP   PHOSPHORYLATION AT TYR-223; TYR-267; TYR-307; TYR-346; TYR-357;
RP   TYR-362; TYR-363; TYR-393; TYR-534; TYR-551 AND TYR-915, MUTAGENESIS
RP   OF TYR-223; TYR-267; TYR-307; TYR-346; TYR-357; TYR-362; TYR-363;
RP   TYR-393; TYR-534; TYR-551 AND TYR-915, AND MASS SPECTROMETRY.
RX   PubMed=17045208; DOI=10.1016/j.ccr.2006.08.021;
RA   Guo Z., Dai B., Jiang T., Xu K., Xie Y., Kim O., Nesheiwat I.,
RA   Kong X., Melamed J., Handratta V.D., Njar V.C., Brodie A.M., Yu L.-R.,
RA   Veenstra T.D., Chen H., Qiu Y.;
RT   "Regulation of androgen receptor activity by tyrosine
RT   phosphorylation.";
RL   Cancer Cell 10:309-319(2006).
RN   [40]
RP   ERRATUM.
RA   Guo Z., Dai B., Jiang T., Xu K., Xie Y., Kim O., Nesheiwat I.,
RA   Kong X., Melamed J., Handratta V.D., Njar V.C., Brodie A.M., Yu L.-R.,
RA   Veenstra T.D., Chen H., Qiu Y.;
RL   Cancer Cell 11:97-97(2007).
RN   [41]
RP   INTERACTION WITH MAK, AND SUBUNIT.
RX   PubMed=16951154; DOI=10.1158/0008-5472.CAN-06-1636;
RA   Ma A.H., Xia L., Desai S.J., Boucher D.L., Guan Y., Shih H.M.,
RA   Shi X.B., deVere White R.W., Chen H.W., Tepper C.G., Kung H.J.;
RT   "Male germ cell-associated kinase, a male-specific kinase regulated by
RT   androgen, is a coactivator of androgen receptor in prostate cancer
RT   cells.";
RL   Cancer Res. 66:8439-8447(2006).
RN   [42]
RP   INTERACTION WITH PRMT2, AND SUBCELLULAR LOCATION.
RX   PubMed=17587566; DOI=10.1016/j.jsbmb.2007.05.006;
RA   Meyer R., Wolf S.S., Obendorf M.;
RT   "PRMT2, a member of the protein arginine methyltransferase family, is
RT   a coactivator of the androgen receptor.";
RL   J. Steroid Biochem. Mol. Biol. 107:1-14(2007).
RN   [43]
RP   INTERACTION WITH RREB1.
RX   PubMed=17550981; DOI=10.1210/me.2006-0503;
RA   Mukhopadhyay N.K., Cinar B., Mukhopadhyay L., Lutchman M.,
RA   Ferdinand A.S., Kim J., Chung L.W.K., Adam R.M., Ray S.K.,
RA   Leiter A.B., Richie J.P., Liu B.C.-S., Freeman M.R.;
RT   "The zinc finger protein Ras-responsive element binding protein-1 is a
RT   coregulator of the androgen receptor: implications for the role of the
RT   Ras pathway in enhancing androgenic signaling in prostate cancer.";
RL   Mol. Endocrinol. 21:2056-2070(2007).
RN   [44]
RP   INTERACTION WITH RANBP10.
RX   PubMed=18222118; DOI=10.1016/j.bbrc.2008.01.072;
RA   Harada N., Yokoyama T., Yamaji R., Nakano Y., Inui H.;
RT   "RanBP10 acts as a novel coactivator for the androgen receptor.";
RL   Biochem. Biophys. Res. Commun. 368:121-125(2008).
RN   [45]
RP   INTERACTION WITH TNK2, PHOSPHORYLATION AT TYR-267 AND TYR-363 BY TNK2,
RP   AND MUTAGENESIS OF TYR-267 AND TYR-363.
RX   PubMed=17494760; DOI=10.1073/pnas.0700420104;
RA   Mahajan N.P., Liu Y., Majumder S., Warren M.R., Parker C.E.,
RA   Mohler J.L., Earp H.S., Whang Y.E.;
RT   "Activated Cdc42-associated kinase Ack1 promotes prostate cancer
RT   progression via androgen receptor tyrosine phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:8438-8443(2007).
RN   [46]
RP   INTERACTION WITH TRIM68.
RX   PubMed=18451177; DOI=10.1158/0008-5472.CAN-07-6059;
RA   Miyajima N., Maruyama S., Bohgaki M., Kano S., Shigemura M.,
RA   Shinohara N., Nonomura K., Hatakeyama S.;
RT   "TRIM68 regulates ligand-dependent transcription of androgen receptor
RT   in prostate cancer cells.";
RL   Cancer Res. 68:3486-3494(2008).
RN   [47]
RP   INTERACTION WITH LPXN.
RX   PubMed=18451096; DOI=10.1210/me.2006-0546;
RA   Kaulfuss S., Grzmil M., Hemmerlein B., Thelen P., Schweyer S.,
RA   Neesen J., Bubendorf L., Glass A.G., Jarry H., Auber B., Burfeind P.;
RT   "Leupaxin, a novel coactivator of the androgen receptor, is expressed
RT   in prostate cancer and plays a role in adhesion and invasion of
RT   prostate carcinoma cells.";
RL   Mol. Endocrinol. 22:1606-1621(2008).
RN   [48]
RP   FUNCTION, AND INTERACTION WITH ZIPK/DAPK3.
RX   PubMed=18084323; DOI=10.1038/sj.onc.1210995;
RA   Leister P., Felten A., Chasan A.I., Scheidtmann K.H.;
RT   "ZIP kinase plays a crucial role in androgen receptor-mediated
RT   transcription.";
RL   Oncogene 27:3292-3300(2008).
RN   [49]
RP   INTERACTION WITH TRIM24.
RX   PubMed=19909775; DOI=10.1016/j.bbamcr.2009.11.001;
RA   Kikuchi M., Okumura F., Tsukiyama T., Watanabe M., Miyajima N.,
RA   Tanaka J., Imamura M., Hatakeyama S.;
RT   "TRIM24 mediates ligand-dependent activation of androgen receptor and
RT   is repressed by a bromodomain-containing protein, BRD7, in prostate
RT   cancer cells.";
RL   Biochim. Biophys. Acta 1793:1828-1836(2009).
RN   [50]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, POLYUBIQUITINATION AT
RP   LYS-845 AND LYS-847 BY RNF6, MUTAGENESIS OF LYS-845 AND LYS-847,
RP   INTERACTION WITH RNF14 AND RNF6, AND SUBCELLULAR LOCATION.
RX   PubMed=19345326; DOI=10.1016/j.ccr.2009.02.021;
RA   Xu K., Shimelis H., Linn D.E., Jiang R., Yang X., Sun F., Guo Z.,
RA   Chen H., Li W., Chen H., Kong X., Melamed J., Fang S., Xiao Z.,
RA   Veenstra T.D., Qiu Y.;
RT   "Regulation of androgen receptor transcriptional activity and
RT   specificity by RNF6-induced ubiquitination.";
RL   Cancer Cell 15:270-282(2009).
RN   [51]
RP   FUNCTION IN AR KINASE, PHOSPHORYLATION AT SER-81 BY CDK9, MUTAGENESIS
RP   OF SER-81, AND INTERACTION WITH CDK9.
RX   PubMed=20980437; DOI=10.1210/me.2010-0238;
RA   Gordon V., Bhadel S., Wunderlich W., Zhang J., Ficarro S.B.,
RA   Mollah S.A., Shabanowitz J., Hunt D.F., Xenarios I., Hahn W.C.,
RA   Conaway M., Carey M.F., Gioeli D.;
RT   "CDK9 regulates AR promoter selectivity and cell growth through serine
RT   81 phosphorylation.";
RL   Mol. Endocrinol. 24:2267-2280(2010).
RN   [52]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; THR-301 AND
RP   TYR-307, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [53]
RP   UBIQUITINATION, DEUBIQUITINATION, AND INTERACTION WITH USP26.
RX   PubMed=20501646; DOI=10.1158/1541-7786.MCR-09-0424;
RA   Dirac A.M., Bernards R.;
RT   "The deubiquitinating enzyme USP26 is a regulator of androgen receptor
RT   signaling.";
RL   Mol. Cancer Res. 8:844-854(2010).
RN   [54]
RP   PHOSPHORYLATION AT TYR-267, AND ENZYME REGULATION.
RX   PubMed=20623637; DOI=10.1002/pros.21163;
RA   Mahajan K., Challa S., Coppola D., Lawrence H., Luo Y., Gevariya H.,
RA   Zhu W., Chen Y.A., Lawrence N.J., Mahajan N.P.;
RT   "Effect of Ack1 tyrosine kinase inhibitor on ligand-independent
RT   androgen receptor activity.";
RL   Prostate 70:1274-1285(2010).
RN   [55]
RP   PHOSPHORYLATION AT SER-650, AND INTERACTION WITH STK4/MST1.
RX   PubMed=21512132; DOI=10.1158/0008-5472.CAN-10-4532;
RA   Cinar B., Collak F.K., Lopez D., Akgul S., Mukhopadhyay N.K.,
RA   Kilicarslan M., Gioeli D.G., Freeman M.R.;
RT   "MST1 is a multifunctional caspase-independent inhibitor of androgenic
RT   signaling.";
RL   Cancer Res. 71:4303-4313(2011).
RN   [56]
RP   PALMITOYLATION.
RX   PubMed=22031296; DOI=10.1091/mbc.E11-07-0638;
RA   Pedram A., Razandi M., Deschenes R.J., Levin E.R.;
RT   "DHHC-7 and -21 are palmitoylacyltransferases for sex steroid
RT   receptors.";
RL   Mol. Biol. Cell 23:188-199(2012).
RN   [57]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 657-919.
RX   MEDLINE=20408960; PubMed=10840043; DOI=10.1074/jbc.M004571200;
RA   Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S.,
RA   Otto N., Joschko S., Scholz P., Wegg A., Baesler S., Schaefer M.,
RA   Egner U., Carrondo M.A.;
RT   "Structural evidence for ligand specificity in the binding domain of
RT   the human androgen receptor. Implications for pathogenic gene
RT   mutations.";
RL   J. Biol. Chem. 275:26164-26171(2000).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 670-917.
RX   MEDLINE=21904580; PubMed=11906285; DOI=10.1021/jm011072j;
RA   Matias P.M., Carrondo M.A., Coelho R., Thomaz M., Zhao X.Y., Wegg A.,
RA   Crusius K., Egner U., Donner P.;
RT   "Structural basis for the glucocorticoid response in a mutant human
RT   androgen receptor (AR(ccr)) derived from an androgen-independent
RT   prostate cancer.";
RL   J. Med. Chem. 45:1439-1446(2002).
RN   [59]
RP   X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 671-919 IN COMPLEXES WITH
RP   N-TERMINAL MODULATING DOMAIN AND NCOA2, INTERACTION WITH NCOA1, AND
RP   CHARACTERIZATION OF VARIANT PROSTATE CANCER M-730.
RX   PubMed=15525515; DOI=10.1016/j.molcel.2004.09.036;
RA   He B., Gampe R.T. Jr., Kole A.J., Hnat A.T., Stanley T.B., An G.,
RA   Stewart E.L., Kalman R.I., Minges J.T., Wilson E.M.;
RT   "Structural basis for androgen receptor interdomain and coactivator
RT   interactions suggests a transition in nuclear receptor activation
RT   function dominance.";
RL   Mol. Cell 16:425-438(2004).
RN   [60]
RP   X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 669-919 IN COMPLEXES WITH
RP   DIHYDROTESTOSTERONE AND NCOA1; NCOA2; NCOA3 AND NCOA4, FUNCTION,
RP   INTERACTION WITH NCOA1; NCOA2; NCOA3 AND NCOA4, AND MUTAGENESIS OF
RP   LYS-720 AND GLU-897.
RX   PubMed=15563469; DOI=10.1074/jbc.M407046200;
RA   Estebanez-Perpina E., Moore J.M.R., Mar E., Delgado-Rodrigues E.,
RA   Nguyen P., Baxter J.D., Buehrer B.M., Webb P., Fletterick R.J.,
RA   Guy R.K.;
RT   "The molecular mechanisms of coactivator utilization in ligand-
RT   dependent transactivation by the androgen receptor.";
RL   J. Biol. Chem. 280:8060-8068(2005).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 664-919 IN COMPLEXES WITH
RP   NONSTEROIDAL LIGANDS, MUTAGENESIS OF TRP-741, CHARACTERIZATION OF
RP   VARIANT PROSTATE CANCER ALA-877, AND CHARACTERIZATION OF VARIANT AIS
RP   THR-895.
RX   PubMed=16129672; DOI=10.1074/jbc.M507464200;
RA   Bohl C.E., Miller D.D., Chen J., Bell C.E., Dalton J.T.;
RT   "Structural basis for accommodation of nonsteroidal ligands in the
RT   androgen receptor.";
RL   J. Biol. Chem. 280:37747-37754(2005).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 654-919 IN COMPLEXES WITH
RP   TESTOSTERONE; DIHYDROTESTOSTERONE AND TETRAHYDROGESTRINONE.
RX   PubMed=16641486; DOI=10.1110/ps.051905906;
RA   Pereira de Jesus-Tran K., Cote P.-L., Cantin L., Blanchet J.,
RA   Labrie F., Breton R.;
RT   "Comparison of crystal structures of human androgen receptor ligand-
RT   binding domain complexed with various agonists reveals molecular
RT   determinants responsible for binding affinity.";
RL   Protein Sci. 15:987-999(2006).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 671-918 IN COMPLEX WITH
RP   NR0B2.
RX   PubMed=18007036; DOI=10.1107/S0907444907045702;
RA   Jouravel N., Sablin E., Arnold L.A., Guy R.K., Fletterick R.J.;
RT   "Interaction between the androgen receptor and a segment of its
RT   corepressor SHP.";
RL   Acta Crystallogr. D 63:1198-1200(2007).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 671-919 OF MUTANT ALA-877 IN
RP   COMPLEX WITH THE ANTIANDROGEN CYPROTERONE ACETATE, CHARACTERIZATION OF
RP   VARIANT PROSTATE CANCER ALA-877, AND MUTAGENESIS OF LEU-701.
RX   PubMed=17311914; DOI=10.1074/jbc.M611711200;
RA   Bohl C.E., Wu Z., Miller D.D., Bell C.E., Dalton J.T.;
RT   "Crystal structure of the T877A human androgen receptor ligand-binding
RT   domain complexed to cyproterone acetate provides insight for ligand-
RT   induced conformational changes and structure-based drug design.";
RL   J. Biol. Chem. 282:13648-13655(2007).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 663-919 OF WILD-TYPE AND
RP   MUTANT TYR-874 IN COMPLEX WITH TESTOSTERONE AND NCOA2, ACTIVATION BY
RP   THE N-TERMINAL MODULATING DOMAIN, INTERACTION WITH NCOA2 AND MAGEA11,
RP   FUNCTION, MUTAGENESIS OF LYS-720 AND GLU-897, AND CHARACTERIZATION OF
RP   VARIANT PROSTATE CANCER TYR-874.
RX   PubMed=17591767; DOI=10.1074/jbc.M703268200;
RA   Askew E.B., Gampe R.T. Jr., Stanley T.B., Faggart J.L., Wilson E.M.;
RT   "Modulation of androgen receptor activation function 2 by testosterone
RT   and dihydrotestosterone.";
RL   J. Biol. Chem. 282:25801-25816(2007).
RN   [66]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 654-919 IN COMPLEX WITH
RP   EM5744.
RX   PubMed=17711855; DOI=10.1074/jbc.M705524200;
RA   Cantin L., Faucher F., Couture J.-F., de Jesus-Tran K.P., Legrand P.,
RA   Ciobanu L.C., Frechette Y., Labrecque R., Singh S.M., Labrie F.,
RA   Breton R.;
RT   "Structural characterization of the human androgen receptor ligand-
RT   binding domain complexed with EM5744, a rationally designed steroidal
RT   ligand bearing a bulky chain directed toward helix 12.";
RL   J. Biol. Chem. 282:30910-30919(2007).
RN   [67]
RP   X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) OF 669-919 IN COMPLEXES WITH
RP   SYNTHETIC LIGANDS, FUNCTION, AND INTERACTION WITH NCOA2.
RX   PubMed=17911242; DOI=10.1073/pnas.0708036104;
RA   Estebanez-Perpina E., Arnold L.A., Nguyen P., Rodrigues E.D., Mar E.,
RA   Bateman R., Pallai P., Shokat K.M., Baxter J.D., Guy R.K., Webb P.,
RA   Fletterick R.J.;
RT   "A surface on the androgen receptor that allosterically regulates
RT   coactivator binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:16074-16079(2007).
RN   [68]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=93092459; PubMed=1458719;
RA   Pinsky L., Trifiro M.A., Kaufman M., Beitel L.K., Mhatre A.,
RA   Kazemi-Esfarjani P., Sabbaghian N., Lumbroso R., Alvarado C.,
RA   Vasiliou M., Gottlieb B.;
RT   "Androgen resistance due to mutation of the androgen receptor.";
RL   Clin. Invest. Med. 15:456-472(1992).
RN   [69]
RP   REVIEW ON VARIANTS AIS.
RX   MEDLINE=93339360; PubMed=8339746; DOI=10.1007/BF02125442;
RA   Brown T.R., Scherer P.A., Chang Y.-T., Migeon C.J., Ghirri P.,
RA   Murono K., Zhou Z.;
RT   "Molecular genetics of human androgen insensitivity.";
RL   Eur. J. Pediatr. 152 Suppl. 2:S62-S69(1993).
RN   [70]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=94059770; PubMed=8240973; DOI=10.1016/0960-0760(93)90178-Y;
RA   Sultan C., Lumbroso S., Poujol N., Belon C., Boudon C.,
RA   Lobaccaro J.-M.;
RT   "Mutations of androgen receptor gene in androgen insensitivity
RT   syndromes.";
RL   J. Steroid Biochem. Mol. Biol. 46:519-530(1993).
RN   [71]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=95023089; PubMed=7937057;
RA   Patterson M.N., Hughes I.A., Gottlieb B., Pinsky L.;
RT   "The androgen receptor gene mutations database.";
RL   Nucleic Acids Res. 22:3560-3562(1994).
RN   [72]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=95352489; PubMed=7626493; DOI=10.1016/0960-0760(95)00090-M;
RA   Brinkmann A.O., Jenster G., Ris-Stalpers C., van der Korput J.A.G.M.,
RA   Bruggenwirth H.T., Boehmer A.L.M., Trapman J.;
RT   "Androgen receptor mutations.";
RL   J. Steroid Biochem. Mol. Biol. 53:443-448(1995).
RN   [73]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=97169385; PubMed=9016528; DOI=10.1093/nar/25.1.158;
RA   Gottlieb B., Trifiro M.A., Lumbroso R., Vasiliou D.M., Pinsky L.;
RT   "The androgen receptor gene mutations database.";
RL   Nucleic Acids Res. 25:158-162(1997).
RN   [74]
RP   REVIEW ON VARIANTS.
RX   PubMed=22334387; DOI=10.1002/humu.22046;
RA   Gottlieb B., Beitel L.K., Nadarajah A., Paliouras M., Trifiro M.;
RT   "The androgen receptor gene mutations database: 2012 update.";
RL   Hum. Mutat. 33:887-894(2012).
RN   [75]
RP   VARIANT LNCAP ALA-877.
RX   MEDLINE=91083633; PubMed=2260966; DOI=10.1016/S0006-291X(05)80067-1;
RA   Veldscholte J., Ris-Stalpers C., Kuiper G.G.J.M., Jenster G.,
RA   Berrevoets C.A., Claassen E., van Rooij H.C.J., Trapman J.,
RA   Brinkmann A.O., Mulder E.;
RT   "A mutation in the ligand binding domain of the androgen receptor of
RT   human LNCaP cells affects steroid binding characteristics and response
RT   to anti-androgens.";
RL   Biochem. Biophys. Res. Commun. 173:534-540(1990).
RN   [76]
RP   VARIANTS AIS CYS-774; GLN-831 AND MET-866.
RX   MEDLINE=91186983; PubMed=2082179;
RA   Brown T.R., Lubahn D.B., Wilson E.M., French F.S., Migeon C.J.,
RA   Corfen J.L.;
RT   "Functional characterization of naturally occurring mutant androgen
RT   receptors from subjects with complete androgen insensitivity.";
RL   Mol. Endocrinol. 4:1759-1772(1990).
RN   [77]
RP   VARIANT CYS-774.
RX   MEDLINE=91310758; PubMed=1856263;
RA   Marcelli M., Tilley W.D., Zoppi S., Griffin J.E., Wilson J.D.,
RA   McPhaul M.J.;
RT   "Androgen resistance associated with a mutation of the androgen
RT   receptor at amino acid 772 (Arg-->Cys) results from a combination of
RT   decreased messenger ribonucleic acid levels and impairment of receptor
RT   function.";
RL   J. Clin. Endocrinol. Metab. 73:318-325(1991).
RN   [78]
RP   VARIANT AIS PRO-617.
RX   MEDLINE=91154385; PubMed=1999491; DOI=10.1172/JCI115076;
RA   Marcelli M., Zoppi S., Grino P.B., Griffin J.E., Wilson J.D.,
RA   McPhaul M.J.;
RT   "A mutation in the DNA-binding domain of the androgen receptor gene
RT   causes complete testicular feminization in a patient with receptor-
RT   positive androgen resistance.";
RL   J. Clin. Invest. 87:1123-1126(1991).
RN   [79]
RP   VARIANT PAIS CYS-763.
RX   MEDLINE=91185626; PubMed=2010552; DOI=10.1172/JCI115147;
RA   McPhaul M.J., Marcelli M., Tilley W.D., Griffin J.E.,
RA   Isidro-Gutierrez R.F., Wilson J.D.;
RT   "Molecular basis of androgen resistance in a family with a qualitative
RT   abnormality of the androgen receptor and responsive to high-dose
RT   androgen therapy.";
RL   J. Clin. Invest. 87:1413-1421(1991).
RN   [80]
RP   POLY-GLN REGION EXPANSION, AND INVOLVEMENT IN SPINAL AND BULBAR
RP   MUSCULAR ATROPHY.
RX   MEDLINE=91287825; PubMed=2062380; DOI=10.1038/352077a0;
RA   la Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H.;
RT   "Androgen receptor gene mutations in X-linked spinal and bulbar
RT   muscular atrophy.";
RL   Nature 352:77-79(1991).
RN   [81]
RP   VARIANTS AIS CYS-774 AND HIS-774.
RX   MEDLINE=92303560; PubMed=1609793;
RA   Prior L., Bordet S., Trifiro M.A., Mhatre A., Kaufman M., Pinsky L.,
RA   Wrogemann K., Belsham D.D., Pereira F., Greenberg C.R., Trapman J.,
RA   Brinkmann A.O., Chang C., Liao S.;
RT   "Replacement of arginine 773 by cysteine or histidine in the human
RT   androgen receptor causes complete androgen insensitivity with
RT   different receptor phenotypes.";
RL   Am. J. Hum. Genet. 51:143-155(1992).
RN   [82]
RP   VARIANTS PAIS LYS-608 AND LEU-866.
RX   MEDLINE=93047389; PubMed=1424203;
RX   DOI=10.1111/j.1365-2265.1992.tb02313.x;
RA   Saunders P.T., Padayachi T., Tincello D.G., Shalet S.M., Wu F.C.;
RT   "Point mutations detected in the androgen receptor gene of three men
RT   with partial androgen insensitivity syndrome.";
RL   Clin. Endocrinol. (Oxf.) 37:214-220(1992).
RN   [83]
RP   VARIANT AIS THR-765.
RX   MEDLINE=93050279; PubMed=1426313;
RA   Sweet C.R., Behzadian M.A., McDonough P.G.;
RT   "A unique point mutation in the androgen receptor gene in a family
RT   with complete androgen insensitivity syndrome.";
RL   Fertil. Steril. 58:703-707(1992).
RN   [84]
RP   VARIANT AIS VAL-749.
RX   MEDLINE=93138625; PubMed=1487249; DOI=10.1007/BF00220088;
RA   Jakubiczka S., Werder E.A., Wieacker P.;
RT   "Point mutation in the steroid-binding domain of the androgen receptor
RT   gene in a family with complete androgen insensitivity syndrome
RT   (CAIS).";
RL   Hum. Genet. 90:311-312(1992).
RN   [85]
RP   VARIANTS AIS, AND VARIANTS PAIS.
RX   MEDLINE=93338440; PubMed=1307250; DOI=10.1093/hmg/1.7.497;
RA   Batch J.A., Williams D.M., Davies H.R., Brown B.D., Evans B.A.J.,
RA   Hughes I.A., Patterson M.N.;
RT   "Androgen receptor gene mutations identified by SSCP in fourteen
RT   subjects with androgen insensitivity syndrome.";
RL   Hum. Mol. Genet. 1:497-503(1992).
RN   [86]
RP   VARIANT AIS VAL-787.
RX   MEDLINE=92235226; PubMed=1569163; DOI=10.1210/jc.74.5.1152;
RA   Nakao R., Haji M., Yanase T., Ogo A., Takayanagi R., Katsube T.,
RA   Fukumaki Y., Nawata H.;
RT   "A single amino acid substitution (Met-786-->Val) in the steroid-
RT   binding domain of human androgen receptor leads to complete androgen
RT   insensitivity syndrome.";
RL   J. Clin. Endocrinol. Metab. 74:1152-1157(1992).
RN   [87]
RP   VARIANTS AIS ARG-741 AND CYS-834.
RX   MEDLINE=93100381; PubMed=1464650; DOI=10.1210/jc.75.6.1474;
RA   Wilson C.M., Griffin J.E., Wilson J.D., Marcelli M., Zoppi S.,
RA   McPhaul M.J.;
RT   "Immunoreactive androgen receptor expression in subjects with androgen
RT   resistance.";
RL   J. Clin. Endocrinol. Metab. 75:1474-1478(1992).
RN   [88]
RP   VARIANTS AIS, AND VARIANTS PAIS.
RX   MEDLINE=93055453; PubMed=1430233; DOI=10.1172/JCI116093;
RA   McPhaul M.J., Marcelli M., Zoppi S., Wilson C.M., Griffin J.E.,
RA   Wilson J.D.;
RT   "Mutations in the ligand-binding domain of the androgen receptor gene
RT   cluster in two regions of the gene.";
RL   J. Clin. Invest. 90:2097-2101(1992).
RN   [89]
RP   VARIANT PROSTATE CANCER ALA-877.
RX   MEDLINE=92222955; PubMed=1562539; DOI=10.1016/0960-0760(92)90401-4;
RA   Veldscholte J., Berrevoets C.A., Ris-Stalpers C., Kuiper G.G.J.M.,
RA   Jenster G., Trapman J., Brinkmann A.O., Mulder E.;
RT   "The androgen receptor in LNCaP cells contains a mutation in the
RT   ligand binding domain which affects steroid binding characteristics
RT   and response to antiandrogens.";
RL   J. Steroid Biochem. Mol. Biol. 41:665-669(1992).
RN   [90]
RP   VARIANTS AIS TYR-559 AND ARG-576, AND VARIANTS PAIS GLY-597 AND
RP   PRO-617.
RX   MEDLINE=92261595; PubMed=1316540; DOI=10.1210/me.6.3.409;
RA   Zoppi S., Marcelli M., Deslypere J.-P., Griffin J.E., Wilson J.D.,
RA   McPhaul M.J.;
RT   "Amino acid substitutions in the DNA-binding domain of the human
RT   androgen receptor are a frequent cause of receptor-binding positive
RT   androgen resistance.";
RL   Mol. Endocrinol. 6:409-415(1992).
RN   [91]
RP   VARIANTS AIS SER-705; VAL-749; PHE-759; HIS-774; CYS-855 AND GLY-864.
RX   MEDLINE=93125565; PubMed=1480178; DOI=10.1210/me.6.11.1909;
RA   De Bellis A., Quigley C.A., Cariello N.F., el-Awady M.K., Sar M.,
RA   Lane M.V., Wilson E.M., French F.S.;
RT   "Single base mutations in the human androgen receptor gene causing
RT   complete androgen insensitivity: rapid detection by a modified
RT   denaturing gradient gel electrophoresis technique.";
RL   Mol. Endocrinol. 6:1909-1920(1992).
RN   [92]
RP   VARIANT PAIS/BREAST CANCER GLN-607.
RX   MEDLINE=93265137; PubMed=1303262; DOI=10.1038/ng1092-132;
RA   Wooster R., Mangion J., Eeles R., Smith S., Dowsett M., Averill D.,
RA   Barrett-Lee P., Easton D.F., Ponder B.A., Stratton M.R.;
RT   "A germline mutation in the androgen receptor gene in two brothers
RT   with breast cancer and Reifenstein syndrome.";
RL   Nat. Genet. 2:132-134(1992).
RN   [93]
RP   VARIANT MET-730.
RX   MEDLINE=92335289; PubMed=1631125; DOI=10.1073/pnas.89.14.6319;
RA   Newmark J.R., Hardy D.O., Tonb D.C., Carter B.S., Epstein J.I.,
RA   Isaacs W.B., Brown T.R., Barrack E.R.;
RT   "Androgen receptor gene mutations in human prostate cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:6319-6323(1992).
RN   [94]
RP   VARIANTS ARG-205 AND ASP-793.
RX   MEDLINE=94027050; PubMed=8213813;
RA   Macke J.P., Hu N., Hu S., Bailey M., King V.L., Brown T., Hamer D.,
RA   Nathans J.;
RT   "Sequence variation in the androgen receptor gene is not a common
RT   determinant of male sexual orientation.";
RL   Am. J. Hum. Genet. 53:844-852(1993).
RN   [95]
RP   VARIANT AIS PHE-581.
RX   MEDLINE=94039857; PubMed=8224266;
RA   Lumbroso S., Lobaccaro J.-M., Belon C., Martin D., Chaussain J.-L.,
RA   Sultan C.;
RT   "A new mutation within the deoxyribonucleic acid-binding domain of the
RT   androgen receptor gene in a family with complete androgen
RT   insensitivity syndrome.";
RL   Fertil. Steril. 60:814-819(1993).
RN   [96]
RP   VARIANT AIS VAL-754.
RX   MEDLINE=93372806; PubMed=8103398; DOI=10.1093/hmg/2.7.1041;
RA   Lobaccaro J.-M., Lumbroso S., Ktari R., Dumas R., Sultan C.;
RT   "An exonic point mutation creates a MaeIII site in the androgen
RT   receptor gene of a family with complete androgen insensitivity
RT   syndrome.";
RL   Hum. Mol. Genet. 2:1041-1043(1993).
RN   [97]
RP   VARIANT PAIS/BREAST CANCER LYS-608.
RX   MEDLINE=94108428; PubMed=8281139; DOI=10.1093/hmg/2.11.1799;
RA   Lobaccaro J.-M., Lumbroso S., Belon C., Galtier-Dereure F.,
RA   Bringer J., Lesimple T., Namer M., Cutuli B.F., Pujol H., Sultan C.;
RT   "Androgen receptor gene mutation in male breast cancer.";
RL   Hum. Mol. Genet. 2:1799-1802(1993).
RN   [98]
RP   VARIANT AIS ARG-807.
RX   MEDLINE=94108430; PubMed=8281140; DOI=10.1093/hmg/2.11.1809;
RA   Adeyemo O., Kallio P.J., Palvimo J.J., Kontula K., Jaenne O.A.;
RT   "A single-base substitution in exon 6 of the androgen receptor gene
RT   causing complete androgen insensitivity: the mutated receptor fails to
RT   transactivate but binds to DNA in vitro.";
RL   Hum. Mol. Genet. 2:1809-1812(1993).
RN   [99]
RP   VARIANT PAIS VAL-743.
RX   MEDLINE=93315568; PubMed=8325932; DOI=10.1210/jc.77.1.103;
RA   Nakao R., Yanase T., Sakai Y., Haji M., Nawata H.;
RT   "A single amino acid substitution (Gly743 --> Val) in the steroid-
RT   binding domain of the human androgen receptor leads to Reifenstein
RT   syndrome.";
RL   J. Clin. Endocrinol. Metab. 77:103-107(1993).
RN   [100]
RP   VARIANTS AIS LYS-681 AND THR-842, AND VARIANTS PAIS HIS-840 AND
RP   LEU-866.
RX   MEDLINE=93315600; PubMed=8325950; DOI=10.1210/jc.77.1.262;
RA   Hiort O., Huang Q., Sinnecker G.H., Sadeghi-Nejad A., Kruse K.,
RA   Wolfe H.J., Yandell D.W.;
RT   "Single strand conformation polymorphism analysis of androgen receptor
RT   gene mutations in patients with androgen insensitivity syndromes:
RT   application for diagnosis, genetic counseling, and therapy.";
RL   J. Clin. Endocrinol. Metab. 77:262-266(1993).
RN   [101]
RP   VARIANTS PAIS HIS-855 AND MET-869.
RX   MEDLINE=93233131; PubMed=8097257;
RA   Batch J.A., Evans B.A.J., Hughes I.A., Patterson M.N.;
RT   "Mutations of the androgen receptor gene identified in perineal
RT   hypospadias.";
RL   J. Med. Genet. 30:198-201(1993).
RN   [102]
RP   VARIANT AIS VAL-743.
RX   MEDLINE=93213715; PubMed=8096390; DOI=10.1016/0960-0760(93)90081-7;
RA   Lobaccaro J.-M., Lumbroso S., Berta P., Chaussain J.-L., Sultan C.;
RT   "Complete androgen insensitivity syndrome associated with a de novo
RT   mutation of the androgen receptor gene detected by single strand
RT   conformation polymorphism.";
RL   J. Steroid Biochem. Mol. Biol. 44:211-216(1993).
RN   [103]
RP   VARIANTS PROSTATE CANCER HIS-701 AND ALA-877.
RX   MEDLINE=94100129; PubMed=8274409; DOI=10.1016/0960-0760(93)90316-O;
RA   Suzuki H., Sato N., Watabe Y., Masai M., Seino S., Shimazaki J.;
RT   "Androgen receptor gene mutations in human prostate cancer.";
RL   J. Steroid Biochem. Mol. Biol. 46:759-765(1993).
RN   [104]
RP   VARIANT AIS MET-866, AND VARIANT PAIS LEU-866.
RX   MEDLINE=93188862; PubMed=8446106; DOI=10.1210/me.7.1.37;
RA   Kazemi-Esfarjani P., Beitel L.K., Trifiro M.A., Kaufman M., Rennie P.,
RA   Sheppard P., Matusik R., Pinsky L.;
RT   "Substitution of valine-865 by methionine or leucine in the human
RT   androgen receptor causes complete or partial androgen insensitivity,
RT   respectively with distinct androgen receptor phenotypes.";
RL   Mol. Endocrinol. 7:37-46(1993).
RN   [105]
RP   VARIANT PROSTATE CANCER MET-715.
RX   MEDLINE=94195311; PubMed=8145761; DOI=10.1210/me.7.12.1541;
RA   Culig Z., Hobisch A., Cronauer M.V., Cato A.C.B., Hittmair A.,
RA   Radmayr C., Eberle J., Bartsch G., Klocker H.;
RT   "Mutant androgen receptor detected in an advanced-stage prostatic
RT   carcinoma is activated by adrenal androgens and progesterone.";
RL   Mol. Endocrinol. 7:1541-1550(1993).
RN   [106]
RP   VARIANTS AIS PHE-581; VAL-743; VAL-754; GLU-767 AND CYS-855.
RA   Lobaccaro J.-M., Lumbroso S., Belon C., Chaussain J.L., Toublanc J.E.,
RA   Leheup B., Sultan C.;
RT   "Androgen receptor (AR) gene mutations in 6 families with androgen
RT   insensitivity syndrome (Abstract #114).";
RL   Pediatr. Res. Suppl. 33:S22-S22(1993).
RN   [107]
RP   VARIANTS PROSTATE CANCER LEU-340 AND GLU-798.
RX   MEDLINE=94189145; PubMed=7511268;
RA   Castagnaro M., Yandell D.W., Dockhorn-Dworniczak B., Wolfe H.J.,
RA   Poremba C.;
RT   "Androgen receptor gene mutations and p53 gene analysis in advanced
RT   prostate cancer.";
RL   Verh. Dtsch. Ges. Pathol. 77:119-123(1993).
RN   [108]
RP   POLY-GLN REGION CONTRACTION, AND INVOLVEMENT IN PROSTATE CANCER.
RX   MEDLINE=94121667; PubMed=8292051; DOI=10.1006/bbrc.1994.1011;
RA   Schoenberg M.P., Hakimi J.M., Wang S., Bova G.S., Epstein J.I.,
RA   Fischbeck K.H., Isaacs W.B., Walsh P.C., Barrack E.R.;
RT   "Microsatellite mutation (CAG24-->18) in the androgen receptor gene in
RT   human prostate cancer.";
RL   Biochem. Biophys. Res. Commun. 198:74-80(1994).
RN   [109]
RP   VARIANT PROSTATE CANCER ALA-877.
RX   MEDLINE=94243798; PubMed=8187068;
RA   Gaddipati J.P., McLeod D.G., Heidenberg H.B., Sesterhenn I.A.,
RA   Finger M.J., Moul J.W., Srivastava S.;
RT   "Frequent detection of codon 877 mutation in the androgen receptor
RT   gene in advanced prostate cancers.";
RL   Cancer Res. 54:2861-2864(1994).
RN   [110]
RP   VARIANT PAIS TRP-568.
RX   MEDLINE=94244054; PubMed=7910529;
RA   Lobaccaro J.-M., Belon C., Lumbroso S., Olewniczack G.,
RA   Carre-Pigeon F., Job J.C., Chaussain J.L., Toublanc J.E., Sultan C.;
RT   "Molecular prenatal diagnosis of partial androgen insensitivity
RT   syndrome based on the Hind III polymorphism of the androgen receptor
RT   gene.";
RL   Clin. Endocrinol. (Oxf.) 40:297-302(1994).
RN   [111]
RP   VARIANT PAIS HIS-840.
RX   MEDLINE=94214640; PubMed=7909256;
RA   Lumbroso S., Lobaccaro J.-M., Belon C., Amram S., Bachelard B.,
RA   Garandeau P., Sultan C.;
RT   "Molecular prenatal exclusion of familial partial androgen
RT   insensitivity (Reifenstein syndrome).";
RL   Eur. J. Endocrinol. 130:327-332(1994).
RN   [112]
RP   VARIANT PAIS HIS-840.
RX   MEDLINE=94264834; PubMed=8205256;
RA   Imasaki K., Hasegawa T., Okabe T., Sakai Y., Haji M., Takayanagi R.,
RA   Nawata H.;
RT   "Single amino acid substitution (840Arg-->His) in the hormone-binding
RT   domain of the androgen receptor leads to incomplete androgen
RT   insensitivity syndrome associated with a thermolabile androgen
RT   receptor.";
RL   Eur. J. Endocrinol. 130:569-574(1994).
RN   [113]
RP   VARIANT PAIS VAL-870.
RX   MEDLINE=94307287; PubMed=8033918; DOI=10.1007/s004310050143;
RA   Hiort O., Klauber G., Cendron M., Sinnecker G.H., Keim L.,
RA   Schwinger E., Wolfe H.J., Yandell D.W.;
RT   "Molecular characterization of the androgen receptor gene in boys with
RT   hypospadias.";
RL   Eur. J. Pediatr. 153:317-321(1994).
RN   [114]
RP   VARIANT PAIS ASP-690 DEL.
RA   Schwartz M., Skovby F., Mueller J., Nielsen O., Skakkebaek N.E.;
RT   "Partial androgen insensitivity (PAIS) in a large eskimo kindred
RT   caused by a delD690 mutation in the androgen receptor (AR) gene
RT   (Abstract #244).";
RL   Horm. Res. 41:117-117(1994).
RN   [115]
RP   VARIANTS AIS PHE-582 DEL; ARG-615 DEL AND HIS-615.
RX   MEDLINE=94214451; PubMed=8162033; DOI=10.1093/hmg/3.1.21;
RA   Beitel L.K., Prior L., Vasiliou D.M., Gottlieb B., Kaufman M.,
RA   Lumbroso R., Alvarado C., McGillivray B., Trifiro M.A., Pinsky L.;
RT   "Complete androgen insensitivity due to mutations in the probable
RT   alpha-helical segments of the DNA-binding domain in the human androgen
RT   receptor.";
RL   Hum. Mol. Genet. 3:21-27(1994).
RN   [116]
RP   VARIANTS PAIS SER-582; TYR-604; ALA-708; LEU-754 AND HIS-771, AND
RP   VARIANT AIS TRP-779.
RX   MEDLINE=95072584; PubMed=7981687; DOI=10.1093/hmg/3.7.1163;
RA   Hiort O., Wodtke A., Struve D., Zoellner A., Sinnecker G.H.;
RT   "Detection of point mutations in the androgen receptor gene using non-
RT   isotopic single strand conformation polymorphism analysis.";
RL   Hum. Mol. Genet. 3:1163-1166(1994).
RN   [117]
RP   VARIANT AIS PHE-601.
RX   MEDLINE=95072586; PubMed=7981689; DOI=10.1093/hmg/3.7.1169;
RA   Baldazzi L., Baroncini C., Pirazzoli P., Balsamo A., Capelli M.,
RA   Marchetti G., Bernardi F., Cacciari E.;
RT   "Two mutations causing complete androgen insensitivity: a frame-shift
RT   in the steroid binding domain and a Cys-->Phe substitution in the
RT   second zinc finger of the androgen receptor.";
RL   Hum. Mol. Genet. 3:1169-1170(1994).
RN   [118]
RP   VARIANTS PAIS ARG-616; HIS-840 AND MET-889.
RX   MEDLINE=94171952; PubMed=8126121; DOI=10.1210/jc.78.3.513;
RA   De Bellis A., Quigley C.A., Marschke K.B., el-Awady M.K., Lane M.V.,
RA   Smith E.P., Sar M., Wilson E.M., French F.S.;
RT   "Characterization of mutant androgen receptors causing partial
RT   androgen insensitivity syndrome.";
RL   J. Clin. Endocrinol. Metab. 78:513-522(1994).
RN   [119]
RP   VARIANT AIS PHE-790.
RX   MEDLINE=95051264; PubMed=7962294; DOI=10.1210/jc.79.4.1202;
RA   Tsukada T., Inoue M., Tachibana S., Nakai Y., Takebe H.;
RT   "An androgen receptor mutation causing androgen resistance in
RT   undervirilized male syndrome.";
RL   J. Clin. Endocrinol. Metab. 79:1202-1207(1994).
RN   [120]
RP   VARIANTS AIS CYS-840 AND HIS-840.
RX   MEDLINE=94314956; PubMed=8040309; DOI=10.1172/JCI117368;
RA   Beitel L.K., Kazemi-Esfarjani P., Kaufman M., Lumbroso R.,
RA   DiGeorge A.M., Killinger D.W., Trifiro M.A., Pinsky L.;
RT   "Substitution of arginine-839 by cysteine or histidine in the androgen
RT   receptor causes different receptor phenotypes in cultured cells and
RT   coordinate degrees of clinical androgen resistance.";
RL   J. Clin. Invest. 94:546-554(1994).
RN   [121]
RP   VARIANTS AIS, AND VARIANTS PAIS.
RX   MEDLINE=95015035; PubMed=7929841; DOI=10.1172/JCI117507;
RA   Marcelli M., Zoppi S., Wilson C.M., Griffin J.E., McPhaul M.J.;
RT   "Amino acid substitutions in the hormone-binding domain of the human
RT   androgen receptor alter the stability of the hormone receptor
RT   complex.";
RL   J. Clin. Invest. 94:1642-1650(1994).
RN   [122]
RP   VARIANT AIS LYS-727.
RX   MEDLINE=94366236; PubMed=7993455; DOI=10.1016/S0140-6736(94)92385-X;
RA   Yong E.L., Ng S.C., Roy A.C., Yun G., Ratnam S.S.;
RT   "Pregnancy after hormonal correction of severe spermatogenic defect
RT   due to mutation in androgen receptor gene.";
RL   Lancet 344:826-827(1994).
RN   [123]
RP   VARIANTS AIS HIS-615 AND LEU-764, AND VARIANTS PAIS VAL-742 AND
RP   THR-745.
RX   MEDLINE=95061051; PubMed=7970939;
RX   DOI=10.1203/00006450-199408000-00015;
RA   Ris-Stalpers C., Hoogenboezem T., Sleddens H.F.B.M.,
RA   Verleun-Mooijman M.C.T., Degenhart H.J., Drop S.L.S., Halley D.J.J.,
RA   Oosterwijk J.C., Hodgins M.B., Trapman J., Brinkmann A.O.;
RT   "A practical approach to the detection of androgen receptor gene
RT   mutations and pedigree analysis in families with X-linked androgen
RT   insensitivity.";
RL   Pediatr. Res. 36:227-234(1994).
RN   [124]
RP   VARIANT AIS HIS-840.
RX   MEDLINE=96113133; PubMed=8830623;
RA   Imai A., Ohno T., Iida K., Ohsuye K., Okano Y., Tamaya T.;
RT   "A frame-shift mutation of the androgen receptor gene in a patient
RT   with receptor-negative complete testicular feminization: comparison
RT   with a single base substitution in a receptor-reduced incomplete
RT   form.";
RL   Ann. Clin. Biochem. 32:482-486(1995).
RN   [125]
RP   VARIANTS PROSTATE CANCER.
RX   MEDLINE=95228039; PubMed=7712463;
RA   Takahashi H., Furusato M., Allsbrook W.C. Jr., Nishii H., Wakui S.,
RA   Barrett J.C., Boyd J.;
RT   "Prevalence of androgen receptor gene mutations in latent prostatic
RT   carcinomas from Japanese men.";
RL   Cancer Res. 55:1621-1624(1995).
RN   [126]
RP   VARIANT AIS VAL-881.
RX   MEDLINE=95368867; PubMed=7641413;
RX   DOI=10.1111/j.1365-2265.1995.tb01895.x;
RA   Davies H.R., Hughes I.A., Patterson M.N.;
RT   "Genetic counselling in complete androgen insensitivity syndrome:
RT   trinucleotide repeat polymorphisms, single-strand conformation
RT   polymorphism and direct detection of two novel mutations in the
RT   androgen receptor gene.";
RL   Clin. Endocrinol. (Oxf.) 43:69-77(1995).
RN   [127]
RP   VARIANTS AIS SER-705 AND HIS-763, AND VARIANTS PAIS LEU-725; THR-737;
RP   HIS-774 AND GLU-798.
RX   MEDLINE=95401910; PubMed=7671849; DOI=10.1210/er.16.3.271;
RA   Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M.,
RA   French F.S.;
RT   "Androgen receptor defects: historical, clinical, and molecular
RT   perspectives.";
RL   Endocr. Rev. 16:271-321(1995).
RN   [128]
RP   ERRATUM.
RA   Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M.,
RA   French F.S.;
RL   Endocr. Rev. 16:546-546(1995).
RN   [129]
RP   VARIANTS AIS LEU-831 AND GLN-831.
RX   MEDLINE=95359952; PubMed=7633398; DOI=10.1093/hmg/4.4.515;
RA   Shkolny D.L., Brown T.R., Punnett H.H., Kaufman M., Trifiro M.A.,
RA   Pinsky L.;
RT   "Characterization of alternative amino acid substitutions at arginine
RT   830 of the androgen receptor that cause complete androgen
RT   insensitivity in three families.";
RL   Hum. Mol. Genet. 4:515-521(1995).
RN   [130]
RP   VARIANT AIS PRO-677.
RX   MEDLINE=95245337; PubMed=7537149; DOI=10.1002/humu.1380050104;
RA   Belsham D.D., Pereira F., Greenberg C.R., Liao S., Wrogemann K.;
RT   "Leu-676-Pro mutation of the androgen receptor causes complete
RT   androgen insensitivity syndrome in a large Hutterite kindred.";
RL   Hum. Mutat. 5:28-33(1995).
RN   [131]
RP   VARIANT PAIS CYS-763, AND VARIANTS AIS TRP-779; VAL-807 AND CYS-855.
RX   MEDLINE=96047148; PubMed=7581399; DOI=10.1002/humu.1380060208;
RA   Murono K., Mendonca B.B., Arnhold I.J.P., Rigon A.C.M.M., Migeon C.J.,
RA   Brown T.R.;
RT   "Human androgen insensitivity due to point mutations encoding amino
RT   acid substitutions in the androgen receptor steroid-binding domain.";
RL   Hum. Mutat. 6:152-162(1995).
RN   [132]
RP   VARIANT PROSTATE CANCER MET-730.
RX   MEDLINE=96074743; PubMed=7591265; DOI=10.1002/ijc.2910630415;
RA   Peterziel H., Culig Z., Stober J., Hobisch A., Radmayr C., Bartsch G.,
RA   Klocker H., Cato A.C.B.;
RT   "Mutant androgen receptors in prostatic tumors distinguish between
RT   amino-acid-sequence requirements for transactivation and ligand
RT   binding.";
RL   Int. J. Cancer 63:544-550(1995).
RN   [133]
RP   VARIANT VAL-568.
RX   MEDLINE=95403657; PubMed=7673412; DOI=10.1210/jc.80.9.2697;
RA   Allera A., Herbst M.A., Griffin J.E., Wilson J.D., Schweikert H.-U.,
RA   McPhaul M.J.;
RT   "Mutations of the androgen receptor coding sequence are infrequent in
RT   patients with isolated hypospadias.";
RL   J. Clin. Endocrinol. Metab. 80:2697-2699(1995).
RN   [134]
RP   VARIANT PROSTATE CANCER LEU-726.
RX   MEDLINE=96094386; PubMed=8530589; DOI=10.1210/jc.80.12.3494;
RA   Elo J.P., Kvist L., Leinonen K., Isomaa V., Henttu P., Lukkarinen O.,
RA   Vihko P.;
RT   "Mutated human androgen receptor gene detected in a prostatic cancer
RT   patient is also activated by estradiol.";
RL   J. Clin. Endocrinol. Metab. 80:3494-3500(1995).
RN   [135]
RP   VARIANT PAIS THR-596.
RX   MEDLINE=95377517; PubMed=7649358; DOI=10.1016/0303-7207(95)03554-K;
RA   Gast A., Neuschmid-Kaspar F., Klocker H., Cato A.C.B.;
RT   "A single amino acid exchange abolishes dimerization of the androgen
RT   receptor and causes Reifenstein syndrome.";
RL   Mol. Cell. Endocrinol. 111:93-98(1995).
RN   [136]
RP   VARIANTS PROSTATE CANCER.
RX   MEDLINE=95240676; PubMed=7723794; DOI=10.1056/NEJM199505253322101;
RA   Taplin M.-E., Bubley G.J., Shuster T.D., Frantz M.E., Spooner A.E.,
RA   Ogata G.K., Keer H.N., Balk S.P.;
RT   "Mutation of the androgen-receptor gene in metastatic androgen-
RT   independent prostate cancer.";
RL   N. Engl. J. Med. 332:1393-1398(1995).
RN   [137]
RP   VARIANTS AIS AND PAIS.
RX   MEDLINE=96298278; PubMed=8723113;
RX   DOI=10.1002/(SICI)1096-8628(19960503)63:1<218::AID-AJMG38>3.0.CO;2-P;
RA   Hiort O., Sinnecker G.H., Holterhus P.M., Nitsche E.M., Kruse K.;
RT   "The clinical and molecular spectrum of androgen insensitivity
RT   syndromes.";
RL   Am. J. Med. Genet. 63:218-222(1996).
RN   [138]
RP   VARIANTS PROSTATE CANCER.
RX   MEDLINE=99035018; PubMed=9816170;
RA   Tilley W.D., Buchanan G., Hickey T.E., Bentel J.M.;
RT   "Mutations in the androgen receptor gene are associated with
RT   progression of human prostate cancer to androgen independence.";
RL   Clin. Cancer Res. 2:277-285(1996).
RN   [139]
RP   VARIANTS PAIS GLN-607; THR-610; LEU-754; HIS-840; THR-842 AND HIS-855,
RP   AND VARIANT AIS MET-866.
RX   MEDLINE=97191382; PubMed=9039340;
RX   DOI=10.1046/j.1365-2265.1996.8600869.x;
RA   Weidemann W., Linck B., Haupt H., Mentrup B., Romalo G.,
RA   Stockklauser K., Brinkmann A.O., Schweikert H.-U., Spindler K.D.;
RT   "Clinical and biochemical investigations and molecular analysis of
RT   subjects with mutations in the androgen receptor gene.";
RL   Clin. Endocrinol. (Oxf.) 45:733-739(1996).
RN   [140]
RP   VARIANT AIS CYS-855.
RX   MEDLINE=97155085; PubMed=9001799;
RA   Malmgren H., Gustavsson J., Tuvemo T., Dahl N.;
RT   "Rapid detection of a mutation hot-spot in the human androgen
RT   receptor.";
RL   Clin. Genet. 50:202-205(1996).
RN   [141]
RP   VARIANTS PAIS ILE-742; ILE-780; GLU-798; CYS-840; HIS-855 AND MET-869.
RX   MEDLINE=96422266; PubMed=8824883; DOI=10.1093/hmg/5.2.265;
RA   Bevan C.L., Brown B.B., Davies H.R., Evans B.A.J., Hughes I.A.,
RA   Patterson M.N.;
RT   "Functional analysis of six androgen receptor mutations identified in
RT   patients with partial androgen insensitivity syndrome.";
RL   Hum. Mol. Genet. 5:265-273(1996).
RN   [142]
RP   VARIANT PAIS ARG-909.
RX   MEDLINE=96141994; PubMed=8550758; DOI=10.1210/jc.81.1.236;
RA   Choong C.S., Sturm M.J., Strophair J.A., McCulloch R.K., Tilley W.D.,
RA   Leedman P.J., Hurley D.M.;
RT   "Partial androgen insensitivity caused by an androgen receptor
RT   mutation at amino acid 907 (Gly-->Arg) that results in decreased
RT   ligand binding affinity and reduced androgen receptor messenger
RT   ribonucleic acid levels.";
RL   J. Clin. Endocrinol. Metab. 81:236-243(1996).
RN   [143]
RP   VARIANT AIS ARG-707.
RX   MEDLINE=96210890; PubMed=8626869; DOI=10.1210/jc.81.5.1984;
RA   Lumbroso S., Lobaccaro J.-M., Georget V., Leger J., Poujol N.,
RA   Terouanne B., Evain-Brion D., Czernichow P., Sultan C.;
RT   "A novel substitution (Leu707Arg) in exon 4 of the androgen receptor
RT   gene causes complete androgen resistance.";
RL   J. Clin. Endocrinol. Metab. 81:1984-1988(1996).
RN   [144]
RP   VARIANT AIS ILE-780.
RX   MEDLINE=96320094; PubMed=8768864; DOI=10.1210/jc.81.8.2994;
RA   Rodien P., Mebarki F., Mowszowicz I., Chaussain J.L., Young J.,
RA   Morel Y., Schaison G.;
RT   "Different phenotypes in a family with androgen insensitivity caused
RT   by the same M780I point mutation in the androgen receptor gene.";
RL   J. Clin. Endocrinol. Metab. 81:2994-2998(1996).
RN   [145]
RP   VARIANT PAIS LYS-2.
RX   MEDLINE=96420610; PubMed=8823308; DOI=10.1172/JCI118930;
RA   Choong C.S., Quigley C.A., French F.S., Wilson E.M.;
RT   "A novel missense mutation in the amino-terminal domain of the human
RT   androgen receptor gene in a family with partial androgen insensitivity
RT   syndrome causes reduced efficiency of protein translation.";
RL   J. Clin. Invest. 98:1423-1431(1996).
RN   [146]
RP   VARIANT AIS ASP-573.
RX   MEDLINE=97078859; PubMed=8918984; DOI=10.1016/0960-0760(96)00095-7;
RA   Bruggenwirth H.T., Boehmer A.L.M., Verleun-Mooijman M.C.T.,
RA   Hoogenboezem T., Kleijer W.J., Otten B.J., Trapman J., Brinkmann A.O.;
RT   "Molecular basis of androgen insensitivity.";
RL   J. Steroid Biochem. Mol. Biol. 58:569-575(1996).
RN   [147]
RP   VARIANT AIS SER-548.
RX   MEDLINE=96289452; PubMed=8683794;
RX   DOI=10.1097/00005392-199608001-00077;
RA   Sutherland R.W., Wiener J.S., Hicks J.P., Marcelli M.,
RA   Gonzales E.T. Jr., Roth D.R., Lamb D.J.;
RT   "Androgen receptor gene mutations are rarely associated with isolated
RT   penile hypospadias.";
RL   J. Urol. 156:828-831(1996).
RN   [148]
RP   VARIANT AIS PRO-616.
RX   MEDLINE=96231386; PubMed=8647313; DOI=10.1016/0303-7207(95)03709-8;
RA   Lobaccaro J.-M., Poujol N., Chiche L., Lumbroso S., Brown T.R.,
RA   Sultan C.;
RT   "Molecular modeling and in vitro investigations of the human androgen
RT   receptor DNA-binding domain: application for the study of two
RT   mutations.";
RL   Mol. Cell. Endocrinol. 116:137-147(1996).
RN   [149]
RP   VARIANT AIS PHE-579, AND VARIANT PAIS TYR-582.
RX   MEDLINE=96405605; PubMed=8809734; DOI=10.1016/0303-7207(96)03812-9;
RA   Imasaki K., Okabe T., Murakami H., Tanaka Y., Haji M., Takayanagi R.,
RA   Nawata H.;
RT   "Androgen insensitivity syndrome due to new mutations in the DNA-
RT   binding domain of the androgen receptor.";
RL   Mol. Cell. Endocrinol. 120:15-24(1996).
RN   [150]
RP   VARIANT PROSTATE CANCER GLU-798.
RX   MEDLINE=96235947; PubMed=8628719;
RX   DOI=10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H;
RA   Evans B.A.J., Harper M.E., Daniells C.E., Watts C.E., Matenhelia S.,
RA   Green J., Griffiths K.;
RT   "Low incidence of androgen receptor gene mutations in human prostatic
RT   tumors using single strand conformation polymorphism analysis.";
RL   Prostate 28:162-171(1996).
RN   [151]
RP   VARIANT PROSTATE CANCER ALA-877.
RX   MEDLINE=96424622; PubMed=8827083;
RX   DOI=10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5;
RA   Suzuki H., Akakura K., Komiya A., Aida S., Akimoto S., Shimazaki J.;
RT   "Codon 877 mutation in the androgen receptor gene in advanced prostate
RT   cancer: relation to antiandrogen withdrawal syndrome.";
RL   Prostate 29:153-158(1996).
RN   [152]
RP   VARIANT AIS HIS-855.
RX   MEDLINE=97260430; PubMed=9106550;
RA   Boehmer A.L.M., Brinkmann A.O., Niermeijer M.F., Bakker L.,
RA   Halley D.J.J., Drop S.L.S.;
RT   "Germ-line and somatic mosaicism in the androgen insensitivity
RT   syndrome: implications for genetic counseling.";
RL   Am. J. Hum. Genet. 60:1003-1006(1997).
RN   [153]
RP   VARIANT PROSTATE CANCER ALA-683.
RX   MEDLINE=97153285; PubMed=9000575;
RA   Koivisto P., Kononen J., Palmberg C., Tammela T., Hyytinen E.,
RA   Isola J., Trapman J., Cleutjens K., Noordzij A., Visakorpi T.,
RA   Kallioniemi O.-P.;
RT   "Androgen receptor gene amplification: a possible molecular mechanism
RT   for androgen deprivation therapy failure in prostate cancer.";
RL   Cancer Res. 57:314-319(1997).
RN   [154]
RP   VARIANTS PAIS LYS-608 AND GLY-772.
RX   MEDLINE=97340104; PubMed=9196614;
RX   DOI=10.1046/j.1365-2265.1997.1140927.x;
RA   Tincello D.G., Saunders P.T., Hodgins M.B., Simpson N.B.,
RA   Edwards C.R., Hargreaves T.B., Wu F.C.;
RT   "Correlation of clinical, endocrine and molecular abnormalities with
RT   in vivo responses to high-dose testosterone in patients with partial
RT   androgen insensitivity syndrome.";
RL   Clin. Endocrinol. (Oxf.) 46:497-506(1997).
RN   [155]
RP   VARIANT AIS MET-889.
RX   MEDLINE=97303883; PubMed=9160185;
RA   Essawi M., Gad Y.Z., el-Rouby O., Temtamy S.A., Sabour Y.A.,
RA   el-Awady M.K.;
RT   "Molecular analysis of androgen resistance syndromes in Egyptian
RT   patients.";
RL   Dis. Markers 13:99-105(1997).
RN   [156]
RP   VARIANT AIS TRP-779.
RX   MEDLINE=97159966; PubMed=9007482; DOI=10.1007/s004310050542;
RA   Sinnecker G.H., Hiort O., Nitsche E.M., Holterhus P.M., Kruse K.;
RT   "Functional assessment and clinical classification of androgen
RT   sensitivity in patients with mutations of the androgen receptor
RT   gene.";
RL   Eur. J. Pediatr. 156:7-14(1997).
RN   [157]
RP   VARIANTS AIS VAL-749; CYS-774; ILE-780 AND SER-794.
RX   MEDLINE=97144184; PubMed=8990010;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<57::AID-HUMU10>3.3.CO;2-0;
RA   Jakubiczka S., Nedel S., Werder E.A., Schleiermacher E., Theile U.,
RA   Wolff G., Wieacker P.;
RT   "Mutations of the androgen receptor gene in patients with complete
RT   androgen insensitivity.";
RL   Hum. Mutat. 9:57-61(1997).
RN   [158]
RP   VARIANTS PROSTATE CANCER IN POLY-GLN REGION; HIS-701 AND ARG-910.
RX   MEDLINE=98100812; PubMed=9438000; DOI=10.1093/jjco/27.6.389;
RA   Watanabe M., Ushijima T., Shiraishi T., Yatani R., Shimazaki J.,
RA   Kotake T., Sugimura T., Nagao M.;
RT   "Genetic alterations of androgen receptor gene in Japanese human
RT   prostate cancer.";
RL   Jpn. J. Clin. Oncol. 27:389-393(1997).
RN   [159]
RP   VARIANT PROSTATE CANCER GLN-629.
RX   MEDLINE=97327856; PubMed=9184448;
RA   Wang C., Uchida T.;
RT   "Androgen receptor gene mutations in prostate cancer.";
RL   Nihon Hinyokika Gakkai Zasshi 88:550-556(1997).
RN   [160]
RP   VARIANTS AIS ARG-194 AND CYS-855.
RX   MEDLINE=97398857; PubMed=9255042;
RA   Komori S., Sakata K., Tanaka H., Shima H., Koyama K.;
RT   "DNA analysis of the androgen receptor gene in two cases with complete
RT   androgen insensitivity syndrome.";
RL   J. Obstet. Gynaecol. Res. 23:277-281(1997).
RN   [161]
RP   VARIANTS PAIS ALA-708 AND GLY-870.
RX   MEDLINE=97469997; PubMed=9329414;
RA   Albers N., Ulrichs C., Gluer S., Hiort O., Sinnecker G.H.,
RA   Mildenberger H., Brodehl J.;
RT   "Etiologic classification of severe hypospadias: implications for
RT   prognosis and management.";
RL   J. Pediatr. 131:386-392(1997).
RN   [162]
RP   VARIANTS AIS ASN-732 AND THR-765.
RX   MEDLINE=97396769; PubMed=9252933;
RA   Ko T.M., Yang Y.S., Wu M.Y., Kao C.H., Hsu P.M., Chuang S.M.,
RA   Lee T.Y.;
RT   "Complete androgen insensitivity syndrome. Molecular characterization
RT   in two Chinese women.";
RL   J. Reprod. Med. 42:424-428(1997).
RN   [163]
RP   VARIANTS AIS ASP-750; PHE-762; THR-765; ASN-864 AND PHE-907.
RX   MEDLINE=97466866; PubMed=9328206; DOI=10.1016/S0960-0760(97)00001-0;
RA   Bevan C.L., Hughes I.A., Patterson M.N.;
RT   "Wide variation in androgen receptor dysfunction in complete androgen
RT   insensitivity syndrome.";
RL   J. Steroid Biochem. Mol. Biol. 61:19-26(1997).
RN   [164]
RP   VARIANT PAIS GLY-703, AND VARIANT AIS LEU-916.
RX   MEDLINE=97445885; PubMed=9302173;
RX   DOI=10.1097/00005392-199710000-00075;
RA   Radmayr C., Culig Z., Glatzl J., Neuschmid-Kaspar F., Bartsch G.,
RA   Klocker H.;
RT   "Androgen receptor point mutations as the underlying molecular defect
RT   in 2 patients with androgen insensitivity syndrome.";
RL   J. Urol. 158:1553-1556(1997).
RN   [165]
RP   VARIANTS AIS CYS-571; GLN-752 AND CYS-774.
RX   MEDLINE=98206019; PubMed=9544375; DOI=10.1007/s004040050206;
RA   Komori S., Kasumi H., Sakata K., Tanaka H., Hamada K., Koyama K.;
RT   "Molecular analysis of the androgen receptor gene in 4 patients with
RT   complete androgen insensitivity.";
RL   Arch. Gynecol. Obstet. 261:95-100(1998).
RN   [166]
RP   VARIANTS AIS HIS-615 AND GLN-752.
RX   MEDLINE=98363978; PubMed=9698822; DOI=10.1590/S0100-879X1998000600008;
RA   Cabral D.F., Maciel-Guerra A.T., Hackel C.;
RT   "Mutations of androgen receptor gene in Brazilian patients with male
RT   pseudohermaphroditism.";
RL   Braz. J. Med. Biol. Res. 31:775-778(1998).
RN   [167]
RP   VARIANT AIS ARG-214.
RX   MEDLINE=99002768; PubMed=9788719;
RA   Wang Q., Ghadessy F.J., Yong E.L.;
RT   "Analysis of the transactivation domain of the androgen receptor in
RT   patients with male infertility.";
RL   Clin. Genet. 54:185-192(1998).
RN   [168]
RP   VARIANTS AIS PRO-255 AND ALA-820.
RX   MEDLINE=98273339; PubMed=9610419;
RA   Tanaka H., Komori S., Sakata K., Shima H., Koyama K.;
RT   "One additional mutation at exon A amplifies thermolability of
RT   androgen receptor in a case with complete androgen insensitivity
RT   syndrome.";
RL   Gynecol. Endocrinol. 12:75-82(1998).
RN   [169]
RP   VARIANTS AIS THR-765; TYR-784 AND THR-895, AND VARIANT PAIS GLY-840.
RX   MEDLINE=99072324; PubMed=9856504; DOI=10.1007/s004390050864;
RA   Lundberg Giwercman Y., Nikoshkov A., Lindsten K., Bystroem B.,
RA   Pousette A., Chibalin A.V., Arvidsson S., Tiulpakov A.,
RA   Semitcheva T.V., Peterkova V., Hagenfeldt K., Ritzen E.M., Wedell A.;
RT   "Functional characterisation of mutations in the ligand-binding domain
RT   of the androgen receptor gene in patients with androgen insensitivity
RT   syndrome.";
RL   Hum. Genet. 103:529-531(1998).
RN   [170]
RP   VARIANT AIS VAL-695.
RX   MEDLINE=98213476; PubMed=9554754;
RA   Doerk T., Schnieders F., Jakubiczka S., Wieacker P.,
RA   Schroeder-Kurth T., Schmidtke J.;
RT   "A new missense substitution at a mutational hot spot of the androgen
RT   receptor in siblings with complete androgen insensitivity syndrome.";
RL   Hum. Mutat. 11:337-339(1998).
RN   [171]
RP   VARIANT ASP-645.
RX   MEDLINE=98213477; PubMed=9554755;
RA   Nordenskjoeld A., Soederhaell S.;
RT   "An androgen receptor gene mutation (A645D) in a boy with a normal
RT   phenotype.";
RL   Hum. Mutat. 11:339-339(1998).
RN   [172]
RP   VARIANT AIS LEU-892.
RA   Knoke I., Jakubiczka S., Rohrer T., Hanimann B., Werder E.A.,
RA   Wieacker P.;
RT   "Single amino acid substitution in the hormone-binding domain of the
RT   androgen receptor in a family with complete androgen insensitivity
RT   syndrome (CAIS).";
RL   Hum. Mutat. 12:220-220(1998).
RN   [173]
RP   VARIANT PAIS GLN-607.
RX   MEDLINE=98202136; PubMed=9543136; DOI=10.1210/jc.83.4.1173;
RA   Weidemann W., Peters B., Romalo G., Spindler K.D., Schweikert H.-U.;
RT   "Response to androgen treatment in a patient with partial androgen
RT   insensitivity and a mutation in the deoxyribonucleic acid-binding
RT   domain of the androgen receptor.";
RL   J. Clin. Endocrinol. Metab. 83:1173-1176(1998).
RN   [174]
RP   VARIANTS PAIS VAL-743 AND CYS-840.
RX   MEDLINE=98439607; PubMed=9768671; DOI=10.1210/jc.83.10.3597;
RA   Georget V., Terouanne B., Lumbroso S., Nicolas J.C., Sultan C.;
RT   "Trafficking of androgen receptor mutants fused to green fluorescent
RT   protein: a new investigation of partial androgen insensitivity
RT   syndrome.";
RL   J. Clin. Endocrinol. Metab. 83:3597-3603(1998).
RN   [175]
RP   VARIANT AIS GLU-798.
RX   MEDLINE=99067093; PubMed=9851768; DOI=10.1210/jc.83.12.4303;
RA   Wang Q., Ghadessy F.J., Trounson A., de Kretser D., McLachlan R.,
RA   Ng S.C., Yong E.L.;
RT   "Azoospermia associated with a mutation in the ligand-binding domain
RT   of an androgen receptor displaying normal ligand binding, but
RT   defective trans-activation.";
RL   J. Clin. Endocrinol. Metab. 83:4303-4309(1998).
RN   [176]
RP   VARIANTS AIS.
RX   MEDLINE=98291052; PubMed=9627582; DOI=10.1016/S0022-3476(98)70387-7;
RA   Hiort O., Sinnecker G.H., Holterhus P.M., Nitsche E.M., Kruse K.;
RT   "Inherited and de novo androgen receptor gene mutations: investigation
RT   of single-case families.";
RL   J. Pediatr. 132:939-943(1998).
RN   [177]
RP   VARIANT PAIS THR-758.
RX   MEDLINE=98268743; PubMed=9607727; DOI=10.1016/S0303-7207(97)00229-3;
RA   Yong E.L., Tut T.G., Ghadessy F.J., Prins G., Ratnam S.S.;
RT   "Partial androgen insensitivity and correlations with the predicted
RT   three dimensional structure of the androgen receptor ligand-binding
RT   domain.";
RL   Mol. Cell. Endocrinol. 137:41-50(1998).
RN   [178]
RP   VARIANT PAIS LEU-911.
RX   MEDLINE=99399430; PubMed=10470409;
RX   DOI=10.1046/j.1439-0272.1999.00278.x;
RA   Knoke I., Jakubiczka S., Lehnert H., Wieacker P.;
RT   "A new point mutation of the androgen receptor gene in a patient with
RT   partial androgen resistance and severe oligozoospermia.";
RL   Andrologia 31:199-201(1999).
RN   [179]
RP   VARIANTS PROSTATE CANCER ALA-877 AND ASN-890.
RX   MEDLINE=99290631; PubMed=10363963;
RA   Taplin M.-E., Bubley G.J., Ko Y.J., Small E.J., Upton M.,
RA   Rajeshkumar B., Balk S.P.;
RT   "Selection for androgen receptor mutations in prostate cancers treated
RT   with androgen antagonist.";
RL   Cancer Res. 59:2511-2515(1999).
RN   [180]
RP   VARIANT PAIS SER-840.
RX   MEDLINE=99434369; PubMed=10502786;
RX   DOI=10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU16>3.0.CO;2-7;
RA   Melo K.F.S., Latronico A.C., Costa E.M.F., Billerbeck A.E.C.,
RA   Mendonca B.B., Arnhold I.J.P.;
RT   "A novel point mutation (R840S) in the androgen receptor in a
RT   Brazilian family with partial androgen insensitivity syndrome.";
RL   Hum. Mutat. 14:353-353(1999).
RN   [181]
RP   VARIANTS AIS ARG-390 AND ARG-443.
RX   MEDLINE=20040031; PubMed=10571951;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO;2-X;
RA   Gottlieb B., Vasiliou D.M., Lumbroso R., Beitel L.K., Pinsky L.,
RA   Trifiro M.A.;
RT   "Analysis of exon 1 mutations in the androgen receptor gene.";
RL   Hum. Mutat. 14:527-539(1999).
RN   [182]
RP   VARIANT PAIS GLN-607, AND VARIANT AIS LYS-681.
RX   MEDLINE=99236881; PubMed=10221692; DOI=10.1093/humrep/14.3.664;
RA   Chen C.P., Chern S.R., Wang T.Y., Wang W., Wang K.L., Jeng C.J.;
RT   "Androgen receptor gene mutations in 46,XY females with germ cell
RT   tumours.";
RL   Hum. Reprod. 14:664-670(1999).
RN   [183]
RP   VARIANT AIS LEU-892.
RX   MEDLINE=99332382; PubMed=10404311;
RX   DOI=10.1046/j.1442-2042.1999.00065.x;
RA   Kanayama H., Naroda T., Inoue Y., Kurokawa Y., Kagawa S.;
RT   "A case of complete testicular feminization: laparoscopic orchiectomy
RT   and analysis of androgen receptor gene mutation.";
RL   Int. J. Urol. 6:327-330(1999).
RN   [184]
RP   VARIANT PAIS ALA-772, AND VARIANT AIS GLY-871.
RX   MEDLINE=99145056; PubMed=10022458; DOI=10.1210/jc.84.2.805;
RA   Shkolny D.L., Beitel L.K., Ginsberg J., Pekeles G., Arbour L.,
RA   Pinsky L., Trifiro M.A.;
RT   "Discordant measures of androgen-binding kinetics in two mutant
RT   androgen receptors causing mild or partial androgen insensitivity,
RT   respectively.";
RL   J. Clin. Endocrinol. Metab. 84:805-810(1999).
RN   [185]
RP   VARIANTS PROSTATE CANCER IN POLY-GLN REGION AND ALA-683.
RX   MEDLINE=20096941; PubMed=10629558;
RX   DOI=10.1002/(SICI)1096-9896(199912)189:4<559::AID-PATH471>3.0.CO;2-Y;
RA   Wallen M.J., Linja M., Kaartinen K., Schleutker J., Visakorpi T.;
RT   "Androgen receptor gene mutations in hormone-refractory prostate
RT   cancer.";
RL   J. Pathol. 189:559-563(1999).
RN   [186]
RP   VARIANTS PROSTATE CANCER HIS-701 AND ALA-877.
RX   MEDLINE=20034906; PubMed=10569618; DOI=10.1016/S0022-5347(05)68158-X;
RA   Zhao X.Y., Boyle B., Krishnan A.V., Navone N.M., Peehl D.M.,
RA   Feldman D.;
RT   "Two mutations identified in the androgen receptor of the new human
RT   prostate cancer cell line MDA PCa 2a.";
RL   J. Urol. 162:2192-2199(1999).
RN   [187]
RP   VARIANT PAIS THR-807.
RX   MEDLINE=20009021; PubMed=10543676; DOI=10.1016/S0140-6736(99)03205-5;
RA   Ong Y.C., Wong H.B., Adaikan G., Yong E.L.;
RT   "Directed pharmacological therapy of ambiguous genitalia due to an
RT   androgen receptor gene mutation.";
RL   Lancet 354:1444-1445(1999).
RN   [188]
RP   VARIANT AIS LEU-892.
RX   MEDLINE=99236959; PubMed=10221770; DOI=10.1016/S0303-7207(98)00237-8;
RA   Peters I., Weidemann W., Romalo G., Knorr D., Schweikert H.-U.,
RA   Spindler K.D.;
RT   "An androgen receptor mutation in the direct vicinity of the proposed
RT   C-terminal alpha-helix of the ligand binding domain containing the AF-
RT   2 transcriptional activating function core is associated with complete
RT   androgen insensitivity.";
RL   Mol. Cell. Endocrinol. 148:47-53(1999).
RN   [189]
RP   VARIANT PROSTATE CANCER TYR-619.
RX   MEDLINE=20065641; PubMed=10598582; DOI=10.1210/me.13.12.2065;
RA   Nazareth L.V., Stenoien D.L., Bingman W.E. III, James A.J., Wu C.,
RA   Zhang Y., Edwards D.P., Mancini M., Marcelli M., Lamb D.J.,
RA   Weigel N.L.;
RT   "A C619Y mutation in the human androgen receptor causes inactivation
RT   and mislocalization of the receptor with concomitant sequestration of
RT   SRC-1.";
RL   Mol. Endocrinol. 13:2065-2075(1999).
RN   [190]
RP   ERRATUM.
RA   Nazareth L.V., Stenoien D.L., Bingman W.E. III, James A.J., Wu C.,
RA   Zhang Y., Edwards D.P., Mancini M., Marcelli M., Lamb D.J.,
RA   Weigel N.L.;
RL   Mol. Endocrinol. 14:544-544(2000).
RN   [191]
RP   VARIANT AIS THR-596.
RX   MEDLINE=20055969; PubMed=10590024;
RX   DOI=10.1203/00006450-199912000-00008;
RA   Holterhus P.M., Wiebel J., Sinnecker G.H., Bruggenwirth H.T.,
RA   Sippell W.G., Brinkmann A.O., Kruse K., Hiort O.;
RT   "Clinical and molecular spectrum of somatic mosaicism in androgen
RT   insensitivity syndrome.";
RL   Pediatr. Res. 46:684-690(1999).
RN   [192]
RP   VARIANTS AIS PHE-812 AND GLN-831.
RX   MEDLINE=99385665; PubMed=10458483; DOI=10.1620/tjem.187.263;
RA   Yaegashi N., Uehara S., Senoo M., Sato J., Fujiwara J., Funato T.,
RA   Sasaki T., Yajima A.;
RT   "Point mutations in the steroid-binding domain of the androgen
RT   receptor gene of five Japanese patients with androgen insensitivity
RT   syndrome.";
RL   Tohoku J. Exp. Med. 187:263-272(1999).
RN   [193]
RP   VARIANTS THR-597 AND LEU-725.
RX   MEDLINE=99190574; PubMed=10092153; DOI=10.1007/s002400050088;
RA   Nordenskjoeld A., Friedman E., Tapper-Persson M., Soederhaell C.,
RA   Leviav A., Svensson J., Anvret M.;
RT   "Screening for mutations in candidate genes for hypospadias.";
RL   Urol. Res. 27:49-55(1999).
RN   [194]
RP   VARIANTS PROSTATE CANCER ALA-575; ARG-580; VAL-586; TYR-619; ALA-757
RP   AND GLY-846.
RX   MEDLINE=20168626; PubMed=10706109;
RA   Marcelli M., Ittmann M., Mariani S., Sutherland R.W., Nigam R.,
RA   Murthy L., Zhao Y., DiConcini D., Puxeddu E., Esen A., Eastham J.,
RA   Weigel N.L., Lamb D.J.;
RT   "Androgen receptor mutations in prostate cancer.";
RL   Cancer Res. 60:944-949(2000).
RN   [195]
RP   VARIANTS AIS AND PAIS.
RX   MEDLINE=20152731; PubMed=10690872; DOI=10.1210/jc.85.2.658;
RA   Ahmed S.F., Cheng A., Dovey L., Hawkins J.R., Martin H., Rowland J.,
RA   Shimura N., Tait A.D., Hughes I.A.;
RT   "Phenotypic features, androgen receptor binding, and mutational
RT   analysis in 278 clinical cases reported as androgen insensitivity
RT   syndrome.";
RL   J. Clin. Endocrinol. Metab. 85:658-665(2000).
RN   [196]
RP   VARIANTS PAIS THR-682 AND GLU-711, AND VARIANTS AIS GLU-743; VAL-827;
RP   ARG-874 AND TYR-879.
RX   MEDLINE=21470699; PubMed=11587068; DOI=10.1007/s100380170021;
RA   Chavez B., Mendez J.P., Ulloa-Aguirre A., Larrea F., Vilchis F.;
RT   "Eight novel mutations of the androgen receptor gene in patients with
RT   androgen insensitivity syndrome.";
RL   J. Hum. Genet. 46:560-565(2001).
RN   [197]
RP   INVOLVEMENT IN AGA.
RX   PubMed=11231320; DOI=10.1046/j.1523-1747.2001.01261.x;
RA   Ellis J.A., Stebbing M., Harrap S.B.;
RT   "Polymorphism of the androgen receptor gene is associated with male
RT   pattern baldness.";
RL   J. Invest. Dermatol. 116:452-455(2001).
RN   [198]
RP   VARIANT AIS TYR-705.
RX   MEDLINE=21610990; PubMed=11744994;
RA   Sills E.S., Sholes T.E., Perloe M., Kaplan C.R., Davis J.G.,
RA   Tucker M.J.;
RT   "Characterization of a novel receptor mutation A->T at exon 4 in
RT   complete androgen insensitivity syndrome and a carrier sibling via
RT   bidirectional polymorphism sequence analysis.";
RL   Int. J. Mol. Med. 9:45-48(2002).
RN   [199]
RP   INVOLVEMENT IN AGA.
RX   PubMed=15902657; DOI=10.1086/431425;
RA   Hillmer A.M., Hanneken S., Ritzmann S., Becker T., Freudenberg J.,
RA   Brockschmidt F.F., Flaquer A., Freudenberg-Hua Y., Jamra R.A.,
RA   Metzen C., Heyn U., Schweiger N., Betz R.C., Blaumeiser B., Hampe J.,
RA   Schreiber S., Schulze T.G., Hennies H.C., Schumacher J., Propping P.,
RA   Ruzicka T., Cichon S., Wienker T.F., Kruse R., Noethen M.M.;
RT   "Genetic variation in the human androgen receptor gene is the major
RT   determinant of common early-onset androgenetic alopecia.";
RL   Am. J. Hum. Genet. 77:140-148(2005).
RN   [200]
RP   INVOLVEMENT IN SMAX1.
RX   PubMed=15851746; DOI=10.1212/01.WNL.0000158617.41819.F3;
RA   Echaniz-Laguna A., Rousso E., Anheim M., Cossee M., Tranchant C.;
RT   "A family with early-onset and rapidly progressive X-linked spinal and
RT   bulbar muscular atrophy.";
RL   Neurology 64:1458-1460(2005).
RN   [201]
RP   CHARACTERIZATION OF VARIANTS AIS ASN-695; CYS-763; HIS-774; GLU-798;
RP   HIS-855 AND PHE-907.
RX   PubMed=16595706; DOI=10.1677/jme.1.01885;
RA   Jaeaeskelaeinen J., Deeb A., Schwabe J.W., Mongan N.P., Martin H.,
RA   Hughes I.A.;
RT   "Human androgen receptor gene ligand-binding-domain mutations leading
RT   to disrupted interaction between the N- and C-terminal domains.";
RL   J. Mol. Endocrinol. 36:361-368(2006).
CC   -!- FUNCTION: Steroid hormone receptors are ligand-activated
CC       transcription factors that regulate eukaryotic gene expression and
CC       affect cellular proliferation and differentiation in target
CC       tissues. Transcription factor activity is modulated by bound
CC       coactivator and corepressor proteins. Transcription activation is
CC       down-regulated by NR0B2. Activated, but not phosphorylated, by
CC       HIPK3 and ZIPK/DAPK3.
CC   -!- ENZYME REGULATION: AIM-100 (4-amino-5,6-biaryl-furo[2,3-
CC       d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-267.
CC       Inhibits the binding of the Tyr-267 phosphorylated form to
CC       androgen-responsive enhancers (AREs) and its transcriptional
CC       activity.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Part of a ternary complex
CC       containing AR, EFCAB6/DJBP and PARK7. Interacts with HIPK3 and
CC       NR0B2 in the presence of androgen. The ligand binding domain
CC       interacts with KAT7/HBO1 in the presence of dihydrotestosterone.
CC       Interacts with EFCAB6/DJBP, PELP1, PQBP1, RANBP9, RBAK, SPDEF,
CC       SRA1, TGFB1I1, ZNF318 and RREB1. Interacts with ZMIZ1/ZIMP10 and
CC       ZMIZ2/ZMIP7 which both enhance its transactivation activity.
CC       Interacts with SLC30A9 and RAD54L2/ARIP4 (By similarity).
CC       Interacts via the ligand-binding domain with LXXLL and FXXLF
CC       motifs from NCOA1, NCOA2, NCOA3, NCOA4 and MAGEA11. The AR N-
CC       terminal poly-Gln region binds Ran resulting in enhancement of AR-
CC       mediated transactivation. Ran-binding decreases as the poly-Gln
CC       length increases. Interacts with HIP1 (via coiled coil domain).
CC       Interacts (via ligand-binding domain) with TRIM68. Interacts with
CC       TNK2. Interacts with USP26. Interacts with RNF6. Interacts
CC       (regulated by RNF6 probably through polyubiquitination) with
CC       RNF14; regulates AR transcriptional activity. Interacts with PRMT2
CC       and TRIM24. Interacts with GNB2L1/RACK1. Interacts with RANBP10;
CC       this interaction enhances dihydrotestosterone-induced AR
CC       transcriptional activity. Interacts with PRPF6 in a hormone-
CC       independent way; this interaction enhances dihydrotestosterone-
CC       induced AR transcriptional activity. Interacts with STK4/MST1.
CC       Interacts with ZIPK/DAPK3. Interacts with LPXN. Interacts with
CC       MAK. Part of a complex containing AR, MAK and NCOA3.
CC   -!- INTERACTION:
CC       P78543:BTG2; NbExp=4; IntAct=EBI-608057, EBI-1047576;
CC       Q92793:CREBBP; NbExp=2; IntAct=EBI-608057, EBI-81215;
CC       P35222:CTNNB1; NbExp=8; IntAct=EBI-608057, EBI-491549;
CC       Q9UER7:DAXX; NbExp=5; IntAct=EBI-608057, EBI-77321;
CC       P20711:DDC; NbExp=2; IntAct=EBI-608057, EBI-1632155;
CC       P11308:ERG; NbExp=2; IntAct=EBI-608057, EBI-79704;
CC       Q9R1E0:Foxo1 (xeno); NbExp=4; IntAct=EBI-608057, EBI-1371343;
CC       P56524:HDAC4; NbExp=4; IntAct=EBI-608057, EBI-308629;
CC       Q16665:HIF1A; NbExp=2; IntAct=EBI-608057, EBI-447269;
CC       Q15652:JMJD1C; NbExp=2; IntAct=EBI-608057, EBI-1224969;
CC       O95251:KAT7; NbExp=5; IntAct=EBI-608057, EBI-473199;
CC       P20794:MAK; NbExp=5; IntAct=EBI-608057, EBI-3911321;
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-608057, EBI-389668;
CC       Q15596:NCOA2; NbExp=2; IntAct=EBI-608057, EBI-81236;
CC       Q14686:NCOA6; NbExp=2; IntAct=EBI-608057, EBI-78670;
CC       Q99497:PARK7; NbExp=6; IntAct=EBI-608057, EBI-1164361;
CC       Q06830:PRDX1; NbExp=3; IntAct=EBI-608057, EBI-353193;
CC       Q9UBS8:RNF14; NbExp=2; IntAct=EBI-608057, EBI-2130308;
CC       Q9Y252:RNF6; NbExp=10; IntAct=EBI-608057, EBI-2341483;
CC       P63165:SUMO1; NbExp=7; IntAct=EBI-608057, EBI-80140;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Predominantly
CC       cytoplasmic in unligated form but translocates to the nucleus upon
CC       ligand-binding. Can also translocate to the nucleus in unligated
CC       form in the presence of GNB2L1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=AR-B;
CC         IsoId=P10275-1; Sequence=Displayed;
CC       Name=2; Synonyms=AR-A, Variant AR45;
CC         IsoId=P10275-2; Sequence=VSP_036889, VSP_036890;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is mainly expressed in heart and
CC       skeletal muscle.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
CC       a DNA-binding domain and a C-terminal ligand-binding domain. In
CC       the presence of bound steroid the ligand-binding domain interacts
CC       with the N-terminal modulating domain, and thereby activates AR
CC       transcription factor activity. Agonist binding is required for
CC       dimerization and binding to target DNA. The transcription factor
CC       activity of the complex formed by ligand-activated AR and DNA is
CC       modulated by interactions with coactivator and corepressor
CC       proteins. Interaction with RANBP9 is mediated by both the N-
CC       terminal domain and the DNA-binding domain. Interaction with
CC       EFCAB6/DJBP is mediated by the DNA-binding domain.
CC   -!- PTM: Sumoylated on Lys-386 (major) and Lys-520. Ubiquitinated.
CC       Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked
CC       polyubiquitination by RNF6 modulates AR transcriptional activity
CC       and specificity.
CC   -!- PTM: Phosphorylated in prostate cancer cells in response to
CC       several growth factors including EGF. Phosphorylation is induced
CC       by c-Src kinase (CSK). Tyr-534 is one of the major phosphorylation
CC       sites and an increase in phosphorylation and Src kinase activity
CC       is associated with prostate cancer progression. Phosphorylation by
CC       TNK2 enhances the DNA-binding and transcriptional activity and may
CC       be responsible for androgen-independent progression of prostate
CC       cancer. Phosphorylation at Ser-81 by CDK9 regulates AR promoter
CC       selectivity and cell growth. Phosphorylation by PAK6 leads to AR-
CC       mediated transcription inhibition.
CC   -!- PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is
CC       required for plasma membrane targeting and for rapid intracellular
CC       signaling via ERK and AKT kinases and cAMP generation.
CC   -!- POLYMORPHISM: The poly-Gln region of AR is highly polymorphic and
CC       the number of Gln varies in the population (from 17 to 26). A
CC       smaller size of the poly-Gln region may be associated with the
CC       development of prostate cancer.
CC   -!- POLYMORPHISM: The poly-Gly region of AR is polymorphic and ranges
CC       from 24 to 31 Gly. A poly-Gly region shorter or equal to 23 may be
CC       associated with the development of androgenetic alopecia.
CC   -!- DISEASE: Defects in AR are the cause of androgen insensitivity
CC       syndrome (AIS) [MIM:300068]; previously known as testicular
CC       feminization syndrome (TFM). AIS is an X-linked recessive form of
CC       pseudohermaphroditism due end-organ resistance to androgen.
CC       Affected males have female external genitalia, female breast
CC       development, blind vagina, absent uterus and female adnexa, and
CC       abdominal or inguinal testes, despite a normal 46,XY karyotype.
CC   -!- DISEASE: Defects in AR are the cause of spinal and bulbar muscular
CC       atrophy X-linked type 1 (SMAX1) [MIM:313200]; also known as
CC       Kennedy disease. SMAX1 is an X-linked recessive form of spinal
CC       muscular atrophy. Spinal muscular atrophy refers to a group of
CC       neuromuscular disorders characterized by degeneration of the
CC       anterior horn cells of the spinal cord, leading to symmetrical
CC       muscle weakness and atrophy. SMAX1 occurs only in men. Age at
CC       onset is usually in the third to fifth decade of life, but earlier
CC       involvement has been reported. It is characterized by slowly
CC       progressive limb and bulbar muscle weakness with fasciculations,
CC       muscle atrophy, and gynecomastia. The disorder is clinically
CC       similar to classic forms of autosomal spinal muscular atrophy.
CC       Note=Caused by trinucleotide CAG repeat expansion. In SMAX1
CC       patients the number of Gln ranges from 38 to 62. Longer expansions
CC       result in earlier onset and more severe clinical manifestations of
CC       the disease.
CC   -!- DISEASE: Note=Defects in AR may play a role in metastatic prostate
CC       cancer. The mutated receptor stimulates prostate growth and
CC       metastases development despite of androgen ablation. This
CC       treatment can reduce primary and metastatic lesions probably by
CC       inducing apoptosis of tumor cells when they express the wild-type
CC       receptor.
CC   -!- DISEASE: Defects in AR are the cause of androgen insensitivity
CC       syndrome partial (PAIS) [MIM:312300]; also known as Reifenstein
CC       syndrome. PAIS is characterized by hypospadias, hypogonadism,
CC       gynecomastia, genital ambiguity, normal XY karyotype, and a
CC       pedigree pattern consistent with X-linked recessive inheritance.
CC       Some patients present azoospermia or severe oligospermia without
CC       other clinical manifestations.
CC   -!- MISCELLANEOUS: In the absence of ligand, steroid hormone receptors
CC       are thought to be weakly associated with nuclear components;
CC       hormone binding greatly increases receptor affinity. The hormone-
CC       receptor complex appears to recognize discrete DNA sequences
CC       upstream of transcriptional start sites.
CC   -!- MISCELLANEOUS: Transcriptional activity is enhanced by binding to
CC       RANBP9.
CC   -!- MISCELLANEOUS: The level of tyrosine phosphorylation may serve as
CC       a diagnostic tool to predict patient outcome in response to
CC       hormone-ablation therapy. Inhibition of tyrosine phosphorylation
CC       may be an effective intervention target for hormone-refractory
CC       prostate cancer.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily.
CC   -!- SIMILARITY: Contains 1 nuclear receptor DNA-binding domain.
CC   -!- WEB RESOURCE: Name=Androgen receptor gene mutations database;
CC       URL="http://androgendb.mcgill.ca";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ARID685chXq12.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/AR";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Androgen receptor entry;
CC       URL="http://en.wikipedia.org/wiki/Androgen_receptor";
CC   -!- WEB RESOURCE: Name=X-chromosome gene database, androgen receptor
CC       (AR); Note=Leiden Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/AR";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M20132; AAA51729.1; -; mRNA.
DR   EMBL; M23263; AAA51775.1; -; mRNA.
DR   EMBL; M27430; AAA51886.1; -; Genomic_DNA.
DR   EMBL; M27423; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27424; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27425; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27426; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27427; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27428; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M27429; AAA51886.1; JOINED; Genomic_DNA.
DR   EMBL; M34233; AAA51780.1; -; mRNA.
DR   EMBL; M21748; AAA51771.1; -; mRNA.
DR   EMBL; M35851; AAA51772.1; -; Genomic_DNA.
DR   EMBL; M35844; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35845; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35846; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35847; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35848; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35849; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; M35850; AAA51772.1; JOINED; Genomic_DNA.
DR   EMBL; AX453758; -; NOT_ANNOTATED_CDS; Unassigned_DNA.
DR   EMBL; AL049564; CAI43080.1; -; Genomic_DNA.
DR   EMBL; AL158016; CAI43080.1; JOINED; Genomic_DNA.
DR   EMBL; AL356358; CAI43080.1; JOINED; Genomic_DNA.
DR   EMBL; AL158016; CAI40853.1; -; Genomic_DNA.
DR   EMBL; AL049564; CAI40853.1; JOINED; Genomic_DNA.
DR   EMBL; AL356358; CAI40853.1; JOINED; Genomic_DNA.
DR   EMBL; AL356358; CAI40496.1; -; Genomic_DNA.
DR   EMBL; AL049564; CAI40496.1; JOINED; Genomic_DNA.
DR   EMBL; AL158016; CAI40496.1; JOINED; Genomic_DNA.
DR   EMBL; CH471132; EAX05380.1; -; Genomic_DNA.
DR   EMBL; BC132975; AAI32976.1; -; mRNA.
DR   EMBL; L29496; AAA51770.1; -; mRNA.
DR   EMBL; U16371; AAB60346.1; -; Genomic_DNA.
DR   EMBL; M20260; AAA51774.1; -; mRNA.
DR   EMBL; S79366; AAB21256.2; -; Genomic_DNA.
DR   EMBL; S79366; AAB21257.2; -; Genomic_DNA.
DR   IPI; IPI00020070; -.
DR   IPI; IPI00982907; -.
DR   PIR; A39248; A39248.
DR   RefSeq; NP_000035.2; NM_000044.3.
DR   RefSeq; NP_001011645.1; NM_001011645.2.
DR   UniGene; Hs.76704; -.
DR   PDB; 1E3G; X-ray; 2.40 A; A=657-919.
DR   PDB; 1GS4; X-ray; 1.95 A; A=670-917.
DR   PDB; 1T5Z; X-ray; 2.30 A; A=669-919.
DR   PDB; 1T63; X-ray; 2.07 A; A=669-919.
DR   PDB; 1T65; X-ray; 1.66 A; A=669-919.
DR   PDB; 1XJ7; X-ray; 2.70 A; A=663-919.
DR   PDB; 1XOW; X-ray; 1.80 A; A=671-919, B=20-30.
DR   PDB; 1XQ3; X-ray; 2.25 A; A=671-919.
DR   PDB; 1Z95; X-ray; 1.80 A; A=672-916.
DR   PDB; 2AM9; X-ray; 1.64 A; A=654-919.
DR   PDB; 2AMA; X-ray; 1.90 A; A=654-919.
DR   PDB; 2AMB; X-ray; 1.75 A; A=654-919.
DR   PDB; 2AO6; X-ray; 1.89 A; A=671-919.
DR   PDB; 2AX6; X-ray; 1.50 A; A=664-919.
DR   PDB; 2AX7; X-ray; 1.90 A; A=664-919.
DR   PDB; 2AX8; X-ray; 1.70 A; A=664-919.
DR   PDB; 2AX9; X-ray; 1.65 A; A=664-919.
DR   PDB; 2AXA; X-ray; 1.80 A; A=664-919.
DR   PDB; 2HVC; X-ray; 2.10 A; A=669-918.
DR   PDB; 2OZ7; X-ray; 1.80 A; A=671-919.
DR   PDB; 2PIO; X-ray; 2.03 A; A=669-919.
DR   PDB; 2PIP; X-ray; 1.80 A; L=669-919.
DR   PDB; 2PIQ; X-ray; 2.40 A; A=669-919.
DR   PDB; 2PIR; X-ray; 2.10 A; A=669-919.
DR   PDB; 2PIT; X-ray; 1.76 A; A=669-919.
DR   PDB; 2PIU; X-ray; 2.12 A; A=669-919.
DR   PDB; 2PIV; X-ray; 1.95 A; A=669-919.
DR   PDB; 2PIW; X-ray; 2.58 A; A=669-919.
DR   PDB; 2PIX; X-ray; 2.40 A; A=669-919.
DR   PDB; 2PKL; X-ray; 2.49 A; A=669-919.
DR   PDB; 2PNU; X-ray; 1.65 A; A=654-919.
DR   PDB; 2Q7I; X-ray; 1.87 A; A=663-919, B=20-30.
DR   PDB; 2Q7J; X-ray; 1.90 A; A=663-919.
DR   PDB; 2Q7K; X-ray; 1.80 A; A=663-919, B=20-30.
DR   PDB; 2Q7L; X-ray; 1.92 A; A=663-919.
DR   PDB; 2YHD; X-ray; 2.20 A; A=671-919.
DR   PDB; 2YLO; X-ray; 2.50 A; A=664-919.
DR   PDB; 2YLP; X-ray; 2.30 A; A=664-919.
DR   PDB; 2YLQ; X-ray; 2.40 A; A=664-919.
DR   PDB; 2Z4J; X-ray; 2.60 A; A=671-918.
DR   PDB; 3B5R; X-ray; 1.80 A; A=671-919.
DR   PDB; 3B65; X-ray; 1.80 A; A=671-919.
DR   PDB; 3B66; X-ray; 1.65 A; A=671-919.
DR   PDB; 3B67; X-ray; 1.90 A; A=671-919.
DR   PDB; 3B68; X-ray; 1.90 A; A=671-919.
DR   PDB; 3BTR; X-ray; 2.60 A; B=621-635.
DR   PDB; 3L3X; X-ray; 1.55 A; A=670-918.
DR   PDB; 3L3Z; X-ray; 2.00 A; A=670-918.
DR   PDB; 3RLJ; X-ray; 1.90 A; A=671-917.
DR   PDB; 3RLL; X-ray; 1.70 A; A=671-917.
DR   PDB; 3V49; X-ray; 1.70 A; A=654-919, B=21-31.
DR   PDB; 3V4A; X-ray; 1.95 A; A=671-919, B=21-31.
DR   PDB; 3ZQT; X-ray; 2.29 A; A=664-919.
DR   PDBsum; 1E3G; -.
DR   PDBsum; 1GS4; -.
DR   PDBsum; 1T5Z; -.
DR   PDBsum; 1T63; -.
DR   PDBsum; 1T65; -.
DR   PDBsum; 1XJ7; -.
DR   PDBsum; 1XOW; -.
DR   PDBsum; 1XQ3; -.
DR   PDBsum; 1Z95; -.
DR   PDBsum; 2AM9; -.
DR   PDBsum; 2AMA; -.
DR   PDBsum; 2AMB; -.
DR   PDBsum; 2AO6; -.
DR   PDBsum; 2AX6; -.
DR   PDBsum; 2AX7; -.
DR   PDBsum; 2AX8; -.
DR   PDBsum; 2AX9; -.
DR   PDBsum; 2AXA; -.
DR   PDBsum; 2HVC; -.
DR   PDBsum; 2OZ7; -.
DR   PDBsum; 2PIO; -.
DR   PDBsum; 2PIP; -.
DR   PDBsum; 2PIQ; -.
DR   PDBsum; 2PIR; -.
DR   PDBsum; 2PIT; -.
DR   PDBsum; 2PIU; -.
DR   PDBsum; 2PIV; -.
DR   PDBsum; 2PIW; -.
DR   PDBsum; 2PIX; -.
DR   PDBsum; 2PKL; -.
DR   PDBsum; 2PNU; -.
DR   PDBsum; 2Q7I; -.
DR   PDBsum; 2Q7J; -.
DR   PDBsum; 2Q7K; -.
DR   PDBsum; 2Q7L; -.
DR   PDBsum; 2YHD; -.
DR   PDBsum; 2YLO; -.
DR   PDBsum; 2YLP; -.
DR   PDBsum; 2YLQ; -.
DR   PDBsum; 2Z4J; -.
DR   PDBsum; 3B5R; -.
DR   PDBsum; 3B65; -.
DR   PDBsum; 3B66; -.
DR   PDBsum; 3B67; -.
DR   PDBsum; 3B68; -.
DR   PDBsum; 3BTR; -.
DR   PDBsum; 3L3X; -.
DR   PDBsum; 3L3Z; -.
DR   PDBsum; 3RLJ; -.
DR   PDBsum; 3RLL; -.
DR   PDBsum; 3V49; -.
DR   PDBsum; 3V4A; -.
DR   PDBsum; 3ZQT; -.
DR   DisProt; DP00492; -.
DR   ProteinModelPortal; P10275; -.
DR   SMR; P10275; 555-918.
DR   DIP; DIP-125N; -.
DR   IntAct; P10275; 39.
DR   MINT; MINT-94801; -.
DR   STRING; P10275; -.
DR   PhosphoSite; P10275; -.
DR   DMDM; 113830; -.
DR   PaxDb; P10275; -.
DR   PRIDE; P10275; -.
DR   Ensembl; ENST00000374690; ENSP00000363822; ENSG00000169083.
DR   Ensembl; ENST00000396043; ENSP00000379358; ENSG00000169083.
DR   GeneID; 367; -.
DR   KEGG; hsa:367; -.
DR   CTD; 367; -.
DR   GeneCards; GC0XP066763; -.
DR   H-InvDB; HIX0056152; -.
DR   HGNC; HGNC:644; AR.
DR   HPA; CAB000001; -.
DR   MIM; 300068; phenotype.
DR   MIM; 312300; phenotype.
DR   MIM; 313200; phenotype.
DR   MIM; 313700; gene.
DR   neXtProt; NX_P10275; -.
DR   Orphanet; 99429; Complete androgen insensitivity syndrome.
DR   Orphanet; 440; Familial hypospadias.
DR   Orphanet; 481; Kennedy disease.
DR   Orphanet; 90797; Partial androgen insensitivity syndrome.
DR   PharmGKB; PA57; -.
DR   eggNOG; NOG245477; -.
DR   HOVERGEN; HBG007583; -.
DR   InParanoid; P10275; -.
DR   KO; K08557; -.
DR   OrthoDB; EOG4XPQFV; -.
DR   Pathway_Interaction_DB; ar_pathway; Coregulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; hnf3apathway; FOXA1 transcription factor network.
DR   Pathway_Interaction_DB; ar_tf_pathway; Regulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; smad2_3nuclearpathway; Regulation of nuclear SMAD2/3 signaling.
DR   Reactome; REACT_71; Gene Expression.
DR   ChEMBL; CHEMBL1871; -.
DR   DrugBank; DB01128; Bicalutamide.
DR   DrugBank; DB04839; Cyproterone.
DR   DrugBank; DB00858; Dromostanolone.
DR   DrugBank; DB01216; Finasteride.
DR   DrugBank; DB01185; Fluoxymesterone.
DR   DrugBank; DB00499; Flutamide.
DR   DrugBank; DB00984; Nandrolone.
DR   DrugBank; DB00665; Nilutamide.
DR   DrugBank; DB00621; Oxandrolone.
DR   DrugBank; DB00624; Testosterone.
DR   EvolutionaryTrace; P10275; -.
DR   GenomeRNAi; 367; -.
DR   NextBio; 1531; -.
DR   PMAP-CutDB; B1AKD7; -.
DR   ArrayExpress; P10275; -.
DR   Bgee; P10275; -.
DR   CleanEx; HS_AR; -.
DR   Genevestigator; P10275; -.
DR   GermOnline; ENSG00000169083; Homo sapiens.
DR   GO; GO:0030424; C:axon; IEA:Compara.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Compara.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0005497; F:androgen binding; NAS:UniProtKB.
DR   GO; GO:0004882; F:androgen receptor activity; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IDA:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; NAS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Compara.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0060520; P:activation of prostate induction by androgen receptor signaling pathway; IEA:Compara.
DR   GO; GO:0008219; P:cell death; IEA:UniProtKB-KW.
DR   GO; GO:0016049; P:cell growth; NAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IEA:Compara.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Compara.
DR   GO; GO:0060599; P:lateral sprouting involved in mammary gland duct morphogenesis; IEA:Compara.
DR   GO; GO:0048808; P:male genitalia morphogenesis; IEA:Compara.
DR   GO; GO:0008584; P:male gonad development; IEA:Compara.
DR   GO; GO:0019102; P:male somatic sex determination; IEA:Compara.
DR   GO; GO:0060749; P:mammary gland alveolus development; IEA:Compara.
DR   GO; GO:0060571; P:morphogenesis of an epithelial fold; IEA:Compara.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Compara.
DR   GO; GO:0045720; P:negative regulation of integrin biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0048645; P:organ formation; IEA:Compara.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Compara.
DR   GO; GO:0045726; P:positive regulation of integrin biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IEA:Compara.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Compara.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IDA:BHF-UCL.
DR   GO; GO:0030850; P:prostate gland development; NAS:UniProtKB.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Compara.
DR   GO; GO:0060736; P:prostate gland growth; IEA:Compara.
DR   GO; GO:0051259; P:protein oligomerization; IDA:MGI.
DR   GO; GO:0050790; P:regulation of catalytic activity; IEA:Compara.
DR   GO; GO:0048638; P:regulation of developmental growth; IEA:Compara.
DR   GO; GO:0090003; P:regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0060685; P:regulation of prostatic bud formation; IEA:Compara.
DR   GO; GO:0032868; P:response to insulin stimulus; IEA:Compara.
DR   GO; GO:0007548; P:sex differentiation; NAS:UniProtKB.
DR   GO; GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; IEA:Compara.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.10.565.10; Nucl_hrmn_rcpt_lig_bd; 2.
DR   Gene3D; 3.30.50.10; Znf_NHR/GATA; 1.
DR   InterPro; IPR001103; Andrgn_rcpt.
DR   InterPro; IPR008946; Nucl_hormone_rcpt_ligand-bd.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd_core.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02166; Androgen_recep; 2.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00521; ANDROGENR.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; Str_ncl_receptor; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; DNA-binding; Isopeptide bond;
KW   Lipid-binding; Lipoprotein; Metal-binding; Neurodegeneration; Nucleus;
KW   Palmitate; Phosphoprotein; Polymorphism; Pseudohermaphroditism;
KW   Receptor; Reference proteome; Steroid-binding; Transcription;
KW   Transcription regulation; Triplet repeat expansion; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    919       Androgen receptor.
FT                                /FTId=PRO_0000053704.
FT   DNA_BIND    559    631       Nuclear receptor.
FT   ZN_FING     559    579       NR C4-type.
FT   ZN_FING     595    619       NR C4-type.
FT   REGION        1    558       Modulating.
FT   REGION      551    919       Interaction with LPXN.
FT   REGION      571    661       Interaction with HIPK3 (By similarity).
FT   REGION      624    919       Interaction with KAT7.
FT   REGION      690    919       Ligand-binding.
FT   COMPBIAS     54     57       Poly-Leu.
FT   COMPBIAS     58     89       Gln-rich.
FT   COMPBIAS     58     78       Poly-Gln.
FT   COMPBIAS     84     89       Poly-Gln.
FT   COMPBIAS    193    197       Poly-Gln.
FT   COMPBIAS    372    381       Poly-Pro.
FT   COMPBIAS    396    402       Poly-Ala.
FT   COMPBIAS    449    472       Poly-Gly.
FT   BINDING     705    705       Androgen.
FT   BINDING     752    752       Androgen.
FT   BINDING     877    877       Androgen.
FT   SITE        720    720       Interaction with coactivator LXXL motif.
FT   SITE        897    897       Interaction with coactivator FXXLF motif.
FT   MOD_RES      81     81       Phosphoserine; by CDK9.
FT   MOD_RES     223    223       Phosphotyrosine; by CSK.
FT   MOD_RES     267    267       Phosphotyrosine; by CSK and TNK2.
FT   MOD_RES     300    300       Phosphoserine.
FT   MOD_RES     301    301       Phosphothreonine.
FT   MOD_RES     307    307       Phosphotyrosine; by CSK.
FT   MOD_RES     346    346       Phosphotyrosine; by CSK.
FT   MOD_RES     357    357       Phosphotyrosine; by CSK.
FT   MOD_RES     362    362       Phosphotyrosine; by CSK.
FT   MOD_RES     363    363       Phosphotyrosine; by CSK and TNK2.
FT   MOD_RES     393    393       Phosphotyrosine; by CSK.
FT   MOD_RES     534    534       Phosphotyrosine; by CSK.
FT   MOD_RES     551    551       Phosphotyrosine; by CSK.
FT   MOD_RES     650    650       Phosphoserine; by STK4/MST1.
FT   MOD_RES     915    915       Phosphotyrosine; by CSK.
FT   CROSSLNK    386    386       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK    520    520       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK    845    845       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   CROSSLNK    847    847       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VAR_SEQ       1    531       Missing (in isoform 2).
FT                                /FTId=VSP_036889.
FT   VAR_SEQ     532    538       GPYGDMR -> MILWLHS (in isoform 2).
FT                                /FTId=VSP_036890.
FT   VARIANT       2      2       E -> K (in PAIS).
FT                                /FTId=VAR_004679.
FT   VARIANT      54     54       L -> S (in prostate cancer).
FT                                /FTId=VAR_004680.
FT   VARIANT      57     57       L -> Q (in prostate cancer).
FT                                /FTId=VAR_004681.
FT   VARIANT      64     64       Q -> R (in prostate cancer).
FT                                /FTId=VAR_009711.
FT   VARIANT      74     78       Missing.
FT                                /FTId=VAR_004682.
FT   VARIANT     112    112       Q -> H (in prostate cancer).
FT                                /FTId=VAR_009712.
FT   VARIANT     180    180       K -> R (in prostate cancer).
FT                                /FTId=VAR_009713.
FT   VARIANT     194    194       Q -> R (in AIS).
FT                                /FTId=VAR_009224.
FT   VARIANT     205    205       S -> R.
FT                                /FTId=VAR_009714.
FT   VARIANT     214    214       G -> R (in AIS; 20% lower transactivation
FT                                capacity).
FT                                /FTId=VAR_009715.
FT   VARIANT     255    255       L -> P (in AIS).
FT                                /FTId=VAR_009225.
FT   VARIANT     266    266       M -> T (in prostate cancer).
FT                                /FTId=VAR_009716.
FT   VARIANT     269    269       P -> S (in prostate cancer).
FT                                /FTId=VAR_009717.
FT   VARIANT     340    340       P -> L (in prostate cancer).
FT                                /FTId=VAR_009718.
FT   VARIANT     390    390       P -> R (in AIS).
FT                                /FTId=VAR_009226.
FT   VARIANT     390    390       P -> S (in AIS).
FT                                /FTId=VAR_009227.
FT   VARIANT     443    443       Q -> R (in AIS; might be a polymorphism).
FT                                /FTId=VAR_009228.
FT   VARIANT     465    472       Missing.
FT                                /FTId=VAR_004683.
FT   VARIANT     491    491       G -> S (in AIS).
FT                                /FTId=VAR_009719.
FT   VARIANT     528    528       D -> G (in prostate cancer).
FT                                /FTId=VAR_009720.
FT   VARIANT     547    547       L -> F (in PAIS).
FT                                /FTId=VAR_009721.
FT   VARIANT     548    548       P -> S (in AIS).
FT                                /FTId=VAR_009722.
FT   VARIANT     559    559       C -> Y (in AIS).
FT                                /FTId=VAR_009723.
FT   VARIANT     568    568       G -> V (in a patient with isolated
FT                                hypospadias).
FT                                /FTId=VAR_009725.
FT   VARIANT     568    568       G -> W (in PAIS).
FT                                /FTId=VAR_009726.
FT   VARIANT     571    571       Y -> C (in AIS).
FT                                /FTId=VAR_009727.
FT   VARIANT     573    573       A -> D (in AIS; defective DNA binding and
FT                                transactivation).
FT                                /FTId=VAR_009728.
FT   VARIANT     574    574       L -> P (in prostate cancer).
FT                                /FTId=VAR_009729.
FT   VARIANT     575    575       T -> A (in prostate cancer).
FT                                /FTId=VAR_009730.
FT   VARIANT     576    576       C -> F (in AIS; lack of DNA binding).
FT                                /FTId=VAR_009731.
FT   VARIANT     576    576       C -> R (in AIS).
FT                                /FTId=VAR_009732.
FT   VARIANT     579    579       C -> F (in AIS; reduced transcription and
FT                                DNA binding).
FT                                /FTId=VAR_009733.
FT   VARIANT     579    579       C -> Y (in AIS).
FT                                /FTId=VAR_009734.
FT   VARIANT     580    580       K -> R (in prostate cancer).
FT                                /FTId=VAR_009735.
FT   VARIANT     581    581       V -> F (in AIS).
FT                                /FTId=VAR_009736.
FT   VARIANT     582    582       F -> S (in PAIS).
FT                                /FTId=VAR_009737.
FT   VARIANT     582    582       F -> Y (in PAIS).
FT                                /FTId=VAR_009738.
FT   VARIANT     582    582       Missing (in AIS).
FT                                /FTId=VAR_009739.
FT   VARIANT     585    585       R -> K (in AIS).
FT                                /FTId=VAR_009740.
FT   VARIANT     586    586       A -> V (in prostate cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_009741.
FT   VARIANT     587    587       A -> S (in prostate cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_009742.
FT   VARIANT     596    596       A -> T (in AIS; abolishes dimerization).
FT                                /FTId=VAR_009743.
FT   VARIANT     597    597       S -> G (in PAIS; high dissociation rate;
FT                                associated with P-617 in a PAIS patient;
FT                                partially restores DNA-binding activity
FT                                of P-617 mutant receptors).
FT                                /FTId=VAR_009744.
FT   VARIANT     597    597       S -> T (in a patient with severe
FT                                hypospadias).
FT                                /FTId=VAR_009745.
FT   VARIANT     601    601       C -> F (in AIS).
FT                                /FTId=VAR_009746.
FT   VARIANT     604    604       D -> Y (in PAIS).
FT                                /FTId=VAR_009747.
FT   VARIANT     607    607       R -> Q (in PAIS and breast cancer).
FT                                /FTId=VAR_004684.
FT   VARIANT     608    608       R -> K (in PAIS and breast cancer;
FT                                defective nuclear localization).
FT                                /FTId=VAR_004685.
FT   VARIANT     610    610       N -> T (in PAIS).
FT                                /FTId=VAR_009748.
FT   VARIANT     611    611       C -> Y (in AIS).
FT                                /FTId=VAR_009749.
FT   VARIANT     615    615       R -> H (in AIS and PAIS).
FT                                /FTId=VAR_009751.
FT   VARIANT     615    615       R -> P (in AIS).
FT                                /FTId=VAR_009752.
FT   VARIANT     615    615       Missing (in AIS).
FT                                /FTId=VAR_009750.
FT   VARIANT     616    616       L -> P (in AIS).
FT                                /FTId=VAR_009753.
FT   VARIANT     616    616       L -> R (in PAIS).
FT                                /FTId=VAR_009754.
FT   VARIANT     617    617       R -> P (in AIS and PAIS; loss of DNA-
FT                                binding activity; associated with G-597
FT                                in a PAIS patient).
FT                                /FTId=VAR_009755.
FT   VARIANT     619    619       C -> Y (in prostate cancer; loss of DNA
FT                                binding; somatic mutation).
FT                                /FTId=VAR_009756.
FT   VARIANT     629    629       R -> Q (in prostate cancer).
FT                                /FTId=VAR_009757.
FT   VARIANT     630    630       K -> T (in prostate cancer).
FT                                /FTId=VAR_009758.
FT   VARIANT     645    645       A -> D (in dbSNP:rs1800053).
FT                                /FTId=VAR_004686.
FT   VARIANT     647    647       S -> N (in prostate cancer).
FT                                /FTId=VAR_009760.
FT   VARIANT     664    664       I -> N (in AIS and PAIS).
FT                                /FTId=VAR_004687.
FT   VARIANT     670    670       Q -> R (in prostate cancer).
FT                                /FTId=VAR_009761.
FT   VARIANT     671    671       P -> H (in PAIS).
FT                                /FTId=VAR_009762.
FT   VARIANT     672    672       I -> T (in prostate cancer).
FT                                /FTId=VAR_009763.
FT   VARIANT     677    677       L -> P (in AIS).
FT                                /FTId=VAR_004688.
FT   VARIANT     681    681       E -> K (in AIS).
FT                                /FTId=VAR_009764.
FT   VARIANT     682    682       P -> T (in PAIS).
FT                                /FTId=VAR_013474.
FT   VARIANT     683    683       G -> A (in prostate cancer).
FT                                /FTId=VAR_009765.
FT   VARIANT     684    684       V -> I (in AIS).
FT                                /FTId=VAR_009766.
FT   VARIANT     686    686       C -> R (in PAIS).
FT                                /FTId=VAR_009767.
FT   VARIANT     687    687       A -> V (in PAIS).
FT                                /FTId=VAR_009768.
FT   VARIANT     688    688       G -> E (in AIS).
FT                                /FTId=VAR_009769.
FT   VARIANT     690    690       Missing (in PAIS).
FT                                /FTId=VAR_009770.
FT   VARIANT     692    692       Missing (in AIS).
FT                                /FTId=VAR_004689.
FT   VARIANT     695    695       D -> H (in AIS).
FT                                /FTId=VAR_004690.
FT   VARIANT     695    695       D -> N (in AIS; almost complete loss of
FT                                androgen binding and transcription
FT                                activation).
FT                                /FTId=VAR_004691.
FT   VARIANT     695    695       D -> V (in AIS).
FT                                /FTId=VAR_004692.
FT   VARIANT     700    700       L -> M (in AIS).
FT                                /FTId=VAR_009771.
FT   VARIANT     701    701       L -> F (in AIS).
FT                                /FTId=VAR_009772.
FT   VARIANT     701    701       L -> H (in AIS and prostate cancer).
FT                                /FTId=VAR_009773.
FT   VARIANT     702    702       S -> A (in AIS).
FT                                /FTId=VAR_009774.
FT   VARIANT     703    703       S -> C (in AIS).
FT                                /FTId=VAR_009775.
FT   VARIANT     703    703       S -> G (in PAIS and AIS).
FT                                /FTId=VAR_004693.
FT   VARIANT     705    705       N -> S (in AIS).
FT                                /FTId=VAR_009776.
FT   VARIANT     705    705       N -> Y (in AIS).
FT                                /FTId=VAR_013475.
FT   VARIANT     707    707       L -> R (in AIS).
FT                                /FTId=VAR_004694.
FT   VARIANT     708    708       G -> A (in PAIS).
FT                                /FTId=VAR_009777.
FT   VARIANT     708    708       G -> V (in AIS).
FT                                /FTId=VAR_009778.
FT   VARIANT     710    710       R -> T (in AIS).
FT                                /FTId=VAR_009779.
FT   VARIANT     711    711       Q -> E (in PAIS).
FT                                /FTId=VAR_013476.
FT   VARIANT     712    712       L -> F (in PAIS).
FT                                /FTId=VAR_009780.
FT   VARIANT     715    715       V -> M (in prostate cancer; gain in
FT                                function).
FT                                /FTId=VAR_009781.
FT   VARIANT     717    717       K -> E (in prostate cancer).
FT                                /FTId=VAR_009782.
FT   VARIANT     720    720       K -> E (in prostate cancer; found in bone
FT                                metastases).
FT                                /FTId=VAR_009783.
FT   VARIANT     721    721       A -> T (in prostate cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_009784.
FT   VARIANT     722    722       L -> F (in AIS).
FT                                /FTId=VAR_009785.
FT   VARIANT     723    723       P -> S (in AIS).
FT                                /FTId=VAR_009786.
FT   VARIANT     724    724       G -> D (in AIS and prostate cancer).
FT                                /FTId=VAR_009787.
FT   VARIANT     725    725       F -> L (in a patient with severe
FT                                hypospadias).
FT                                /FTId=VAR_009788.
FT   VARIANT     726    726       R -> L (in prostate cancer).
FT                                /FTId=VAR_009789.
FT   VARIANT     727    727       N -> K (in AIS).
FT                                /FTId=VAR_009790.
FT   VARIANT     728    728       L -> S (in PAIS).
FT                                /FTId=VAR_009791.
FT   VARIANT     730    730       V -> M (in prostate cancer; increases
FT                                transcription activation).
FT                                /FTId=VAR_004695.
FT   VARIANT     732    732       D -> N (in AIS).
FT                                /FTId=VAR_004696.
FT   VARIANT     732    732       D -> Y (in AIS).
FT                                /FTId=VAR_004697.
FT   VARIANT     733    733       Q -> H (in PAIS).
FT                                /FTId=VAR_009792.
FT   VARIANT     737    737       I -> T (in PAIS).
FT                                /FTId=VAR_009793.
FT   VARIANT     741    741       W -> R (in AIS).
FT                                /FTId=VAR_009794.
FT   VARIANT     742    742       M -> I (in PAIS).
FT                                /FTId=VAR_004698.
FT   VARIANT     742    742       M -> V (in PAIS).
FT                                /FTId=VAR_009795.
FT   VARIANT     743    743       G -> E (in AIS).
FT                                /FTId=VAR_013477.
FT   VARIANT     743    743       G -> V (in PAIS and AIS).
FT                                /FTId=VAR_004699.
FT   VARIANT     744    744       L -> F (in AIS and prostate cancer).
FT                                /FTId=VAR_009796.
FT   VARIANT     745    745       M -> T (in PAIS).
FT                                /FTId=VAR_009797.
FT   VARIANT     746    746       V -> M (in PAIS).
FT                                /FTId=VAR_009798.
FT   VARIANT     748    748       A -> D (in PAIS).
FT                                /FTId=VAR_009799.
FT   VARIANT     748    748       A -> T (in prostate cancer).
FT                                /FTId=VAR_009800.
FT   VARIANT     748    748       A -> V (in prostate cancer).
FT                                /FTId=VAR_009801.
FT   VARIANT     749    749       M -> I (in prostate cancer).
FT                                /FTId=VAR_009802.
FT   VARIANT     749    749       M -> V (in PAIS and AIS).
FT                                /FTId=VAR_004700.
FT   VARIANT     750    750       G -> D (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_004701.
FT   VARIANT     750    750       G -> S (in prostate cancer).
FT                                /FTId=VAR_009803.
FT   VARIANT     751    751       W -> R (in AIS).
FT                                /FTId=VAR_009804.
FT   VARIANT     752    752       R -> Q (in AIS).
FT                                /FTId=VAR_004702.
FT   VARIANT     754    754       F -> L (in PAIS and prostate cancer).
FT                                /FTId=VAR_009805.
FT   VARIANT     754    754       F -> V (in AIS).
FT                                /FTId=VAR_004703.
FT   VARIANT     755    755       T -> A (in prostate cancer).
FT                                /FTId=VAR_009806.
FT   VARIANT     756    756       N -> S (in PAIS).
FT                                /FTId=VAR_009807.
FT   VARIANT     757    757       V -> A (in prostate cancer).
FT                                /FTId=VAR_009808.
FT   VARIANT     758    758       N -> T (in PAIS; 50% reduction in
FT                                transactivation).
FT                                /FTId=VAR_009809.
FT   VARIANT     759    759       S -> F (in AIS).
FT                                /FTId=VAR_009810.
FT   VARIANT     759    759       S -> P (in prostate cancer).
FT                                /FTId=VAR_009811.
FT   VARIANT     762    762       L -> F (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_004704.
FT   VARIANT     763    763       Y -> C (in PAIS and prostate cancer;
FT                                partial loss of androgen binding).
FT                                /FTId=VAR_004705.
FT   VARIANT     763    763       Y -> H (in AIS).
FT                                /FTId=VAR_009812.
FT   VARIANT     764    764       F -> L (in AIS).
FT                                /FTId=VAR_009813.
FT   VARIANT     765    765       A -> T (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_004707.
FT   VARIANT     765    765       A -> V (in AIS).
FT                                /FTId=VAR_009814.
FT   VARIANT     766    766       P -> S (in AIS).
FT                                /FTId=VAR_009815.
FT   VARIANT     767    767       D -> E (in AIS).
FT                                /FTId=VAR_009816.
FT   VARIANT     768    768       L -> P (in AIS).
FT                                /FTId=VAR_009817.
FT   VARIANT     771    771       N -> H (in PAIS).
FT                                /FTId=VAR_009818.
FT   VARIANT     772    772       E -> A (in PAIS).
FT                                /FTId=VAR_009819.
FT   VARIANT     772    772       E -> G (in PAIS).
FT                                /FTId=VAR_009820.
FT   VARIANT     774    774       R -> C (in AIS; loss of androgen binding;
FT                                frequent mutation).
FT                                /FTId=VAR_004709.
FT   VARIANT     774    774       R -> H (in AIS and PAIS; almost complete
FT                                loss of androgen binding).
FT                                /FTId=VAR_004708.
FT   VARIANT     779    779       R -> W (in AIS).
FT                                /FTId=VAR_004710.
FT   VARIANT     780    780       M -> I (in PAIS and AIS).
FT                                /FTId=VAR_004711.
FT   VARIANT     782    782       S -> N (in prostate cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_009821.
FT   VARIANT     784    784       C -> Y (in AIS; loss of androgen binding
FT                                and of transactivation).
FT                                /FTId=VAR_004712.
FT   VARIANT     787    787       M -> V (in AIS).
FT                                /FTId=VAR_004713.
FT   VARIANT     788    788       R -> S (in AIS).
FT                                /FTId=VAR_009822.
FT   VARIANT     790    790       L -> F (in AIS).
FT                                /FTId=VAR_009823.
FT   VARIANT     791    791       S -> P (in prostate cancer).
FT                                /FTId=VAR_009824.
FT   VARIANT     793    793       E -> D.
FT                                /FTId=VAR_009825.
FT   VARIANT     794    794       F -> S (in AIS).
FT                                /FTId=VAR_004714.
FT   VARIANT     798    798       Q -> E (in PAIS, AIS and prostate cancer;
FT                                reduced transcription activation).
FT                                /FTId=VAR_004715.
FT   VARIANT     806    806       C -> Y (in PAIS).
FT                                /FTId=VAR_009826.
FT   VARIANT     807    807       M -> R (in AIS; loss of transactivation).
FT                                /FTId=VAR_004716.
FT   VARIANT     807    807       M -> T (in PAIS).
FT                                /FTId=VAR_009827.
FT   VARIANT     807    807       M -> V (in AIS; 25% androgen binding).
FT                                /FTId=VAR_004717.
FT   VARIANT     812    812       L -> F (in AIS).
FT                                /FTId=VAR_009828.
FT   VARIANT     814    814       S -> N (in AIS and PAIS).
FT                                /FTId=VAR_004718.
FT   VARIANT     820    820       G -> A (in AIS).
FT                                /FTId=VAR_009829.
FT   VARIANT     821    821       L -> V (in PAIS).
FT                                /FTId=VAR_009830.
FT   VARIANT     827    827       F -> V (in PAIS).
FT                                /FTId=VAR_013478.
FT   VARIANT     830    830       L -> P (in prostate cancer).
FT                                /FTId=VAR_009831.
FT   VARIANT     831    831       R -> L (in AIS).
FT                                /FTId=VAR_004719.
FT   VARIANT     831    831       R -> Q (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_004720.
FT   VARIANT     834    834       Y -> C (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_009832.
FT   VARIANT     840    840       R -> C (in AIS).
FT                                /FTId=VAR_004721.
FT   VARIANT     840    840       R -> G (in PAIS).
FT                                /FTId=VAR_004722.
FT   VARIANT     840    840       R -> H (in AIS).
FT                                /FTId=VAR_004723.
FT   VARIANT     840    840       R -> S (in PAIS).
FT                                /FTId=VAR_009229.
FT   VARIANT     841    841       I -> S (in PAIS).
FT                                /FTId=VAR_009833.
FT   VARIANT     842    842       I -> T (in AIS).
FT                                /FTId=VAR_004724.
FT   VARIANT     846    846       R -> G (in prostate cancer).
FT                                /FTId=VAR_009834.
FT   VARIANT     854    854       R -> K (in PAIS).
FT                                /FTId=VAR_009835.
FT   VARIANT     855    855       R -> C (in AIS).
FT                                /FTId=VAR_004725.
FT   VARIANT     855    855       R -> H (in AIS; strongly reduced
FT                                transcription activation).
FT                                /FTId=VAR_004726.
FT   VARIANT     856    856       F -> L (in AIS).
FT                                /FTId=VAR_009836.
FT   VARIANT     863    863       L -> R (in AIS).
FT                                /FTId=VAR_009837.
FT   VARIANT     864    864       D -> G (in AIS).
FT                                /FTId=VAR_009838.
FT   VARIANT     864    864       D -> N (in AIS; loss of androgen
FT                                binding).
FT                                /FTId=VAR_004727.
FT   VARIANT     865    865       S -> P (in AIS).
FT                                /FTId=VAR_009839.
FT   VARIANT     866    866       V -> E (in AIS).
FT                                /FTId=VAR_004728.
FT   VARIANT     866    866       V -> L (in PAIS).
FT                                /FTId=VAR_004729.
FT   VARIANT     866    866       V -> M (in AIS and prostate cancer).
FT                                /FTId=VAR_004730.
FT   VARIANT     869    869       I -> M (in PAIS).
FT                                /FTId=VAR_004731.
FT   VARIANT     870    870       A -> G (in PAIS).
FT                                /FTId=VAR_009840.
FT   VARIANT     870    870       A -> V (in PAIS).
FT                                /FTId=VAR_009841.
FT   VARIANT     871    871       R -> G (in AIS).
FT                                /FTId=VAR_009842.
FT   VARIANT     874    874       H -> R (in AIS).
FT                                /FTId=VAR_013479.
FT   VARIANT     874    874       H -> Y (in prostate cancer; increases
FT                                affinity for testosterone, androgen
FT                                sensitivity and transcription
FT                                activation).
FT                                /FTId=VAR_009843.
FT   VARIANT     877    877       T -> A (in prostate cancer; alters
FT                                receptor specificity so that
FT                                transcription is activated by
FT                                antiandrogens, such as cyproterone
FT                                acetate; found in bone metastases).
FT                                /FTId=VAR_004732.
FT   VARIANT     877    877       T -> S (in prostate cancer).
FT                                /FTId=VAR_009844.
FT   VARIANT     879    879       D -> Y (in AIS).
FT                                /FTId=VAR_013480.
FT   VARIANT     880    880       L -> Q (in prostate cancer).
FT                                /FTId=VAR_009845.
FT   VARIANT     881    881       L -> V (in AIS).
FT                                /FTId=VAR_009846.
FT   VARIANT     886    886       M -> V (in AIS).
FT                                /FTId=VAR_009847.
FT   VARIANT     889    889       V -> M (in AIS and PAIS).
FT                                /FTId=VAR_009848.
FT   VARIANT     890    890       D -> N (in prostate cancer).
FT                                /FTId=VAR_009849.
FT   VARIANT     891    891       F -> L (in prostate cancer).
FT                                /FTId=VAR_009850.
FT   VARIANT     892    892       P -> L (in AIS).
FT                                /FTId=VAR_004733.
FT   VARIANT     895    895       M -> T (in AIS; low androgen binding and
FT                                transactivation).
FT                                /FTId=VAR_004734.
FT   VARIANT     896    896       A -> T (in prostate cancer).
FT                                /FTId=VAR_009851.
FT   VARIANT     898    898       I -> T (in AIS).
FT                                /FTId=VAR_009852.
FT   VARIANT     902    902       Q -> R (in prostate cancer).
FT                                /FTId=VAR_009853.
FT   VARIANT     903    903       V -> M (in PAIS).
FT                                /FTId=VAR_009854.
FT   VARIANT     904    904       P -> H (in AIS).
FT                                /FTId=VAR_009855.
FT   VARIANT     904    904       P -> S (in AIS).
FT                                /FTId=VAR_009856.
FT   VARIANT     907    907       L -> F (in AIS; almost complete loss of
FT                                transcription activation).
FT                                /FTId=VAR_004735.
FT   VARIANT     909    909       G -> E (in prostate cancer).
FT                                /FTId=VAR_009857.
FT   VARIANT     909    909       G -> R (in PAIS).
FT                                /FTId=VAR_009858.
FT   VARIANT     910    910       K -> R (in prostate cancer).
FT                                /FTId=VAR_009859.
FT   VARIANT     911    911       V -> L (in PAIS).
FT                                /FTId=VAR_009860.
FT   VARIANT     913    913       P -> S (in PAIS).
FT                                /FTId=VAR_004736.
FT   VARIANT     916    916       F -> L (in AIS).
FT                                /FTId=VAR_009861.
FT   VARIANT     917    917       H -> R (in AIS).
FT                                /FTId=VAR_009862.
FT   VARIANT     919    919       Q -> R (in prostate cancer).
FT                                /FTId=VAR_009863.
FT   MUTAGEN      81     81       S->A: Reduced cell growth.
FT   MUTAGEN     223    223       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     267    267       Y->F: Decrease of CSK-induced
FT                                phosphorylation and phosphorylation by
FT                                TNK2. Complete loss of TNK2-dependent
FT                                phosphorylation; when associated with F-
FT                                363.
FT   MUTAGEN     307    307       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     346    346       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     357    357       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     362    362       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     363    363       Y->F: Decrease of CSK-induced
FT                                phosphorylation and phosphorylation by
FT                                TNK2. Complete loss of TNK2-dependent
FT                                phosphorylation; when associated with F-
FT                                267.
FT   MUTAGEN     393    393       Y->F: Decrease of CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     534    534       Y->F: Greatest decrease of CSK-induced
FT                                phosphorylation and inhibition of
FT                                transcriptional activity induced by EGF.
FT   MUTAGEN     551    551       Y->F: Decrease in CSK-induced
FT                                phosphorylation.
FT   MUTAGEN     701    701       L->A: Alters receptor specificity, so
FT                                that transcription is activated by the
FT                                antiandrogen cyproterone acetate.
FT   MUTAGEN     720    720       K->A: Loss of transcription activation in
FT                                the presence of androgen and of
FT                                interaction with NCOA2.
FT   MUTAGEN     741    741       W->L: Strongly decreased transcription
FT                                activation in the presence of androgen.
FT   MUTAGEN     845    845       K->R: Prevents ubiquitination by RNF6.
FT                                Prevents AR transcriptional activation by
FT                                RNF14 in absence of hormone.
FT   MUTAGEN     847    847       K->R: Partially prevents ubiquitination
FT                                by RNF6.
FT   MUTAGEN     897    897       E->A,Q: Reduced transcription activation
FT                                in the presence of androgen.
FT   MUTAGEN     897    897       E->K,R: Loss of transcription activation
FT                                in the presence of androgen.
FT   MUTAGEN     915    915       Y->F: Decrease in CSK-induced
FT                                phosphorylation.
FT   CONFLICT    166    166       G -> A (in Ref. 5; AAA51780).
FT   CONFLICT    212    212       A -> R (in Ref. 3 and 6; AAA51771/
FT                                AAA51772).
FT   CONFLICT    475    475       G -> E (in Ref. 2; AAA51775 and 12;
FT                                AAA51770).
FT   CONFLICT    565    565       E -> K (in Ref. 14; AAA51774).
FT   CONFLICT    634    634       L -> P (in Ref. 18; AAB21256/AAB21257).
FT   CONFLICT    675    675       N -> I (in Ref. 18; AAB21256/AAB21257).
FT   CONFLICT    810    810       L -> M (in Ref. 5; AAA51780).
FT   STRAND      666    668
FT   HELIX       672    680
FT   STRAND      691    693
FT   HELIX       697    720
FT   HELIX       725    727
FT   HELIX       730    757
FT   STRAND      760    765
FT   STRAND      768    770
FT   HELIX       772    777
FT   HELIX       781    796
FT   HELIX       801    812
FT   STRAND      814    817
FT   HELIX       824    842
FT   TURN        843    845
FT   HELIX       850    883
FT   HELIX       884    886
FT   HELIX       893    901
FT   HELIX       903    907
FT   STRAND      910    913
SQ   SEQUENCE   919 AA;  98989 MW;  93B096927740B6FF CRC64;
     MEVQLGLGRV YPRPPSKTYR GAFQNLFQSV REVIQNPGPR HPEAASAAPP GASLLLLQQQ
     QQQQQQQQQQ QQQQQQQQET SPRQQQQQQG EDGSPQAHRR GPTGYLVLDE EQQPSQPQSA
     LECHPERGCV PEPGAAVAAS KGLPQQLPAP PDEDDSAAPS TLSLLGPTFP GLSSCSADLK
     DILSEASTMQ LLQQQQQEAV SEGSSSGRAR EASGAPTSSK DNYLGGTSTI SDNAKELCKA
     VSVSMGLGVE ALEHLSPGEQ LRGDCMYAPL LGVPPAVRPT PCAPLAECKG SLLDDSAGKS
     TEDTAEYSPF KGGYTKGLEG ESLGCSGSAA AGSSGTLELP STLSLYKSGA LDEAAAYQSR
     DYYNFPLALA GPPPPPPPPH PHARIKLENP LDYGSAWAAA AAQCRYGDLA SLHGAGAAGP
     GSGSPSAAAS SSWHTLFTAE EGQLYGPCGG GGGGGGGGGG GGGGGGGGGG GGEAGAVAPY
     GYTRPPQGLA GQESDFTAPD VWYPGGMVSR VPYPSPTCVK SEMGPWMDSY SGPYGDMRLE
     TARDHVLPID YYFPPQKTCL ICGDEASGCH YGALTCGSCK VFFKRAAEGK QKYLCASRND
     CTIDKFRRKN CPSCRLRKCY EAGMTLGARK LKKLGNLKLQ EEGEASSTTS PTEETTQKLT
     VSHIEGYECQ PIFLNVLEAI EPGVVCAGHD NNQPDSFAAL LSSLNELGER QLVHVVKWAK
     ALPGFRNLHV DDQMAVIQYS WMGLMVFAMG WRSFTNVNSR MLYFAPDLVF NEYRMHKSRM
     YSQCVRMRHL SQEFGWLQIT PQEFLCMKAL LLFSIIPVDG LKNQKFFDEL RMNYIKELDR
     IIACKRKNPT SCSRRFYQLT KLLDSVQPIA RELHQFTFDL LIKSHMVSVD FPEMMAEIIS
     VQVPKILSGK VKPIYFHTQ
//
ID   CAT1_NEUCR              Reviewed;         736 AA.
AC   Q9C168; Q7RUZ1;
DT   09-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   06-FEB-2013, entry version 104.
DE   RecName: Full=Catalase-1;
DE            EC=1.11.1.6;
GN   Name=cat-1; ORFNames=NCU08791;
OS   Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM
OS   1257 / FGSC 987).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina;
OC   Sordariomycetes; Sordariomycetidae; Sordariales; Sordariaceae;
OC   Neurospora.
OX   NCBI_TaxID=367110;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 48-60; 152-167
RP   AND 254-266, CATALYTIC ACTIVITY, DEVELOPMENTAL STAGE, AND INDUCTION.
RC   STRAIN=ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987;
RC   TISSUE=Conidium;
RX   MEDLINE=22150829; PubMed=12160934; DOI=10.1016/S0891-5849(02)00909-7;
RA   Michan S., Lledias F., Baldwin J.D., Natvig D.O., Hansberg W.;
RT   "Regulation and oxidation of two large monofunctional catalases.";
RL   Free Radic. Biol. Med. 33:521-532(2002).
RN   [2]
RP   SEQUENCE REVISION TO N-TERMINUS.
RA   Michan S., Ebbole D., Hansberg W.;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987;
RX   MEDLINE=22598136; PubMed=12712197; DOI=10.1038/nature01554;
RA   Galagan J.E., Calvo S.E., Borkovich K.A., Selker E.U., Read N.D.,
RA   Jaffe D.B., FitzHugh W., Ma L.-J., Smirnov S., Purcell S., Rehman B.,
RA   Elkins T., Engels R., Wang S., Nielsen C.B., Butler J., Endrizzi M.,
RA   Qui D., Ianakiev P., Bell-Pedersen D., Nelson M.A.,
RA   Werner-Washburne M., Selitrennikoff C.P., Kinsey J.A., Braun E.L.,
RA   Zelter A., Schulte U., Kothe G.O., Jedd G., Mewes H.-W., Staben C.,
RA   Marcotte E., Greenberg D., Roy A., Foley K., Naylor J.,
RA   Stange-Thomann N., Barrett R., Gnerre S., Kamal M., Kamvysselis M.,
RA   Mauceli E.W., Bielke C., Rudd S., Frishman D., Krystofova S.,
RA   Rasmussen C., Metzenberg R.L., Perkins D.D., Kroken S., Cogoni C.,
RA   Macino G., Catcheside D.E.A., Li W., Pratt R.J., Osmani S.A.,
RA   DeSouza C.P.C., Glass N.L., Orbach M.J., Berglund J.A., Voelker R.,
RA   Yarden O., Plamann M., Seiler S., Dunlap J.C., Radford A., Aramayo R.,
RA   Natvig D.O., Alex L.A., Mannhaupt G., Ebbole D.J., Freitag M.,
RA   Paulsen I., Sachs M.S., Lander E.S., Nusbaum C., Birren B.W.;
RT   "The genome sequence of the filamentous fungus Neurospora crassa.";
RL   Nature 422:859-868(2003).
RN   [4]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   SUBCELLULAR LOCATION, INDUCTION, AND GLYCOSYLATION.
RX   MEDLINE=21585605; PubMed=11728803; DOI=10.1016/S0891-5849(01)00637-2;
RA   Diaz A., Rangel P., Montes de Oca Y., Lledias F., Hansberg W.;
RT   "Molecular and kinetic study of catalase-1, a durable large catalase
RT   of Neurospora crassa.";
RL   Free Radic. Biol. Med. 31:1323-1333(2001).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 22-736 IN COMPLEX WITH
RP   COFACTOR, ACTIVE SITE, AND CROSS-LINK.
RX   PubMed=15342250; DOI=10.1016/j.jmb.2004.07.027;
RA   Diaz A., Horjales E., Rudino-Pinera E., Arreola R., Hansberg W.;
RT   "Unusual Cys-Tyr covalent bond in a large catalase.";
RL   J. Mol. Biol. 342:971-985(2004).
CC   -!- FUNCTION: Occurs in almost all aerobically respiring organisms and
CC       serves to protect cells from the toxic effects of hydrogen
CC       peroxide (By similarity).
CC   -!- CATALYTIC ACTIVITY: 2 H(2)O(2) = O(2) + 2 H(2)O.
CC   -!- COFACTOR: Heme group.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Active from pH 4 to 12;
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Secreted, cell wall. Note=Principally
CC       associated with the cell wall of conidia.
CC   -!- DEVELOPMENTAL STAGE: Main catalase activity in conidia, during
CC       germination of conidia, and initial growth.
CC   -!- INDUCTION: During prestationary growth. By ethanol and in the
CC       presence of air by heat shock. Inactivated by isopropanol and 20
CC       mM 3-amino-1,2,4-triazole.
CC   -!- PTM: Glycosylated; with alpha-glucose and/or alpha-mannose.
CC   -!- SIMILARITY: Belongs to the catalase family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EAA26998.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY027545; AAK15808.2; -; Genomic_DNA.
DR   EMBL; AABX02000017; EAA26998.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; XP_956234.1; XM_951141.2.
DR   UniGene; Ncr.12809; -.
DR   PDB; 1SY7; X-ray; 1.75 A; A/B=22-736.
DR   PDBsum; 1SY7; -.
DR   ProteinModelPortal; Q9C168; -.
DR   SMR; Q9C168; 39-736.
DR   MINT; MINT-2515819; -.
DR   STRING; Q9C168; -.
DR   PeroxiBase; 5207; NcKat01.
DR   EnsemblFungi; EFNCRT00000004624; EFNCRP00000004624; EFNCRG00000004618.
DR   GeneID; 3872372; -.
DR   KEGG; ncr:NCU08791; -.
DR   eggNOG; COG0753; -.
DR   HOGENOM; HOG000087851; -.
DR   KO; K03781; -.
DR   OrthoDB; EOG4B8NN5; -.
DR   EvolutionaryTrace; Q9C168; -.
DR   GO; GO:0005619; C:ascospore wall; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0004096; F:catalase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048315; P:conidium formation; IDA:UniProtKB.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:UniProtKB.
DR   Gene3D; 2.40.180.10; Catalase_N; 1.
DR   InterPro; IPR018028; Catalase.
DR   InterPro; IPR020835; Catalase-like_dom.
DR   InterPro; IPR024708; Catalase_AS.
DR   InterPro; IPR024712; Catalase_clade2.
DR   InterPro; IPR011614; Catalase_core.
DR   InterPro; IPR002226; Catalase_haem_BS.
DR   InterPro; IPR010582; Catalase_immune_responsive.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   PANTHER; PTHR11465; PTHR11465; 1.
DR   Pfam; PF00199; Catalase; 1.
DR   Pfam; PF06628; Catalase-rel; 1.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF038927; Catalase_clade2; 1.
DR   PRINTS; PR00067; CATALASE.
DR   SMART; SM01060; Catalase; 1.
DR   SUPFAM; SSF56634; Catalase_N; 1.
DR   PROSITE; PS00437; CATALASE_1; 1.
DR   PROSITE; PS00438; CATALASE_2; 1.
DR   PROSITE; PS51402; CATALASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell wall; Complete proteome; Direct protein sequencing;
KW   Glycoprotein; Heme; Hydrogen peroxide; Iron; Metal-binding;
KW   Oxidoreductase; Peroxidase; Reference proteome; Secreted;
KW   Thioether bond.
FT   CHAIN         1    736       Catalase-1.
FT                                /FTId=PRO_0000084923.
FT   ACT_SITE     92     92
FT   ACT_SITE    165    165
FT   METAL       379    379       Iron (heme axial ligand).
FT   BINDING      89     89       Heme.
FT   BINDING     129    129       Heme.
FT   BINDING     178    178       Heme.
FT   BINDING     375    375       Heme.
FT   BINDING     386    386       Heme.
FT   CROSSLNK    356    379       3-(S-cysteinyl)-tyrosine (Cys-Tyr).
FT   STRAND       57     59
FT   STRAND       64     67
FT   HELIX        72     82
FT   STRAND       90     92
FT   STRAND       94    106
FT   TURN        109    111
FT   HELIX       115    117
FT   STRAND      124    131
FT   STRAND      133    135
FT   STRAND      143    145
FT   STRAND      148    155
FT   STRAND      158    169
FT   HELIX       175    177
FT   HELIX       178    185
FT   TURN        189    192
FT   HELIX       201    209
FT   HELIX       211    213
FT   HELIX       214    220
FT   HELIX       223    225
FT   STRAND      226    228
FT   HELIX       230    232
FT   STRAND      241    244
FT   STRAND      250    259
FT   HELIX       268    277
FT   HELIX       281    291
FT   STRAND      297    306
FT   HELIX       307    309
FT   STRAND      313    315
FT   TURN        326    328
FT   STRAND      332    341
FT   HELIX       346    349
FT   TURN        350    352
FT   HELIX       372    381
FT   HELIX       383    386
FT   HELIX       391    393
FT   TURN        395    397
FT   STRAND      423    425
FT   TURN        436    439
FT   HELIX       458    461
FT   HELIX       465    473
FT   HELIX       476    491
FT   HELIX       496    506
FT   TURN        507    509
FT   HELIX       511    521
FT   HELIX       543    545
FT   STRAND      549    551
FT   STRAND      557    561
FT   HELIX       568    580
FT   STRAND      584    590
FT   STRAND      595    597
FT   STRAND      606    608
FT   TURN        609    611
FT   HELIX       614    616
FT   STRAND      617    622
FT   HELIX       626    633
FT   HELIX       636    647
FT   STRAND      651    655
FT   HELIX       658    666
FT   STRAND      676    678
FT   STRAND      680    682
FT   STRAND      685    690
FT   TURN        693    697
FT   HELIX       709    718
FT   HELIX       723    727
FT   HELIX       731    733
SQ   SEQUENCE   736 AA;  82268 MW;  76AC6E3A51336299 CRC64;
     MSNIISQAGQ KAKEALTSAP SSKKVDDLKN EFKETDKSAR LTTDYGVKQT TADDWLRIVS
     DDKIGPSLLE DPFARERIMR FDHERIPERV VHARGSGAFG KFKVYESASD LTMAPVLTDT
     SRETPVFVRF STVLGSRGSA DTVRDVRGFA VKFYTEEGNW DLVGNNIPVF FIQDAIKFPD
     VIHAGKPEPH NEVPQAQSAH NNFWDFQFNH TEATHMFTWA MSDRAIPRSL RMMQGFGVNT
     YTLINAQGKR HFVKFHWTPE LGVHSLVWDE ALKLAGQDPD FHRKDLWEAI ENGAYPKWKF
     GIQAIAEEDE HKFDFDILDA TKIWPEDLVP VRYIGEMELN RNPDEFFPQT EQIAFCTSHV
     VNGIGFSDDP LLQGRNFSYF DTQISRLGVN FQELPINRPV CPVMNFNRDG AMRHTISRGT
     VNYYPNRFDA CPPASLKEGG YLEYAQKVAG IKARARSAKF KEHFSQAQLF YNSMSPIEKQ
     HMINAFGFEL DHCEDPVVYG RMVQRLADID LGLAQTIAEM VGGEAPTTTN HPNHGRKTIN
     LSQTEFPPAT PTIKSRRVAI IIADGYDNVA YDAAYAAISA NQAIPLVIGP RRSKVTAANG
     STVQPHHHLE GFRSTMVDAI FIPGGAKAAE TLSKNGRALH WIREAFGHLK AIGATGEAVD
     LVAKAIALPQ VTVSSEAEVH ESYGVVTLKK VKPESFTDAV KIAKGAAGFL GEFFYAIAQH
     RNWDRELDGL HSMIAY
//
ID   CATE_MYCAV              Reviewed;         706 AA.
AC   P50979;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-NOV-2012, entry version 67.
DE   RecName: Full=Catalase HPII;
DE            EC=1.11.1.6;
GN   Name=katE;
OS   Mycobacterium avium.
OC   Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales;
OC   Corynebacterineae; Mycobacteriaceae; Mycobacterium;
OC   Mycobacterium avium complex (MAC).
OX   NCBI_TaxID=1764;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96419168; PubMed=8821941;
RX   DOI=10.1046/j.1365-2958.1996.352876.x;
RA   Milano A., de Rossi E., Gusberti L., Heym B., Marone P., Riccardi G.;
RT   "The katE gene, which encodes the catalase HPII of Mycobacterium
RT   avium.";
RL   Mol. Microbiol. 19:113-123(1996).
CC   -!- FUNCTION: Decomposes hydrogen peroxide into water and oxygen;
CC       serves to protect cells from the toxic effects of hydrogen
CC       peroxide.
CC   -!- CATALYTIC ACTIVITY: 2 H(2)O(2) = O(2) + 2 H(2)O.
CC   -!- COFACTOR: Heme group.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Probable).
CC   -!- SIMILARITY: Belongs to the catalase family. HPII subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41246; AAC18407.1; -; Genomic_DNA.
DR   PIR; S70665; S70665.
DR   ProteinModelPortal; P50979; -.
DR   SMR; P50979; 29-245.
DR   eggNOG; COG0753; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004096; F:catalase activity; IEA:EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.180.10; Catalase_N; 1.
DR   InterPro; IPR018028; Catalase.
DR   InterPro; IPR020835; Catalase-like_dom.
DR   InterPro; IPR024708; Catalase_AS.
DR   InterPro; IPR024712; Catalase_clade2.
DR   InterPro; IPR011614; Catalase_core.
DR   InterPro; IPR002226; Catalase_haem_BS.
DR   InterPro; IPR010582; Catalase_immune_responsive.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   PANTHER; PTHR11465; PTHR11465; 1.
DR   Pfam; PF00199; Catalase; 1.
DR   Pfam; PF06628; Catalase-rel; 1.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF038927; Catalase_clade2; 1.
DR   PRINTS; PR00067; CATALASE.
DR   SMART; SM01060; Catalase; 1.
DR   SUPFAM; SSF56634; Catalase_N; 1.
DR   PROSITE; PS00437; CATALASE_1; 1.
DR   PROSITE; PS00438; CATALASE_2; 1.
DR   PROSITE; PS51402; CATALASE_3; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Heme; Hydrogen peroxide; Iron; Metal-binding;
KW   Oxidoreductase; Peroxidase.
FT   CHAIN         1    706       Catalase HPII.
FT                                /FTId=PRO_0000084972.
FT   ACT_SITE     77     77       By similarity.
FT   ACT_SITE    151    151       By similarity.
FT   METAL       365    365       Iron (heme axial ligand) (By similarity).
SQ   SEQUENCE   706 AA;  78175 MW;  549269AC4F51AECF CRC64;
     MATDHTSDAP DPKQRDLESA RFRRDTGYLT TQQGVRVDHT DDALTVGERG PTLLEDFHAR
     EKITHFDHER IPERVVHARG AGAYGYFEPY DDRLAQYTAA KFLTSPGTRT PVFVRFSTVA
     GSRGSADTVR DVRGFATKFY TEQGNYDLVG NNFPVFFIQD GIKFPVLVHA VKPEPHNEIP
     QAQSAHDTLW DFVSLQPETL HAIMWLMSDR ALPRSYRMMQ GFGVHTFRLV NARGRGTFVK
     FHWKPRLGVH SLIWDECQKI AGKDPDYNRR DLWEAIESGQ YPEWELGVQL VAEDDEFSFD
     FDLLDATKII PEEQVPVLPV GKMVLNRNPD NFFAETEQVA FHTANVVPGI DFTNDPLLQF
     RNFSYLDTQL IRLGGPNFAQ LPVNRPVAQV RTNQHDGYAQ HAIPQGRSSY FKNSIGGGCP
     ALADEDVFRH YTQRVDGQTI GKRAEAFQNH YGQARMFFKS MSPVEAEHIV AAFAFELGKV
     EMPEIRSAVV AQLARVDDQL AAQVAAKLGL PEPPEEQVDE SAPVSPALSQ VTDGGDTIAS
     RRIAVLAADG VDVVGTQRFT ELMEQRGAVV EVLAPVAGGT LAGGSGGELR VDRSFTTMAS
     VLYDAVVVAC GPRSVSTLSD DGYAVHFVTE AYKHLKPIGA YGAGVDLLRK AGIDNRLAED
     TDVLNDQAVV TTKAAADELP ERFAEEFAAA LAQHRCWQRR TDAVPA
//
ID   CATE_PSEAE              Reviewed;         709 AA.
AC   Q9I1W8;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-NOV-2012, entry version 68.
DE   RecName: Full=Catalase HPII;
DE            EC=1.11.1.6;
GN   Name=katE; OrderedLocusNames=PA2147;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG
OS   12228).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   MEDLINE=20437337; PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
CC   -!- FUNCTION: Decomposes hydrogen peroxide into water and oxygen;
CC       serves to protect cells from the toxic effects of hydrogen
CC       peroxide (By similarity).
CC   -!- CATALYTIC ACTIVITY: 2 H(2)O(2) = O(2) + 2 H(2)O.
CC   -!- COFACTOR: Heme group (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Probable).
CC   -!- SIMILARITY: Belongs to the catalase family. HPII subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE004091; AAG05535.1; -; Genomic_DNA.
DR   PIR; B83376; B83376.
DR   RefSeq; NP_250837.1; NC_002516.2.
DR   HSSP; P21179; 1P80.
DR   ProteinModelPortal; Q9I1W8; -.
DR   SMR; Q9I1W8; 24-709.
DR   PeroxiBase; 4089; PaerKat03_PAO1.
DR   GeneID; 881554; -.
DR   GenomeReviews; AE004091_GR; PA2147.
DR   KEGG; pae:PA2147; -.
DR   PATRIC; 19838730; VBIPseAer58763_2245.
DR   PseudoCAP; PA2147; -.
DR   eggNOG; COG0753; -.
DR   HOGENOM; HOG000087851; -.
DR   KO; K03781; -.
DR   OMA; IFHFDHE; -.
DR   ProtClustDB; PRK11249; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004096; F:catalase activity; IEA:EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.180.10; Catalase_N; 1.
DR   InterPro; IPR018028; Catalase.
DR   InterPro; IPR020835; Catalase-like_dom.
DR   InterPro; IPR024708; Catalase_AS.
DR   InterPro; IPR024712; Catalase_clade2.
DR   InterPro; IPR011614; Catalase_core.
DR   InterPro; IPR002226; Catalase_haem_BS.
DR   InterPro; IPR010582; Catalase_immune_responsive.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   PANTHER; PTHR11465; PTHR11465; 1.
DR   Pfam; PF00199; Catalase; 1.
DR   Pfam; PF06628; Catalase-rel; 1.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF038927; Catalase_clade2; 1.
DR   PRINTS; PR00067; CATALASE.
DR   SMART; SM01060; Catalase; 1.
DR   SUPFAM; SSF56634; Catalase_N; 1.
DR   PROSITE; PS00437; CATALASE_1; 1.
DR   PROSITE; PS00438; CATALASE_2; 1.
DR   PROSITE; PS51402; CATALASE_3; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Cytoplasm; Heme; Hydrogen peroxide; Iron;
KW   Metal-binding; Oxidoreductase; Peroxidase; Reference proteome.
FT   CHAIN         1    709       Catalase HPII.
FT                                /FTId=PRO_0000287752.
FT   ACT_SITE     90     90       By similarity.
FT   ACT_SITE    163    163       By similarity.
FT   METAL       377    377       Iron (heme axial ligand) (By similarity).
SQ   SEQUENCE   709 AA;  77963 MW;  EF3977DA832D6E1E CRC64;
     MSEQNNEQRS QAAGTDTVDR GNSNAKLEQL EAYREDATGE ALSTNTGTRI ADNQNTLKAG
     ERGPSLLEDF IMREKITHFD HERIPERVVH ARGSAAHGYF EAYEDLSDLT KAGFLAEAGK
     RTPVFVRFST VQGPRGSADT VRDVRGFAVK FYTDEGNFDL VGNNMPVFFI QDAIKFPDFV
     HAVKPEPHNE IPTGASAHDT FWDFVSLTPE SAHMVMWLMS DRAIPIAYRN MQGFGVHTFR
     LVNAAGESVL VKFHWRPKSG TCSLVWDEAQ KLAGKDPDFN RRTLWEDIEK GDYPEWELGL
     QVIPENQQDS FDFDLLDPTK LVPEELVPVR VVGRMVLNRN PDNFFAETEQ VAFHVGHVVP
     GIDFTNDPLL QGRLFSYTDT QLLRLSGPNF NEIPINRPLC PFHNNQRDAP HRQTINRGRA
     SYEPNSIDGG WPKETPPAAR NGGFSTYHEP VSGSKLRKRA DSFADHFSQA ALFWHSMSEA
     EQAHIVAAYS FELSKVERQS IREREVNQIL LNIDPQLAAR VAANVGVQLA APANPTPQPK
     PSPALSQMNL LSGDIRSRKV AILIADGVAE SDVSDLRDAL RQEGADAKLI APSASPVQAE
     NGAELSPEGT WDGLPSVAFD AVFVPGGAAS SQAIGADGRG LHYLLEAYKH LKPVAFAGDA
     QALASQLSLP GDPGVVLGAT ATDVFPGLRQ ALMQHRIWQR EAATKAIPA
//
ID   CDHR_PSEAE              Reviewed;         336 AA.
AC   Q9HTH5;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-NOV-2012, entry version 75.
DE   RecName: Full=HTH-type transcriptional regulator CdhR;
DE   AltName: Full=Carnitine catabolism transcriptional activator;
GN   Name=cdhR; OrderedLocusNames=PA5389;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG
OS   12228).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   MEDLINE=20437337; PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION AS A TRANSCRIPTIONAL REGULATOR, ROLE IN CARNITINE CATABOLISM,
RP   AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   PubMed=19406895; DOI=10.1099/mic.0.028787-0;
RA   Wargo M.J., Hogan D.A.;
RT   "Identification of genes required for Pseudomonas aeruginosa carnitine
RT   catabolism.";
RL   Microbiology 155:2411-2419(2009).
CC   -!- FUNCTION: Induces the transcription of the PA5384-PA5388 operon in
CC       response to carnitine. This operon is involved in the degradation
CC       of L-carnitine, and allows P.aeruginosa to grow on L-carnitine as
CC       the sole source of carbon and nitrogen.
CC   -!- DISRUPTION PHENOTYPE: Cells are incapable of growth on carnitine.
CC   -!- SIMILARITY: Contains 1 HTH araC/xylS-type DNA-binding domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE004091; AAG08774.1; -; Genomic_DNA.
DR   PIR; A82973; A82973.
DR   RefSeq; NP_254076.1; NC_002516.2.
DR   ProteinModelPortal; Q9HTH5; -.
DR   SMR; Q9HTH5; 1-315.
DR   GeneID; 880749; -.
DR   GenomeReviews; AE004091_GR; PA5389.
DR   KEGG; pae:PA5389; -.
DR   PATRIC; 19845655; VBIPseAer58763_5649.
DR   PseudoCAP; PA5389; -.
DR   HOGENOM; HOG000063196; -.
DR   OMA; ASNGMSV; -.
DR   ProtClustDB; CLSK869313; -.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.60; Homeodomain-rel; 2.
DR   InterPro; IPR025628; DJ-1_InhA.
DR   InterPro; IPR009057; Homeodomain-like.
DR   InterPro; IPR018060; HTH_AraC.
DR   InterPro; IPR018062; HTH_AraC-typ_CS.
DR   Pfam; PF13278; DUF4066; 1.
DR   Pfam; PF12833; HTH_18; 1.
DR   SMART; SM00342; HTH_ARAC; 1.
DR   SUPFAM; SSF46689; Homeodomain_like; 2.
DR   PROSITE; PS00041; HTH_ARAC_FAMILY_1; 1.
DR   PROSITE; PS01124; HTH_ARAC_FAMILY_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    336       HTH-type transcriptional regulator CdhR.
FT                                /FTId=PRO_0000417912.
FT   DOMAIN      213    311       HTH araC/xylS-type.
FT   DNA_BIND    230    251       H-T-H motif (By similarity).
FT   DNA_BIND    278    301       H-T-H motif (By similarity).
SQ   SEQUENCE   336 AA;  37078 MW;  4F8FE077E6605B50 CRC64;
     MSQDFWFLLL PGFSVMGFVS AVEPLRVANR FHADLYRWHV LSADGGPVLA SNGMSVNSDG
     ALEPLKKGDL LFVVAGFEPL RAVTPALVQW LRKLDRNGVT LGGIDTGSVV LAEAGLLDGR
     RATLHWEAID AFQESYPQLS VTQELFEIDG PRITSAGGTA SIDLMLDLIA QAHGPQLAVQ
     VSEQFVLGRI RPRQDHQRLQ VATRYGVSNR KLVQVIGEME RHTEPPLTTL ELAERIQVTR
     RQLERLFRVH LDDTPSNFYL GLRLDKARQL LRQTDLSVLQ VSLACGFESP SYFSRSYRAR
     FAASPSQDRA VLPLKAPAAT PPGAPAGHRT PRAERG
//
ID   EFCB6_HUMAN             Reviewed;        1501 AA.
AC   Q5THR3; A8K8P6; A8K8Y3; B0QYI4; B0QYI6; Q5U5T6; Q9BY88; Q9H5C4;
AC   Q9NSF5;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   28-NOV-2012, entry version 83.
DE   RecName: Full=EF-hand calcium-binding domain-containing protein 6;
DE   AltName: Full=CAP-binding protein complex-interacting protein 1;
DE   AltName: Full=DJ-1-binding protein;
DE            Short=DJBP;
GN   Name=EFCAB6; Synonyms=DJBP, KIAA1672;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, INTERACTION WITH PARK7 AND AR, AND
RP   VARIANT VAL-1059.
RC   TISSUE=Testis;
RX   MEDLINE=22499918; PubMed=12612053;
RA   Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S.M.M., Ariga H.;
RT   "DJBP: a novel DJ-1-binding protein, negatively regulates the androgen
RT   receptor by recruiting histone deacetylase complex, and DJ-1
RT   antagonizes this inhibition by abrogation of this complex.";
RL   Mol. Cancer Res. 1:247-261(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   VARIANTS ALA-351; TYR-400; ALA-680 AND VAL-1059.
RC   TISSUE=Lung, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=12529303; DOI=10.1101/gr.695703;
RA   Collins J.E., Goward M.E., Cole C.G., Smink L.J., Huckle E.J.,
RA   Knowles S., Bye J.M., Beare D.M., Dunham I.;
RT   "Reevaluating human gene annotation: a second-generation analysis of
RT   chromosome 22.";
RL   Genome Res. 13:27-36(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-1059.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 855-1501 (ISOFORM 5).
RC   TISSUE=Brain;
RX   MEDLINE=21156230; PubMed=11258795; DOI=10.1093/dnares/8.1.1;
RA   Hirosawa M., Nagase T., Murahashi Y., Kikuno R., Ohara O.;
RT   "Identification of novel transcribed sequences on human chromosome 22
RT   by expressed sequence tag mapping.";
RL   DNA Res. 8:1-9(2001).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1160-1260.
RA   Honbou K., Suzuki N.N., Horiuchi M., Taira T., Niki T., Ariga H.,
RA   Inagaki F.;
RT   "Crystal structure of DJBP fragment which was obtained by limited
RT   proteolysis.";
RL   Submitted (AUG-2005) to the PDB data bank.
CC   -!- FUNCTION: Negatively regulates the androgen receptor by recruiting
CC       histone deacetylase complex, and protein DJ-1 antagonizes this
CC       inhibition by abrogation of this complex.
CC   -!- SUBUNIT: Binds PARK7. Part of a ternary complex containing PARK7,
CC       EFCAB6/DJBP and AR.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q5THR3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Isoform b;
CC         IsoId=Q5THR3-2; Sequence=VSP_019810;
CC       Name=3;
CC         IsoId=Q5THR3-3; Sequence=VSP_019809;
CC       Name=4;
CC         IsoId=Q5THR3-4; Sequence=VSP_019808, VSP_019811;
CC         Note=No experimental confirmation available;
CC       Name=6;
CC         IsoId=Q5THR3-6; Sequence=VSP_034831, VSP_034832;
CC         Note=No experimental confirmation available;
CC       Name=5;
CC         IsoId=Q5THR3-5; Sequence=VSP_019812, VSP_019813;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in the testis.
CC   -!- SIMILARITY: Contains 17 EF-hand domains.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB073862; BAB71780.1; -; mRNA.
DR   EMBL; AK027241; BAB15703.1; -; mRNA.
DR   EMBL; AK292411; BAF85100.1; -; mRNA.
DR   EMBL; AK292498; BAF85187.1; -; mRNA.
DR   EMBL; AL355841; CAB91065.1; -; mRNA.
DR   EMBL; Z82201; CAQ07046.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ07046.1; JOINED; Genomic_DNA.
DR   EMBL; AL031843; CAQ07046.1; JOINED; Genomic_DNA.
DR   EMBL; AL118498; CAQ07046.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ07046.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ07047.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ07047.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ07047.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ09926.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ09926.1; JOINED; Genomic_DNA.
DR   EMBL; AL031843; CAQ09926.1; JOINED; Genomic_DNA.
DR   EMBL; AL118498; CAQ09926.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ09926.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ09928.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ09928.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ09928.1; JOINED; Genomic_DNA.
DR   EMBL; AL023801; CAQ10020.1; -; Genomic_DNA.
DR   EMBL; AL031843; CAQ10020.1; JOINED; Genomic_DNA.
DR   EMBL; AL118498; CAQ10020.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ10020.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ10020.1; JOINED; Genomic_DNA.
DR   EMBL; AL023801; CAQ10022.1; -; Genomic_DNA.
DR   EMBL; Z82201; CAQ10022.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ10022.1; JOINED; Genomic_DNA.
DR   EMBL; AL031843; CAQ10334.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ10334.1; JOINED; Genomic_DNA.
DR   EMBL; AL118498; CAQ10334.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ10334.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ10334.1; JOINED; Genomic_DNA.
DR   EMBL; AL118498; CAQ11050.1; -; Genomic_DNA.
DR   EMBL; AL023801; CAQ11050.1; JOINED; Genomic_DNA.
DR   EMBL; AL031843; CAQ11050.1; JOINED; Genomic_DNA.
DR   EMBL; Z82201; CAQ11050.1; JOINED; Genomic_DNA.
DR   EMBL; Z97055; CAQ11050.1; JOINED; Genomic_DNA.
DR   EMBL; BC039315; AAH39315.1; -; mRNA.
DR   EMBL; AB051459; BAB33342.1; -; mRNA.
DR   IPI; IPI00009724; -.
DR   IPI; IPI00394845; -.
DR   IPI; IPI00760567; -.
DR   IPI; IPI00760664; -.
DR   IPI; IPI00761031; -.
DR   IPI; IPI00889705; -.
DR   RefSeq; NP_073622.2; NM_022785.3.
DR   RefSeq; NP_942153.1; NM_198856.2.
DR   UniGene; Hs.658996; -.
DR   PDB; 1WLZ; X-ray; 1.60 A; A/B/C/D=1160-1260.
DR   PDBsum; 1WLZ; -.
DR   ProteinModelPortal; Q5THR3; -.
DR   SMR; Q5THR3; 71-135, 177-234, 303-361, 411-465, 512-567, 758-804, 851-1134, 1160-1242, 1331-1386, 1440-1498.
DR   STRING; Q5THR3; -.
DR   PhosphoSite; Q5THR3; -.
DR   DMDM; 74756634; -.
DR   PaxDb; Q5THR3; -.
DR   PRIDE; Q5THR3; -.
DR   Ensembl; ENST00000262726; ENSP00000262726; ENSG00000186976.
DR   Ensembl; ENST00000396231; ENSP00000379533; ENSG00000186976.
DR   GeneID; 64800; -.
DR   KEGG; hsa:64800; -.
DR   UCSC; uc003bdy.2; human.
DR   UCSC; uc003bea.2; human.
DR   UCSC; uc010gzj.1; human.
DR   CTD; 64800; -.
DR   GeneCards; GC22M043924; -.
DR   H-InvDB; HIX0016558; -.
DR   HGNC; HGNC:24204; EFCAB6.
DR   HPA; HPA003098; -.
DR   HPA; HPA018946; -.
DR   neXtProt; NX_Q5THR3; -.
DR   PharmGKB; PA162384324; -.
DR   eggNOG; NOG46752; -.
DR   HOVERGEN; HBG095997; -.
DR   InParanoid; Q5THR3; -.
DR   OMA; GMPMDDD; -.
DR   PhylomeDB; Q5THR3; -.
DR   EvolutionaryTrace; Q5THR3; -.
DR   GenomeRNAi; 64800; -.
DR   NextBio; 66882; -.
DR   ArrayExpress; Q5THR3; -.
DR   Bgee; Q5THR3; -.
DR   CleanEx; HS_EFCAB6; -.
DR   Genevestigator; Q5THR3; -.
DR   GermOnline; ENSG00000186976; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.238.10; EF-Hand_type; 12.
DR   InterPro; IPR011992; EF-hand-like_dom.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR018249; EF_HAND_2.
DR   InterPro; IPR002048; EF_hand_Ca-bd.
DR   InterPro; IPR015070; EF_hand_Ca-bd_contain_6.
DR   Pfam; PF08976; DUF1880; 1.
DR   SMART; SM00054; EFh; 12.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 17.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1501       EF-hand calcium-binding domain-containing
FT                                protein 6.
FT                                /FTId=PRO_0000246024.
FT   DOMAIN       70    105       EF-hand 1.
FT   DOMAIN      172    207       EF-hand 2.
FT   DOMAIN      297    332       EF-hand 3.
FT   DOMAIN      403    438       EF-hand 4.
FT   DOMAIN      439    474       EF-hand 5.
FT   DOMAIN      504    539       EF-hand 6.
FT   DOMAIN      634    669       EF-hand 7.
FT   DOMAIN      741    776       EF-hand 8.
FT   DOMAIN      847    882       EF-hand 9.
FT   DOMAIN      883    918       EF-hand 10.
FT   DOMAIN      964    999       EF-hand 11.
FT   DOMAIN     1069   1104       EF-hand 12.
FT   DOMAIN     1176   1211       EF-hand 13.
FT   DOMAIN     1212   1247       EF-hand 14.
FT   DOMAIN     1359   1394       EF-hand 15.
FT   DOMAIN     1434   1469       EF-hand 16.
FT   DOMAIN     1470   1501       EF-hand 17.
FT   CA_BIND     754    765       Potential.
FT   REGION     1303   1501       Interaction with PARK7.
FT   REGION     1407   1501       Interaction with AR.
FT   MOD_RES     283    283       Phosphoserine (By similarity).
FT   VAR_SEQ       1   1139       Missing (in isoform 4).
FT                                /FTId=VSP_019808.
FT   VAR_SEQ       1    931       Missing (in isoform 3).
FT                                /FTId=VSP_019809.
FT   VAR_SEQ       1    152       Missing (in isoform 2).
FT                                /FTId=VSP_019810.
FT   VAR_SEQ     418    420       KPD -> VRF (in isoform 6).
FT                                /FTId=VSP_034831.
FT   VAR_SEQ     421   1501       Missing (in isoform 6).
FT                                /FTId=VSP_034832.
FT   VAR_SEQ    1140   1140       E -> M (in isoform 4).
FT                                /FTId=VSP_019811.
FT   VAR_SEQ    1217   1249       FDRLWNEMPVNAKGRLKYPDFLSRFSSETAATP -> VRNA
FT                                SQSSPCTPLAERQPGPWPECTEFKTVLYF (in isoform
FT                                5).
FT                                /FTId=VSP_019812.
FT   VAR_SEQ    1250   1501       Missing (in isoform 5).
FT                                /FTId=VSP_019813.
FT   VARIANT     166    166       V -> A (in dbSNP:rs16990981).
FT                                /FTId=VAR_048648.
FT   VARIANT     199    199       R -> G (in dbSNP:rs3747203).
FT                                /FTId=VAR_048649.
FT   VARIANT     351    351       T -> A (in dbSNP:rs5764214).
FT                                /FTId=VAR_048650.
FT   VARIANT     384    384       S -> A (in dbSNP:rs6006438).
FT                                /FTId=VAR_048651.
FT   VARIANT     400    400       H -> Y (in dbSNP:rs137794).
FT                                /FTId=VAR_048652.
FT   VARIANT     680    680       T -> A (in dbSNP:rs137731).
FT                                /FTId=VAR_048653.
FT   VARIANT     780    780       D -> N (in dbSNP:rs12159591).
FT                                /FTId=VAR_048654.
FT   VARIANT     800    800       R -> W (in dbSNP:rs6006514).
FT                                /FTId=VAR_048655.
FT   VARIANT    1059   1059       A -> V (in dbSNP:rs9614382).
FT                                /FTId=VAR_048656.
FT   CONFLICT    478    478       S -> P (in Ref. 2; BAF85187).
FT   CONFLICT    726    726       I -> V (in Ref. 2; BAF85187).
FT   CONFLICT    833    833       A -> V (in Ref. 2; BAF85187).
FT   CONFLICT    882    882       P -> S (in Ref. 2; BAF85100).
FT   CONFLICT    990    990       Q -> H (in Ref. 1; BAB71780 and 2;
FT                                BAB15703).
FT   CONFLICT   1082   1082       D -> G (in Ref. 5; AAH39315).
FT   CONFLICT   1139   1139       E -> G (in Ref. 2; BAF85100).
FT   CONFLICT   1182   1182       T -> P (in Ref. 2; BAF85187).
FT   CONFLICT   1218   1218       D -> G (in Ref. 5; AAH39315).
FT   HELIX      1164   1176
FT   HELIX      1178   1188
FT   HELIX      1198   1208
FT   HELIX      1214   1221
FT   HELIX      1234   1241
SQ   SEQUENCE   1501 AA;  172930 MW;  1D380F63D7FA8FF9 CRC64;
     MCKMAIIPDW LRSHPHTRKF THSRPHSSPC RVYSRNGSPN KFRSSSTTAV ANPTLSSLDV
     KRILFQKITD RGDELQKAFQ LLDTGQNLTV SKSELRRIIT DFLMPLTREQ FQDVLAQIPL
     STSGTVPYLA FLSRFGGIDL YINGIKRGGG NEMNCCRTLR ELEIQVGEKV FKNIKTVMKA
     FELIDVNKTG LVRPQELRRV LETFCMKLRD EEYEKFSKHY NIHKDTAVDY NVFLKNLSIN
     NDLNLRYCMG NQEVSLENQQ AKNSKKERLL GSASSEDIWR NYSLDEIERN FCLQLSKSYE
     KVEKALSAGD PCKGGYVSFN YLKIVLDTFV YQIPRRIFIQ LMKRFGLKAT TKINWKQFLT
     SFHEPQGLQV SSKGPLTKRN SINSRNESHK ENIITKLFRH TEDHSASLKK ALLIINTKPD
     GPITREEFRY ILNCMAVKLS DSEFKELMQM LDPGDTGVVN TSMFIDLIEE NCRMRKTSPC
     TDAKTPFLLA WDSVEEIVHD TITRNLQAFY NMLRSYDLGD TGRIGRNNFK KIMHVFCPFL
     TNAHFIKLCS KIQDIGSGRI LYKKLLACIG IDGPPTVSPV LVPKDQLLSE HLQKDEQQQP
     DLSERTKLTE DKTTLTKKMT TEEVIEKFKK CIQQQDPAFK KRFLDFSKEP NGKINVHDFK
     KVLEDTGMPM DDDQYALLTT KIGFEKEGMS YLDFAAGFED PPMRGPETTP PQPPTPSKSY
     VNSHFITAEE CLKLFPRRLK ESFRDPYSAF FKTDADRDGI INMHDLHRLL LHLLLNLKDD
     EFERFLGLLG LRLSVTLNFR EFQNLCEKRP WRTDEAPQRL IRPKQKVADS ELACEQAHQY
     LVTKAKNRWS DLSKNFLETD NEGNGILRRR DIKNALYGFD IPLTPREFEK LWARYDTEGK
     GHITYQEFLQ KLGINYSPAV HRPCAEDYFN FMGHFTKPQQ LQEEMKELQQ STEKAVAARD
     KLMDRHQDIS KAFTKTDQSK TNYISICKMQ EVLEECGCSL TEGELTHLLN SWGVSRHDNA
     INYLDFLRAV ENSKSTGAQP KEKEESMPIN FATLNPQEAV RKIQEVVESS QLALSTAFSA
     LDKEDTGFVK ATEFGQVLKD FCYKLTDNQY HYFLRKLRIH LTPYINWKYF LQNFSCFLEE
     TADEWAEKMP KGPPPTSPKA TADRDILARL HKAVTSHYHA ITQEFENFDT MKTNTISREE
     FRAICNRRVQ ILTDEQFDRL WNEMPVNAKG RLKYPDFLSR FSSETAATPM ATGDSAVAQR
     GSSVPDVSEG TRSALSLPTQ ELRPGSKSQS HPCTPASTTV IPGTPPLQNC DPIESRLRKR
     IQGCWRQLLK ECKEKDVARQ GDINASDFLA LVEKFNLDIS KEECQQLIIK YDLKSNGKFA
     YCDFIQSCVL LLKAKESSLM HRMKIQNAHK MKEAGAETPS FYSALLRIQP KIVHCWRPMR
     RTFKSYDEAG TGLLSVADFR TVLRQYSINL SEEEFFHILE YYDKTLSSKI SYNDFLRAFL
     Q
//
ID   EFCB6_MACFA             Reviewed;         646 AA.
AC   Q4R8T1;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   28-NOV-2012, entry version 40.
DE   RecName: Full=EF-hand calcium-binding domain-containing protein 6;
DE   AltName: Full=DJ-1-binding protein;
DE            Short=DJBP;
DE   Flags: Fragment;
GN   Name=EFCAB6; Synonyms=DJBP; ORFNames=QtsA-11542;
OS   Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Cercopithecidae; Cercopithecinae; Macaca.
OX   NCBI_TaxID=9541;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RG   International consortium for macaque cDNA sequencing and analysis;
RT   "DNA sequences of macaque genes expressed in brain or testis and its
RT   evolutionary implications.";
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Negatively regulates the androgen receptor by recruiting
CC       histone deacetylase complex, and protein DJ-1 antagonizes this
CC       inhibition by abrogation of this complex (By similarity).
CC   -!- SUBUNIT: Binds PARK7. Part of a ternary complex containing PARK7,
CC       EFCAB6/DJBP and AR (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity).
CC   -!- SIMILARITY: Contains at least 10 EF-hand domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE00490.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB168367; BAE00490.1; ALT_INIT; mRNA.
DR   ProteinModelPortal; Q4R8T1; -.
DR   SMR; Q4R8T1; 305-387.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.238.10; EF-Hand_type; 6.
DR   InterPro; IPR011992; EF-hand-like_dom.
DR   InterPro; IPR018249; EF_HAND_2.
DR   InterPro; IPR002048; EF_hand_Ca-bd.
DR   InterPro; IPR015070; EF_hand_Ca-bd_contain_6.
DR   Pfam; PF08976; DUF1880; 1.
DR   SMART; SM00054; EFh; 6.
DR   PROSITE; PS00018; EF_HAND_1; FALSE_NEG.
DR   PROSITE; PS50222; EF_HAND_2; 10.
PE   2: Evidence at transcript level;
KW   Calcium; Nucleus; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN        <1    646       EF-hand calcium-binding domain-containing
FT                                protein 6.
FT                                /FTId=PRO_0000246025.
FT   DOMAIN       <1     27       EF-hand 1.
FT   DOMAIN       28     63       EF-hand 2.
FT   DOMAIN      109    144       EF-hand 3.
FT   DOMAIN      214    249       EF-hand 4.
FT   DOMAIN      321    356       EF-hand 5.
FT   DOMAIN      357    392       EF-hand 6.
FT   DOMAIN      468    503       EF-hand 7.
FT   DOMAIN      504    539       EF-hand 8.
FT   DOMAIN      579    614       EF-hand 9.
FT   DOMAIN      615    646       EF-hand 10.
FT   REGION      448    646       Interaction with PARK7 (By similarity).
FT   REGION      552    646       Interaction with AR (By similarity).
FT   NON_TER       1      1
SQ   SEQUENCE   646 AA;  74091 MW;  BACAD0B0B8AFE4AD CRC64;
     FLETDNEGNG ILRRRDIKNA LYGFDIPLTP REFEKLWASY DTEGKGHITY QEFLQKLGVN
     YSPAVHRPCA EDYFNFMGHF TKPQQLQEEM KELQQSTEKA VAARDKLVDC YQDISKAFTK
     IDKSKTNYIS ICKMQKVLEE CGCSLTEGEL TNLLNSWGVS RHDNSINYLD FLRAVENSKS
     TGAQPKEKEE SMPINFATLN PQEVVRKIQE VVESSQLALS TAFSALDKED TGFVKSTEFG
     QVLKDFCHKL TDNQYHYFLR KLRIHLTPYI NWKYFLQNFS CFLEETAEEW AEKMPKGPPP
     TSPKAMASRD ILARLHKAVT SHYHAITQEF ENFDTMKTNT ISREEFRAVC NRNVQILTDE
     QFDRLWNEMP VNAKGRLKYP DFLSRFSSER AATPTATGDS AAAQRGSSVP DVSEGIRSAL
     SLPNQELRPG SKPQSHPCTA ASTTAIPGTP PLQNCDPIES RLRKRIQGCW RQLLKECKEK
     DVARQGDISA SEFLALVEKF NLDISKEECQ QLIIKYDLKN NGKFAYCDFI QSCVLLLKAK
     ESSLMQRMKI QNAHKMKDSG AETSSFYSAL LRIQPKIVHC WRPMRRTFKS YDEAGTGLLS
     VADFRTVLRQ YSINLSEEEF FHILEYYDKT LSSNISYNDF LRAFLQ
//
ID   EFCB6_MOUSE             Reviewed;        1516 AA.
AC   Q6P1E8; A6PW10; A6PW11; A6PW12; Q5DTV8; Q6PGK8; Q9D2D8;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   28-NOV-2012, entry version 75.
DE   RecName: Full=EF-hand calcium-binding domain-containing protein 6;
DE   AltName: Full=DJ-1-binding protein;
DE            Short=DJBP;
GN   Name=Efcab6; Synonyms=Djbp, Kiaa1672;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RA   Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Nagase T., Ohara O.,
RA   Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene.
RT   The complete nucleotide sequences of mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=19367708; DOI=10.1021/pr800599n;
RA   Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,
RA   Faessler R., Mann M.;
RT   "Solid tumor proteome and phosphoproteome analysis by high resolution
RT   mass spectrometry.";
RL   J. Proteome Res. 7:5314-5326(2008).
CC   -!- FUNCTION: Negatively regulates the androgen receptor by recruiting
CC       histone deacetylase complex, and protein DJ-1 antagonizes this
CC       inhibition by abrogation of this complex (By similarity).
CC   -!- SUBUNIT: Binds PARK7. Part of a ternary complex containing PARK7,
CC       EFCAB6/DJBP and AR (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6P1E8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6P1E8-3; Sequence=VSP_019814;
CC       Name=3;
CC         IsoId=Q6P1E8-4; Sequence=VSP_029427, VSP_029428;
CC         Note=Gene prediction based on EST data;
CC   -!- SIMILARITY: Contains 15 EF-hand domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH56955.1; Type=Erroneous initiation;
CC       Sequence=AAH65111.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK019850; BAB31880.1; -; mRNA.
DR   EMBL; AK220412; BAD90458.1; -; mRNA.
DR   EMBL; AL513354; CAO78062.1; -; Genomic_DNA.
DR   EMBL; AL603867; CAO78062.1; JOINED; Genomic_DNA.
DR   EMBL; AL513354; CAO78063.1; -; Genomic_DNA.
DR   EMBL; AL513354; CAO78064.1; -; Genomic_DNA.
DR   EMBL; AL603867; CAO77882.1; -; Genomic_DNA.
DR   EMBL; AL513354; CAO77882.1; JOINED; Genomic_DNA.
DR   EMBL; BC056955; AAH56955.1; ALT_INIT; mRNA.
DR   EMBL; BC065111; AAH65111.1; ALT_INIT; mRNA.
DR   IPI; IPI00134721; -.
DR   IPI; IPI00761712; -.
DR   IPI; IPI00857697; -.
DR   RefSeq; NP_001155100.1; NM_001161628.1.
DR   RefSeq; NP_001155101.1; NM_001161629.1.
DR   RefSeq; NP_084222.4; NM_029946.4.
DR   UniGene; Mm.196288; -.
DR   ProteinModelPortal; Q6P1E8; -.
DR   SMR; Q6P1E8; 101-159, 201-262, 326-383, 432-489, 533-592, 661-720, 771-825, 877-931, 983-1259, 1342-1402, 1455-1511.
DR   PhosphoSite; Q6P1E8; -.
DR   PaxDb; Q6P1E8; -.
DR   PRIDE; Q6P1E8; -.
DR   Ensembl; ENSMUST00000156187; ENSMUSP00000114909; ENSMUSG00000022441.
DR   GeneID; 77627; -.
DR   KEGG; mmu:77627; -.
DR   UCSC; uc007xbo.1; mouse.
DR   UCSC; uc007xbq.1; mouse.
DR   UCSC; uc007xbr.1; mouse.
DR   CTD; 64800; -.
DR   MGI; MGI:1924877; Efcab6.
DR   eggNOG; NOG46752; -.
DR   GeneTree; ENSGT00390000013629; -.
DR   HOVERGEN; HBG095997; -.
DR   InParanoid; Q6P1E8; -.
DR   OMA; GMPMDDD; -.
DR   OrthoDB; EOG4T1HKM; -.
DR   NextBio; 347254; -.
DR   ArrayExpress; Q6P1E8; -.
DR   Bgee; Q6P1E8; -.
DR   CleanEx; MM_EFCAB6; -.
DR   Genevestigator; Q6P1E8; -.
DR   GermOnline; ENSMUSG00000022441; Mus musculus.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.238.10; EF-Hand_type; 13.
DR   InterPro; IPR011992; EF-hand-like_dom.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR018249; EF_HAND_2.
DR   InterPro; IPR002048; EF_hand_Ca-bd.
DR   InterPro; IPR015070; EF_hand_Ca-bd_contain_6.
DR   Pfam; PF08976; DUF1880; 1.
DR   Pfam; PF13202; EF_hand_3; 1.
DR   SMART; SM00054; EFh; 11.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 15.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN         1   1516       EF-hand calcium-binding domain-containing
FT                                protein 6.
FT                                /FTId=PRO_0000246026.
FT   DOMAIN       96    131       EF-hand 1.
FT   DOMAIN      197    232       EF-hand 2.
FT   DOMAIN      321    356       EF-hand 3.
FT   DOMAIN      427    462       EF-hand 4.
FT   DOMAIN      528    563       EF-hand 5.
FT   DOMAIN      655    690       EF-hand 6.
FT   DOMAIN      763    798       EF-hand 7.
FT   DOMAIN      905    940       EF-hand 8.
FT   DOMAIN     1086   1121       EF-hand 9.
FT   DOMAIN     1193   1228       EF-hand 10.
FT   DOMAIN     1229   1264       EF-hand 11.
FT   DOMAIN     1338   1373       EF-hand 12.
FT   DOMAIN     1374   1409       EF-hand 13.
FT   DOMAIN     1449   1484       EF-hand 14.
FT   DOMAIN     1485   1516       EF-hand 15.
FT   CA_BIND     109    120       1 (Potential).
FT   CA_BIND     210    221       2 (Potential).
FT   CA_BIND     776    787       7 (Potential).
FT   CA_BIND    1462   1473       14 (Potential).
FT   REGION     1318   1516       Interaction with PARK7 (By similarity).
FT   REGION     1422   1516       Interaction with AR (By similarity).
FT   MOD_RES     307    307       Phosphoserine.
FT   VAR_SEQ       1    838       Missing (in isoform 3).
FT                                /FTId=VSP_029427.
FT   VAR_SEQ       1    688       Missing (in isoform 2).
FT                                /FTId=VSP_019814.
FT   VAR_SEQ     839    844       PQRLIR -> MSKKHG (in isoform 3).
FT                                /FTId=VSP_029428.
FT   CONFLICT    632    632       E -> K (in Ref. 4; AAH65111).
FT   CONFLICT   1101   1101       E -> V (in Ref. 2; BAD90458).
FT   CONFLICT   1181   1181       R -> K (in Ref. 2; BAD90458).
FT   CONFLICT   1391   1391       Missing (in Ref. 4; AAH56955).
SQ   SEQUENCE   1516 AA;  175771 MW;  786C634E6CFA5CFD CRC64;
     MKRNGTRLNF AKANSTKSGS TRARDLMNKM SIIPEWHSLY SNTRKLPCSR PHSSPCKMQR
     TIFQDLCRPS SSTTAIANPV LSYLDIERIL AQKISSRRDD IKKVFQILDR NHNQMVTKGD
     LKRVITAFLI PLTKDQFQDL LAQIPISSLG NVPYLEFLSR FGGGIDININ GIKRVNENEV
     DNRRTVKEVQ LTEKIFRNMR SIRKVFQVMD VNNTGLVQPQ ELRRVLETFC LRMQDGDYEK
     FLEQYNIDKT TAVDYNAFLK NLSVKNDASF KYLLSNAAEL SRETQQGKNG KRLLDTGSSE
     DVWKNYSLDD LEKTFCQEFS KSYEKIEKAL SAGDPSKGGY ISLNYLKVVL DTFIYRLPRR
     IFIQLIRRFG LKTSTKINWK QFLTAIYERQ KLEVSKTLPL KKRSSTEARN RSRKENIIKK
     LFKYSEDRYT ALKKTLLIIS STPSGHITWE ELRHILNCMV AKLNDSEFSE LKQTFDPEGT
     GAVRVNSLLD VLDDSTKVRK MSPSTDTKTP LPVAWDSVEE LVLDSITRNL QAFYSMLQSY
     DLRDTGTIGK NNFRKVMRVF CPYLSNEHLV RFSSKFQEAG SGRILYKKFL LSIGVGIPPP
     TPPLSSPKVQ LSDQFQIEEP GQQDERTQPS GEKTSEINNM TKEEVIDGLK HRIQQKDPVF
     RKQFLSISKE PDVKINQEEF RKVLERSGMP MNDCQYAMLA SKLGFKNEEG MSYQDFTMGF
     EDCMLSGLET VPLQSRTASR TNMDEHFISA EECLRIFPKK LKESFRDVYS AFFRIDLDRD
     GIISMHDFHR LLQYLQLNMV DLEFERFLSL LGLRLSVTLN FREFQNLCEK RPWKSDEAPQ
     RLIRCKQKVA DSELACEQAH QYLIMKAKTR WADLSKNFIE TDNEGNGILR RRDIKNSLYG
     FDIPLTPREF EKLWQNYDTE GRGYITYQEF LHRLGIRYSP KVHRPYKEDY FNFLGHFTKP
     KQVQEEIQEL QQISEREKLM NHYEEISKAF NAMEKSKPVA LCRVQKVLQE CGCPLKEEEL
     ISLLKSLDVS VHNNHIDPVE FLRALEISWA SKARPKEKEE SSPPPISFSK VTPDEVIKTM
     QEVVESSQPA LVEAFSALDK EDTGFVKAME FGDVLRSVCQ KLTDNQYHYF LRRLRLHLTP
     NIHWKYFLEN FSTFQDETAD DWAENMPKAP PPMSPKETAH RDIVARVQKA VASHYHTIVQ
     EFENFDTLKS NTVSRDEFRS ICTRHIQILT DEQFDRLWSE LPVNAKGRLK YQDFLSKLSI
     ERVPSPPMAA GDSGESTMAQ RGSSAPEFSQ GTRSNLYSPP RDSRVGLKSR SHPCTPVGTP
     PLQNCEPIES RLRKQIQGCW RELLRECKEK DTDKQGTISA AEFLALVEKF KLDISREESQ
     QLIVKYDLKN NGKFAYCDFI QSCVLLLKAK ETSLMRRMRI QNADKMKEAG METPSFYSAL
     LRIQPKIVHC WRPMRRSFKT YDKNGTGLLS VADFRKVLRQ YSINLSEEEF FHVLEYYDKS
     LSSKISYNDF LRAFLQ
//
ID   EFCB6_PONAB             Reviewed;        1013 AA.
AC   Q5RE62;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   28-NOV-2012, entry version 46.
DE   RecName: Full=EF-hand calcium-binding domain-containing protein 6;
DE   AltName: Full=DJ-1-binding protein;
DE            Short=DJBP;
GN   Name=EFCAB6; Synonyms=DJBP;
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Negatively regulates the androgen receptor by recruiting
CC       histone deacetylase complex, and protein DJ-1 antagonizes this
CC       inhibition by abrogation of this complex (By similarity).
CC   -!- SUBUNIT: Binds PARK7. Part of a ternary complex containing PARK7,
CC       EFCAB6/DJBP and AR (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity).
CC   -!- SIMILARITY: Contains 11 EF-hand domains.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR857675; CAH89945.1; -; Transcribed_RNA.
DR   ProteinModelPortal; Q5RE62; -.
DR   HOVERGEN; HBG095997; -.
DR   InParanoid; Q5RE62; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.238.10; EF-Hand_type; 9.
DR   InterPro; IPR011992; EF-hand-like_dom.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR018249; EF_HAND_2.
DR   InterPro; IPR002048; EF_hand_Ca-bd.
DR   SMART; SM00054; EFh; 9.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 11.
PE   3: Inferred from homology;
KW   Calcium; Complete proteome; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1013       EF-hand calcium-binding domain-containing
FT                                protein 6.
FT                                /FTId=PRO_0000246027.
FT   DOMAIN       20     55       EF-hand 1.
FT   DOMAIN      145    180       EF-hand 2.
FT   DOMAIN      251    286       EF-hand 3.
FT   DOMAIN      287    322       EF-hand 4.
FT   DOMAIN      352    387       EF-hand 5.
FT   DOMAIN      482    517       EF-hand 6.
FT   DOMAIN      589    624       EF-hand 7.
FT   DOMAIN      695    730       EF-hand 8.
FT   DOMAIN      731    766       EF-hand 9.
FT   DOMAIN      812    847       EF-hand 10.
FT   DOMAIN      917    952       EF-hand 11.
FT   CA_BIND     602    613       Potential.
FT   MOD_RES     131    131       Phosphoserine (By similarity).
SQ   SEQUENCE   1013 AA;  117761 MW;  5C1E8DB93920AB42 CRC64;
     MNCCRTLREL EIQVGEKVFK NIKTVMKAFK LIDVNKTGLV RPQELRRVLE TFCLKLRDEE
     YEKFSKHYNI HNDTAVDYNV FLKNLSINND LNLRYCMGNQ EVSLENQQAR NSKKERLLGS
     ASSEDIWRNY SLDDIERNFC LELSKSYEKI EKALSAGDPC KGGYVSFNYL KIVLDTFIYQ
     IPRRIFIQLM KRFGLKATTK INWKQFLTSF HEPQGLQVSN KGPLTKRNSI NSRSESRKEN
     IITKLFRCTE DRSASLKKAL LIINTKPDGP ITREEFRYIL NCVAIKLSDS EFKELMQILD
     PGDTGVVNTS MFIDLIEENC RMRKTSPCTD AKTPFLLAWD SVEEIVHDTI ARNLQAFYNM
     LRSYDLGDTG LIGRNNFKKI MHVFCPFLTN AHFIKLCSKI QDIGSGRILY KKLLACIGID
     GPPTVSPVLV PKDQLLSEHL QKDEQQQPDL SERTKPTEDK TTLTKKMTTE EVIEKFRKYI
     QQQDPAFKKR FLDFSKEPNG KINVHDFRKI LEDTGMPMDD DQYALLTTKI GFEKEGMSYL
     DFAAGFEDPP MRGLETTPPQ PPTPSKSYVN SHLITAEECL KLFPRRLKES FRDPYSAFFK
     TDVDRDGIIN MHDLHRLLLH LLLNLKDDEF ERFLGLLGLR LSVTLNFREF QNLCEKRPWR
     TDEAPQRLIR PKQKVADSEL ACEQAHQYLV TKAKNRWSDL SKNFLETDNE GNGILRRRDI
     KNALYGFDIP LTPREFEKLW ARYNTEGKGH ITYQEFLQKL GINYSPAVHQ PCAEDYFNFM
     GHFTKPQQLQ EEMKELQQST EKAMAARDKL MDLHQDISKA FTKIDKSKTN YISICKMQKV
     LEECGCSLTE GELTHLLNSW GVSRHENAIN YLDFLRAVEN SKSTGAQPKE KEESMPISFA
     TLNPQEVVRK IQEVVESSQL ALSTAFSALD KEDTGFVKAT EFGQVLKDFC YKLMDNQYHY
     FLRKLRIHLT PYINWKYFLQ NFSCFLEEVR ISAAHKHLFE NELKLVFTKW IID
//
ID   ELBB_ECOLI              Reviewed;         217 AA.
AC   P0ABU5; P26428; P76673; Q2M903;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   28-NOV-2012, entry version 63.
DE   RecName: Full=Enhancing lycopene biosynthesis protein 2;
DE   AltName: Full=Sigma cross-reacting protein 27A;
DE            Short=SCRP-27A;
GN   Name=elbB; Synonyms=elb2, yzzB; OrderedLocusNames=b3209, JW3176;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Smillie D.A., Fujita N., Townsley F.M., Ishihama A., Hayward R.S.;
RT   "Sequence and characterisation of the gene encoding the sigma cross-
RT   reacting protein 27A in Escherichia coli.";
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   MEDLINE=97426617; PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1474(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 1-24.
RX   MEDLINE=92246944; PubMed=1575737; DOI=10.1016/0006-291X(92)90636-Y;
RA   Ueshima R., Fujita N., Ishihama A.;
RT   "Identification of Escherichia coli proteins cross-reacting with
RT   antibodies against region 2.2 peptide of RNA polymerase sigma
RT   subunit.";
RL   Biochem. Biophys. Res. Commun. 184:634-639(1992).
RN   [5]
RP   POSSIBLE FUNCTION.
RX   MEDLINE=98269038; PubMed=9603997;
RA   Hemmi H., Ohnuma S., Nagaoka K., Nishino T.;
RT   "Identification of genes affecting lycopene formation in Escherichia
RT   coli transformed with carotenoid biosynthetic genes: candidates for
RT   early genes in isoprenoid biosynthesis.";
RL   J. Biochem. 123:1088-1096(1998).
CC   -!- FUNCTION: May be involved in the early steps of isoprenoid
CC       biosynthesis.
CC   -!- INTERACTION:
CC       P0A8V2:rpoB; NbExp=1; IntAct=EBI-1132026, EBI-544996;
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58011.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13188; BAA02487.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA58011.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC76241.2; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77253.1; -; Genomic_DNA.
DR   PIR; C65112; C65112.
DR   RefSeq; NP_417676.2; NC_000913.2.
DR   RefSeq; YP_491394.1; NC_007779.1.
DR   PDB; 1OY1; X-ray; 2.95 A; A/B/C/D=1-217.
DR   PDB; 1VHQ; X-ray; 1.65 A; A/B=1-217.
DR   PDBsum; 1OY1; -.
DR   PDBsum; 1VHQ; -.
DR   ProteinModelPortal; P0ABU5; -.
DR   SMR; P0ABU5; 1-217.
DR   DIP; DIP-48002N; -.
DR   IntAct; P0ABU5; 1.
DR   SWISS-2DPAGE; P0ABU5; -.
DR   PRIDE; P0ABU5; -.
DR   EnsemblBacteria; EBESCT00000005027; EBESCP00000005027; EBESCG00000004103.
DR   EnsemblBacteria; EBESCT00000017456; EBESCP00000016747; EBESCG00000016512.
DR   GeneID; 12933434; -.
DR   GeneID; 947903; -.
DR   GenomeReviews; AP009048_GR; JW3176.
DR   GenomeReviews; U00096_GR; b3209.
DR   KEGG; ecj:Y75_p3129; -.
DR   KEGG; eco:b3209; -.
DR   PATRIC; 32121838; VBIEscCol129921_3303.
DR   EchoBASE; EB1356; -.
DR   EcoGene; EG11383; elbB.
DR   eggNOG; COG3155; -.
DR   HOGENOM; HOG000269874; -.
DR   OMA; QCFAPDI; -.
DR   ProtClustDB; PRK11780; -.
DR   BioCyc; EcoCyc:EG11383-MONOMER; -.
DR   BioCyc; ECOL316407:JW3176-MONOMER; -.
DR   EvolutionaryTrace; P0ABU5; -.
DR   Genevestigator; P0ABU5; -.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IMP:EcoliWiki.
DR   GO; GO:0045828; P:positive regulation of isoprenoid metabolic process; IMP:EcoliWiki.
DR   InterPro; IPR026041; Elb2.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF006320; Elb2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Isoprene biosynthesis; Reference proteome.
FT   CHAIN         1    217       Enhancing lycopene biosynthesis protein
FT                                2.
FT                                /FTId=PRO_0000201681.
FT   CONFLICT    111    111       C -> S (in Ref. 1; BAA02487).
FT   CONFLICT    195    217       AQNIAEAASGIDKLVSRVLVLAE -> RRTLQKRRAALISW
FT                                FPACWFWLNE (in Ref. 1; BAA02487).
FT   STRAND        3      7
FT   STRAND       10     12
FT   TURN         13     15
FT   HELIX        19     31
FT   STRAND       35     40
FT   STRAND       42     44
FT   TURN         51     53
FT   HELIX        63     67
FT   TURN         68     73
FT   HELIX        78     80
FT   HELIX        83     85
FT   STRAND       87     91
FT   HELIX        96     99
FT   HELIX       104    107
FT   HELIX       108    110
FT   HELIX       115    126
FT   STRAND      131    134
FT   HELIX       137    140
FT   HELIX       141    144
FT   HELIX       157    165
FT   STRAND      179    181
FT   TURN        182    185
FT   STRAND      186    189
FT   HELIX       191    193
FT   HELIX       198    216
SQ   SEQUENCE   217 AA;  22982 MW;  48A7957C29384DAC CRC64;
     MKKIGVILSG CGVYDGSEIH EAVLTLLAIS RSGAQAVCFA PDKQQVDVIN HLTGEAMTET
     RNVLIEAARI TRGEIRPLAQ ADAAELDALI VPGGFGAAKN LSNFASLGSE CTVDRELKAL
     AQAMHQAGKP LGFMCIAPAM LPKIFDFPLR LTIGTDIDTA EVLEEMGAEH VPCPVDDIVV
     DEDNKIVTTP AYMLAQNIAE AASGIDKLVS RVLVLAE
//
ID   ELBB_SHIFL              Reviewed;         217 AA.
AC   P0ABU6; P26428; P76673;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   28-NOV-2012, entry version 41.
DE   RecName: Full=Enhancing lycopene biosynthesis protein 2;
GN   Name=elbB; OrderedLocusNames=SF3249, S3467;
OS   Shigella flexneri.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=301 / Serotype 2a;
RX   MEDLINE=22272406; PubMed=12384590; DOI=10.1093/nar/gkf566;
RA   Jin Q., Yuan Z., Xu J., Wang Y., Shen Y., Lu W., Wang J., Liu H.,
RA   Yang J., Yang F., Zhang X., Zhang J., Yang G., Wu H., Qu D., Dong J.,
RA   Sun L., Xue Y., Zhao A., Gao Y., Zhu J., Kan B., Ding K., Chen S.,
RA   Cheng H., Yao Z., He B., Chen R., Ma D., Qiang B., Wen Y., Hou Y.,
RA   Yu J.;
RT   "Genome sequence of Shigella flexneri 2a: insights into pathogenicity
RT   through comparison with genomes of Escherichia coli K12 and O157.";
RL   Nucleic Acids Res. 30:4432-4441(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700930 / 2457T / Serotype 2a;
RX   MEDLINE=22590274; PubMed=12704152;
RX   DOI=10.1128/IAI.71.5.2775-2786.2003;
RA   Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W.,
RA   Fournier G., Mayhew G.F., Plunkett G. III, Rose D.J., Darling A.,
RA   Mau B., Perna N.T., Payne S.M., Runyen-Janecky L.J., Zhou S.,
RA   Schwartz D.C., Blattner F.R.;
RT   "Complete genome sequence and comparative genomics of Shigella
RT   flexneri serotype 2a strain 2457T.";
RL   Infect. Immun. 71:2775-2786(2003).
CC   -!- FUNCTION: May be involved in the early steps of isoprenoid
CC       biosynthesis (By similarity).
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005674; AAN44714.2; -; Genomic_DNA.
DR   EMBL; AE014073; AAP18528.1; -; Genomic_DNA.
DR   RefSeq; NP_709007.2; NC_004337.2.
DR   RefSeq; NP_838717.1; NC_004741.1.
DR   ProteinModelPortal; P0ABU6; -.
DR   SMR; P0ABU6; 1-217.
DR   PRIDE; P0ABU6; -.
DR   EnsemblBacteria; EBESCT00000085717; EBESCP00000082539; EBESCG00000084762.
DR   EnsemblBacteria; EBESCT00000092786; EBESCP00000089422; EBESCG00000091830.
DR   GeneID; 1027090; -.
DR   GeneID; 1079698; -.
DR   GenomeReviews; AE005674_GR; SF3249.
DR   GenomeReviews; AE014073_GR; S3467.
DR   KEGG; sfl:SF3249; -.
DR   KEGG; sfx:S3467; -.
DR   PATRIC; 18708687; VBIShiFle31049_3789.
DR   eggNOG; COG3155; -.
DR   HOGENOM; HOG000269874; -.
DR   ProtClustDB; PRK11780; -.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR026041; Elb2.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF006320; Elb2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Isoprene biosynthesis.
FT   CHAIN         1    217       Enhancing lycopene biosynthesis protein
FT                                2.
FT                                /FTId=PRO_0000201682.
SQ   SEQUENCE   217 AA;  22982 MW;  48A7957C29384DAC CRC64;
     MKKIGVILSG CGVYDGSEIH EAVLTLLAIS RSGAQAVCFA PDKQQVDVIN HLTGEAMTET
     RNVLIEAARI TRGEIRPLAQ ADAAELDALI VPGGFGAAKN LSNFASLGSE CTVDRELKAL
     AQAMHQAGKP LGFMCIAPAM LPKIFDFPLR LTIGTDIDTA EVLEEMGAEH VPCPVDDIVV
     DEDNKIVTTP AYMLAQNIAE AASGIDKLVS RVLVLAE
//
ID   ES1_DANRE               Reviewed;         270 AA.
AC   Q90257;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   06-FEB-2013, entry version 66.
DE   RecName: Full=ES1 protein, mitochondrial;
DE   Flags: Precursor;
GN   Name=es1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Eye;
RX   MEDLINE=97410119; PubMed=9266834; DOI=10.1006/bbrc.1997.7081;
RA   Chang H., Gilbert W.;
RT   "A novel zebrafish gene expressed specifically in the photoreceptor
RT   cells of the retina.";
RL   Biochem. Biophys. Res. Commun. 237:84-89(1997).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion (Potential).
CC   -!- TISSUE SPECIFICITY: Expressed specifically in photoreceptor cells
CC       of the retina.
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10403; AAC60261.1; -; mRNA.
DR   IPI; IPI00500054; -.
DR   PIR; JC5603; JC5603.
DR   RefSeq; NP_571114.1; NM_131039.1.
DR   UniGene; Dr.1461; -.
DR   ProteinModelPortal; Q90257; -.
DR   STRING; Q90257; -.
DR   PRIDE; Q90257; -.
DR   GeneID; 30237; -.
DR   KEGG; dre:30237; -.
DR   CTD; 30237; -.
DR   ZFIN; ZDB-GENE-980526-188; es1.
DR   eggNOG; COG3155; -.
DR   HOGENOM; HOG000269874; -.
DR   HOVERGEN; HBG001844; -.
DR   InParanoid; Q90257; -.
DR   OrthoDB; EOG4NS3CF; -.
DR   NextBio; 20806691; -.
DR   ArrayExpress; Q90257; -.
DR   GO; GO:0005739; C:mitochondrion; IBA:RefGenome.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Mitochondrion; Reference proteome; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion (Potential).
FT   CHAIN         ?    270       ES1 protein, mitochondrial.
FT                                /FTId=PRO_0000008546.
SQ   SEQUENCE   270 AA;  30685 MW;  602B1BEB0EC7AB64 CRC64;
     MLASRALLAK QAAAMLVRQP ACLMHHGGDW GNWGNTNIAV VFSGCGWWDG TDIHEAAYTM
     YHLSRNGARF QIFAPNQQQM HVMDHMKMQP SSSDNRNIMM ESARFSHGQG MMQMNDLSKL
     DANSFDAVIF PGGHGIVKNM STFSKDGKDC KLNNDVERVL KDFHRARKPI GLSSMAPLLA
     CRVLPSLEVT MGYERDESSR WGRWPNTNMV QAVKSMGARH NTREPYEAYV DEKNKVISTP
     TFMWETDYHY HYIFDGIGNM VKHVMRMTAK
//
ID   ES1_HUMAN               Reviewed;         268 AA.
AC   P30042; A6NFJ6; A6NJY7; O00650; O00660; O15011; O15012; P55346;
AC   P78474; Q92505; Q92507;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   28-NOV-2012, entry version 122.
DE   RecName: Full=ES1 protein homolog, mitochondrial;
DE   AltName: Full=Protein GT335;
DE   AltName: Full=Protein KNP-I;
DE   Flags: Precursor;
GN   Name=C21orf33; Synonyms=HES1, KNPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-6.
RC   TISSUE=Brain;
RX   MEDLINE=96354831; PubMed=8753807; DOI=10.1006/bbrc.1996.1218;
RA   Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ito F.,
RA   Shimizu N.;
RT   "Isolation of cDNA for a novel human protein KNP-I that is homologous
RT   to the E. coli SCRP-27A protein from the autoimmune polyglandular
RT   disease type I (APECED) region of chromosome 21q22.3.";
RL   Biochem. Biophys. Res. Commun. 225:608-616(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-6.
RX   MEDLINE=97131503; PubMed=8975701; DOI=10.1006/geno.1996.0627;
RA   Lafreniere R.G., Rochefort D.L., Kibar Z., Fon E.A., Han F.-Y.,
RA   Cochius J., Kang X., Baird S., Korneluk R.G., Andermann E.,
RA   Rommens J.M., Rouleau G.A.;
RT   "Isolation and characterization of GT335, a novel human gene conserved
RT   in Escherichia coli and mapping to 21q22.3.";
RL   Genomics 38:264-272(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-6.
RX   MEDLINE=97295076; PubMed=9150728; DOI=10.1007/s004390050416;
RA   Scott H.S., Chen H., Rossier C., Lalioti M.D., Antonarakis S.E.;
RT   "Isolation of a human gene (HES1) with homology to an Escherichia coli
RT   and a zebrafish protein that maps to chromosome 21q22.3.";
RL   Hum. Genet. 99:616-623(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20289799; PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-6.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-226.
RX   MEDLINE=97349125; PubMed=9205129; DOI=10.1006/geno.1997.4761;
RA   Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ito F.,
RA   Shimizu N.;
RT   "Genomic organization and complete nucleotide sequence of the human
RT   PWP2 gene on chromosome 21.";
RL   Genomics 42:528-531(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 117-141, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 144-174.
RA   Shimizu N.;
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PROTEIN SEQUENCE OF 42-54.
RC   TISSUE=Liver;
RX   MEDLINE=93162045; PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-164, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P30042-1; Sequence=Displayed;
CC       Name=Short; Synonyms=KNP-IB;
CC         IsoId=P30042-2; Sequence=VSP_001454;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, but strongly expressed in heart
CC       and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/C21orf33";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D86061; BAA12984.1; -; mRNA.
DR   EMBL; D86062; BAA12985.1; -; mRNA.
DR   EMBL; U53003; AAC50937.1; -; mRNA.
DR   EMBL; U53007; AAC50938.1; -; Genomic_DNA.
DR   EMBL; U53004; AAC50938.1; JOINED; Genomic_DNA.
DR   EMBL; U53005; AAC50938.1; JOINED; Genomic_DNA.
DR   EMBL; U53006; AAC50938.1; JOINED; Genomic_DNA.
DR   EMBL; Y07572; CAA68857.1; -; mRNA.
DR   EMBL; BC002370; AAH02370.1; -; mRNA.
DR   EMBL; BC003587; AAH03587.1; -; mRNA.
DR   EMBL; AP001753; BAA95554.1; -; Genomic_DNA.
DR   EMBL; AB001517; BAA21138.1; -; Genomic_DNA.
DR   EMBL; AB001517; BAA21139.1; -; Genomic_DNA.
DR   EMBL; D86060; BAA20888.1; -; Genomic_DNA.
DR   IPI; IPI00024913; -.
DR   IPI; IPI00218482; -.
DR   PIR; JC4913; JC4913.
DR   PIR; JC4914; JC4914.
DR   RefSeq; NP_004640.3; NM_004649.6.
DR   RefSeq; NP_937798.3; NM_198155.3.
DR   UniGene; Hs.413482; -.
DR   ProteinModelPortal; P30042; -.
DR   SMR; P30042; 43-267.
DR   IntAct; P30042; 3.
DR   MINT; MINT-1423060; -.
DR   STRING; P30042; -.
DR   MEROPS; C56.975; -.
DR   PhosphoSite; P30042; -.
DR   DMDM; 116241354; -.
DR   OGP; P30042; -.
DR   REPRODUCTION-2DPAGE; IPI00024913; -.
DR   Siena-2DPAGE; P30042; -.
DR   SWISS-2DPAGE; P30042; -.
DR   UCD-2DPAGE; P30042; -.
DR   PaxDb; P30042; -.
DR   PRIDE; P30042; -.
DR   DNASU; 8209; -.
DR   Ensembl; ENST00000291577; ENSP00000291577; ENSG00000160221.
DR   Ensembl; ENST00000348499; ENSP00000344901; ENSG00000160221.
DR   GeneID; 8209; -.
DR   KEGG; hsa:8209; -.
DR   UCSC; uc002zec.4; human.
DR   UCSC; uc002zed.4; human.
DR   CTD; 8209; -.
DR   GeneCards; GC21P045553; -.
DR   H-InvDB; HIX0016163; -.
DR   HGNC; HGNC:1273; C21orf33.
DR   MIM; 601659; gene.
DR   neXtProt; NX_P30042; -.
DR   PharmGKB; PA25828; -.
DR   eggNOG; COG3155; -.
DR   HOVERGEN; HBG001844; -.
DR   InParanoid; P30042; -.
DR   OrthoDB; EOG4XPQGK; -.
DR   GenomeRNAi; 8209; -.
DR   NextBio; 30923; -.
DR   ArrayExpress; P30042; -.
DR   Bgee; P30042; -.
DR   CleanEx; HS_HES1; -.
DR   Genevestigator; P30042; -.
DR   GermOnline; ENSG00000160221; Homo sapiens.
DR   GO; GO:0005739; C:mitochondrion; IBA:RefGenome.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Mitochondrion; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     41       Mitochondrion.
FT   CHAIN        42    268       ES1 protein homolog, mitochondrial.
FT                                /FTId=PRO_0000008544.
FT   MOD_RES     164    164       N6-acetyllysine.
FT   MOD_RES     219    219       N6-acetyllysine (By similarity).
FT   VAR_SEQ     144    174       Missing (in isoform Short).
FT                                /FTId=VSP_001454.
FT   VARIANT       6      6       V -> A (in dbSNP:rs968714).
FT                                /FTId=VAR_027920.
FT   VARIANT     148    148       V -> M (in dbSNP:rs17264865).
FT                                /FTId=VAR_027921.
FT   VARIANT     248    248       L -> V (in dbSNP:rs2838497).
FT                                /FTId=VAR_020441.
FT   CONFLICT    213    213       I -> M (in Ref. 3; CAA68857).
SQ   SEQUENCE   268 AA;  28170 MW;  FCDE084D43173330 CRC64;
     MAAVRVLVAS RLAAASAFTS LSPGGRTPSQ RAALHLSVPR PAARVALVLS GCGVYDGTEI
     HEASAILVHL SRGGAEVQIF APDVPQMHVI DHTKGQPSEG ESRNVLTESA RIARGKITDL
     ANLSAANHDA AIFPGGFGAA KNLSTFAVDG KDCKVNKEVE RVLKEFHQAG KPIGLCCIAP
     VLAAKVLRGV EVTVGHEQEE GGKWPYAGTA EAIKALGAKH CVKEVVEAHV DQKNKVVTTP
     AFMCETALHY IHDGIGAMVR KVLELTGK
//
ID   ES1_MOUSE               Reviewed;         266 AA.
AC   Q9D172;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-NOV-2012, entry version 75.
DE   RecName: Full=ES1 protein homolog, mitochondrial;
DE   Flags: Precursor;
GN   Name=D10Jhu81e;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 71-92; 102-109; 115-149; 169-183; 187-212 AND
RP   222-231, AND MASS SPECTROMETRY.
RC   STRAIN=C57BL/6, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-217, AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=16916647; DOI=10.1016/j.molcel.2006.06.026;
RA   Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,
RA   Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
RT   "Substrate and functional diversity of lysine acetylation revealed by
RT   a proteomics survey.";
RL   Mol. Cell 23:607-618(2006).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion (Potential).
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK003866; BAB23047.1; -; mRNA.
DR   EMBL; BC013475; AAH13475.1; -; mRNA.
DR   IPI; IPI00133284; -.
DR   RefSeq; NP_613067.1; NM_138601.2.
DR   RefSeq; XP_001474527.1; XM_001474477.2.
DR   UniGene; Mm.268691; -.
DR   ProteinModelPortal; Q9D172; -.
DR   SMR; Q9D172; 41-265.
DR   STRING; Q9D172; -.
DR   PhosphoSite; Q9D172; -.
DR   REPRODUCTION-2DPAGE; Q9D172; -.
DR   PaxDb; Q9D172; -.
DR   PRIDE; Q9D172; -.
DR   Ensembl; ENSMUST00000001242; ENSMUSP00000001242; ENSMUSG00000053329.
DR   GeneID; 100046684; -.
DR   GeneID; 28295; -.
DR   KEGG; mmu:100046684; -.
DR   KEGG; mmu:28295; -.
DR   UCSC; uc007fxj.1; mouse.
DR   MGI; MGI:1351861; D10Jhu81e.
DR   eggNOG; COG3155; -.
DR   GeneTree; ENSGT00390000003706; -.
DR   HOGENOM; HOG000269874; -.
DR   HOVERGEN; HBG001844; -.
DR   InParanoid; Q9D172; -.
DR   OMA; QCFAPDI; -.
DR   OrthoDB; EOG4XPQGK; -.
DR   NextBio; 460128; -.
DR   ArrayExpress; Q9D172; -.
DR   Bgee; Q9D172; -.
DR   Genevestigator; Q9D172; -.
DR   GermOnline; ENSMUSG00000053329; Mus musculus.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Direct protein sequencing;
KW   Mitochondrion; Reference proteome; Transit peptide.
FT   TRANSIT       1     39       Mitochondrion (By similarity).
FT   CHAIN        40    266       ES1 protein homolog, mitochondrial.
FT                                /FTId=PRO_0000008545.
FT   MOD_RES     162    162       N6-acetyllysine (By similarity).
FT   MOD_RES     217    217       N6-acetyllysine.
SQ   SEQUENCE   266 AA;  28090 MW;  9F311AD7288F4C2B CRC64;
     MAAVRVLVAP RLASALLPLS RYHRAPSQRA ALHSSAPRPG ARVALVLSGC GVYDGTEIHE
     ASAILVHLSR GGAEVQIFAP DVPQMHVIDH TKGEPSERES RNVLAESARI ARGKITSLAQ
     LNAANHDAAI FPGGFGAAKN LSTFAVDGKD CKVNKEVERV LKEFHGAKKP IGLCCIAPVL
     AAKVIKGVEV TVGHEQEEGG KWPYAGTAEA IKALGAKHCV KGVTEAHVDQ KNKVVTTPAF
     MCETALHHIH DGIGAMVKNV LELTGK
//
ID   ES1_RAT                 Reviewed;         266 AA.
AC   P56571; Q68FS5;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   03-OCT-2012, entry version 72.
DE   RecName: Full=ES1 protein homolog, mitochondrial;
DE   Flags: Precursor;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 40-50.
RC   STRAIN=Wistar; TISSUE=Heart;
RX   PubMed=10344264;
RX   DOI=10.1002/(SICI)1522-2683(19990101)20:4/5<891::AID-ELPS891>3.0.CO;2-2;
RA   Li X.P., Pleissner K.-P., Scheler C., Regitz-Zagrosek V., Salnikow J.,
RA   Jungblut P.R.;
RT   "A two-dimensional electrophoresis database of rat heart proteins.";
RL   Electrophoresis 20:891-897(1999).
RN   [3]
RP   PROTEIN SEQUENCE OF 115-139; 169-183 AND 222-231, AND MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion (Potential).
CC   -!- MISCELLANEOUS: By 2D-PAGE, the determined pI of this protein (spot
CC       P2) is: 8.9, its MW is: 25 kDa.
CC   -!- SIMILARITY: Belongs to the ES1 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC079380; AAH79380.1; -; mRNA.
DR   IPI; IPI00231028; -.
DR   RefSeq; NP_001004225.1; NM_001004225.1.
DR   UniGene; Rn.11498; -.
DR   ProteinModelPortal; P56571; -.
DR   IntAct; P56571; 1.
DR   STRING; P56571; -.
DR   PRIDE; P56571; -.
DR   Ensembl; ENSRNOT00000001609; ENSRNOP00000001609; ENSRNOG00000001211.
DR   GeneID; 294326; -.
DR   KEGG; rno:294326; -.
DR   UCSC; RGD:1303003; rat.
DR   CTD; 294326; -.
DR   RGD; 1303003; RGD1303003.
DR   eggNOG; COG3155; -.
DR   GeneTree; ENSGT00390000003706; -.
DR   HOGENOM; HOG000269874; -.
DR   HOVERGEN; HBG001844; -.
DR   InParanoid; P56571; -.
DR   OrthoDB; EOG4XPQGK; -.
DR   NextBio; 637992; -.
DR   ArrayExpress; P56571; -.
DR   Genevestigator; P56571; -.
DR   GermOnline; ENSRNOG00000001211; Rattus norvegicus.
DR   GO; GO:0005739; C:mitochondrion; IBA:RefGenome.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Direct protein sequencing;
KW   Mitochondrion; Reference proteome; Transit peptide.
FT   TRANSIT       1     39       Mitochondrion (By similarity).
FT   CHAIN        40    266       ES1 protein homolog, mitochondrial.
FT                                /FTId=PRO_0000043354.
FT   MOD_RES     162    162       N6-acetyllysine (By similarity).
FT   MOD_RES     217    217       N6-acetyllysine (By similarity).
FT   CONFLICT     50     50       C -> T (in Ref. 2; AA sequence).
SQ   SEQUENCE   266 AA;  28173 MW;  033D1C13DFF8606F CRC64;
     MAAVRVLVSP RLASALLPLS GRHRTTSQRA AIHSSAPRPR ARVALVLSGC GVYDGTEIHE
     ASAILVHLSR GGAEVHIFAP DVPQMHVIDH TKGEPSEKES RNVLAESARI ARGKITNLAQ
     LSAANHDAAI FPGGFGAAKN LSTFAVDGKD CKVNKEVERV LKEFHGAKKP IGLCCIAPVL
     AAKVIKGVEV TVGHEQEEGG KWPYAGTAEA VKALGAKHCV KGVTEAHVDQ KNKVVTTPAF
     MCETELHHIH DGIGAMVKKV LELTGK
//
ID   GLXA_RHIME              Reviewed;         324 AA.
AC   O87389;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   28-NOV-2012, entry version 84.
DE   RecName: Full=HTH-type transcriptional regulator GlxA;
GN   Name=glxA; OrderedLocusNames=R00086; ORFNames=SMc02609;
OS   Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium
OS   meliloti).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Rhizobiaceae; Sinorhizobium/Ensifer group; Sinorhizobium.
OX   NCBI_TaxID=266834;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=1021;
RA   Powers E.L., Vuyyuru V., Kahn M.L.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1021;
RX   MEDLINE=21396507; PubMed=11481430; DOI=10.1073/pnas.161294398;
RA   Capela D., Barloy-Hubler F., Gouzy J., Bothe G., Ampe F., Batut J.,
RA   Boistard P., Becker A., Boutry M., Cadieu E., Dreano S., Gloux S.,
RA   Godrie T., Goffeau A., Kahn D., Kiss E., Lelaure V., Masuy D.,
RA   Pohl T., Portetelle D., Puehler A., Purnelle B., Ramsperger U.,
RA   Renard C., Thebault P., Vandenbol M., Weidner S., Galibert F.;
RT   "Analysis of the chromosome sequence of the legume symbiont
RT   Sinorhizobium meliloti strain 1021.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9877-9882(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1021;
RX   MEDLINE=21368234; PubMed=11474104; DOI=10.1126/science.1060966;
RA   Galibert F., Finan T.M., Long S.R., Puehler A., Abola P., Ampe F.,
RA   Barloy-Hubler F., Barnett M.J., Becker A., Boistard P., Bothe G.,
RA   Boutry M., Bowser L., Buhrmester J., Cadieu E., Capela D., Chain P.,
RA   Cowie A., Davis R.W., Dreano S., Federspiel N.A., Fisher R.F.,
RA   Gloux S., Godrie T., Goffeau A., Golding B., Gouzy J., Gurjal M.,
RA   Hernandez-Lucas I., Hong A., Huizar L., Hyman R.W., Jones T., Kahn D.,
RA   Kahn M.L., Kalman S., Keating D.H., Kiss E., Komp C., Lelaure V.,
RA   Masuy D., Palm C., Peck M.C., Pohl T.M., Portetelle D., Purnelle B.,
RA   Ramsperger U., Surzycki R., Thebault P., Vandenbol M.,
RA   Vorhoelter F.J., Weidner S., Wells D.H., Wong K., Yeh K.-C., Batut J.;
RT   "The composite genome of the legume symbiont Sinorhizobium meliloti.";
RL   Science 293:668-672(2001).
CC   -!- SIMILARITY: Contains 1 HTH araC/xylS-type DNA-binding domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF055582; AAC62219.1; -; Genomic_DNA.
DR   EMBL; AL591688; CAC41473.1; -; Genomic_DNA.
DR   RefSeq; NP_384192.1; NC_003047.1.
DR   ProteinModelPortal; O87389; -.
DR   GeneID; 1231717; -.
DR   GenomeReviews; AL591688_GR; R00086.
DR   KEGG; sme:SMc02609; -.
DR   PATRIC; 23629341; VBISinMel96828_1443.
DR   eggNOG; COG4977; -.
DR   HOGENOM; HOG000063196; -.
DR   OMA; TDWADTS; -.
DR   ProtClustDB; CLSK784605; -.
DR   BioCyc; SMEL266834:GJF6-92-MONOMER; -.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.60; Homeodomain-rel; 2.
DR   InterPro; IPR025628; DJ-1_InhA.
DR   InterPro; IPR009057; Homeodomain-like.
DR   InterPro; IPR018060; HTH_AraC.
DR   InterPro; IPR018062; HTH_AraC-typ_CS.
DR   InterPro; IPR020449; Tscrpt_reg_HTH_AraC-type.
DR   Pfam; PF13278; DUF4066; 1.
DR   Pfam; PF12833; HTH_18; 1.
DR   PRINTS; PR00032; HTHARAC.
DR   SMART; SM00342; HTH_ARAC; 1.
DR   SUPFAM; SSF46689; Homeodomain_like; 2.
DR   PROSITE; PS00041; HTH_ARAC_FAMILY_1; 1.
DR   PROSITE; PS01124; HTH_ARAC_FAMILY_2; 1.
PE   4: Predicted;
KW   Complete proteome; DNA-binding; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    324       HTH-type transcriptional regulator GlxA.
FT                                /FTId=PRO_0000194523.
FT   DNA_BIND    239    257       H-T-H motif (By similarity).
SQ   SEQUENCE   324 AA;  34960 MW;  4D622F5473575D0D CRC64;
     MAASSDSRNV QRIGFLLVRN FALMSYASAT EPLRAANLLA GRPLYQIVPL APGGGTVASS
     SGLSVGCADL ESEGESCHTV FVCAGGEPTD WADTSASHTT LRRLSRLGIR IGGISSGAFV
     LAAAGLLDNR DFTIHWEHAP ALKEAFPHLN PRHARFVLDG GIATCGGGVA PLDMMHAMIA
     ERLGTDFARR VSDWYLHAAV AEPAAPQRGS AAERFGTNHP ALLAVLEKME TAIERPLDRT
     AMARLAGVSP RHLDRLFREH RGTGFLDTYR EIRLRHARRL LQQSPLSIPE IAYATGFSSP
     AHFSNAFKRL FSQTPGSLRR RSGS
//
ID   GS18_BACSU              Reviewed;         172 AA.
AC   P80876;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   09-JAN-2013, entry version 83.
DE   RecName: Full=General stress protein 18;
DE            Short=GSP18;
DE            EC=3.2.-.-;
GN   Name=yfkM; OrderedLocusNames=BSU07850;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168 / AC327;
RX   MEDLINE=97124190; PubMed=8969503; DOI=10.1099/13500872-142-11-3057;
RA   Yamamoto H., Uchiyama S., Sekiguchi J.;
RT   "Cloning and sequencing of a 40.6 kb segment in the 73 degrees-76
RT   degrees region of the Bacillus subtilis chromosome containing genes
RT   for trehalose metabolism and acetoin utilization.";
RL   Microbiology 142:3057-3065(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   MEDLINE=98044033; PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-30.
RC   STRAIN=168 / IS58;
RX   MEDLINE=97443988; PubMed=9298659; DOI=10.1002/elps.1150180820;
RA   Antelmann H., Bernhardt J., Schmid R., Mach H., Voelker U., Hecker M.;
RT   "First steps from a two-dimensional protein index towards a response-
RT   regulation map for Bacillus subtilis.";
RL   Electrophoresis 18:1451-1463(1997).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168;
RX   PubMed=19170879; DOI=10.1111/j.1365-2958.2008.06568.x;
RA   Nguyen T.T.H., Eiamphungporn W., Maeder U., Liebeke M., Lalk M.,
RA   Hecker M., Helmann J.D., Antelmann H.;
RT   "Genome-wide responses to carbonyl electrophiles in Bacillus subtilis:
RT   control of the thiol-dependent formaldehyde dehydrogenase AdhA and
RT   cysteine proteinase YraA by the MerR-family regulator YraB (AdhR).";
RL   Mol. Microbiol. 71:876-894(2009).
CC   -!- FUNCTION: Functions in the protection against aldehyde-stress,
CC       possibly by degrading damaged proteins.
CC   -!- INDUCTION: By heat shock, salt stress, oxidative stress, glucose
CC       limitation and oxygen limitation.
CC   -!- DISRUPTION PHENOTYPE: When combined with a yraA disruption shows
CC       significantly reduced growth in the presence of formaldehye and
CC       methylglyoxal.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D83967; BAA23403.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB12614.1; -; Genomic_DNA.
DR   PIR; H69808; H69808.
DR   RefSeq; NP_388666.1; NC_000964.3.
DR   ProteinModelPortal; P80876; -.
DR   SMR; P80876; 1-170.
DR   EnsemblBacteria; EBBACT00000001036; EBBACP00000001036; EBBACG00000001034.
DR   GeneID; 938808; -.
DR   GenomeReviews; AL009126_GR; BSU07850.
DR   KEGG; bsu:BSU07850; -.
DR   PATRIC; 18973218; VBIBacSub10457_0823.
DR   GenoList; BSU07850; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   OMA; ATGYTSI; -.
DR   ProtClustDB; CLSK886869; -.
DR   BioCyc; BSUB:BSU07850-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Hydrolase; Protease;
KW   Reference proteome; Stress response.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    172       General stress protein 18.
FT                                /FTId=PRO_0000157832.
FT   DOMAIN        3    171       PfpI endopeptidase.
FT   ACT_SITE    104    104       Nucleophile (By similarity).
FT   ACT_SITE    105    105       Potential.
SQ   SEQUENCE   172 AA;  18863 MW;  DA183A4EE10BEB1E CRC64;
     MGKKIAVVLT YYFEDSEYTE PAKAFKEAGH ELTVIEKEKG KTVKGKQGTA EVTVDASIDD
     VNSSDFDALL IPGGFSPDQL RADDRFVQFT KAFMTDKKPV FAICHGPQLL INAKALDGRK
     ATGYTSIRVD MENAGADVVD KEVVVCQDQL VTSRTPDDIP AFNRESLALL EK
//
ID   HCHA_ECO24              Reviewed;         283 AA.
AC   A7ZN88;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   28-NOV-2012, entry version 34.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=EcE24377A_2198;
OS   Escherichia coli O139:H28 (strain E24377A / ETEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=331111;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=E24377A / ETEC;
RX   PubMed=18676672; DOI=10.1128/JB.00619-08;
RA   Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA   Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA   Henderson I.R., Sperandio V., Ravel J.;
RT   "The pangenome structure of Escherichia coli: comparative genomic
RT   analysis of E. coli commensal and pathogenic isolates.";
RL   J. Bacteriol. 190:6881-6893(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000800; ABV17409.1; -; Genomic_DNA.
DR   RefSeq; YP_001463267.1; NC_009801.1.
DR   ProteinModelPortal; A7ZN88; -.
DR   SMR; A7ZN88; 5-283.
DR   STRING; A7ZN88; -.
DR   EnsemblBacteria; EBESCT00000021298; EBESCP00000020360; EBESCG00000020352.
DR   GeneID; 5588379; -.
DR   GenomeReviews; CP000800_GR; EcE24377A_2198.
DR   KEGG; ecw:EcE24377A_2198; -.
DR   PATRIC; 18293655; VBIEscCol31211_2477.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL331111:GH7P-2259-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064274.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31146 MW;  5CA8BE844F734B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDIAGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO45              Reviewed;         283 AA.
AC   B7MCM0;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   06-FEB-2013, entry version 27.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECS88_2019;
OS   Escherichia coli O45:K1 (strain S88 / ExPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585035;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=S88 / ExPEC;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928161; CAR03317.1; -; Genomic_DNA.
DR   RefSeq; YP_002391734.1; NC_011742.1.
DR   ProteinModelPortal; B7MCM0; -.
DR   SMR; B7MCM0; 6-283.
DR   STRING; B7MCM0; -.
DR   EnsemblBacteria; EBESCT00000140627; EBESCP00000127235; EBESCG00000139210.
DR   GeneID; 7128963; -.
DR   GenomeReviews; CU928161_GR; ECS88_2019.
DR   KEGG; ecz:ECS88_2019; -.
DR   PATRIC; 18411762; VBIEscCol91599_2010.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL585035:GJWP-2019-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136174.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31205 MW;  9531197D59E35C7D CRC64;
     MTVQKSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESEDVAAA LQWAIENDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO55              Reviewed;         283 AA.
AC   B7L8Y4;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   28-NOV-2012, entry version 26.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=EC55989_2193;
OS   Escherichia coli (strain 55989 / EAEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585055;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=55989 / EAEC;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928145; CAU98066.1; -; Genomic_DNA.
DR   RefSeq; YP_002403239.1; NC_011748.1.
DR   ProteinModelPortal; B7L8Y4; -.
DR   SMR; B7L8Y4; 5-283.
DR   STRING; B7L8Y4; -.
DR   EnsemblBacteria; EBESCT00000131325; EBESCP00000122809; EBESCG00000126037.
DR   GeneID; 7146576; -.
DR   GenomeReviews; CU928145_GR; EC55989_2193.
DR   KEGG; eck:EC55989_2193; -.
DR   PATRIC; 38477861; VBIEscCol113220_2230.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL585055:GJOM-2237-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000149603.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31220 MW;  40D8A5385FD83202 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGTLIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO57              Reviewed;         283 AA.
AC   Q8XB78;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-NOV-2012, entry version 58.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=Z3059, ECs2705;
OS   Escherichia coli O157:H7.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / EDL933 / ATCC 700927 / EHEC;
RX   MEDLINE=21074935; PubMed=11206551; DOI=10.1038/35054089;
RA   Perna N.T., Plunkett G. III, Burland V., Mau B., Glasner J.D.,
RA   Rose D.J., Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A.,
RA   Posfai G., Hackett J., Klink S., Boutin A., Shao Y., Miller L.,
RA   Grotbeck E.J., Davis N.W., Lim A., Dimalanta E.T., Potamousis K.,
RA   Apodaca J., Anantharaman T.S., Lin J., Yen G., Schwartz D.C.,
RA   Welch R.A., Blattner F.R.;
RT   "Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.";
RL   Nature 409:529-533(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   MEDLINE=21156231; PubMed=11258796; DOI=10.1093/dnares/8.1.11;
RA   Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K.,
RA   Han C.-G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T.,
RA   Iida T., Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T.,
RA   Kuhara S., Shiba T., Hattori M., Shinagawa H.;
RT   "Complete genome sequence of enterohemorrhagic Escherichia coli
RT   O157:H7 and genomic comparison with a laboratory strain K-12.";
RL   DNA Res. 8:11-22(2001).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005174; AAG56980.1; -; Genomic_DNA.
DR   EMBL; BA000007; BAB36128.1; -; Genomic_DNA.
DR   PIR; A99967; A99967.
DR   PIR; H85814; H85814.
DR   RefSeq; NP_288426.1; NC_002655.2.
DR   RefSeq; NP_310732.1; NC_002695.1.
DR   ProteinModelPortal; Q8XB78; -.
DR   SMR; Q8XB78; 5-283.
DR   EnsemblBacteria; EBESCT00000024553; EBESCP00000023446; EBESCG00000023607.
DR   EnsemblBacteria; EBESCT00000057112; EBESCP00000054940; EBESCG00000056160.
DR   GeneID; 912670; -.
DR   GeneID; 961970; -.
DR   GenomeReviews; AE005174_GR; Z3059.
DR   GenomeReviews; BA000007_GR; ECs2705.
DR   KEGG; ece:Z3059; -.
DR   KEGG; ecs:ECs2705; -.
DR   PATRIC; 18354798; VBIEscCol44059_2607.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL386585:GJFA-2669-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209413.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31181 MW;  E36046A5F8325F98 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP QKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO5E              Reviewed;         283 AA.
AC   B5YSJ3;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 1.
DT   28-NOV-2012, entry version 24.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECH74115_2746;
OS   Escherichia coli O157:H7 (strain EC4115 / EHEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=444450;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=EC4115 / EHEC;
RA   Eppinger M., Sebastian Y., Ravel J.;
RT   "Complete genome sequence of Escherichia coli O157:H7 str. EC4115.";
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP001164; ACI36666.1; -; Genomic_DNA.
DR   RefSeq; YP_002271080.1; NC_011353.1.
DR   ProteinModelPortal; B5YSJ3; -.
DR   SMR; B5YSJ3; 5-283.
DR   STRING; B5YSJ3; -.
DR   EnsemblBacteria; EBESCT00000031926; EBESCP00000030629; EBESCG00000030976.
DR   GeneID; 6971307; -.
DR   GenomeReviews; CP001164_GR; ECH74115_2746.
DR   KEGG; ecf:ECH74115_2746; -.
DR   PATRIC; 18366204; VBIEscCol74651_2770.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL444450:GHOB-2278-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136175.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31181 MW;  E36046A5F8325F98 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP QKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO7I              Reviewed;         283 AA.
AC   B7NRB5;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   28-NOV-2012, entry version 25.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECIAI39_1090;
OS   Escherichia coli O7:K1 (strain IAI39 / ExPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585057;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=IAI39 / ExPEC;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928164; CAR17224.1; -; Genomic_DNA.
DR   RefSeq; YP_002407102.1; NC_011750.1.
DR   ProteinModelPortal; B7NRB5; -.
DR   SMR; B7NRB5; 5-282.
DR   STRING; B7NRB5; -.
DR   EnsemblBacteria; EBESCT00000148039; EBESCP00000137432; EBESCG00000146228.
DR   GeneID; 7153701; -.
DR   GenomeReviews; CU928164_GR; ECIAI39_1090.
DR   KEGG; ect:ECIAI39_1090; -.
DR   PATRIC; 18330812; VBIEscCol51957_1140.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL585057:GJ8I-1135-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136176.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31236 MW;  5598412CA61821B2 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHSDNP LNGYSICAFP DAADKQTPDI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAS
//
ID   HCHA_ECO81              Reviewed;         283 AA.
AC   B7MWF3;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   28-NOV-2012, entry version 27.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECED1_2232;
OS   Escherichia coli O81 (strain ED1a).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585397;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ED1a;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928162; CAR08419.2; -; Genomic_DNA.
DR   RefSeq; YP_002398172.1; NC_011745.1.
DR   ProteinModelPortal; B7MWF3; -.
DR   SMR; B7MWF3; 5-283.
DR   STRING; B7MWF3; -.
DR   EnsemblBacteria; EBESCT00000143048; EBESCP00000136778; EBESCG00000141141.
DR   GeneID; 7140010; -.
DR   GenomeReviews; CU928162_GR; ECED1_2232.
DR   KEGG; ecq:ECED1_2232; -.
DR   PATRIC; 38488514; VBIEscCol8292_2259.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL585397:GJCU-2262-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000149604.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECO8A              Reviewed;         283 AA.
AC   B7M3A5;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   28-NOV-2012, entry version 25.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECIAI1_2047;
OS   Escherichia coli O8 (strain IAI1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585034;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=IAI1;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928160; CAQ98897.1; -; Genomic_DNA.
DR   RefSeq; YP_002387458.1; NC_011741.1.
DR   ProteinModelPortal; B7M3A5; -.
DR   SMR; B7M3A5; 6-283.
DR   STRING; B7M3A5; -.
DR   EnsemblBacteria; EBESCT00000132561; EBESCP00000127006; EBESCG00000132700.
DR   GeneID; 7126827; -.
DR   GenomeReviews; CU928160_GR; ECIAI1_2047.
DR   KEGG; ecr:ECIAI1_2047; -.
DR   PATRIC; 18323379; VBIEscCol26572_2021.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL585034:GJ84-2069-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136177.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31173 MW;  D13BB3CD9BE34EA6 CRC64;
     MTVQKSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDIAGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOBW              Reviewed;         283 AA.
AC   C4ZQN7;
DT   22-SEP-2009, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 1.
DT   28-NOV-2012, entry version 23.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=BWG_1768;
OS   Escherichia coli (strain K12 / MC4100 / BW2952).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=595496;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MC4100 / BW2952;
RX   PubMed=19376874; DOI=10.1128/JB.00118-09;
RA   Ferenci T., Zhou Z., Betteridge T., Ren Y., Liu Y., Feng L.,
RA   Reeves P.R., Wang L.;
RT   "Genomic sequencing reveals regulatory mutations and recombinational
RT   events in the widely used MC4100 lineage of Escherichia coli K-12.";
RL   J. Bacteriol. 191:4025-4029(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP001396; ACR63433.1; -; Genomic_DNA.
DR   RefSeq; YP_002926964.1; NC_012759.1.
DR   ProteinModelPortal; C4ZQN7; -.
DR   SMR; C4ZQN7; 5-283.
DR   STRING; C4ZQN7; -.
DR   EnsemblBacteria; EBESCT00000156031; EBESCP00000144336; EBESCG00000151287.
DR   GeneID; 7952181; -.
DR   GenomeReviews; CP001396_GR; BWG_1768.
DR   KEGG; ebw:BWG_1768; -.
DR   PATRIC; 18272815; VBIEscCol60876_1937.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL595496:GI18-1891-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000213421.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31190 MW;  5CA8A53843A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECODH              Reviewed;         283 AA.
AC   B1X6B7;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 1.
DT   28-NOV-2012, entry version 30.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECDH10B_2110;
OS   Escherichia coli (strain K12 / DH10B).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=316385;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / DH10B;
RX   PubMed=18245285; DOI=10.1128/JB.01695-07;
RA   Durfee T., Nelson R., Baldwin S., Plunkett G. III, Burland V., Mau B.,
RA   Petrosino J.F., Qin X., Muzny D.M., Ayele M., Gibbs R.A., Csorgo B.,
RA   Posfai G., Weinstock G.M., Blattner F.R.;
RT   "The complete genome sequence of Escherichia coli DH10B: insights into
RT   the biology of a laboratory workhorse.";
RL   J. Bacteriol. 190:2597-2606(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000948; ACB03149.1; -; Genomic_DNA.
DR   RefSeq; YP_001730927.1; NC_010473.1.
DR   ProteinModelPortal; B1X6B7; -.
DR   SMR; B1X6B7; 5-283.
DR   STRING; B1X6B7; -.
DR   EnsemblBacteria; EBESCT00000011243; EBESCP00000010771; EBESCG00000010305.
DR   GeneID; 6059114; -.
DR   GenomeReviews; CP000948_GR; ECDH10B_2110.
DR   KEGG; ecd:ECDH10B_2110; -.
DR   PATRIC; 18464084; VBIEscCol59506_2134.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL316385:GJ8B-2043-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136178.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31190 MW;  5CA8A53843A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOHS              Reviewed;         283 AA.
AC   A8A1G6;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   28-NOV-2012, entry version 32.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=EcHS_A2068;
OS   Escherichia coli O9:H4 (strain HS).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=331112;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HS;
RX   PubMed=18676672; DOI=10.1128/JB.00619-08;
RA   Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA   Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA   Henderson I.R., Sperandio V., Ravel J.;
RT   "The pangenome structure of Escherichia coli: comparative genomic
RT   analysis of E. coli commensal and pathogenic isolates.";
RL   J. Bacteriol. 190:6881-6893(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000802; ABV06370.1; -; Genomic_DNA.
DR   RefSeq; YP_001458753.1; NC_009800.1.
DR   ProteinModelPortal; A8A1G6; -.
DR   SMR; A8A1G6; 5-283.
DR   STRING; A8A1G6; -.
DR   EnsemblBacteria; EBESCT00000051889; EBESCP00000049874; EBESCG00000050937.
DR   GeneID; 5593137; -.
DR   GenomeReviews; CP000802_GR; EcHS_A2068.
DR   KEGG; ecx:EcHS_A2068; -.
DR   PATRIC; 18314111; VBIEscCol77814_2024.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL331112:GHHI-2165-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064275.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOK1              Reviewed;         283 AA.
AC   A1ACB2;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 1.
DT   28-NOV-2012, entry version 41.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=Ecok1_18080; ORFNames=APECO1_1002;
OS   Escherichia coli O1:K1 / APEC.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=405955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=17293413; DOI=10.1128/JB.01726-06;
RA   Johnson T.J., Kariyawasam S., Wannemuehler Y., Mangiamele P.,
RA   Johnson S.J., Doetkott C., Skyberg J.A., Lynne A.M., Johnson J.R.,
RA   Nolan L.K.;
RT   "The genome sequence of avian pathogenic Escherichia coli strain
RT   O1:K1:H7 shares strong similarities with human extraintestinal
RT   pathogenic E. coli genomes.";
RL   J. Bacteriol. 189:3228-3236(2007).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000468; ABJ01302.1; -; Genomic_DNA.
DR   RefSeq; YP_853016.1; NC_008563.1.
DR   ProteinModelPortal; A1ACB2; -.
DR   SMR; A1ACB2; 6-283.
DR   STRING; A1ACB2; -.
DR   EnsemblBacteria; EBESCT00000036338; EBESCP00000034855; EBESCG00000035388.
DR   GeneID; 4492646; -.
DR   GenomeReviews; CP000468_GR; Ecok1_18080.
DR   KEGG; ecv:APECO1_1002; -.
DR   PATRIC; 18215577; VBIEscCol127180_2061.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064276.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31205 MW;  9531197D59E35C7D CRC64;
     MTVQKSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESEDVAAA LQWAIENDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOL5              Reviewed;         283 AA.
AC   Q0TGM8;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   28-NOV-2012, entry version 41.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECP_1900;
OS   Escherichia coli O6:K15:H31 (strain 536 / UPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=362663;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=536 / UPEC;
RX   PubMed=16879640; DOI=10.1111/j.1365-2958.2006.05255.x;
RA   Hochhut B., Wilde C., Balling G., Middendorf B., Dobrindt U.,
RA   Brzuszkiewicz E., Gottschalk G., Carniel E., Hacker J.;
RT   "Role of pathogenicity island-associated integrases in the genome
RT   plasticity of uropathogenic Escherichia coli strain 536.";
RL   Mol. Microbiol. 61:584-595(2006).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000247; ABG69901.1; -; Genomic_DNA.
DR   RefSeq; YP_669802.1; NC_008253.1.
DR   ProteinModelPortal; Q0TGM8; -.
DR   SMR; Q0TGM8; 5-282.
DR   STRING; Q0TGM8; -.
DR   EnsemblBacteria; EBESCT00000045884; EBESCP00000044073; EBESCG00000044934.
DR   GeneID; 4187260; -.
DR   GenomeReviews; CP000247_GR; ECP_1900.
DR   KEGG; ecp:ECP_1900; -.
DR   PATRIC; 18194570; VBIEscCol77757_1936.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   PhylomeDB; Q0TGM8; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL362663:GIY5-1909-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064277.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31236 MW;  5598412CA61821B2 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHSDNP LNGYSICAFP DAADKQTPDI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAS
//
ID   HCHA_ECOL6              Reviewed;         283 AA.
AC   P59331;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-OCT-2012, entry version 57.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=c2385;
OS   Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=199310;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=CFT073 / ATCC 700928 / UPEC;
RX   MEDLINE=22388234; PubMed=12471157; DOI=10.1073/pnas.252529799;
RA   Welch R.A., Burland V., Plunkett G. III, Redford P., Roesch P.,
RA   Rasko D., Buckles E.L., Liou S.-R., Boutin A., Hackett J., Stroud D.,
RA   Mayhew G.F., Rose D.J., Zhou S., Schwartz D.C., Perna N.T.,
RA   Mobley H.L.T., Donnenberg M.S., Blattner F.R.;
RT   "Extensive mosaic structure revealed by the complete genome sequence
RT   of uropathogenic Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:17020-17024(2002).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014075; AAN80844.1; -; Genomic_DNA.
DR   RefSeq; NP_754277.1; NC_004431.1.
DR   ProteinModelPortal; P59331; -.
DR   SMR; P59331; 5-282.
DR   MEROPS; C56.006; -.
DR   EnsemblBacteria; EBESCT00000042543; EBESCP00000040892; EBESCG00000041593.
DR   GeneID; 1037145; -.
DR   GenomeReviews; AE014075_GR; c2385.
DR   KEGG; ecc:c2385; -.
DR   PATRIC; 18282653; VBIEscCol75197_2240.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209414.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31236 MW;  5598412CA61821B2 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHSDNP LNGYSICAFP DAADKQTPDI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAS
//
ID   HCHA_ECOLC              Reviewed;         283 AA.
AC   B1IZU5;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 1.
DT   28-NOV-2012, entry version 29.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=EcolC_1678;
OS   Escherichia coli (strain ATCC 8739 / DSM 1576 / Crooks).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=481805;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 8739 / DSM 1576 / Crooks;
RA   Copeland A., Lucas S., Lapidus A., Glavina del Rio T., Dalin E.,
RA   Tice H., Bruce D., Goodwin L., Pitluck S., Kiss H., Brettin T.,
RA   Detter J.C., Han C., Kuske C.R., Schmutz J., Larimer F., Land M.,
RA   Hauser L., Kyrpides N., Mikhailova N., Ingram L., Richardson P.;
RT   "Complete sequence of Escherichia coli C str. ATCC 8739.";
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000946; ACA77330.1; -; Genomic_DNA.
DR   RefSeq; YP_001724657.1; NC_010468.1.
DR   ProteinModelPortal; B1IZU5; -.
DR   SMR; B1IZU5; 5-283.
DR   STRING; B1IZU5; -.
DR   EnsemblBacteria; EBESCT00000009422; EBESCP00000009106; EBESCG00000008485.
DR   GeneID; 6066273; -.
DR   GenomeReviews; CP000946_GR; EcolC_1678.
DR   KEGG; ecl:EcolC_1678; -.
DR   PATRIC; 18226146; VBIEscCol82905_1801.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL481805:GI3G-1719-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000084409.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOLI              Reviewed;         283 AA.
AC   P31658; P76338;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-NOV-2012, entry version 111.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Aminopeptidase HchA;
DE            EC=3.4.11.-;
DE   AltName: Full=D-lactate dehydratase;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; Synonyms=yedU, yzzC; OrderedLocusNames=b1967, JW1950;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   MEDLINE=97251358; PubMed=9097040; DOI=10.1093/dnares/3.6.379;
RA   Itoh T., Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K.,
RA   Kasai H., Kimura S., Kitakawa M., Kitagawa M., Makino K., Miki T.,
RA   Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S., Nakamura Y.,
RA   Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G., Seki Y.,
RA   Sivasundaram S., Tagami H., Takeda J., Takemoto K., Wada C.,
RA   Yamamoto Y., Horiuchi T.;
RT   "A 460-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 40.1-50.0 min region on the linkage map.";
RL   DNA Res. 3:379-392(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   MEDLINE=97426617; PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1474(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-21.
RC   STRAIN=K12;
RX   MEDLINE=93204884; PubMed=8455549; DOI=10.1007/BF00282791;
RA   Yoshida T., Ueguchi C., Yamada H., Mizuno T.;
RT   "Function of the Escherichia coli nucleoid protein, H-NS: molecular
RT   analysis of a subset of proteins whose expression is enhanced in a hns
RT   deletion mutant.";
RL   Mol. Gen. Genet. 237:113-122(1993).
RN   [5]
RP   FUNCTION AS A GLYOXALASE, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY,
RP   ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=7848303;
RA   Misra K., Banerjee A.B., Ray S., Ray M.;
RT   "Glyoxalase III from Escherichia coli: a single novel enzyme for the
RT   conversion of methylglyoxal into D-lactate without reduced
RT   glutathione.";
RL   Biochem. J. 305:999-1003(1995).
RN   [6]
RP   FUNCTION AS A CHAPERONE, SUBUNIT, AND ENZYME REGULATION.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   MEDLINE=22336357; PubMed=12235139; DOI=10.1074/jbc.M205800200;
RA   Sastry M.S.R., Korotkov K., Brodsky Y., Baneyx F.;
RT   "Hsp31, the Escherichia coli yedU gene product, is a molecular
RT   chaperone whose activity is inhibited by ATP at high temperatures.";
RL   J. Biol. Chem. 277:46026-46034(2002).
RN   [7]
RP   FUNCTION AS A CHAPERONE, AND SUBUNIT.
RX   PubMed=12565879; DOI=10.1016/S0006-291X(02)03053-X;
RA   Malki A., Kern R., Abdallah J., Richarme G.;
RT   "Characterization of the Escherichia coli YedU protein as a molecular
RT   chaperone.";
RL   Biochem. Biophys. Res. Commun. 301:430-436(2003).
RN   [8]
RP   FUNCTION AS A CHAPERONE, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=14731284; DOI=10.1046/j.1365-2958.2003.03871.x;
RA   Mujacic M., Bader M.W., Baneyx F.;
RT   "Escherichia coli Hsp31 functions as a holding chaperone that
RT   cooperates with the DnaK-DnaJ-GrpE system in the management of protein
RT   misfolding under severe stress conditions.";
RL   Mol. Microbiol. 51:849-859(2004).
RN   [9]
RP   DOMAIN.
RX   PubMed=15173574; DOI=10.1073/pnas.0403033101;
RA   Sastry M.S.R., Quigley P.M., Hol W.G.J., Baneyx F.;
RT   "The linker-loop region of Escherichia coli chaperone Hsp31 functions
RT   as a gate that modulates high-affinity substrate binding at elevated
RT   temperatures.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8587-8592(2004).
RN   [10]
RP   FUNCTION AS AN AMINOPEPTIDASE, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15550391; DOI=10.1074/jbc.M408296200;
RA   Malki A., Caldas T., Abdallah J., Kern R., Eckey V., Kim S.J.,
RA   Cha S.S., Mori H., Richarme G.;
RT   "Peptidase activity of the Escherichia coli Hsp31 chaperone.";
RL   J. Biol. Chem. 280:14420-14426(2005).
RN   [11]
RP   FUNCTION IN STRESS RESISTANCE.
RX   PubMed=16796689; DOI=10.1111/j.1365-2958.2006.05207.x;
RA   Mujacic M., Baneyx F.;
RT   "Regulation of Escherichia coli hchA, a stress-inducible gene encoding
RT   molecular chaperone Hsp31.";
RL   Mol. Microbiol. 60:1576-1589(2006).
RN   [12]
RP   FUNCTION IN ACID STRESS RESISTANCE.
RX   PubMed=17158627; DOI=10.1128/AEM.02429-06;
RA   Mujacic M., Baneyx F.;
RT   "Chaperone Hsp31 contributes to acid resistance in stationary-phase
RT   Escherichia coli.";
RL   Appl. Environ. Microbiol. 73:1014-1018(2007).
RN   [13]
RP   FUNCTION AS A GLYOXALASE, CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-77;
RP   CYS-185 AND HIS-186, DISRUPTION PHENOTYPE, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=21696459; DOI=10.1111/j.1365-2958.2011.07736.x;
RA   Subedi K.P., Choi D., Kim I., Min B., Park C.;
RT   "Hsp31 of Escherichia coli K-12 is glyoxalase III.";
RL   Mol. Microbiol. 81:926-936(2011).
RN   [14]
RP   CRYSTALLIZATION.
RX   MEDLINE=22071426; PubMed=12077448; DOI=10.1107/S0907444902007369;
RA   Kim O.-G., Kim I.-K., Kim G.-H., Ko J., Park C., Suh P.-G.,
RA   Kang S.-O., Lee H.-S., Cha S.-S.;
RT   "Crystallization and preliminary X-ray crystallographic analysis of a
RT   yedU gene product from Escherichia coli.";
RL   Acta Crystallogr. D 58:1217-1219(2002).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), PROTEOLYTIC ACTIVITY, AND
RP   MUTAGENESIS OF CYS-185.
RX   PubMed=12939276; DOI=10.1074/jbc.M304517200;
RA   Lee S.-J., Kim S.J., Kim I.-K., Ko J., Jeong C.-S., Kim G.-H.,
RA   Park C., Kang S.-O., Suh P.-G., Lee H.-S., Cha S.-S.;
RT   "Crystal structures of human DJ-1 and Escherichia coli Hsp31, which
RT   share an evolutionarily conserved domain.";
RL   J. Biol. Chem. 278:44552-44559(2003).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 6-291.
RX   PubMed=12621151; DOI=10.1073/pnas.0530312100;
RA   Quigley P.M., Korotkov K., Baneyx F., Hol W.G.J.;
RT   "The 1.6-A crystal structure of the class of chaperones represented by
RT   Escherichia coli Hsp31 reveals a putative catalytic triad.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:3137-3142(2003).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS), AND METAL-BINDING.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=14500888; DOI=10.1110/ps.03121403;
RA   Zhao Y., Liu D., Kaluarachchi W.D., Bellamy H.D., White M.A.,
RA   Fox R.O.;
RT   "The crystal structure of Escherichia coli heat shock protein YedU
RT   reveals three potential catalytic active sites.";
RL   Protein Sci. 12:2303-2311(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS).
RX   PubMed=14691241; DOI=10.1110/ps.03399604;
RA   Quigley P.M., Korotkov K., Baneyx F., Hol W.G.J.;
RT   "A new native EcHsp31 structure suggests a key role of structural
RT   flexibility for chaperone function.";
RL   Protein Sci. 13:269-277(2004).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It uses
CC       temperature-induced exposure of structured hydrophobic domains to
CC       capture and stabilizes early unfolding and denatured protein
CC       intermediates under severe thermal stress. Catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step. It can also use phenylglyoxal
CC       as substrate. Glyoxalase activity protects cells against
CC       dicarbonyl stress. Displays an aminopeptidase activity that is
CC       specific against peptide substrates with alanine or basic amino
CC       acids (lysine, arginine) at N-terminus.
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins. The
CC       glyoxalase activity is inhibited by copper and zinc cations, and
CC       activated by ferrous cations. The aminopeptidase activity is
CC       inhibited by iodoacetamide, dithiothreitol, EDTA and 1, 10-
CC       phenanthroline.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=55 uM for lysine (at 37 degrees Celsius and pH 8.5);
CC         KM=95 uM for arginine (at 37 degrees Celsius and pH 8.5);
CC         KM=120 uM for alanine (at 37 degrees Celsius and pH 8.5);
CC         KM=1.43 mM for methylglyoxal;
CC       pH dependence:
CC         Optimum pH is between 6 and 8 for both aminopeptidase and
CC         glyoxalase activities. Significant inhibition below pH 5;
CC       Temperature dependence:
CC         Optimum temperature is around 37 degrees Celsius;
CC   -!- SUBUNIT: Homodimer.
CC   -!- INTERACTION:
CC       P0ACI6:asnC; NbExp=1; IntAct=EBI-909144, EBI-1133670;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: By heat shock.
CC   -!- DOMAIN: Consists of a large A domain and a smaller P domain
CC       connected by a linker. The thermally induced motion of the
CC       flexible linker-loop region leads to the uncovering of a high-
CC       affinity substrate-binding site that is essential to capture
CC       nonnative proteins at high temperatures.
CC   -!- DISRUPTION PHENOTYPE: Abolishes the glyoxalase and reduces
CC       aminopeptidase activity. Cells exhibit growth defects above 48
CC       degrees Celsius and accumulate higher levels of peptides than
CC       wild-type.
CC   -!- MISCELLANEOUS: According to some authors, HchA exhibits an
CC       exceedingly weak proteolytic activity against bovine serum albumin
CC       (BSA) and some peptidase activity against small single amino acids
CC       conjugated to a fluorogenic reporter (PubMed:12939276). Another
CC       report showed that HchA does not display any significant
CC       proteolytic activity but displays a physiologically relevant
CC       aminopeptidase activity (PubMed:15550391).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00096; AAC75033.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15794.1; -; Genomic_DNA.
DR   PIR; C64961; C64961.
DR   RefSeq; NP_416476.1; NC_000913.2.
DR   RefSeq; YP_490217.1; NC_007779.1.
DR   PDB; 1IZY; X-ray; 2.80 A; A/B=1-283.
DR   PDB; 1IZZ; X-ray; 2.31 A; A=1-283.
DR   PDB; 1N57; X-ray; 1.60 A; A=1-283.
DR   PDB; 1ONS; X-ray; 2.20 A; A=2-283.
DR   PDB; 1PV2; X-ray; 2.71 A; A/B/C/D/E/F/G/H=1-283.
DR   PDBsum; 1IZY; -.
DR   PDBsum; 1IZZ; -.
DR   PDBsum; 1N57; -.
DR   PDBsum; 1ONS; -.
DR   PDBsum; 1PV2; -.
DR   ProteinModelPortal; P31658; -.
DR   SMR; P31658; 5-283.
DR   DIP; DIP-11851N; -.
DR   IntAct; P31658; 32.
DR   SWISS-2DPAGE; P31658; -.
DR   PRIDE; P31658; -.
DR   EnsemblBacteria; EBESCT00000003176; EBESCP00000003176; EBESCG00000002607.
DR   EnsemblBacteria; EBESCT00000003177; EBESCP00000003177; EBESCG00000002607.
DR   EnsemblBacteria; EBESCT00000015530; EBESCP00000014821; EBESCG00000014590.
DR   GeneID; 12931400; -.
DR   GeneID; 946481; -.
DR   GenomeReviews; AP009048_GR; JW1950.
DR   GenomeReviews; U00096_GR; b1967.
DR   KEGG; ecj:Y75_p1934; -.
DR   KEGG; eco:b1967; -.
DR   PATRIC; 32119265; VBIEscCol129921_2047.
DR   EchoBASE; EB1705; -.
DR   EcoGene; EG11755; hchA.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; EcoCyc:G7055-MONOMER; -.
DR   BioCyc; ECOL316407:JW1950-MONOMER; -.
DR   BioCyc; MetaCyc:G7055-MONOMER; -.
DR   EvolutionaryTrace; P31658; -.
DR   Genevestigator; P31658; -.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0019172; F:glyoxalase III activity; IDA:EcoCyc.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019243; P:methylglyoxal catabolic process to D-lactate; IMP:EcoCyc.
DR   GO; GO:0010447; P:response to acidity; IMP:EcoCyc.
DR   GO; GO:0051595; P:response to methylglyoxal; IMP:EcoCyc.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Lyase; Metal-binding;
KW   Reference proteome; Stress response; Zinc.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209412.
FT   ACT_SITE    185    185       Probable.
FT   ACT_SITE    186    186       Probable.
FT   ACT_SITE    214    214       Probable.
FT   METAL        86     86       Zinc.
FT   METAL        91     91       Zinc.
FT   METAL       123    123       Zinc.
FT   MUTAGEN      77     77       E->A: Almost completely abolishes
FT                                glyoxalase activity.
FT   MUTAGEN     185    185       C->A: Almost completely abolishes
FT                                glyoxalase and aminopeptidase activities.
FT   MUTAGEN     186    186       H->A: Shows approximately 17% remaining
FT                                glyoxalase activity compared with that of
FT                                the wild-type.
FT   STRAND        8     11
FT   STRAND       18     20
FT   HELIX        23     29
FT   STRAND       50     54
FT   STRAND       60     62
FT   STRAND       68     70
FT   HELIX        75     87
FT   STRAND       92     99
FT   HELIX       106    108
FT   HELIX       116    128
FT   HELIX       133    138
FT   STRAND      145    151
FT   HELIX       155    158
FT   HELIX       161    163
FT   HELIX       165    176
FT   STRAND      180    184
FT   HELIX       187    194
FT   STRAND      195    197
FT   TURN        200    203
FT   HELIX       211    215
FT   TURN        216    221
FT   STRAND      222    225
FT   STRAND      227    229
FT   HELIX       231    237
FT   STRAND      251    254
FT   STRAND      257    262
FT   HELIX       263    265
FT   HELIX       266    281
SQ   SEQUENCE   283 AA;  31190 MW;  5CA8A53843A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKLLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOLU              Reviewed;         283 AA.
AC   B7NBV8;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   24-MAR-2009, sequence version 1.
DT   28-NOV-2012, entry version 26.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECUMN_2258;
OS   Escherichia coli O17:K52:H18 (strain UMN026 / ExPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=585056;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UMN026 / ExPEC;
RX   PubMed=19165319; DOI=10.1371/journal.pgen.1000344;
RA   Touchon M., Hoede C., Tenaillon O., Barbe V., Baeriswyl S., Bidet P.,
RA   Bingen E., Bonacorsi S., Bouchier C., Bouvet O., Calteau A.,
RA   Chiapello H., Clermont O., Cruveiller S., Danchin A., Diard M.,
RA   Dossat C., Karoui M.E., Frapy E., Garry L., Ghigo J.M., Gilles A.M.,
RA   Johnson J., Le Bouguenec C., Lescat M., Mangenot S.,
RA   Martinez-Jehanne V., Matic I., Nassif X., Oztas S., Petit M.A.,
RA   Pichon C., Rouy Z., Ruf C.S., Schneider D., Tourret J., Vacherie B.,
RA   Vallenet D., Medigue C., Rocha E.P.C., Denamur E.;
RT   "Organised genome dynamics in the Escherichia coli species results in
RT   highly diverse adaptive paths.";
RL   PLoS Genet. 5:E1000344-E1000344(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU928163; CAR13448.1; -; Genomic_DNA.
DR   RefSeq; YP_002412977.1; NC_011751.1.
DR   ProteinModelPortal; B7NBV8; -.
DR   SMR; B7NBV8; 5-283.
DR   STRING; B7NBV8; -.
DR   EnsemblBacteria; EBESCT00000116841; EBESCP00000110952; EBESCG00000115516.
DR   GeneID; 7155070; -.
DR   GenomeReviews; CU928163_GR; ECUMN_2258.
DR   KEGG; eum:ECUMN_2258; -.
DR   PATRIC; 18443775; VBIEscCol32010_2446.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136179.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOSE              Reviewed;         283 AA.
AC   B6I112;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 1.
DT   28-NOV-2012, entry version 25.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=ECSE_2196;
OS   Escherichia coli (strain SE11).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=409438;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=SE11;
RX   PubMed=18931093; DOI=10.1093/dnares/dsn026;
RA   Oshima K., Toh H., Ogura Y., Sasamoto H., Morita H., Park S.-H.,
RA   Ooka T., Iyoda S., Taylor T.D., Hayashi T., Itoh K., Hattori M.;
RT   "Complete genome sequence and comparative analysis of the wild-type
RT   commensal Escherichia coli strain SE11 isolated from a healthy
RT   adult.";
RL   DNA Res. 15:375-386(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP009240; BAG77720.1; -; Genomic_DNA.
DR   RefSeq; YP_002293471.1; NC_011415.1.
DR   ProteinModelPortal; B6I112; -.
DR   SMR; B6I112; 5-283.
DR   STRING; B6I112; -.
DR   EnsemblBacteria; EBESCT00000106318; EBESCP00000101783; EBESCG00000105510.
DR   GeneID; 7000574; -.
DR   GenomeReviews; AP009240_GR; ECSE_2196.
DR   KEGG; ecy:ECSE_2196; -.
DR   PATRIC; 18422926; VBIEscCol83070_2353.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL409438:GHUU-2387-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136180.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31146 MW;  5CA8BE844F734B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDIAGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOSM              Reviewed;         283 AA.
AC   B1LQP2;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 1.
DT   28-NOV-2012, entry version 30.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=EcSMS35_1218;
OS   Escherichia coli (strain SMS-3-5 / SECEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=439855;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=SMS-3-5 / SECEC;
RX   PubMed=18708504; DOI=10.1128/JB.00661-08;
RA   Fricke W.F., Wright M.S., Lindell A.H., Harkins D.M., Baker-Austin C.,
RA   Ravel J., Stepanauskas R.;
RT   "Insights into the environmental resistance gene pool from the genome
RT   sequence of the multidrug-resistant environmental isolate Escherichia
RT   coli SMS-3-5.";
RL   J. Bacteriol. 190:6779-6794(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000970; ACB20144.1; -; Genomic_DNA.
DR   RefSeq; YP_001743279.1; NC_010498.1.
DR   ProteinModelPortal; B1LQP2; -.
DR   SMR; B1LQP2; 5-283.
DR   STRING; B1LQP2; -.
DR   EnsemblBacteria; EBESCT00000064198; EBESCP00000061840; EBESCG00000063245.
DR   GeneID; 6145412; -.
DR   GenomeReviews; CP000970_GR; EcSMS35_1218.
DR   KEGG; ecm:EcSMS35_1218; -.
DR   PATRIC; 18431303; VBIEscCol6161_1379.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL439855:GHHB-4761-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136181.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_ECOUT              Reviewed;         283 AA.
AC   Q1RAH5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 1.
DT   28-NOV-2012, entry version 39.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=UTI89_C2166;
OS   Escherichia coli (strain UTI89 / UPEC).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=364106;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UTI89 / UPEC;
RX   PubMed=16585510; DOI=10.1073/pnas.0600938103;
RA   Chen S.L., Hung C.-S., Xu J., Reigstad C.S., Magrini V., Sabo A.,
RA   Blasiar D., Bieri T., Meyer R.R., Ozersky P., Armstrong J.R.,
RA   Fulton R.S., Latreille J.P., Spieth J., Hooton T.M., Mardis E.R.,
RA   Hultgren S.J., Gordon J.I.;
RT   "Identification of genes subject to positive selection in
RT   uropathogenic strains of Escherichia coli: a comparative genomics
RT   approach.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5977-5982(2006).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000243; ABE07639.1; -; Genomic_DNA.
DR   RefSeq; YP_541170.1; NC_007946.1.
DR   ProteinModelPortal; Q1RAH5; -.
DR   SMR; Q1RAH5; 6-283.
DR   STRING; Q1RAH5; -.
DR   EnsemblBacteria; EBESCT00000066433; EBESCP00000063911; EBESCG00000065480.
DR   GeneID; 3992545; -.
DR   GenomeReviews; CP000243_GR; UTI89_C2166.
DR   KEGG; eci:UTI89_C2166; -.
DR   PATRIC; 18453920; VBIEscCol42261_2204.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; ECOL364106:GHPQ-2221-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064278.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31205 MW;  9531197D59E35C7D CRC64;
     MTVQKSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESEDVAAA LQWAIENDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_PSEA8              Reviewed;         291 AA.
AC   B7UX51;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   28-NOV-2012, entry version 24.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=PLES_41841;
OS   Pseudomonas aeruginosa (strain LESB58).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=557722;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LESB58;
RX   PubMed=19047519; DOI=10.1101/gr.086082.108;
RA   Winstanley C., Langille M.G.I., Fothergill J.L., Kukavica-Ibrulj I.,
RA   Paradis-Bleau C., Sanschagrin F., Thomson N.R., Winsor G.L.,
RA   Quail M.A., Lennard N., Bignell A., Clarke L., Seeger K., Saunders D.,
RA   Harris D., Parkhill J., Hancock R.E.W., Brinkman F.S.L.,
RA   Levesque R.C.;
RT   "Newly introduced genomic prophage islands are critical determinants
RT   of in vivo competitiveness in the Liverpool epidemic strain of
RT   Pseudomonas aeruginosa.";
RL   Genome Res. 19:12-23(2009).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FM209186; CAW28939.1; -; Genomic_DNA.
DR   RefSeq; YP_002441768.1; NC_011770.1.
DR   ProteinModelPortal; B7UX51; -.
DR   STRING; B7UX51; -.
DR   GeneID; 7178292; -.
DR   GenomeReviews; FM209186_GR; PLES_41841.
DR   KEGG; pag:PLES_41841; -.
DR   PATRIC; 19818174; VBIPseAer113719_4312.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; PAER557722:GHJW-3189-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    291       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136182.
FT   ACT_SITE    188    188       By similarity.
FT   ACT_SITE    189    189       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   291 AA;  31955 MW;  1F64F068E2B6035E CRC64;
     MSNERDTSRT PTPDHAEHNA FFPSPYSLSQ YTSAKTDFDG ADYPTPYKGG KKVLMIGTDE
     RYILMQNGSM FSTGNHPVEM LLPMYHLDKA GFEFDVATLS GNPVKLEMWA MPGEDEAVKS
     IYAKYLPKLK APQKLADLLE QAVADDSPYA AVFVPGGHGV LAGIPHSREV KRLLNAFLAK
     DRYIITLCHG PACLLAPAVE EKPEDYPFKD YEICVFPDAL DTGANLEIGY MPGPLPWLVG
     ENLQKLGVKI LNKGITGQVH RDRKLLTGDS PLASNNLGKL AAKTLLEAFA R
//
ID   HCHA_PSEAB              Reviewed;         291 AA.
AC   Q02IV5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 1.
DT   28-NOV-2012, entry version 35.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=PA14_49710;
OS   Pseudomonas aeruginosa (strain UCBPP-PA14).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208963;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UCBPP-PA14;
RX   PubMed=17038190; DOI=10.1186/gb-2006-7-10-r90;
RA   Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S.,
RA   Diggins L.T., He J., Saucier M., Deziel E., Friedman L., Li L.,
RA   Grills G., Montgomery K., Kucherlapati R., Rahme L.G., Ausubel F.M.;
RT   "Genomic analysis reveals that Pseudomonas aeruginosa virulence is
RT   combinatorial.";
RL   Genome Biol. 7:R90.1-R90.14(2006).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000438; ABJ10303.1; -; Genomic_DNA.
DR   RefSeq; YP_792131.1; NC_008463.1.
DR   ProteinModelPortal; Q02IV5; -.
DR   SMR; Q02IV5; 8-289.
DR   STRING; Q02IV5; -.
DR   GeneID; 4380103; -.
DR   GenomeReviews; CP000438_GR; PA14_49710.
DR   KEGG; pau:PA14_49710; -.
DR   PATRIC; 19854284; VBIPseAer79785_4085.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; PAER208963:GI5K-4060-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    291       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064279.
FT   ACT_SITE    188    188       By similarity.
FT   ACT_SITE    189    189       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   291 AA;  31883 MW;  EF669F94DBB44816 CRC64;
     MSNERDTSRT PTPDHAEHNA FFPSPYSLSQ YTSAKTDFDG ADYPTPYNGG KKVLMIGTDE
     RYILMQNGSM FSTGNHPVEM LLPMYHLDKA GFEFDVATLS GNPVKLEMWA MPGEDEAVKS
     IYAKYLPKLK APQKLADLLE QAVADDSPYA AVFVPGGHGV LAGIPHSREV KRLLNAFLAK
     DRYIITLCHG PACLLAPAVE EKPEDYPFKG YEICVFPDAL DTGANLEIGY MPGPLPWLVG
     ENLQKLGVKI LNKGITGQVH RDRKLLTGDS PLASNNLGKL AAKTLLEAFA R
//
ID   HCHA_PSEAE              Reviewed;         291 AA.
AC   Q9I4K0;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-NOV-2012, entry version 56.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=PA1135;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG
OS   12228).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   MEDLINE=20437337; PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE004091; AAG04524.1; -; Genomic_DNA.
DR   PIR; C83504; C83504.
DR   RefSeq; NP_249826.1; NC_002516.2.
DR   ProteinModelPortal; Q9I4K0; -.
DR   SMR; Q9I4K0; 7-290.
DR   DNASU; 879881; -.
DR   GeneID; 879881; -.
DR   GenomeReviews; AE004091_GR; PA1135.
DR   KEGG; pae:PA1135; -.
DR   PATRIC; 19836588; VBIPseAer58763_1180.
DR   PseudoCAP; PA1135; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Reference proteome.
FT   CHAIN         1    291       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209415.
FT   ACT_SITE    188    188       By similarity.
FT   ACT_SITE    189    189       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   291 AA;  31899 MW;  B55BCD412EE4AA0A CRC64;
     MSNERDTSRT PTPDPAEHNA FFPSPYSLSQ YTSAKTDFDG ADYPTPYKGG KKVLMIGTDE
     RYILMQNASM FSTGNHPVEM LLPMYHLDKA GFEFDVATLS GNPVKLEMWA MPGEDEAVKS
     IYAKYLPKLK APRKLADLLE QAVADDSPYA AVFVPGGHGV LAGIPHSREV KRLLNAFLAK
     DRYIITLCHG PACLLAPAVE EKPEDYPFKG YEICVFPDAL DTGANLEIGY MPGPLPWLVG
     ENLQKLGVKI LNKGITGQVH RDRKLLTGDS PLASNNLGKL AAKTLLEAFA R
//
ID   HCHA_SHIB3              Reviewed;         283 AA.
AC   B2TWL8;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 1.
DT   28-NOV-2012, entry version 26.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SbBS512_E0916;
OS   Shigella boydii serotype 18 (strain CDC 3083-94 / BS512).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=344609;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=CDC 3083-94 / BS512;
RA   Rasko D.A., Rosovitz M., Maurelli A.T., Myers G., Seshadri R., Cer R.,
RA   Jiang L., Ravel J., Sebastian Y.;
RT   "Complete sequence of Shigella boydii serotype 18 strain BS512.";
RL   Submitted (MAY-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP001063; ACD08859.1; -; Genomic_DNA.
DR   RefSeq; YP_001879604.1; NC_010658.1.
DR   ProteinModelPortal; B2TWL8; -.
DR   SMR; B2TWL8; 5-283.
DR   STRING; B2TWL8; -.
DR   MEROPS; C56.006; -.
DR   EnsemblBacteria; EBESCT00000073444; EBESCP00000070763; EBESCG00000072491.
DR   GeneID; 6273305; -.
DR   GenomeReviews; CP001063_GR; SbBS512_E0916.
DR   KEGG; sbc:SbBS512_E0916; -.
DR   PATRIC; 18668442; VBIShiBoy129590_1018.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SBOY344609:GI0O-3237-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000136183.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31176 MW;  5CA8BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAG
//
ID   HCHA_SHIF8              Reviewed;         283 AA.
AC   Q0T3G3;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   28-NOV-2012, entry version 39.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SFV_2012;
OS   Shigella flexneri serotype 5b (strain 8401).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=373384;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=8401;
RX   PubMed=16822325; DOI=10.1186/1471-2164-7-173;
RA   Nie H., Yang F., Zhang X., Yang J., Chen L., Wang J., Xiong Z.,
RA   Peng J., Sun L., Dong J., Xue Y., Xu X., Chen S., Yao Z., Shen Y.,
RA   Jin Q.;
RT   "Complete genome sequence of Shigella flexneri 5b and comparison with
RT   Shigella flexneri 2a.";
RL   BMC Genomics 7:173-173(2006).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000266; ABF04152.1; -; Genomic_DNA.
DR   RefSeq; YP_689457.1; NC_008258.1.
DR   ProteinModelPortal; Q0T3G3; -.
DR   SMR; Q0T3G3; 5-282.
DR   STRING; Q0T3G3; -.
DR   EnsemblBacteria; EBESCT00000095547; EBESCP00000091743; EBESCG00000094591.
DR   GeneID; 4206871; -.
DR   GenomeReviews; CP000266_GR; SFV_2012.
DR   KEGG; sfv:SFV_2012; -.
DR   PATRIC; 18727652; VBIShiFle33408_2328.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SFLE373384:GHZM-2086-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064280.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31280 MW;  55985ECD581821B2 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHSDNP LNGYSICAFP DAADKQTPDI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKRLTG DSPFAANALG KLAAQEMLAA YAS
//
ID   HCHA_SHIFL              Reviewed;         283 AA.
AC   P59332;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-NOV-2012, entry version 65.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SF2014, S2111;
OS   Shigella flexneri.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=301 / Serotype 2a;
RX   MEDLINE=22272406; PubMed=12384590; DOI=10.1093/nar/gkf566;
RA   Jin Q., Yuan Z., Xu J., Wang Y., Shen Y., Lu W., Wang J., Liu H.,
RA   Yang J., Yang F., Zhang X., Zhang J., Yang G., Wu H., Qu D., Dong J.,
RA   Sun L., Xue Y., Zhao A., Gao Y., Zhu J., Kan B., Ding K., Chen S.,
RA   Cheng H., Yao Z., He B., Chen R., Ma D., Qiang B., Wen Y., Hou Y.,
RA   Yu J.;
RT   "Genome sequence of Shigella flexneri 2a: insights into pathogenicity
RT   through comparison with genomes of Escherichia coli K12 and O157.";
RL   Nucleic Acids Res. 30:4432-4441(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700930 / 2457T / Serotype 2a;
RX   MEDLINE=22590274; PubMed=12704152;
RX   DOI=10.1128/IAI.71.5.2775-2786.2003;
RA   Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W.,
RA   Fournier G., Mayhew G.F., Plunkett G. III, Rose D.J., Darling A.,
RA   Mau B., Perna N.T., Payne S.M., Runyen-Janecky L.J., Zhou S.,
RA   Schwartz D.C., Blattner F.R.;
RT   "Complete genome sequence and comparative genomics of Shigella
RT   flexneri serotype 2a strain 2457T.";
RL   Infect. Immun. 71:2775-2786(2003).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005674; AAN43559.1; -; Genomic_DNA.
DR   EMBL; AE014073; AAP17385.1; -; Genomic_DNA.
DR   RefSeq; NP_707852.1; NC_004337.2.
DR   RefSeq; NP_837576.1; NC_004741.1.
DR   ProteinModelPortal; P59332; -.
DR   SMR; P59332; 5-282.
DR   MEROPS; C56.006; -.
DR   EnsemblBacteria; EBESCT00000085657; EBESCP00000082479; EBESCG00000084702.
DR   EnsemblBacteria; EBESCT00000091095; EBESCP00000087731; EBESCG00000090139.
DR   GeneID; 1025257; -.
DR   GeneID; 1078425; -.
DR   GenomeReviews; AE005674_GR; SF2014.
DR   GenomeReviews; AE014073_GR; S2111.
DR   KEGG; sfl:SF2014; -.
DR   KEGG; sfx:S2111; -.
DR   PATRIC; 18705727; VBIShiFle31049_2351.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209416.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
FT   CONFLICT    276    283       EMLAAYAS -> KCWQLTRVNPCYIVM (in Ref. 2;
FT                                AAP17385).
SQ   SEQUENCE   283 AA;  31280 MW;  55985ECD581821B2 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHSDNP LNGYSICAFP DAADKQTPDI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKRLTG DSPFAANALG KLAAQEMLAA YAS
//
ID   HCHA_SHISS              Reviewed;         283 AA.
AC   Q3Z0M5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 1.
DT   28-NOV-2012, entry version 44.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SSON_2023;
OS   Shigella sonnei (strain Ss046).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=300269;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Ss046;
RX   PubMed=16275786; DOI=10.1093/nar/gki954;
RA   Yang F., Yang J., Zhang X., Chen L., Jiang Y., Yan Y., Tang X.,
RA   Wang J., Xiong Z., Dong J., Xue Y., Zhu Y., Xu X., Sun L., Chen S.,
RA   Nie H., Peng J., Xu J., Wang Y., Yuan Z., Wen Y., Yao Z., Shen Y.,
RA   Qiang B., Hou Y., Yu J., Jin Q.;
RT   "Genome dynamics and diversity of Shigella species, the etiologic
RT   agents of bacillary dysentery.";
RL   Nucleic Acids Res. 33:6445-6458(2005).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- ENZYME REGULATION: Binding of ATP at high temperatures induces a
CC       conformational change that reduces HchA surface hydrophobicity and
CC       interferes with its ability to capture substrate proteins (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- INDUCTION: By heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000038; AAZ88687.1; -; Genomic_DNA.
DR   RefSeq; YP_310922.1; NC_007384.1.
DR   ProteinModelPortal; Q3Z0M5; -.
DR   SMR; Q3Z0M5; 5-282.
DR   STRING; Q3Z0M5; -.
DR   EnsemblBacteria; EBESCT00000099148; EBESCP00000095177; EBESCG00000098192.
DR   GeneID; 3667021; -.
DR   GenomeReviews; CP000038_GR; SSON_2023.
DR   KEGG; ssn:SSON_2023; -.
DR   PATRIC; 18738211; VBIShiSon107113_2445.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Metal-binding;
KW   Stress response; Zinc.
FT   CHAIN         1    283       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064281.
FT   ACT_SITE    185    185       By similarity.
FT   ACT_SITE    186    186       By similarity.
FT   ACT_SITE    214    214       By similarity.
FT   METAL        86     86       Zinc (By similarity).
FT   METAL        91     91       Zinc (By similarity).
FT   METAL       123    123       Zinc (By similarity).
SQ   SEQUENCE   283 AA;  31234 MW;  5E78BE99F9A83B72 CRC64;
     MTVQTSKNPQ VDIAEDNAFF PSEYSLSQYT SPVSDLDGVD YPKPYRGKHK ILVIAADERY
     LPTDNGKLFS TGNHPIETLL PLYHLHAAGF EFEVATISGL MTKFEYWAMP HKDEKVMPFF
     EQHKSLFRNP KKLADVVASL NADSEYAAIF VPGGHGALIG LPESQDVAAA LQWAIKNDRF
     VISLCHGPAA FLALRHGDNP LNGYSICAFP DAADKQTPEI GYMPGHLTWY FGEELKKMGM
     NIINDDITGR VHKDRKVLTG DSPFAANALG KLAAQEMLAA YAD
//
ID   HCHA_STAA1              Reviewed;         292 AA.
AC   A7WYY0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   09-JAN-2013, entry version 33.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAHV_0549;
OS   Staphylococcus aureus (strain Mu3 / ATCC 700698).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=418127;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Mu3 / ATCC 700698;
RX   PubMed=17954695; DOI=10.1128/AAC.00534-07;
RA   Neoh H.-M., Cui L., Yuzawa H., Takeuchi F., Matsuo M., Hiramatsu K.;
RT   "Mutated response regulator graR is responsible for phenotypic
RT   conversion of Staphylococcus aureus from heterogeneous vancomycin-
RT   intermediate resistance to vancomycin-intermediate resistance.";
RL   Antimicrob. Agents Chemother. 52:45-53(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP009324; BAF77432.1; -; Genomic_DNA.
DR   RefSeq; YP_001441139.1; NC_009782.1.
DR   ProteinModelPortal; A7WYY0; -.
DR   SMR; A7WYY0; 8-291.
DR   STRING; A7WYY0; -.
DR   EnsemblBacteria; EBSTAT00000004300; EBSTAP00000004199; EBSTAG00000004300.
DR   GeneID; 5559654; -.
DR   GenomeReviews; AP009324_GR; SAHV_0549.
DR   KEGG; saw:SAHV_0549; -.
DR   PATRIC; 19556067; VBIStaAur127830_0554.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR418127:GJP9-566-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064282.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAA2              Reviewed;         292 AA.
AC   A6TZ28;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   09-JAN-2013, entry version 34.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SaurJH1_0588;
OS   Staphylococcus aureus (strain JH1).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=359787;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JH1;
RG   US DOE Joint Genome Institute;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C.,
RA   Glavina del Rio T., Hammon N., Israni S., Dalin E., Tice H.,
RA   Pitluck S., Chain P., Malfatti S., Shin M., Vergez L., Schmutz J.,
RA   Larimer F., Land M., Hauser L., Kyrpides N., Ivanova N., Tomasz A.,
RA   Richardson P.;
RT   "Complete sequence of chromosome of Staphylococcus aureus subsp.
RT   aureus JH1.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000736; ABR51446.1; -; Genomic_DNA.
DR   RefSeq; YP_001315733.1; NC_009632.1.
DR   ProteinModelPortal; A6TZ28; -.
DR   SMR; A6TZ28; 8-291.
DR   STRING; A6TZ28; -.
DR   EnsemblBacteria; EBSTAT00000015254; EBSTAP00000014757; EBSTAG00000015253.
DR   GeneID; 5317283; -.
DR   GenomeReviews; CP000736_GR; SaurJH1_0588.
DR   KEGG; sah:SaurJH1_0588; -.
DR   PATRIC; 19533011; VBIStaAur98826_0616.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000084410.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAA3              Reviewed;         292 AA.
AC   Q2FJ89;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   09-JAN-2013, entry version 36.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAUSA300_0536;
OS   Staphylococcus aureus (strain USA300).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=367830;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=USA300;
RX   PubMed=16517273; DOI=10.1016/S0140-6736(06)68231-7;
RA   Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G.,
RA   Lin F., Lin J., Carleton H.A., Mongodin E.F., Sensabaugh G.F.,
RA   Perdreau-Remington F.;
RT   "Complete genome sequence of USA300, an epidemic clone of community-
RT   acquired meticillin-resistant Staphylococcus aureus.";
RL   Lancet 367:731-739(2006).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000255; ABD21878.1; -; Genomic_DNA.
DR   RefSeq; YP_493239.1; NC_007793.1.
DR   ProteinModelPortal; Q2FJ89; -.
DR   SMR; Q2FJ89; 8-291.
DR   EnsemblBacteria; EBSTAT00000037309; EBSTAP00000036017; EBSTAG00000037307.
DR   GeneID; 3914160; -.
DR   GenomeReviews; CP000255_GR; SAUSA300_0536.
DR   KEGG; saa:SAUSA300_0536; -.
DR   PATRIC; 19590336; VBIStaAur129981_0598.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR451515:GH3C-594-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064283.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAA8              Reviewed;         292 AA.
AC   Q2G0M7;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   09-JAN-2013, entry version 36.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAOUHSC_00533;
OS   Staphylococcus aureus (strain NCTC 8325).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W.,
RA   Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC8325 genome.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000253; ABD29681.1; -; Genomic_DNA.
DR   RefSeq; YP_499105.1; NC_007795.1.
DR   ProteinModelPortal; Q2G0M7; -.
DR   SMR; Q2G0M7; 8-291.
DR   STRING; Q2G0M7; -.
DR   EnsemblBacteria; EBSTAT00000028520; EBSTAP00000027471; EBSTAG00000028519.
DR   GeneID; 3920386; -.
DR   GenomeReviews; CP000253_GR; SAOUHSC_00533.
DR   KEGG; sao:SAOUHSC_00533; -.
DR   PATRIC; 19578638; VBIStaAur99865_0479.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR93061:GIWJ-515-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase; Reference proteome.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064284.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAA9              Reviewed;         292 AA.
AC   A5IQA5;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 1.
DT   09-JAN-2013, entry version 35.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SaurJH9_0574;
OS   Staphylococcus aureus (strain JH9).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=359786;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JH9;
RG   US DOE Joint Genome Institute;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C.,
RA   Glavina del Rio T., Hammon N., Israni S., Pitluck S., Chain P.,
RA   Malfatti S., Shin M., Vergez L., Schmutz J., Larimer F., Land M.,
RA   Hauser L., Kyrpides N., Kim E., Tomasz A., Richardson P.;
RT   "Complete sequence of chromosome of Staphylococcus aureus subsp.
RT   aureus JH9.";
RL   Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000703; ABQ48378.1; -; Genomic_DNA.
DR   RefSeq; YP_001245954.1; NC_009487.1.
DR   ProteinModelPortal; A5IQA5; -.
DR   SMR; A5IQA5; 8-291.
DR   STRING; A5IQA5; -.
DR   EnsemblBacteria; EBSTAT00000018767; EBSTAP00000018186; EBSTAG00000018766.
DR   GeneID; 5169768; -.
DR   GenomeReviews; CP000703_GR; SaurJH9_0574.
DR   KEGG; saj:SaurJH9_0574; -.
DR   PATRIC; 19538869; VBIStaAur42398_0626.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR359786:GJEM-597-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000084411.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAB              Reviewed;         292 AA.
AC   Q2YSB0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   06-FEB-2013, entry version 41.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAB0502;
OS   Staphylococcus aureus (strain bovine RF122 / ET3-1).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=273036;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=bovine RF122 / ET3-1;
RX   PubMed=17971880; DOI=10.1371/journal.pone.0001120;
RA   Herron-Olson L., Fitzgerald J.R., Musser J.M., Kapur V.;
RT   "Molecular correlates of host specialization in Staphylococcus
RT   aureus.";
RL   PLoS ONE 2:E1120-E1120(2007).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ938182; CAI80190.1; -; Genomic_DNA.
DR   RefSeq; YP_416000.1; NC_007622.1.
DR   ProteinModelPortal; Q2YSB0; -.
DR   SMR; Q2YSB0; 9-289.
DR   STRING; Q2YSB0; -.
DR   EnsemblBacteria; EBSTAT00000012793; EBSTAP00000012450; EBSTAG00000012792.
DR   GeneID; 3793598; -.
DR   GenomeReviews; AJ938182_GR; SAB0502.
DR   KEGG; sab:SAB0502; -.
DR   PATRIC; 19521783; VBIStaAur92441_0543.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR273036:GJVS-521-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000064285.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32191 MW;  02888B0B1CC89B67 CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPAKLEL WAMPTEDEAV
     ITTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQKTLDWAL
     ENDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     ELLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAC              Reviewed;         292 AA.
AC   Q5HIC4;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   09-JAN-2013, entry version 49.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SACOL0597;
OS   Staphylococcus aureus (strain COL).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=93062;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=COL;
RX   PubMed=15774886; DOI=10.1128/JB.187.7.2426-2438.2005;
RA   Gill S.R., Fouts D.E., Archer G.L., Mongodin E.F., DeBoy R.T.,
RA   Ravel J., Paulsen I.T., Kolonay J.F., Brinkac L.M., Beanan M.J.,
RA   Dodson R.J., Daugherty S.C., Madupu R., Angiuoli S.V., Durkin A.S.,
RA   Haft D.H., Vamathevan J.J., Khouri H., Utterback T.R., Lee C.,
RA   Dimitrov G., Jiang L., Qin H., Weidman J., Tran K., Kang K.H.,
RA   Hance I.R., Nelson K.E., Fraser C.M.;
RT   "Insights on evolution of virulence and resistance from the complete
RT   genome analysis of an early methicillin-resistant Staphylococcus
RT   aureus strain and a biofilm-producing methicillin-resistant
RT   Staphylococcus epidermidis strain.";
RL   J. Bacteriol. 187:2426-2438(2005).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000046; AAW37707.1; -; Genomic_DNA.
DR   RefSeq; YP_185483.1; NC_002951.2.
DR   ProteinModelPortal; Q5HIC4; -.
DR   SMR; Q5HIC4; 8-291.
DR   STRING; Q5HIC4; -.
DR   EnsemblBacteria; EBSTAT00000009145; EBSTAP00000008880; EBSTAG00000009144.
DR   GeneID; 3236436; -.
DR   GenomeReviews; CP000046_GR; SACOL0597.
DR   KEGG; sac:SACOL0597; -.
DR   PATRIC; 19527456; VBIStaAur112458_0581.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209417.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAE              Reviewed;         292 AA.
AC   A6QEK3;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   09-JAN-2013, entry version 33.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=NWMN_0513;
OS   Staphylococcus aureus (strain Newman).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=426430;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Newman;
RX   PubMed=17951380; DOI=10.1128/JB.01000-07;
RA   Baba T., Bae T., Schneewind O., Takeuchi F., Hiramatsu K.;
RT   "Genome sequence of Staphylococcus aureus strain Newman and
RT   comparative analysis of staphylococcal genomes: polymorphism and
RT   evolution of two major pathogenicity islands.";
RL   J. Bacteriol. 190:300-310(2008).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP009351; BAF66785.1; -; Genomic_DNA.
DR   RefSeq; YP_001331547.1; NC_009641.1.
DR   ProteinModelPortal; A6QEK3; -.
DR   SMR; A6QEK3; 9-289.
DR   STRING; A6QEK3; -.
DR   EnsemblBacteria; EBSTAT00000031778; EBSTAP00000030648; EBSTAG00000031776.
DR   GeneID; 5330268; -.
DR   GenomeReviews; AP009351_GR; NWMN_0513.
DR   KEGG; sae:NWMN_0513; -.
DR   PATRIC; 19584468; VBIStaAur133992_0560.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR426430:GIXC-514-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000072991.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7DDA56307D762398 CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG INREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAM              Reviewed;         292 AA.
AC   P64312; Q99W58;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   06-FEB-2013, entry version 47.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAV0551;
OS   Staphylococcus aureus (strain Mu50 / ATCC 700699).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158878;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Mu50 / ATCC 700699;
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000017; BAB56713.1; -; Genomic_DNA.
DR   RefSeq; NP_371075.1; NC_002758.2.
DR   ProteinModelPortal; P64312; -.
DR   SMR; P64312; 8-291.
DR   STRING; P64312; -.
DR   World-2DPAGE; 0002:P64312; -.
DR   EnsemblBacteria; EBSTAT00000007586; EBSTAP00000007404; EBSTAG00000007585.
DR   GeneID; 1120524; -.
DR   GenomeReviews; BA000017_GR; SAV0551.
DR   KEGG; sav:SAV0551; -.
DR   PATRIC; 19561754; VBIStaAur52173_0557.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR158878:GJJ5-569-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   1: Evidence at protein level;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209420.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAN              Reviewed;         292 AA.
AC   P64313; Q99W58;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   09-JAN-2013, entry version 50.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SA0509;
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=N315;
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=N315;
RA   Vaezzadeh A.R., Deshusses J., Lescuyer P., Hochstrasser D.F.;
RT   "Shotgun proteomic analysis of total and membrane protein extracts of
RT   S. aureus strain N315.";
RL   Submitted (OCT-2007) to UniProtKB.
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000018; BAB41740.1; -; Genomic_DNA.
DR   PIR; A89823; A89823.
DR   RefSeq; NP_373762.1; NC_002745.2.
DR   ProteinModelPortal; P64313; -.
DR   SMR; P64313; 8-291.
DR   STRING; P64313; -.
DR   PhosSite; P0909760; -.
DR   EnsemblBacteria; EBSTAT00000000216; EBSTAP00000000216; EBSTAG00000000216.
DR   GeneID; 1123314; -.
DR   GenomeReviews; BA000018_GR; SA0509.
DR   KEGG; sau:SA0509; -.
DR   PATRIC; 19573130; VBIStaAur116463_0535.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR158879:GJCB-543-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   1: Evidence at protein level;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209422.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAR              Reviewed;         292 AA.
AC   Q6GJB7;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 47.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAR0556;
OS   Staphylococcus aureus (strain MRSA252).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282458;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MRSA252;
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571856; CAG39577.1; -; Genomic_DNA.
DR   RefSeq; YP_040005.1; NC_002952.2.
DR   ProteinModelPortal; Q6GJB7; -.
DR   SMR; Q6GJB7; 9-289.
DR   STRING; Q6GJB7; -.
DR   EnsemblBacteria; EBSTAT00000020315; EBSTAP00000019651; EBSTAG00000020314.
DR   GeneID; 2861088; -.
DR   GenomeReviews; BX571856_GR; SAR0556.
DR   KEGG; sar:SAR0556; -.
DR   PATRIC; 19544662; VBIStaAur71814_0564.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR282458:GJA5-572-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209418.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32192 MW;  A1BD47D5BBD8ABA6 CRC64;
     MSQDVNKLSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPAKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     ENDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQSLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAS              Reviewed;         292 AA.
AC   Q6GBT6;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 47.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=SAS0509;
OS   Staphylococcus aureus (strain MSSA476).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282459;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MSSA476;
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571857; CAG42284.1; -; Genomic_DNA.
DR   RefSeq; YP_042637.1; NC_002953.3.
DR   ProteinModelPortal; Q6GBT6; -.
DR   SMR; Q6GBT6; 9-289.
DR   STRING; Q6GBT6; -.
DR   PRIDE; Q6GBT6; -.
DR   EnsemblBacteria; EBSTAT00000023224; EBSTAP00000022391; EBSTAG00000023223.
DR   GeneID; 2861897; -.
DR   GenomeReviews; BX571857_GR; SAS0509.
DR   KEGG; sas:SAS0509; -.
DR   PATRIC; 19550426; VBIStaAur96780_0531.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209419.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32181 MW;  CA9E227128741960 CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSTLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAT              Reviewed;         292 AA.
AC   A8YZP8;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 1.
DT   09-JAN-2013, entry version 29.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=USA300HOU_0544;
OS   Staphylococcus aureus (strain USA300 / TCH1516).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=451516;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=USA300 / TCH1516;
RX   PubMed=17986343; DOI=10.1186/1471-2180-7-99;
RA   Highlander S.K., Hulten K.G., Qin X., Jiang H., Yerrapragada S.,
RA   Mason E.O. Jr., Shang Y., Williams T.M., Fortunov R.M., Liu Y.,
RA   Igboeli O., Petrosino J., Tirumalai M., Uzman A., Fox G.E.,
RA   Cardenas A.M., Muzny D.M., Hemphill L., Ding Y., Dugan S., Blyth P.R.,
RA   Buhay C.J., Dinh H.H., Hawes A.C., Holder M., Kovar C.L., Lee S.L.,
RA   Liu W., Nazareth L.V., Wang Q., Zhou J., Kaplan S.L., Weinstock G.M.;
RT   "Subtle genetic changes enhance virulence of methicillin resistant and
RT   sensitive Staphylococcus aureus.";
RL   BMC Microbiol. 7:99-99(2007).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000730; ABX28570.1; -; Genomic_DNA.
DR   RefSeq; YP_001574449.1; NC_010079.1.
DR   ProteinModelPortal; A8YZP8; -.
DR   SMR; A8YZP8; 8-291.
DR   STRING; A8YZP8; -.
DR   EnsemblBacteria; EBSTAT00000035381; EBSTAP00000034170; EBSTAG00000035379.
DR   GeneID; 5776791; -.
DR   GenomeReviews; CP000730_GR; USA300HOU_0544.
DR   KEGG; sax:USA300HOU_0544; -.
DR   PATRIC; 19596137; VBIStaAur36919_0588.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR451516:GJQ4-562-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_1000084412.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32177 MW;  7ADA2635287373CD CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSPLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HCHA_STAAW              Reviewed;         292 AA.
AC   Q8NXY2;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   09-JAN-2013, entry version 53.
DE   RecName: Full=Molecular chaperone Hsp31 and glyoxalase 3;
DE            EC=4.2.1.130;
DE   AltName: Full=Glyoxalase III;
DE   AltName: Full=Holdase;
DE   AltName: Full=Holding molecular chaperone;
GN   Name=hchA; OrderedLocusNames=MW0506;
OS   Staphylococcus aureus (strain MW2).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=196620;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MW2;
RX   MEDLINE=22040717; PubMed=12044378; DOI=10.1016/S0140-6736(02)08713-5;
RA   Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A.,
RA   Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L.,
RA   Yamamoto K., Hiramatsu K.;
RT   "Genome and virulence determinants of high virulence community-
RT   acquired MRSA.";
RL   Lancet 359:1819-1827(2002).
CC   -!- FUNCTION: Functions as a holding molecular chaperone (holdase)
CC       which stabilizes unfolding intermediates and rapidly releases them
CC       in an active form once stress has abated. Plays an important role
CC       in protecting cells from severe heat shock and starvation, as well
CC       as in acid resistance of stationary-phase cells. It catalyzes the
CC       conversion of methylglyoxal (MG) to D-lactate in a single
CC       glutathione (GSH)-independent step (By similarity).
CC   -!- CATALYTIC ACTIVITY: (R)-lactate = methylglyoxal + H(2)O.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family. HchA subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000033; BAB94371.1; -; Genomic_DNA.
DR   RefSeq; NP_645323.1; NC_003923.1.
DR   ProteinModelPortal; Q8NXY2; -.
DR   SMR; Q8NXY2; 9-289.
DR   STRING; Q8NXY2; -.
DR   PRIDE; Q8NXY2; -.
DR   EnsemblBacteria; EBSTAT00000026892; EBSTAP00000025931; EBSTAG00000026891.
DR   GeneID; 1002617; -.
DR   GenomeReviews; BA000033_GR; MW0506.
DR   KEGG; sam:MW0506; -.
DR   PATRIC; 19567546; VBIStaAur44266_0535.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000221774; -.
DR   KO; K05523; -.
DR   OMA; LPMYHLD; -.
DR   ProtClustDB; PRK04155; -.
DR   BioCyc; SAUR196620:GJ9Z-527-MONOMER; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   HAMAP; MF_01046; Chaperone_HchA; 1; -.
DR   InterPro; IPR017283; Hsp31_and_glyoxalase_3.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PIRSF; PIRSF037798; Chaperone_HchA; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Cytoplasm; Lyase.
FT   CHAIN         1    292       Molecular chaperone Hsp31 and glyoxalase
FT                                3.
FT                                /FTId=PRO_0000209421.
FT   ACT_SITE    190    190       By similarity.
FT   ACT_SITE    191    191       By similarity.
FT   ACT_SITE    221    221       By similarity.
SQ   SEQUENCE   292 AA;  32181 MW;  CA9E227128741960 CRC64;
     MSQDVNELSK QPTPDKAEDN AFFPSPYSLS QYTAPKTDFD GVEHKGAYKD GKWKVLMIAA
     EERYVLLENG KMFSTGNHPV EMLLPLHHLM EAGFDVDVAT LSGYPVKLEL WAMPTEDEAV
     ISTYNKLKEK LKQPKKLADV IKNELGPDSD YLSVFIPGGH AAVVGISESE DVQQTLDWAL
     DNDRFIVTLC HGPAALLSAG LNREKSTLEG YSVCVFPDSL DEGANIEIGY LPGRLKWLVA
     DLLTKQGLKV VNDDMTGRTL KDRKLLTGDS PLASNELGKL AVNEMLNAIQ NK
//
ID   HDAC6_HUMAN             Reviewed;        1215 AA.
AC   Q9UBN7; O94975; Q6NT75; Q7L3E5; Q96CY0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   06-FEB-2013, entry version 126.
DE   RecName: Full=Histone deacetylase 6;
DE            Short=HD6;
DE            EC=3.5.1.98;
GN   Name=HDAC6; Synonyms=KIAA0901; ORFNames=JM21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-994.
RX   MEDLINE=99238449; PubMed=10220385; DOI=10.1073/pnas.96.9.4868;
RA   Grozinger C.M., Hassig C.A., Schreiber S.L.;
RT   "Three proteins define a class of human histone deacetylases related
RT   to yeast Hda1p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4868-4873(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=99156230; PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Kikuno R., Nagase T., Ishikawa K.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-994.
RC   TISSUE=Brain;
RA   Strom T.M., Gutwillinger N., Nyakatura G., Hellebrand H., Drescher B.,
RA   Rosenthal A., Meindl A.;
RT   "Transcription map in Xp11.23.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ASP-1200.
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH CBFA2T3.
RX   PubMed=11533236; DOI=10.1128/MCB.21.19.6470-6483.2001;
RA   Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N.,
RA   Downing J.R., Meyers S., Hiebert S.W.;
RT   "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts
RT   with multiple histone deacetylases and binds mSin3A through its
RT   oligomerization domain.";
RL   Mol. Cell. Biol. 21:6470-6483(2001).
RN   [9]
RP   INTERACTION WITH HDAC11.
RX   MEDLINE=22095522; PubMed=11948178; DOI=10.1074/jbc.M111871200;
RA   Gao L., Cueto M.A., Asselbergs F., Atadja P.;
RT   "Cloning and functional characterization of HDAC11, a novel member of
RT   the human histone deacetylase family.";
RL   J. Biol. Chem. 277:25748-25755(2002).
RN   [10]
RP   SUMOYLATION.
RX   MEDLINE=22027703; PubMed=12032081; DOI=10.1093/emboj/21.11.2682;
RA   Kirsh O., Seeler J.-S., Pichler A., Gast A., Mueller S., Miska E.,
RA   Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A.;
RT   "The SUMO E3 ligase RanBP2 promotes modification of the HDAC4
RT   deacetylase.";
RL   EMBO J. 21:2682-2691(2002).
RN   [11]
RP   UBIQUITINATION, AND MUTAGENESIS OF HIS-216 AND HIS-611.
RX   MEDLINE=22269913; PubMed=12354939; DOI=10.1073/pnas.172511699;
RA   Hook S.S., Orian A., Cowley S.M., Eisenman R.N.;
RT   "Histone deacetylase 6 binds polyubiquitin through its zinc finger
RT   (PAZ domain) and copurifies with deubiquitinating enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13425-13430(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [13]
RP   FUNCTION.
RX   MEDLINE=22022144; PubMed=12024216; DOI=10.1038/417455a;
RA   Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A.,
RA   Yoshida M., Wang X.-F., Yao T.-P.;
RT   "HDAC6 is a microtubule-associated deacetylase.";
RL   Nature 417:455-458(2002).
RN   [14]
RP   INTERACTION WITH SIRT2.
RX   MEDLINE=22508548; PubMed=12620231; DOI=10.1016/S1097-2765(03)00038-8;
RA   North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E.;
RT   "The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin
RT   deacetylase.";
RL   Mol. Cell 11:437-444(2003).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   PHOSPHORYLATION BY AURKA.
RX   PubMed=17604723; DOI=10.1016/j.cell.2007.04.035;
RA   Pugacheva E.N., Jablonski S.A., Hartman T.R., Henske E.P.,
RA   Golemis E.A.;
RT   "HEF1-dependent Aurora A activation induces disassembly of the primary
RT   cilium.";
RL   Cell 129:1351-1363(2007).
RN   [17]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.M703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [18]
RP   FUNCTION.
RX   PubMed=17846173; DOI=10.1083/jcb.200611128;
RA   Olzmann J.A., Li L., Chudaev M.V., Chen J., Perez F.A., Palmiter R.D.,
RA   Chin L.S.;
RT   "Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1
RT   to aggresomes via binding to HDAC6.";
RL   J. Cell Biol. 178:1025-1038(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-30, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [20]
RP   INTERACTION WITH BBIP10.
RX   PubMed=19081074; DOI=10.1016/j.devcel.2008.11.001;
RA   Loktev A.V., Zhang Q., Beck J.S., Searby C.C., Scheetz T.E., Bazan F.,
RA   Slusarski D.C., Sheffield V.C., Jackson P.K., Nachury M.V.;
RT   "A BBSome subunit links ciliogenesis, microtubule stability and
RT   acetylation.";
RL   Dev. Cell 15:854-865(2008).
RN   [21]
RP   INTERACTION WITH UBD.
RX   PubMed=19033385; DOI=10.1242/jcs.035006;
RA   Kalveram B., Schmidtke G., Groettrup M.;
RT   "The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes
RT   to aggresomes under proteasome inhibition.";
RL   J. Cell Sci. 121:4079-4088(2008).
RN   [22]
RP   ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=20102703; DOI=10.1016/j.bbrc.2010.01.091;
RA   Zhuang Y., Nguyen H.T., Lasky J.A., Cao S., Li C., Hu J., Guo X.,
RA   Burow M.E., Shan B.;
RT   "Requirement of a novel splicing variant of human histone deacetylase
RT   6 for TGF-beta1-mediated gene activation.";
RL   Biochem. Biophys. Res. Commun. 392:608-613(2010).
RN   [23]
RP   INTERACTION WITH CYLD.
RX   PubMed=19893491; DOI=10.1038/emboj.2009.317;
RA   Wickstrom S.A., Masoumi K.C., Khochbin S., Fassler R., Massoumi R.;
RT   "CYLD negatively regulates cell-cycle progression by inactivating
RT   HDAC6 and increasing the levels of acetylated tubulin.";
RL   EMBO J. 29:131-144(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 1109-1215 IN COMPLEX WITH
RP   ZINC IONS.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human HDAC6 zinc finger domain.";
RL   Submitted (FEB-2008) to the PDB data bank.
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 1109-1215 IN COMPLEX WITH
RP   ZINC IONS AND UBIQUITIN C-TERMINAL PEPTIDE RLRGG.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human HDAC6 zinc finger domain and ubiquitin C-
RT   terminal peptide RLRGG.";
RL   Submitted (APR-2009) to the PDB data bank.
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes (By similarity).
CC       Plays a central role in microtubule-dependent cell motility via
CC       deacetylation of tubulin.
CC   -!- FUNCTION: In addition to its protein deacetylase activity, plays a
CC       key role in the degradation of misfolded proteins: when misfolded
CC       proteins are too abundant to be degraded by the chaperone
CC       refolding system and the ubiquitin-proteasome, mediates the
CC       transport of misfolded proteins to a cytoplasmic juxtanuclear
CC       structure called aggresome. Probably acts as an adapter that
CC       recognizes polyubiquitinated misfolded proteins and target them to
CC       the aggresome, facilitating their clearance by autophagy.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- COFACTOR: Binds 3 zinc ions per subunit.
CC   -!- SUBUNIT: Interacts with CBFA2T3, HDAC11 and SIRT2. Interacts with
CC       F-actin. Interacts with BBIP10. Under proteasome impairment
CC       conditions, interacts with UBD via its histone deacetylase 1 and
CC       UBP-type zinc-finger regions. Interacts with CYLD. Interacts with
CC       ZMYND15 (By similarity). Interacts with DDIT3/CHOP.
CC   -!- INTERACTION:
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-301697, EBI-6308763;
CC       Q9HCU9:BRMS1; NbExp=2; IntAct=EBI-301697, EBI-714781;
CC       Q62623:Cdc20 (xeno); NbExp=2; IntAct=EBI-301697, EBI-2256532;
CC       P00533:EGFR; NbExp=8; IntAct=EBI-301697, EBI-297353;
CC       P03409:tax (xeno); NbExp=4; IntAct=EBI-301697, EBI-5236464;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=It is mainly
CC       cytoplasmic, where it is associated with microtubules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HDAC6p131;
CC         IsoId=Q9UBN7-1; Sequence=Displayed;
CC       Name=2; Synonyms=HDAC6p114;
CC         IsoId=Q9UBN7-2; Sequence=VSP_044576;
CC         Note=Required for TGF-beta1-activated gene expression associated
CC         with epithelial-mesenchymal transition (EMT) in A549 cells;
CC   -!- PTM: Phosphorylated by AURKA.
CC   -!- PTM: Ubiquitinated. Its polyubiquitination however does not lead
CC       to its degradation.
CC   -!- PTM: Sumoylated in vitro.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily.
CC   -!- SIMILARITY: Contains 1 UBP-type zinc finger.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74924.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF132609; AAD29048.1; -; mRNA.
DR   EMBL; AB020708; BAA74924.2; ALT_INIT; mRNA.
DR   EMBL; AJ011972; CAA09893.1; -; mRNA.
DR   EMBL; AF196971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471224; EAW50748.1; -; Genomic_DNA.
DR   EMBL; BC013737; AAH13737.1; -; mRNA.
DR   EMBL; BC069243; AAH69243.1; -; mRNA.
DR   IPI; IPI00005711; -.
DR   IPI; IPI00940882; -.
DR   RefSeq; NP_006035.2; NM_006044.2.
DR   UniGene; Hs.6764; -.
DR   PDB; 3C5K; X-ray; 1.55 A; A=1109-1215.
DR   PDB; 3GV4; X-ray; 1.72 A; A=1109-1215.
DR   PDB; 3PHD; X-ray; 3.00 A; A/B/C/D=1109-1215.
DR   PDBsum; 3C5K; -.
DR   PDBsum; 3GV4; -.
DR   PDBsum; 3PHD; -.
DR   ProteinModelPortal; Q9UBN7; -.
DR   SMR; Q9UBN7; 85-439, 480-835, 1109-1210.
DR   DIP; DIP-27544N; -.
DR   IntAct; Q9UBN7; 20.
DR   MINT; MINT-238367; -.
DR   STRING; Q9UBN7; -.
DR   PhosphoSite; Q9UBN7; -.
DR   DMDM; 205371758; -.
DR   PaxDb; Q9UBN7; -.
DR   PRIDE; Q9UBN7; -.
DR   DNASU; 10013; -.
DR   Ensembl; ENST00000334136; ENSP00000334061; ENSG00000094631.
DR   Ensembl; ENST00000376619; ENSP00000365804; ENSG00000094631.
DR   GeneID; 10013; -.
DR   KEGG; hsa:10013; -.
DR   UCSC; uc004dks.1; human.
DR   CTD; 10013; -.
DR   GeneCards; GC0XP048659; -.
DR   H-InvDB; HIX0016783; -.
DR   HGNC; HGNC:14064; HDAC6.
DR   HPA; CAB004236; -.
DR   HPA; HPA003714; -.
DR   HPA; HPA026321; -.
DR   MIM; 300272; gene.
DR   neXtProt; NX_Q9UBN7; -.
DR   Orphanet; 163966; X-linked dominant chondrodysplasia, Chassaing-Lacombe type.
DR   PharmGKB; PA29231; -.
DR   eggNOG; COG0123; -.
DR   HOGENOM; HOG000004769; -.
DR   HOVERGEN; HBG051894; -.
DR   InParanoid; Q9UBN7; -.
DR   KO; K11407; -.
DR   OrthoDB; EOG40P464; -.
DR   PhylomeDB; Q9UBN7; -.
DR   BRENDA; 3.5.1.98; 2681.
DR   Pathway_Interaction_DB; hdac_classi_pathway; Signaling events mediated by HDAC Class I.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Reactome; REACT_111102; Signal Transduction.
DR   ChEMBL; CHEMBL1865; -.
DR   DrugBank; DB02546; Vorinostat.
DR   EvolutionaryTrace; Q9UBN7; -.
DR   GenomeRNAi; 10013; -.
DR   NextBio; 37827; -.
DR   ArrayExpress; Q9UBN7; -.
DR   Bgee; Q9UBN7; -.
DR   CleanEx; HS_HDAC6; -.
DR   Genevestigator; Q9UBN7; -.
DR   GermOnline; ENSG00000094631; Homo sapiens.
DR   GO; GO:0016235; C:aggresome; IDA:BHF-UCL.
DR   GO; GO:0005901; C:caveola; IDA:BHF-UCL.
DR   GO; GO:0031252; C:cell leading edge; IDA:BHF-UCL.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0000118; C:histone deacetylase complex; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005875; C:microtubule associated complex; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0043014; F:alpha-tubulin binding; IDA:BHF-UCL.
DR   GO; GO:0070840; F:dynein complex binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; ISS:UniProtKB.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:EC.
DR   GO; GO:0031593; F:polyubiquitin binding; IDA:BHF-UCL.
DR   GO; GO:0048156; F:tau protein binding; IDA:BHF-UCL.
DR   GO; GO:0042903; F:tubulin deacetylase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0070842; P:aggresome assembly; IMP:BHF-UCL.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:BHF-UCL.
DR   GO; GO:0071218; P:cellular response to misfolded protein; IEA:Compara.
DR   GO; GO:0035967; P:cellular response to topologically incorrect protein; IMP:BHF-UCL.
DR   GO; GO:0070932; P:histone H3 deacetylation; IEA:GOC.
DR   GO; GO:0070933; P:histone H4 deacetylation; IEA:GOC.
DR   GO; GO:0070846; P:Hsp90 deacetylation; IMP:BHF-UCL.
DR   GO; GO:0032418; P:lysosome localization; IMP:BHF-UCL.
DR   GO; GO:0016236; P:macroautophagy; IMP:BHF-UCL.
DR   GO; GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0010727; P:negative regulation of hydrogen peroxide metabolic process; IC:BHF-UCL.
DR   GO; GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Compara.
DR   GO; GO:0051354; P:negative regulation of oxidoreductase activity; IC:BHF-UCL.
DR   GO; GO:0043242; P:negative regulation of protein complex disassembly; IMP:BHF-UCL.
DR   GO; GO:0045861; P:negative regulation of proteolysis; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; ISS:UniProtKB.
DR   GO; GO:0034983; P:peptidyl-lysine deacetylation; IMP:BHF-UCL.
DR   GO; GO:0070845; P:polyubiquitinated misfolded protein transport; IMP:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0090035; P:positive regulation of chaperone-mediated protein complex assembly; IMP:BHF-UCL.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IMP:BHF-UCL.
DR   GO; GO:0010870; P:positive regulation of receptor biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0009967; P:positive regulation of signal transduction; IMP:BHF-UCL.
DR   GO; GO:0043241; P:protein complex disassembly; IEA:Compara.
DR   GO; GO:0000209; P:protein polyubiquitination; IEA:Compara.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0060632; P:regulation of microtubule-based movement; IC:BHF-UCL.
DR   GO; GO:0010469; P:regulation of receptor activity; IMP:BHF-UCL.
DR   GO; GO:0070848; P:response to growth factor stimulus; IMP:BHF-UCL.
DR   GO; GO:0051788; P:response to misfolded protein; IMP:BHF-UCL.
DR   GO; GO:0009636; P:response to toxin; IMP:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IEA:Compara.
DR   Gene3D; 3.40.800.20; His_deacetylse; 2.
DR   Gene3D; 3.30.40.10; Znf_RING/FYVE/PHD; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF00850; Hist_deacetyl; 2.
DR   Pfam; PF02148; zf-UBP; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Autophagy;
KW   Chromatin regulator; Complete proteome; Cytoplasm; Hydrolase;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1215       Histone deacetylase 6.
FT                                /FTId=PRO_0000114703.
FT   ZN_FING    1131   1192       UBP-type.
FT   REGION       87    404       Histone deacetylase 1.
FT   REGION      482    800       Histone deacetylase 2.
FT   REGION     1154   1156       Ubiquitin binding.
FT   REGION     1182   1189       Ubiquitin binding.
FT   ACT_SITE    216    216       1.
FT   ACT_SITE    611    611       2.
FT   METAL      1113   1113       Zinc 1.
FT   METAL      1115   1115       Zinc 1.
FT   METAL      1133   1133       Zinc 3.
FT   METAL      1136   1136       Zinc 3.
FT   METAL      1145   1145       Zinc 2.
FT   METAL      1148   1148       Zinc 2.
FT   METAL      1153   1153       Zinc 3.
FT   METAL      1160   1160       Zinc 3.
FT   METAL      1164   1164       Zinc 2.
FT   METAL      1170   1170       Zinc 2.
FT   METAL      1183   1183       Zinc 1.
FT   METAL      1186   1186       Zinc 1.
FT   MOD_RES      16     16       Phosphoserine (By similarity).
FT   MOD_RES      22     22       Phosphoserine.
FT   MOD_RES      30     30       Phosphothreonine.
FT   VAR_SEQ       1    152       Missing (in isoform 2).
FT                                /FTId=VSP_044576.
FT   VARIANT     994    994       T -> I (in dbSNP:rs1127346).
FT                                /FTId=VAR_046300.
FT   VARIANT    1200   1200       N -> D (in dbSNP:rs151130423).
FT                                /FTId=VAR_068962.
FT   MUTAGEN     216    216       H->A: Reduces histone deacetylase
FT                                activity.
FT   MUTAGEN     611    611       H->A: Reduces histone deacetylase
FT                                activity.
FT   HELIX      1116   1118
FT   TURN       1134   1136
FT   STRAND     1140   1145
FT   TURN       1146   1148
FT   STRAND     1151   1153
FT   TURN       1155   1158
FT   HELIX      1160   1168
FT   STRAND     1172   1175
FT   TURN       1176   1178
FT   STRAND     1181   1183
FT   TURN       1184   1187
FT   STRAND     1188   1190
FT   HELIX      1193   1195
FT   HELIX      1196   1207
SQ   SEQUENCE   1215 AA;  131419 MW;  6F17731268A33114 CRC64;
     MTSTGQDSTT TRQRRSRQNP QSPPQDSSVT SKRNIKKGAV PRSIPNLAEV KKKGKMKKLG
     QAMEEDLIVG LQGMDLNLEA EALAGTGLVL DEQLNEFHCL WDDSFPEGPE RLHAIKEQLI
     QEGLLDRCVS FQARFAEKEE LMLVHSLEYI DLMETTQYMN EGELRVLADT YDSVYLHPNS
     YSCACLASGS VLRLVDAVLG AEIRNGMAII RPPGHHAQHS LMDGYCMFNH VAVAARYAQQ
     KHRIRRVLIV DWDVHHGQGT QFTFDQDPSV LYFSIHRYEQ GRFWPHLKAS NWSTTGFGQG
     QGYTINVPWN QVGMRDADYI AAFLHVLLPV ALEFQPQLVL VAAGFDALQG DPKGEMAATP
     AGFAQLTHLL MGLAGGKLIL SLEGGYNLRA LAEGVSASLH TLLGDPCPML ESPGAPCRSA
     QASVSCALEA LEPFWEVLVR STETVERDNM EEDNVEESEE EGPWEPPVLP ILTWPVLQSR
     TGLVYDQNMM NHCNLWDSHH PEVPQRILRI MCRLEELGLA GRCLTLTPRP ATEAELLTCH
     SAEYVGHLRA TEKMKTRELH RESSNFDSIY ICPSTFACAQ LATGAACRLV EAVLSGEVLN
     GAAVVRPPGH HAEQDAACGF CFFNSVAVAA RHAQTISGHA LRILIVDWDV HHGNGTQHMF
     EDDPSVLYVS LHRYDHGTFF PMGDEGASSQ IGRAAGTGFT VNVAWNGPRM GDADYLAAWH
     RLVLPIAYEF NPELVLVSAG FDAARGDPLG GCQVSPEGYA HLTHLLMGLA SGRIILILEG
     GYNLTSISES MAACTRSLLG DPPPLLTLPR PPLSGALASI TETIQVHRRY WRSLRVMKVE
     DREGPSSSKL VTKKAPQPAK PRLAERMTTR EKKVLEAGMG KVTSASFGEE STPGQTNSET
     AVVALTQDQP SEAATGGATL AQTISEAAIG GAMLGQTTSE EAVGGATPDQ TTSEETVGGA
     ILDQTTSEDA VGGATLGQTT SEEAVGGATL AQTTSEAAME GATLDQTTSE EAPGGTELIQ
     TPLASSTDHQ TPPTSPVQGT TPQISPSTLI GSLRTLELGS ESQGASESQA PGEENLLGEA
     AGGQDMADSM LMQGSRGLTD QAIFYAVTPL PWCPHLVAVC PIPAAGLDVT QPCGDCGTIQ
     ENWVCLSCYQ VYCGRYINGH MLQHHGNSGH PLVLSYIDLS AWCYYCQAYV HHQALLDVKN
     IAHQNKFGED MPHPH
//
ID   HIPK1_HUMAN             Reviewed;        1210 AA.
AC   Q86Z02; A6NJ34; O75125; Q5SQL2; Q5SQL4; Q5SQL5; Q8IYD7; Q8NDN5;
AC   Q8NEB6; Q8TBZ1;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   09-JAN-2013, entry version 102.
DE   RecName: Full=Homeodomain-interacting protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Nuclear body-associated kinase 2;
GN   Name=HIPK1; Synonyms=KIAA0630, MYAK, NBAK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Miyata Y.;
RT   "Molecular cloning of human HIPK1.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 318-1210 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 720-1210 (ISOFORMS 1/3/4).
RC   TISSUE=Brain;
RX   MEDLINE=98403880; PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [7]
RP   FUNCTION, AND PHOSPHORYLATION BY JNK1.
RX   PubMed=12968034; DOI=10.1074/jbc.M213201200;
RA   Song J.J., Lee Y.J.;
RT   "Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1
RT   oligomerization.";
RL   J. Biol. Chem. 278:47245-47252(2003).
RN   [8]
RP   TISSUE SPECIFICITY, AND INTERACTION WITH DAXX.
RX   MEDLINE=22417486; PubMed=12529400; DOI=10.1128/MCB.23.3.950-960.2003;
RA   Ecsedy J.A., Michaelson J.S., Leder P.;
RT   "Homeodomain-interacting protein kinase 1 modulates Daxx localization,
RT   phosphorylation, and transcriptional activity.";
RL   Mol. Cell. Biol. 23:950-960(2003).
RN   [9]
RP   INTERACTION WITH TP53, TISSUE SPECIFICITY, AND FUNCTION.
RX   MEDLINE=22608637; PubMed=12702766; DOI=10.1073/pnas.0530308100;
RA   Kondo S., Lu Y., Debbas M., Lin A.W., Sarosi I., Itie A., Wakeham A.,
RA   Tuan J., Saris C., Elliott G., Ma W., Benchimol S., Lowe S.W.,
RA   Mak T.W., Thukral S.K.;
RT   "Characterization of cells and gene-targeted mice deficient for the
RT   p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5431-5436(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH DAB2IP AND MAP3K5, SUBCELLULAR LOCATION,
RP   SUMOYLATION AT LYS-25 AND LYS-1203, DESUMOYLATION MEDIATED BY TNF, AND
RP   MUTAGENESIS OF LYS-25; ASP-315; LYS-317; LYS-440; LYS-556 AND
RP   LYS-1203.
RX   PubMed=15701637; DOI=10.1074/jbc.M414262200;
RA   Li X., Zhang R., Luo D., Park S.-J., Wang Q., Kim Y., Min W.;
RT   "Tumor necrosis factor alpha-induced desumoylation and cytoplasmic
RT   translocation of homeodomain-interacting protein kinase 1 are critical
RT   for apoptosis signal-regulating kinase 1-JNK/p38 activation.";
RL   J. Biol. Chem. 280:15061-15070(2005).
RN   [11]
RP   FUNCTION IN ANTI-OXIDATIVE STRESS, INTERACTION WITH PARK7, SUBCELLULAR
RP   LOCATION, AND DEGRADATION BY PARK7.
RX   PubMed=16390825; DOI=10.1080/10715760500456847;
RA   Sekito A., Koide-Yoshida S., Niki T., Taira T., Iguchi-Ariga S.M.M.,
RA   Ariga H.;
RT   "DJ-1 interacts with HIPK1 and affects H2O2-induced cell death.";
RL   Free Radic. Res. 40:155-165(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-352, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [13]
RP   DESUMOYLATION BY SENP1, AND SUBCELLULAR LOCATION.
RX   PubMed=18219322; DOI=10.1038/sj.cdd.4402303;
RA   Li X., Luo Y., Yu L., Lin Y., Luo D., Zhang H., He Y., Kim Y.-O.,
RA   Kim Y., Tang S., Min W.;
RT   "SENP1 mediates TNF-induced desumoylation and cytoplasmic
RT   translocation of HIPK1 to enhance ASK1-dependent apoptosis.";
RL   Cell Death Differ. 15:739-750(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-352, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   FUNCTION AS MYB KINASE, INTERACTION WITH MYB, MUTAGENESIS OF LYS-219,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=19646965; DOI=10.1016/j.bbrc.2009.07.139;
RA   Matre V., Nordgaard O., Alm-Kristiansen A.H., Ledsaak M.,
RA   Gabrielsen O.S.;
RT   "HIPK1 interacts with c-Myb and modulates its activity through
RT   phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 388:150-154(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-352 AND SER-872, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-310 AND VAL-1165.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in
CC       transcription regulation and TNF-mediated cellular apoptosis.
CC       Plays a role as a corepressor for homeodomain transcription
CC       factors. Phosphorylates DAXX and MYB. Phosphorylates DAXX in
CC       response to stress, and mediates its translocation from the
CC       nucleus to the cytoplasm. Inactivates MYB transcription factor
CC       activity by phosphorylation. Prevents MAP3K5-JNK activation in the
CC       absence of TNF. TNF triggers its translocation to the cytoplasm in
CC       response to stress stimuli, thus activating nuclear MAP3K5-JNK by
CC       derepression and promoting apoptosis. May be involved in anti-
CC       oxidative stress responses. Involved in the regulation of eye
CC       size, lens formation and retinal lamination during late
CC       embryogenesis. Promotes angiogenesis and to be involved in
CC       erythroid differentiation. May be involved in malignant squamous
CC       cell tumor formation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with Nkx1-2, Nkx2-5, MYB, PARK7, DAXX and
CC       p53/TP53. Part of a cytoplasmic complex made of HIPK1, DAB2IP and
CC       MAP3K5 in response to TNF. This complex formation promotes MAP3K5-
CC       JNK activation and subsequent apoptosis.
CC   -!- INTERACTION:
CC       P04637:TP53; NbExp=2; IntAct=EBI-692891, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Predominantly
CC       nuclear. Translocates from nucleus to cytoplasm in response to
CC       stress stimuli via SENP1-mediated desumoylation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=HIPK1-alpha;
CC         IsoId=Q86Z02-1; Sequence=Displayed;
CC       Name=2; Synonyms=HIPK1-beta;
CC         IsoId=Q86Z02-2; Sequence=VSP_013130, VSP_013131;
CC       Name=3;
CC         IsoId=Q86Z02-3; Sequence=VSP_013128;
CC       Name=4;
CC         IsoId=Q86Z02-4; Sequence=VSP_013127, VSP_013129;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in
CC       skeletal muscle and heart. Overexpressed in breast cancer cell
CC       lines. Isoform 2 is highly expressed in testis.
CC   -!- PTM: Autophosphorylated. Phosphorylated and activated by JNK1.
CC   -!- PTM: Degraded by PARK7 at the protein level.
CC   -!- PTM: Sumoylated. When conjugated it is directed to nuclear
CC       speckles. SENP1-mediated desumoylation is mediated by TNF in
CC       response to stress stimuli, triggering transient translocation
CC       from nucleus to cytoplasm.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. HIPK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB089957; BAC57075.1; -; mRNA.
DR   EMBL; AL731797; CAI22792.1; -; Genomic_DNA.
DR   EMBL; AL731797; CAI22793.1; -; Genomic_DNA.
DR   EMBL; AL731797; CAI22795.1; -; Genomic_DNA.
DR   EMBL; AL137856; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56590.1; -; Genomic_DNA.
DR   EMBL; BC028408; AAH28408.1; -; mRNA.
DR   EMBL; BC033012; AAH33012.1; -; mRNA.
DR   EMBL; BC036057; AAH36057.1; -; mRNA.
DR   EMBL; AL833829; CAD38689.1; -; mRNA.
DR   EMBL; AB014530; BAA31605.1; -; mRNA.
DR   IPI; IPI00178582; -.
DR   IPI; IPI00302302; -.
DR   IPI; IPI00383559; -.
DR   IPI; IPI00942467; -.
DR   RefSeq; NP_689909.2; NM_152696.3.
DR   RefSeq; NP_852003.1; NM_181358.2.
DR   RefSeq; NP_938009.1; NM_198268.2.
DR   RefSeq; NP_938010.1; NM_198269.2.
DR   UniGene; Hs.532363; -.
DR   ProteinModelPortal; Q86Z02; -.
DR   SMR; Q86Z02; 167-519.
DR   IntAct; Q86Z02; 6.
DR   MINT; MINT-1187651; -.
DR   STRING; Q86Z02; -.
DR   PhosphoSite; Q86Z02; -.
DR   DMDM; 34395641; -.
DR   PaxDb; Q86Z02; -.
DR   PRIDE; Q86Z02; -.
DR   Ensembl; ENST00000340480; ENSP00000340956; ENSG00000163349.
DR   Ensembl; ENST00000369553; ENSP00000358566; ENSG00000163349.
DR   Ensembl; ENST00000369558; ENSP00000358571; ENSG00000163349.
DR   Ensembl; ENST00000369559; ENSP00000358572; ENSG00000163349.
DR   Ensembl; ENST00000406344; ENSP00000384960; ENSG00000163349.
DR   Ensembl; ENST00000443627; ENSP00000409673; ENSG00000163349.
DR   GeneID; 204851; -.
DR   KEGG; hsa:204851; -.
DR   UCSC; uc001eel.3; human.
DR   UCSC; uc001eem.3; human.
DR   UCSC; uc001eep.3; human.
DR   CTD; 204851; -.
DR   GeneCards; GC01P114471; -.
DR   HGNC; HGNC:19006; HIPK1.
DR   HPA; HPA016664; -.
DR   MIM; 608003; gene.
DR   neXtProt; NX_Q86Z02; -.
DR   PharmGKB; PA134897980; -.
DR   eggNOG; COG0515; -.
DR   HOVERGEN; HBG051908; -.
DR   InParanoid; Q86Z02; -.
DR   KO; K08826; -.
DR   OrthoDB; EOG4K9BBD; -.
DR   PhylomeDB; Q86Z02; -.
DR   ChEMBL; CHEMBL5427; -.
DR   GenomeRNAi; 204851; -.
DR   NextBio; 90482; -.
DR   ArrayExpress; Q86Z02; -.
DR   Bgee; Q86Z02; -.
DR   CleanEx; HS_HIPK1; -.
DR   Genevestigator; Q86Z02; -.
DR   GermOnline; ENSG00000163349; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IEA:Compara.
DR   GO; GO:0016605; C:PML body; IEA:Compara.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Compara.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0060216; P:definitive hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Compara.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEA:Compara.
DR   GO; GO:0001654; P:eye development; ISS:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Compara.
DR   GO; GO:0061072; P:iris morphogenesis; IEA:Compara.
DR   GO; GO:0060235; P:lens induction in camera-type eye; IEA:Compara.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Compara.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Compara.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0010842; P:retina layer formation; IEA:Compara.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Compara.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Isopeptide bond; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN         1   1210       Homeodomain-interacting protein kinase 1.
FT                                /FTId=PRO_0000085993.
FT   DOMAIN      190    518       Protein kinase.
FT   NP_BIND     196    204       ATP (Probable).
FT   REGION      844    847       Nuclear localization signal 1 (NLS1) (By
FT                                similarity).
FT   REGION      885   1093       Interaction with TP53.
FT   REGION      891    998       Required for localization to nuclear
FT                                speckles (By similarity).
FT   REGION      902    926       SUMO interaction motifs (SIM); required
FT                                for nuclear localization and kinase
FT                                activity (By similarity).
FT   ACT_SITE    315    315       Proton acceptor (Probable).
FT   BINDING     219    219       ATP (Probable).
FT   MOD_RES     352    352       Phosphotyrosine.
FT   MOD_RES     872    872       Phosphoserine.
FT   CROSSLNK     25     25       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK   1203   1203       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO)
FT                                (Probable).
FT   VAR_SEQ       1    394       Missing (in isoform 4).
FT                                /FTId=VSP_013127.
FT   VAR_SEQ       1    374       Missing (in isoform 3).
FT                                /FTId=VSP_013128.
FT   VAR_SEQ     395    399       ASEYD -> MVLMF (in isoform 4).
FT                                /FTId=VSP_013129.
FT   VAR_SEQ    1049   1075       NQQSSAAPTSQERSSNPAPRRQQAFVA -> VSAMGYCLLF
FT                                GPCTVVTFWRTLLLAGC (in isoform 2).
FT                                /FTId=VSP_013130.
FT   VAR_SEQ    1076   1210       Missing (in isoform 2).
FT                                /FTId=VSP_013131.
FT   VARIANT       6      6       Q -> R (in dbSNP:rs35324789).
FT                                /FTId=VAR_051626.
FT   VARIANT     310    310       G -> C.
FT                                /FTId=VAR_040546.
FT   VARIANT    1165   1165       L -> V.
FT                                /FTId=VAR_046047.
FT   MUTAGEN      25     25       K->R: Reduced sumoylation and cytoplasmic
FT                                subcellular location. Impaired
FT                                sumoylation and cytoplasmic subcellular
FT                                location; when associated with R-317; R-
FT                                440; R-556 and R-1203.
FT   MUTAGEN     219    219       K->A: Loss of kinase activity.
FT   MUTAGEN     315    315       D->N: Loss of kinase activity and
FT                                impaired MAP3K5-JNK inactivation.
FT   MUTAGEN     317    317       K->R: Nuclear subcellular location.
FT                                Impaired sumoylation and cytoplasmic
FT                                subcellular location; when associated
FT                                with R-25; R-440; R-556 and R-1203.
FT   MUTAGEN     440    440       K->R: Nuclear subcellular location.
FT                                Impaired sumoylation and cytoplasmic
FT                                subcellular location; when associated
FT                                with R-25; R-317; R-556 and R-1203.
FT   MUTAGEN     556    556       K->R: Nuclear subcellular location.
FT                                Impaired sumoylation and cytoplasmic
FT                                subcellular location; when associated
FT                                with R-25; R-317; R-440 and R-1203.
FT   MUTAGEN    1203   1203       K->R: Nuclear subcellular location.
FT                                Impaired sumoylation and cytoplasmic
FT                                subcellular location; when associated
FT                                with R-25; R-317; R-440 and R-556.
FT   CONFLICT    721    721       P -> Q (in Ref. 4; AAH33012).
FT   CONFLICT    747    747       Missing (in Ref. 6; BAA31605).
FT   CONFLICT    799    799       H -> Y (in Ref. 5; CAD38689).
FT   CONFLICT   1054   1054       A -> V (in Ref. 4; AAH36057).
SQ   SEQUENCE   1210 AA;  130843 MW;  DB0BBFA6DF152909 CRC64;
     MASQLQVFSP PSVSSSAFCS AKKLKIEPSG WDVSGQSSND KYYTHSKTLP ATQGQANSSH
     QVANFNIPAY DQGLLLPAPA VEHIVVTAAD SSGSAATSTF QSSQTLTHRS NVSLLEPYQK
     CGLKRKSEEV DSNGSVQIIE EHPPLMLQNR TVVGAAATTT TVTTKSSSSS GEGDYQLVQH
     EILCSMTNSY EVLEFLGRGT FGQVAKCWKR STKEIVAIKI LKNHPSYARQ GQIEVSILSR
     LSSENADEYN FVRSYECFQH KNHTCLVFEM LEQNLYDFLK QNKFSPLPLK YIRPILQQVA
     TALMKLKSLG LIHADLKPEN IMLVDPVRQP YRVKVIDFGS ASHVSKAVCS TYLQSRYYRA
     PEIILGLPFC EAIDMWSLGC VIAELFLGWP LYPGASEYDQ IRYISQTQGL PAEYLLSAGT
     KTTRFFNRDP NLGYPLWRLK TPEEHELETG IKSKEARKYI FNCLDDMAQV NMSTDLEGTD
     MLAEKADRRE YIDLLKKMLT IDADKRITPL KTLNHQFVTM THLLDFPHSN HVKSCFQNME
     ICKRRVHMYD TVSQIKSPFT THVAPNTSTN LTMSFSNQLN TVHNQASVLA SSSTAAAATL
     SLANSDVSLL NYQSALYPSS AAPVPGVAQQ GVSLQPGTTQ ICTQTDPFQQ TFIVCPPAFQ
     TGLQATTKHS GFPVRMDNAV PIVPQAPAAQ PLQIQSGVLT QGSCTPLMVA TLHPQVATIT
     PQYAVPFTLS CAAGRPALVE QTAAVLQAWP GGTQQILLPS TWQQLPGVAL HNSVQPTAMI
     PEAMGSGQQL ADWRNAHSHG NQYSTIMQQP SLLTNHVTLA TAQPLNVGVA HVVRQQQSSS
     LPSKKNKQSA PVSSKSSLDV LPSQVYSLVG SSPLRTTSSY NSLVPVQDQH QPIIIPDTPS
     PPVSVITIRS DTDEEEDNKY KPSSSGLKPR SNVISYVTVN DSPDSDSSLS SPYSTDTLSA
     LRGNSGSVLE GPGRVVADGT GTRTIIVPPL KTQLGDCTVA TQASGLLSNK TKPVASVSGQ
     SSGCCITPTG YRAQRGGTSA AQPLNLSQNQ QSSAAPTSQE RSSNPAPRRQ QAFVAPLSQA
     PYTFQHGSPL HSTGHPHLAP APAHLPSQAH LYTYAAPTSA AALGSTSSIA HLFSPQGSSR
     HAAAYTTHPS TLVHQVPVSV GPSLLTSASV APAQYQHQFA TQSYIGSSRG STIYTGYPLS
     PTKISQYSYL
//
ID   HSP31_YEAST             Reviewed;         237 AA.
AC   Q04432; D6VTF4; E9P8V9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   09-JAN-2013, entry version 95.
DE   RecName: Full=Probable chaperone protein HSP31;
DE            EC=3.2.-.-;
DE   AltName: Full=Heat shock protein 31;
GN   Name=HSP31; OrderedLocusNames=YDR533C; ORFNames=D9719.36;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   MEDLINE=97313263; PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N.,
RA   Paulin L., Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M.,
RA   Prydz H., Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L.,
RA   Rieger M., Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M.,
RA   Scharfe M., Schmidt E.R., Schneider C., Scholler P., Schwarz S.,
RA   Soler-Mira A., Urrestarazu L.A., Verhasselt P., Vissers S., Voet M.,
RA   Volckaert G., Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S.,
RA   Harris D.E., Bowman S., Brown D., Churcher C.M., Connor R., Dedman K.,
RA   Gentles S., Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D.,
RA   Niblett D., Odell C., Oliver K., Rajandream M.A., Richards C.,
RA   Shore L., Walsh S.V., Barrell B.G., Dietrich F.S., Mulligan J.T.,
RA   Allen E., Araujo R., Aviles E., Berno A., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Hunicke-Smith S., Hyman R.W.,
RA   Komp C., Lashkari D., Lew H., Lin D., Mosedale D., Nakahara K.,
RA   Namath A., Oefner P., Oh C., Petel F.X., Roberts D., Schramm S.,
RA   Schroeder M., Shogren T., Shroff N., Winant A., Yelton M.A.,
RA   Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S.,
RA   Greco T., Hallsworth K., Hawkins J., Hillier L.W., Jier M.,
RA   Johnson D., Johnston L., Kirsten J., Kucaba T., Langston Y.,
RA   Latreille P., Le T., Mardis E., Menezes S., Miller N., Nhan M.,
RA   Pauley A., Peluso D., Rifkin L., Riles L., Taich A., Trevaskis E.,
RA   Vignati D., Wilcox L., Wohldman P., Vaudin M., Wilson R.,
RA   Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RG   Saccharomyces Genome Database;
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [4]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   MEDLINE=22923965; PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), AND SUBUNIT.
RX   PubMed=14745011; DOI=10.1073/pnas.0308089100;
RA   Wilson M.A., St Amour C.V., Collins J.L., Ringe D., Petsko G.A.;
RT   "The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces
RT   cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:1531-1536(2004).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS), AND SUBUNIT.
RX   PubMed=15130476; DOI=10.1016/j.str.2004.02.030;
RA   Graille M., Quevillon-Cheruel S., Leulliot N., Zhou C.-Z.,
RA   de la Sierra Gallay I.L., Jacquamet L., Ferrer J.-L., Liger D.,
RA   Poupon A., Janin J., van Tilbeurgh H.;
RT   "Crystal structure of the YDR533c S. cerevisiae protein, a class II
RT   member of the Hsp31 family.";
RL   Structure 12:839-847(2004).
CC   -!- FUNCTION: Probable protease. May act as a chaperone.
CC   -!- SUBUNIT: Homodimer.
CC   -!- PTM: Cys-138 is easily oxidized to sulfinic acid.
CC   -!- MISCELLANEOUS: Present with 358 molecules/cell in log phase SD
CC       medium.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U33057; AAB64972.1; -; Genomic_DNA.
DR   EMBL; AY558337; AAS56663.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12364.1; -; Genomic_DNA.
DR   PIR; S69588; S69588.
DR   RefSeq; NP_010822.1; NM_001180841.1.
DR   PDB; 1QVV; X-ray; 2.35 A; A/B/C/D=1-237.
DR   PDB; 1QVW; X-ray; 1.90 A; A/B=1-237.
DR   PDB; 1QVZ; X-ray; 1.85 A; A/B=1-237.
DR   PDB; 1RW7; X-ray; 1.80 A; A=1-237.
DR   PDBsum; 1QVV; -.
DR   PDBsum; 1QVW; -.
DR   PDBsum; 1QVZ; -.
DR   PDBsum; 1RW7; -.
DR   ProteinModelPortal; Q04432; -.
DR   SMR; Q04432; 2-236.
DR   DIP; DIP-4315N; -.
DR   IntAct; Q04432; 3.
DR   MINT; MINT-525838; -.
DR   STRING; Q04432; -.
DR   MEROPS; C56.004; -.
DR   PaxDb; Q04432; -.
DR   PeptideAtlas; Q04432; -.
DR   EnsemblFungi; YDR533C; YDR533C; YDR533C.
DR   GeneID; 852146; -.
DR   KEGG; sce:YDR533C; -.
DR   CYGD; YDR533c; -.
DR   SGD; S000002941; HSP31.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000013431; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; HAPAVFH; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   EvolutionaryTrace; Q04432; -.
DR   NextBio; 970567; -.
DR   ArrayExpress; Q04432; -.
DR   Genevestigator; Q04432; -.
DR   GermOnline; YDR533C; Saccharomyces cerevisiae.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; ISS:SGD.
DR   GO; GO:0051082; F:unfolded protein binding; ISS:SGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chaperone; Complete proteome; Hydrolase; Oxidation;
KW   Protease; Reference proteome; Stress response.
FT   CHAIN         1    237       Probable chaperone protein HSP31.
FT                                /FTId=PRO_0000157852.
FT   ACT_SITE    138    138       Potential.
FT   ACT_SITE    139    139       Potential.
FT   ACT_SITE    170    170       Potential.
FT   MOD_RES     138    138       Cysteine sulfinic acid (-SO2H).
FT   CONFLICT     31     31       A -> T (in Ref. 3; AAS56663).
FT   STRAND        5      9
FT   HELIX        28     40
FT   STRAND       44     48
FT   STRAND       50     52
FT   HELIX        58     61
FT   TURN         63     65
FT   HELIX        68     75
FT   HELIX        80     86
FT   HELIX        91     93
FT   HELIX        96     98
FT   STRAND       99    104
FT   HELIX       110    113
FT   HELIX       114    116
FT   HELIX       118    129
FT   STRAND      133    137
FT   HELIX       140    144
FT   TURN        150    152
FT   STRAND      153    155
FT   TURN        156    159
FT   HELIX       167    172
FT   HELIX       176    181
FT   HELIX       187    193
FT   STRAND      209    212
FT   STRAND      215    218
FT   HELIX       221    223
FT   HELIX       224    233
FT   HELIX       234    236
SQ   SEQUENCE   237 AA;  25670 MW;  088697FB888DF7D5 CRC64;
     MAPKKVLLAL TSYNDVFYSD GAKTGVFVVE ALHPFNTFRK EGFEVDFVSE TGKFGWDEHS
     LAKDFLNGQD ETDFKNKDSD FNKTLAKIKT PKEVNADDYQ IFFASAGHGT LFDYPKAKDL
     QDIASEIYAN GGVVAAVCHG PAIFDGLTDK KTGRPLIEGK SITGFTDVGE TILGVDSILK
     AKNLATVEDV AKKYGAKYLA PVGPWDDYSI TDGRLVTGVN PASAHSTAVR SIDALKN
//
ID   HSP32_YEAST             Reviewed;         237 AA.
AC   Q08992; D6W392;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   09-JAN-2013, entry version 64.
DE   RecName: Full=Probable chaperone protein HSP32;
DE            EC=3.2.-.-;
DE   AltName: Full=Heat shock protein 32;
GN   Name=HSP32; OrderedLocusNames=YPL280W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204511 / S288c / AB972;
RX   MEDLINE=97313271; PubMed=9169875;
RA   Bussey H., Storms R.K., Ahmed A., Albermann K., Allen E., Ansorge W.,
RA   Araujo R., Aparicio A., Barrell B.G., Badcock K., Benes V.,
RA   Botstein D., Bowman S., Brueckner M., Carpenter J., Cherry J.M.,
RA   Chung E., Churcher C.M., Coster F., Davis K., Davis R.W.,
RA   Dietrich F.S., Delius H., DiPaolo T., Dubois E., Duesterhoeft A.,
RA   Duncan M., Floeth M., Fortin N., Friesen J.D., Fritz C., Goffeau A.,
RA   Hall J., Hebling U., Heumann K., Hilbert H., Hillier L.W.,
RA   Hunicke-Smith S., Hyman R.W., Johnston M., Kalman S., Kleine K.,
RA   Komp C., Kurdi O., Lashkari D., Lew H., Lin A., Lin D., Louis E.J.,
RA   Marathe R., Messenguy F., Mewes H.-W., Mirtipati S., Moestl D.,
RA   Mueller-Auer S., Namath A., Nentwich U., Oefner P., Pearson D.,
RA   Petel F.X., Pohl T.M., Purnelle B., Rajandream M.A., Rechmann S.,
RA   Rieger M., Riles L., Roberts D., Schaefer M., Scharfe M., Scherens B.,
RA   Schramm S., Schroeder M., Sdicu A.-M., Tettelin H., Urrestarazu L.A.,
RA   Ushinsky S., Vierendeels F., Vissers S., Voss H., Walsh S.V.,
RA   Wambutt R., Wang Y., Wedler E., Wedler H., Winnett E., Zhong W.-W.,
RA   Zollner A., Vo D.H., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.";
RL   Nature 387:103-105(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RG   Saccharomyces Genome Database;
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable protease. May act as a chaperone (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z73636; CAA98017.1; -; Genomic_DNA.
DR   EMBL; BK006949; DAA11158.1; -; Genomic_DNA.
DR   PIR; S65313; S65313.
DR   RefSeq; NP_015043.1; NM_001184094.1.
DR   HSSP; Q04432; 1RW7.
DR   ProteinModelPortal; Q08992; -.
DR   SMR; Q08992; 4-237.
DR   DIP; DIP-3919N; -.
DR   IntAct; Q08992; 3.
DR   MINT; MINT-540906; -.
DR   STRING; Q08992; -.
DR   EnsemblFungi; YPL280W; YPL280W; YPL280W.
DR   GeneID; 855849; -.
DR   KEGG; sce:YPL280W; -.
DR   CYGD; YPL280w; -.
DR   SGD; S000006201; HSP32.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000013431; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; KETYERG; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   NextBio; 980443; -.
DR   Genevestigator; Q08992; -.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; ISS:SGD.
DR   GO; GO:0051082; F:unfolded protein binding; ISS:SGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Hydrolase; Protease; Reference proteome;
KW   Stress response.
FT   CHAIN         1    237       Probable chaperone protein HSP32.
FT                                /FTId=PRO_0000270555.
FT   ACT_SITE    138    138       Potential.
FT   ACT_SITE    139    139       Potential.
FT   ACT_SITE    170    170       Potential.
SQ   SEQUENCE   237 AA;  25940 MW;  004EB2E702222905 CRC64;
     MTPKRALISL TSYHGPFYKD GAKTGVFVVE ILRSFDTFEK HGFEVDFVSE TGGFGWDEHY
     LPKSFIGGED KMNFETKNSA FNKALARIKT ANEVNASDYK IFFASAGHGA LFDYPKAKNL
     QDIASKIYAN GGVIAAICHG PLLFDGLIDI KTTRPLIEGK AITGFPLEGE IALGVDDILR
     SRKLTTVERV ANKNGAKYLA PIHPWDDYSI TDGKLVTGVN ANSSYSTTIR AINALYS
//
ID   HSP33_YEAST             Reviewed;         237 AA.
AC   Q08914; D6W384;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   09-JAN-2013, entry version 64.
DE   RecName: Full=Probable chaperone protein HSP33;
DE            EC=3.2.-.-;
DE   AltName: Full=Heat shock protein 33;
GN   Name=HSP33; OrderedLocusNames=YOR391C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   MEDLINE=97313270; PubMed=9169874;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W.,
RA   Arino J., Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R.,
RA   Boyer J., Camasses A., Casamayor A., Casas C., Cheret G.,
RA   Cziepluch C., Daignan-Fornier B., Dang V.-D., de Haan M., Delius H.,
RA   Durand P., Fairhead C., Feldmann H., Gaillon L., Galisson F.,
RA   Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E., Grivell L.A.,
RA   Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J.,
RA   Maarse A.C., Madania A., Mannhaupt G., Marck C., Martin R.P.,
RA   Mewes H.-W., Michaux G., Paces V., Parle-McDermott A.G., Pearson B.M.,
RA   Perrin A., Pettersson B., Poch O., Pohl T.M., Poirey R.,
RA   Portetelle D., Pujol A., Purnelle B., Ramezani Rad M., Rechmann S.,
RA   Schwager C., Schweizer M., Sor F., Sterky F., Tarassov I.A.,
RA   Teodoru C., Tettelin H., Thierry A., Tobiasch E., Tzermia M.,
RA   Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I., Vlcek C.,
RA   Voet M., Volckaert G., Voss H., Wambutt R., Wedler H., Wiemann S.,
RA   Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RG   Saccharomyces Genome Database;
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable protease. May act as a chaperone (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z75299; CAA99723.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA11150.1; -; Genomic_DNA.
DR   RefSeq; NP_015036.3; NM_001183811.3.
DR   RefSeq; NP_015039.3; NM_001183814.3.
DR   PDB; 3KKL; X-ray; 2.03 A; A/B=1-237.
DR   PDB; 3MII; X-ray; 2.40 A; A/B=1-237.
DR   PDBsum; 3KKL; -.
DR   PDBsum; 3MII; -.
DR   ProteinModelPortal; Q08914; -.
DR   SMR; Q08914; 4-237.
DR   IntAct; Q08914; 3.
DR   STRING; Q08914; -.
DR   MEROPS; C56.A03; -.
DR   EnsemblFungi; YOR391C; YOR391C; YOR391C.
DR   GeneID; 854573; -.
DR   GeneID; 854576; -.
DR   KEGG; sce:YOR391C; -.
DR   CYGD; YOR391c; -.
DR   SGD; S000005918; HSP33.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000013431; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; NGADYSA; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   EvolutionaryTrace; Q08914; -.
DR   NextBio; 977030; -.
DR   Genevestigator; Q08914; -.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; ISS:SGD.
DR   GO; GO:0051082; F:unfolded protein binding; ISS:SGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chaperone; Complete proteome; Hydrolase; Protease;
KW   Reference proteome; Stress response.
FT   CHAIN         1    237       Probable chaperone protein HSP33.
FT                                /FTId=PRO_0000270556.
FT   ACT_SITE    138    138       Potential.
FT   ACT_SITE    139    139       Potential.
FT   ACT_SITE    170    170       Potential.
FT   STRAND        5      9
FT   HELIX        28     39
FT   TURN         40     42
FT   STRAND       44     52
FT   HELIX        58     60
FT   HELIX        62     65
FT   HELIX        69     75
FT   HELIX        82     86
FT   HELIX        91     93
FT   HELIX        96     98
FT   STRAND      100    104
FT   HELIX       110    113
FT   HELIX       114    116
FT   HELIX       118    129
FT   STRAND      133    137
FT   HELIX       140    144
FT   TURN        150    152
FT   STRAND      153    155
FT   TURN        156    159
FT   HELIX       167    172
FT   TURN        173    175
FT   HELIX       176    181
FT   HELIX       187    192
FT   TURN        193    195
FT   STRAND      209    212
FT   STRAND      215    220
FT   HELIX       221    223
FT   HELIX       224    235
SQ   SEQUENCE   237 AA;  25926 MW;  0E817A44022231A6 CRC64;
     MTPKRALISL TSYHGPFYKD GAKTGVFVVE ILRSFDTFEK HGFEVDFVSE TGGFGWDEHY
     LPKSFIGGED KMNFETKNSA FNKALARIKT ANEVNASDYK VFFASAGHGA LFDYPKAKNL
     QDIASKIYAN GGVIAAICHG PLLFDGLIDI KTTRPLIEGK AITGFPLEGE IALGVDDILR
     SRKLTTVERV ANKNGAKYLA PIHPWDDYSI TDGKLVTGVN ANSSYSTTIR AINALYS
//
ID   INHA_PSEPU              Reviewed;         228 AA.
AC   Q8G9F9;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-NOV-2012, entry version 23.
DE   RecName: Full=Isonitrile hydratase;
DE            EC=4.2.1.103;
DE   AltName: Full=Cyclohexyl-isocyanide hydratase;
GN   Name=inhA;
OS   Pseudomonas putida (Arthrobacter siderocapsulatus).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=303;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-79; 117-201
RP   AND 206-228, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, GENE NAME, AND
RP   MUTAGENESIS OF GLU-79; GLU-81; CYS-101 AND THE-102.
RC   STRAIN=N19-2;
RX   MEDLINE=22336389; PubMed=12244065; DOI=10.1074/jbc.M208571200;
RA   Goda M., Hashimoto Y., Takase M., Herai S., Iwahara Y.,
RA   Higashibata H., Kobayashi M.;
RT   "Isonitrile hydratase from Pseudomonas putida N19-2. Cloning,
RT   sequencing, gene expression, and identification of its active acid
RT   residue.";
RL   J. Biol. Chem. 277:45860-45865(2002).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-11, FUNCTION, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RC   STRAIN=N19-2;
RX   PubMed=11306561; DOI=10.1074/jbc.M007856200;
RA   Goda M., Hashimoto Y., Shimizu S., Kobayashi M.;
RT   "Discovery of a novel enzyme, isonitrile hydratase, involved in
RT   nitrogen-carbon triple bond cleavage.";
RL   J. Biol. Chem. 276:23480-23485(2001).
CC   -!- FUNCTION: Catalyzes the hydration of cyclohexyl isocyanide to N-
CC       cyclohexylformamide. Acts on various isonitriles, but not on
CC       nitriles or amides. Probably involved in detoxification.
CC   -!- CATALYTIC ACTIVITY: N-cyclohexylformamide = cyclohexyl isocyanide
CC       + H(2)O.
CC   -!- ENZYME REGULATION: Sensitive to thiol reagents and oxidizing
CC       reagents, but is not influenced by chelators or reducing reagents.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16.2 mM for cyclohexyl isocyanide;
CC         Vmax=39.6 umol/min/mg enzyme;
CC       pH dependence:
CC         Optimum pH is 6.0-6.5;
CC       Temperature dependence:
CC         Optimum temperature is 35 degrees Celsius. Activity is rapidly
CC         lost above 40 degrees Celsius;
CC   -!- SUBUNIT: Homodimer.
CC   -!- MISCELLANEOUS: Does not require metal ion for activity
CC       (PubMed:11306561).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB088117; BAC41251.1; -; Genomic_DNA.
DR   ProteinModelPortal; Q8G9F9; -.
DR   BioCyc; MetaCyc:MONOMER-15823; -.
DR   BRENDA; 4.2.1.103; 403.
DR   GO; GO:0050549; F:cyclohexyl-isocyanide hydratase activity; IDA:UniProtKB.
DR   InterPro; IPR025628; DJ-1_InhA.
DR   Pfam; PF13278; DUF4066; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Lyase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    228       Isonitrile hydratase.
FT                                /FTId=PRO_0000418615.
FT   ACT_SITE    101    101       Probable.
FT   MUTAGEN      79     79       E->Q: Almost no change in activity.
FT   MUTAGEN      81     81       E->Q: Almost no change in activity.
FT   MUTAGEN     101    101       C->A: Lack of activity.
FT   MUTAGEN     102    102       T->A: Strong decrease in activity.
SQ   SEQUENCE   228 AA;  24213 MW;  F8A4722145A9CDF7 CRC64;
     MALQIGFLLF PQVQQLDLTG PYDVLASLPD VQVHLVWKDL VPVTSSTGLQ LKPTTTFEDC
     PVLDVICVPG GAGVGPLMED EQTLDFIRSQ AAQARYVTSV CTGSLVLGAA GLLQGKRATT
     HWAYHDLLPT LGAIPVKDRV VRDGNLFTGG GITAGIDFAL TLAQELVGVD TAQLVQLQLE
     YAPAPPFDSG SPDTAPSAVV DEARKRAAPS LKLRTEITER AAAKLNLR
//
ID   PARK7_BOVIN             Reviewed;         189 AA.
AC   Q5E946; Q3ZC96;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   09-JAN-2013, entry version 55.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=PARK7;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16305752; DOI=10.1186/1471-2164-6-166;
RA   Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L.,
RA   Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.;
RT   "Characterization of 954 bovine full-CDS cDNA sequences.";
RL   BMC Genomics 6:166-166(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Crossbred X Angus; TISSUE=Ileum;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity).
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-
CC       terminus) with OTUD7B. Interacts with HIPK1, BBS1, CLCF1 and MTERF
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT021074; AAX09091.1; -; mRNA.
DR   EMBL; BC102707; -; NOT_ANNOTATED_CDS; mRNA.
DR   IPI; IPI00702765; -.
DR   RefSeq; NP_001015572.1; NM_001015572.1.
DR   UniGene; Bt.21745; -.
DR   HSSP; Q99497; 1PS4.
DR   ProteinModelPortal; Q5E946; -.
DR   SMR; Q5E946; 1-189.
DR   STRING; Q5E946; -.
DR   PRIDE; Q5E946; -.
DR   Ensembl; ENSBTAT00000027339; ENSBTAP00000027339; ENSBTAG00000020518.
DR   GeneID; 511268; -.
DR   KEGG; bta:511268; -.
DR   CTD; 11315; -.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000001231; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   InParanoid; Q5E946; -.
DR   KO; K05687; -.
DR   OMA; GDHYKYS; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   NextBio; 20869854; -.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:Compara.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Compara.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IEA:Compara.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; IEA:Compara.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Compara.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Compara.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Compara.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Compara.
DR   GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IEA:Compara.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Autophagy; Chaperone; Complete proteome; Cytoplasm;
KW   Fertilization; Hydrolase; Inflammatory response; Isopeptide bond;
KW   Mitochondrion; Nucleus; Oxidation; Phosphoprotein; Protease;
KW   Reference proteome; RNA-binding; Stress response; Tumor suppressor;
KW   Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000252485.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405556.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   MOD_RES     148    148       N6-acetyllysine (By similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  20035 MW;  C63FAA8D71056F2C CRC64;
     MASKRALVIL AKGAEEMETV IPVDVMRRAG IKVTVAGLAG KDPVQCSRDV VICPDASLED
     AKKEGPYDVV VLPGGNLGAQ NLSESAAVKE ILKEQEKRKG LIAAICAGPT ALLAHEIGFG
     SKVTTHPLAK DKMMNGSHYS YSENRVEKDG LILTSRGPGT SFEFALKIVE VLVGKEVADQ
     VKAPLVLKD
//
ID   PARK7_CHICK             Reviewed;         189 AA.
AC   Q8UW59;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   09-JAN-2013, entry version 57.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=PARK7;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves;
OC   Neognathae; Galliformes; Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15976810; DOI=10.1038/sj.cdd.4401704;
RA   Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,
RA   Seino C., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Proper SUMO-1 conjugation is essential to DJ-1 to exert its full
RT   activities.";
RL   Cell Death Differ. 13:96-108(2006).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Binds to a
CC       number of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- PTM: Sumoylated on Lys-130; which is essential for cell-growth
CC       promoting activity and transforming activity (By similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB076264; BAB79527.1; -; mRNA.
DR   IPI; IPI00600709; -.
DR   RefSeq; NP_989916.1; NM_204585.1.
DR   UniGene; Gga.3836; -.
DR   HSSP; Q99497; 1PS4.
DR   ProteinModelPortal; Q8UW59; -.
DR   SMR; Q8UW59; 1-189.
DR   STRING; Q8UW59; -.
DR   MEROPS; C56.002; -.
DR   PRIDE; Q8UW59; -.
DR   GeneID; 395277; -.
DR   KEGG; gga:395277; -.
DR   CTD; 11315; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   InParanoid; Q8UW59; -.
DR   KO; K05687; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   NextBio; 20815365; -.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:AgBase.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; ISS:AgBase.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; ISS:AgBase.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   2: Evidence at transcript level;
KW   Autophagy; Chaperone; Complete proteome; Cytoplasm; Fertilization;
KW   Hydrolase; Inflammatory response; Isopeptide bond; Mitochondrion;
KW   Nucleus; Oxidation; Phosphoprotein; Protease; Reference proteome;
KW   RNA-binding; Stress response; Tumor suppressor; Ubl conjugation;
KW   Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000252486.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405562.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  19943 MW;  A39FE229D97DB942 CRC64;
     MASKRALVIL AKGAEEMETV IPTDVMRRAG IKVTVAGLTG KEPVQCSRDV LICPDASLED
     ARKEGPYDVI VLPGGNLGAQ NLSESAAVKD ILKDQESRKG LIAAICAGPT ALLAHGIGFG
     SKVITHPLAK DKMMNGAHYC YSESRVEKDG NILTSRGPGT SFEFGLAIVE ALMGKEVAEQ
     VKAPLILKD
//
ID   PARK7_CHLAE             Reviewed;         189 AA.
AC   Q95LI9;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   09-JAN-2013, entry version 48.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=PARK7;
OS   Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Cercopithecidae; Cercopithecinae; Chlorocebus.
OX   NCBI_TaxID=9534;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15976810; DOI=10.1038/sj.cdd.4401704;
RA   Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,
RA   Seino C., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Proper SUMO-1 conjugation is essential to DJ-1 to exert its full
RT   activities.";
RL   Cell Death Differ. 13:96-108(2006).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity).
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-
CC       terminus) with OTUD7B. Interacts with HIPK1, BBS1, CLCF1 and MTERF
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB073863; BAB71781.1; -; mRNA.
DR   HSSP; Q99497; 1PS4.
DR   ProteinModelPortal; Q95LI9; -.
DR   SMR; Q95LI9; 1-189.
DR   MEROPS; C56.002; -.
DR   PRIDE; Q95LI9; -.
DR   HOVERGEN; HBG053511; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Autophagy; Chaperone; Cytoplasm; Fertilization;
KW   Hydrolase; Inflammatory response; Isopeptide bond; Mitochondrion;
KW   Nucleus; Oxidation; Phosphoprotein; Protease; RNA-binding;
KW   Stress response; Tumor suppressor; Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000250480.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405557.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   MOD_RES     148    148       N6-acetyllysine (By similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  19905 MW;  589950C2F0175367 CRC64;
     MASKRALVIL AKGAEEMETV IPVDVMRRAG IKVTIAGLAG KDPVQCSRDV VICPDASLED
     AKKEGPYDVV VLPGGNLGAQ NLSESAAVKE ILKEQENRKG LIAAICAGPT ALLAHEIGFG
     SKVTTHPLAK DKMMNGGHYT YSENRVEKDG LILTSRGPGT SFEFALAIVE ALNGKEVAAQ
     VKAPLVLKD
//
ID   PARK7_DANRE             Reviewed;         189 AA.
AC   Q5XJ36;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   09-JAN-2013, entry version 60.
DE   RecName: Full=Protein DJ-1;
DE            Short=zDJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=park7; Synonyms=dj1; ORFNames=zgc:103725;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   STRAIN=AB; TISSUE=Brain;
RX   PubMed=16942755; DOI=10.1016/j.brainres.2006.07.057;
RA   Bai Q., Mullett S.J., Garver J.A., Hinkle D.A., Burton E.A.;
RT   "Zebrafish DJ-1 is evolutionarily conserved and expressed in
RT   dopaminergic neurons.";
RL   Brain Res. 1113:33-44(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17166173; DOI=10.1111/j.1471-4159.2006.04291.x;
RA   Bretaud S., Allen C., Ingham P.W., Bandmann O.;
RT   "p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model
RT   of Parkinson's disease.";
RL   J. Neurochem. 100:1626-1635(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=AB; TISSUE=Liver;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Binds to a
CC       number of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity). Protects dopaminergic neurons against cell death
CC       arising from oxidative stress and proteasome inhibition, probably
CC       by a TP53/p53-dependent mechanism.
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- TISSUE SPECIFICITY: Larval brain and gut from 96 hours post-
CC       fertilization (hpf). Ubiquitous in adult; most abundant in brain,
CC       eye, heart and muscle. Within brain, neuronal expression is
CC       widespread, particularly in the cerebellum, medullary reticular
CC       formation and diencephalon. Expressed in major forebrain and
CC       diencephalic dopaminergic cell groups.
CC   -!- DEVELOPMENTAL STAGE: Present from tailbud stage (10 hpf) through
CC       to adult. Levels increase from 24-120 hpf.
CC   -!- PTM: Sumoylated on Lys-130 by pias2 or pias4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ882651; ABI64158.1; -; mRNA.
DR   EMBL; BC083475; AAH83475.1; -; mRNA.
DR   IPI; IPI00504978; -.
DR   RefSeq; NP_001005938.1; NM_001005938.1.
DR   UniGene; Dr.85181; -.
DR   HSSP; Q99497; 1PS4.
DR   ProteinModelPortal; Q5XJ36; -.
DR   SMR; Q5XJ36; 1-189.
DR   STRING; Q5XJ36; -.
DR   PRIDE; Q5XJ36; -.
DR   Ensembl; ENSDART00000041531; ENSDARP00000041530; ENSDARG00000034826.
DR   GeneID; 449674; -.
DR   KEGG; dre:449674; -.
DR   CTD; 11315; -.
DR   ZFIN; ZDB-GENE-041010-5; park7.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000001231; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   InParanoid; Q5XJ36; -.
DR   KO; K05687; -.
DR   OMA; GDHYKYS; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   NextBio; 20832773; -.
DR   ArrayExpress; Q5XJ36; -.
DR   Bgee; Q5XJ36; -.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   2: Evidence at transcript level;
KW   Autophagy; Chaperone; Complete proteome; Cytoplasm; Fertilization;
KW   Hydrolase; Inflammatory response; Isopeptide bond; Mitochondrion;
KW   Nucleus; Oxidation; Protease; Reference proteome; RNA-binding;
KW   Stress response; Tumor suppressor; Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000285970.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405563.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  19764 MW;  F1C4F9F923FB2FF1 CRC64;
     MAGKRALVIL AKGAEEMETV IPVDVMRRAG IAVTVAGLAG KEPVQCSREV MICPDSSLED
     AHKQGPYDVV LLPGGLLGAQ NLSESPAVKE VLKDQEGRKG LIAAICAGPT ALLAHGIAYG
     STVTTHPGAK DKMMAGDHYK YSEARVQKDG NVITSRGPGT SFEFALTIVE ELMGAEVAAQ
     VKAPLILKD
//
ID   PARK7_DICDI             Reviewed;         205 AA.
AC   Q54MG7;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   16-MAY-2012, entry version 35.
DE   RecName: Full=Protein DJ-1;
DE   AltName: Full=Parkinson disease protein 7 homolog;
GN   ORFNames=DDB_G0285969;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000082; EAL64519.1; -; Genomic_DNA.
DR   RefSeq; XP_638023.1; XM_632931.1.
DR   ProteinModelPortal; Q54MG7; -.
DR   STRING; Q54MG7; -.
DR   EnsemblProtists; DDB0267060; DDB0267060; DDB_G0285969.
DR   GeneID; 8625374; -.
DR   KEGG; ddi:DDB_G0285969; -.
DR   dictyBase; DDB_G0285969; -.
DR   eggNOG; COG0693; -.
DR   KO; K03152; -.
DR   OMA; DVMGWAR; -.
DR   InterPro; IPR025628; DJ-1_InhA.
DR   Pfam; PF13278; DUF4066; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Reference proteome.
FT   CHAIN         1    205       Protein DJ-1.
FT                                /FTId=PRO_0000331198.
SQ   SEQUENCE   205 AA;  22866 MW;  626B0C7B3F6CC6E1 CRC64;
     MTKKILLLLC KGFEVMEFTP FVDVMGWARE DDNNEDKADI QVVTCGLYNK MVTSTFGVKV
     QVDVLLGEVV KSLDEFDALA IPGGFENYSF YEEAYSEDVS QLIRDFDSKG KHIASVCVAA
     LALGKSGILK GRNATTYRNS LREHSVRQQQ LRDFGANVIA DQSIVIDKNV ITSYNPQTAP
     YVAFELLSRL SDENKAKKVK TLMGF
//
ID   PARK7_HUMAN             Reviewed;         189 AA.
AC   Q99497; B2R4Z1; O14805; Q6DR95; Q7LFU2;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 2.
DT   09-JAN-2013, entry version 130.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Oncogene DJ1;
DE   AltName: Full=Parkinson disease protein 7;
DE   Flags: Precursor;
GN   Name=PARK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=97223489; PubMed=9070310; DOI=10.1006/bbrc.1997.6132;
RA   Nagakubo D., Taita T., Kitaura H., Ikeda M., Tamai K.,
RA   Iguchi-Ariga S.M.M., Ariga H.;
RT   "DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in
RT   cooperation with ras.";
RL   Biochem. Biophys. Res. Commun. 231:509-513(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RA   Beaudoin R., Hod Y.;
RT   "Homo sapiens RNA-binding protein regulatory subunit mRNA.";
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Ariga H., Niki T.;
RT   "Human DJ-1 cDNA from PC3 cells.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RC   TISSUE=Kidney;
RX   MEDLINE=21125241; PubMed=11223268; DOI=10.1016/S0378-1119(00)00590-4;
RA   Taira T., Takahashi K., Kitagawa R., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Molecular cloning of human and mouse DJ-1 genes and identification of
RT   Sp1-dependent activation of the human DJ-1 promoter.";
RL   Gene 263:285-292(2001).
RN   [9]
RP   PROTEIN SEQUENCE OF 6-27; 33-89; 99-122 AND 149-175, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 138-189, AND VARIANT SER-150.
RA   Zou H.Q., Chan P.;
RT   "DJ-1 gene G150S mutation.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   INTERACTION WITH PIAS2, SUBCELLULAR LOCATION, AND FUNCTION.
RX   MEDLINE=21463059; PubMed=11477070; DOI=10.1074/jbc.M101730200;
RA   Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M.M.,
RA   Ariga H.;
RT   "DJ-1 positively regulates the androgen receptor by impairing the
RT   binding of PIASx alpha to the receptor.";
RL   J. Biol. Chem. 276:37556-37563(2001).
RN   [12]
RP   DEGRADATION BY THE PROTEASOME, SUBCELLULAR LOCATION, INTERACTION WITH
RP   PIAS2, HOMODIMERIZATION, MUTAGENESIS OF LYS-130, AND CHARACTERIZATION
RP   OF VARIANT PARK7 PRO-166.
RX   PubMed=12851414; DOI=10.1074/jbc.M304272200;
RA   Miller D.W., Ahmad R., Hague S., Baptista M.J., Canet-Aviles R.,
RA   McLendon C., Carter D.M., Zhu P.-P., Stadler J., Chandran J.,
RA   Klinefelter G.R., Blackstone C., Cookson M.R.;
RT   "L166P mutant DJ-1, causative for recessive Parkinson's disease, is
RT   degraded through the ubiquitin-proteasome system.";
RL   J. Biol. Chem. 278:36588-36595(2003).
RN   [13]
RP   DEGRADATION BY THE PROTEASOME, AND CHARACTERIZATION OF VARIANTS PARK7
RP   ILE-26 AND PRO-166.
RX   PubMed=14713311;
RA   Moore D.J., Zhang L., Dawson T.M., Dawson V.L.;
RT   "A missense mutation (L166P) in DJ-1, linked to familial Parkinson's
RT   disease, confers reduced protein stability and impairs homo-
RT   oligomerization.";
RL   J. Neurochem. 87:1558-1567(2003).
RN   [14]
RP   INTERACTION WITH EFCAB6, AND FUNCTION.
RX   MEDLINE=22499918; PubMed=12612053;
RA   Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S.M.M., Ariga H.;
RT   "DJBP: a novel DJ-1-binding protein, negatively regulates the androgen
RT   receptor by recruiting histone deacetylase complex, and DJ-1
RT   antagonizes this inhibition by abrogation of this complex.";
RL   Mol. Cancer Res. 1:247-261(2003).
RN   [15]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=14579415; DOI=10.1002/mrd.10360;
RA   Yoshida K., Sato Y., Yoshiike M., Nozawa S., Ariga H., Iwamoto T.;
RT   "Immunocytochemical localization of DJ-1 in human male reproductive
RT   tissue.";
RL   Mol. Reprod. Dev. 66:391-397(2003).
RN   [16]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=14705119; DOI=10.1002/ana.10782;
RA   Rizzu P., Hinkle D.A., Zhukareva V., Bonifati V., Severijnen L.-A.,
RA   Martinez D., Ravid R., Kamphorst W., Eberwine J.H., Lee V.M.-Y.,
RA   Trojanowski J.Q., Heutink P.;
RT   "DJ-1 colocalizes with tau inclusions: a link between parkinsonism and
RT   dementia.";
RL   Ann. Neurol. 55:113-118(2004).
RN   [17]
RP   TISSUE SPECIFICITY.
RX   PubMed=14662519; DOI=10.1093/brain/awh054;
RA   Bandopadhyay R., Kingsbury A.E., Cookson M.R., Reid A.R., Evans I.M.,
RA   Hope A.D., Pittman A.M., Lashley T., Canet-Aviles R., Miller D.W.,
RA   McLendon C., Strand C., Leonard A.J., Abou-Sleiman P.M., Healy D.G.,
RA   Ariga H., Wood N.W., de Silva R., Revesz T., Hardy J.A., Lees A.J.;
RT   "The expression of DJ-1 (PARK7) in normal human CNS and idiopathic
RT   Parkinson's disease.";
RL   Brain 127:420-430(2004).
RN   [18]
RP   FUNCTION, INDUCTION, AND MUTAGENESIS OF VAL-51 AND CYS-53.
RX   PubMed=14749723; DOI=10.1038/sj.embor.7400074;
RA   Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K.,
RA   Ariga H.;
RT   "DJ-1 has a role in antioxidative stress to prevent cell death.";
RL   EMBO Rep. 5:213-218(2004).
RN   [19]
RP   FUNCTION, AND MUTAGENESIS OF CYS-46; CYS-53 AND CYS-106.
RX   PubMed=15502874; DOI=10.1371/journal.pbio.0020362;
RA   Shendelman S., Jonason A., Martinat C., Leete T., Abeliovich A.;
RT   "DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-
RT   synuclein aggregate formation.";
RL   PLoS Biol. 2:1-10(2004).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-67, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [21]
RP   SUMOYLATION AT LYS-130, OXIDATION, SUBCELLULAR LOCATION, INDUCTION,
RP   AND FUNCTION.
RX   PubMed=15976810; DOI=10.1038/sj.cdd.4401704;
RA   Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,
RA   Seino C., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Proper SUMO-1 conjugation is essential to DJ-1 to exert its full
RT   activities.";
RL   Cell Death Differ. 13:96-108(2006).
RN   [22]
RP   FUNCTION, INTERACTION WITH HIPK1, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF CYS-106.
RX   PubMed=16390825; DOI=10.1080/10715760500456847;
RA   Sekito A., Koide-Yoshida S., Niki T., Taira T., Iguchi-Ariga S.M.M.,
RA   Ariga H.;
RT   "DJ-1 interacts with HIPK1 and affects H2O2-induced cell death.";
RL   Free Radic. Res. 40:155-165(2006).
RN   [23]
RP   FUNCTION.
RX   PubMed=17015834; DOI=10.1073/pnas.0607260103;
RA   Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P.;
RT   "DJ-1, a cancer- and Parkinson's disease-associated protein,
RT   stabilizes the antioxidant transcriptional master regulator Nrf2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15091-15096(2006).
RN   [24]
RP   FUNCTION.
RX   PubMed=18626009; DOI=10.1073/pnas.0708518105;
RA   van der Brug M.P., Blackinton J., Chandran J., Hao L.Y., Lal A.,
RA   Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K.J.,
RA   Beilina A., Gibbs J.R., Ding J., Myers A.J., Zhan M., Cai H.,
RA   Bonini N.M., Gorospe M., Cookson M.R.;
RT   "RNA binding activity of the recessive parkinsonism protein DJ-1
RT   supports involvement in multiple cellular pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10244-10249(2008).
RN   [25]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-46; CYS-53 AND
RP   CYS-106.
RX   PubMed=18711745; DOI=10.1002/jnr.21831;
RA   Junn E., Jang W.H., Zhao X., Jeong B.S., Mouradian M.M.;
RT   "Mitochondrial localization of DJ-1 leads to enhanced
RT   neuroprotection.";
RL   J. Neurosci. Res. 87:123-129(2009).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [27]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITES, AND MUTAGENESIS
RP   OF CYS-106 AND HIS-126.
RX   PubMed=20304780; DOI=10.1093/hmg/ddq113;
RA   Chen J., Li L., Chin L.S.;
RT   "Parkinson disease protein DJ-1 converts from a zymogen to a protease
RT   by carboxyl-terminal cleavage.";
RL   Hum. Mol. Genet. 19:2395-2408(2010).
RN   [28]
RP   FUNCTION, INTERACTION WITH BBS1; CLCF1; MTERF AND OTUD7B, AND
RP   MUTAGENESIS OF CYS-106.
RX   PubMed=21097510; DOI=10.1074/jbc.M110.147371;
RA   McNally R.S., Davis B.K., Clements C.M., Accavitti-Loper M.A.,
RA   Mak T.W., Ting J.P.;
RT   "DJ-1 enhances cell survival through the binding of cezanne, a
RT   negative regulator of NF-{kappa}B.";
RL   J. Biol. Chem. 286:4098-4106(2011).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS), AND HOMODIMERIZATION.
RX   PubMed=12914946; DOI=10.1016/S0014-5793(03)00764-6;
RA   Huai Q., Sun Y., Wang H., Chin L.-S., Li L., Robinson H., Ke H.;
RT   "Crystal structure of DJ-1/RS and implication on familial Parkinson's
RT   disease.";
RL   FEBS Lett. 549:171-175(2003).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF WILD-TYPE AND MUTANT ARG-130,
RP   AND HOMODIMERIZATION.
RX   PubMed=12761214; DOI=10.1074/jbc.M304221200;
RA   Tao X., Tong L.;
RT   "Crystal structure of human DJ-1, a protein associated with early
RT   onset Parkinson's disease.";
RL   J. Biol. Chem. 278:31372-31379(2003).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS), AND HOMODIMERIZATION.
RX   PubMed=12796482; DOI=10.1074/jbc.M305878200;
RA   Honbou K., Suzuki N.N., Horiuchi M., Niki T., Taira T., Ariga H.,
RA   Inagaki F.;
RT   "The crystal structure of DJ-1, a protein related to male fertility
RT   and Parkinson's disease.";
RL   J. Biol. Chem. 278:31380-31384(2003).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), FUNCTION, OXIDATION, AND
RP   HOMODIMERIZATION.
RX   PubMed=12939276; DOI=10.1074/jbc.M304517200;
RA   Lee S.-J., Kim S.J., Kim I.-K., Ko J., Jeong C.-S., Kim G.-H.,
RA   Park C., Kang S.-O., Suh P.-G., Lee H.-S., Cha S.-S.;
RT   "Crystal structures of human DJ-1 and Escherichia coli Hsp31, which
RT   share an evolutionarily conserved domain.";
RL   J. Biol. Chem. 278:44552-44559(2003).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS), HOMODIMERIZATION, OXIDATION,
RP   AND LACK OF PROTEOLYTIC ACTIVITY.
RX   PubMed=12855764; DOI=10.1073/pnas.1133288100;
RA   Wilson M.A., Collins J.L., Hod Y., Ringe D., Petsko G.A.;
RT   "The 1.1-A resolution crystal structure of DJ-1, the protein mutated
RT   in autosomal recessive early onset Parkinson's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:9256-9261(2003).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS), MUTAGENESIS OF CYS-46; CYS-53
RP   AND CYS-106, OXIDATION, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15181200; DOI=10.1073/pnas.0402959101;
RA   Canet-Aviles R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C.,
RA   Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R.;
RT   "The Parkinson's disease protein DJ-1 is neuroprotective due to
RT   cysteine-sulfinic acid-driven mitochondrial localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9103-9108(2004).
RN   [36]
RP   VARIANTS PARK7 ILE-26 AND ALA-149, AND VARIANT GLN-98.
RX   PubMed=12953260; DOI=10.1002/ana.10675;
RA   Abou-Sleiman P.M., Healy D.G., Quinn N., Lees A.J., Wood N.W.;
RT   "The role of pathogenic DJ-1 mutations in Parkinson's disease.";
RL   Ann. Neurol. 54:283-286(2003).
RN   [37]
RP   VARIANT PARK7 PRO-166, AND SUBCELLULAR LOCATION.
RX   PubMed=12446870; DOI=10.1126/science.1077209;
RA   Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J.,
RA   Krieger E., Dekker M.C.J., Squitieri F., Ibanez P., Joosse M.,
RA   van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G.,
RA   van Duijn C.M., Oostra B.A., Heutink P.;
RT   "Mutations in the DJ-1 gene associated with autosomal recessive early-
RT   onset Parkinsonism.";
RL   Science 299:256-259(2003).
RN   [38]
RP   VARIANT GLN-98.
RX   PubMed=14705128; DOI=10.1002/ana.10816;
RA   Hedrich K., Schaefer N., Hering R., Hagenah J., Lanthaler A.J.,
RA   Schwinger E., Kramer P.L., Ozelius L.J., Bressman S.B., Abbruzzese G.,
RA   Martinelli P., Kostic V., Pramstaller P.P., Vieregge P., Riess O.,
RA   Klein C.;
RT   "The R98Q variation in DJ-1 represents a rare polymorphism.";
RL   Ann. Neurol. 55:145-146(2004).
RN   [39]
RP   VARIANT PARK7 ASP-64, AND X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=15365989; DOI=10.1002/humu.20089;
RA   Hering R., Strauss K.M., Tao X., Bauer A., Woitalla D., Mietz E.M.,
RA   Petrovic S., Bauer P., Schaible W., Mueller T., Schoels L., Klein C.,
RA   Berg D., Meyer P.T., Schulz J.B., Wollnik B., Tong L., Krueger R.,
RA   Riess O.;
RT   "Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson
RT   disease (PARK7).";
RL   Hum. Mutat. 24:321-329(2004).
RN   [40]
RP   CHARACTERIZATION OF VARIANTS PARK7 ASP-64 AND PRO-166.
RX   PubMed=14607841; DOI=10.1074/jbc.M309204200;
RA   Goerner K., Holtorf E., Odoy S., Nuscher B., Yamamoto A., Regula J.T.,
RA   Beyer K., Haass C., Kahle P.J.;
RT   "Differential effects of Parkinson's disease-associated mutations on
RT   stability and folding of DJ-1.";
RL   J. Biol. Chem. 279:6943-6951(2004).
RN   [41]
RP   VARIANT PARK7 THR-104, AND VARIANTS GLN-98 AND SER-171.
RX   PubMed=15254937; DOI=10.1002/mds.20131;
RA   Clark L.N., Afridi S., Mejia-Santana H., Harris J., Louis E.D.,
RA   Cote L.J., Andrews H., Singleton A., Wavrant De-Vrieze F., Hardy J.,
RA   Mayeux R., Fahn S., Waters C., Ford B., Frucht S., Ottman R.,
RA   Marder K.;
RT   "Analysis of an early-onset Parkinson's disease cohort for DJ-1
RT   mutations.";
RL   Mov. Disord. 19:796-800(2004).
RN   [42]
RP   VARIANT GLN-98.
RX   PubMed=14872018;
RA   Hedrich K., Djarmati A., Schafer N., Hering R., Wellenbrock C.,
RA   Weiss P.H., Hilker R., Vieregge P., Ozelius L.J., Heutink P.,
RA   Bonifati V., Schwinger E., Lang A.E., Noth J., Bressman S.B.,
RA   Pramstaller P.P., Riess O., Klein C.;
RT   "DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2)
RT   mutations in early-onset Parkinson disease.";
RL   Neurology 62:389-394(2004).
RN   [43]
RP   VARIANT LYS-163.
RX   PubMed=16240358; DOI=10.1002/ana.20666;
RA   Annesi G., Savettieri G., Pugliese P., D'Amelio M., Tarantino P.,
RA   Ragonese P., La Bella V., Piccoli T., Civitelli D., Annesi F.,
RA   Fierro B., Piccoli F., Arabia G., Caracciolo M., Ciro Candiano I.C.,
RA   Quattrone A.;
RT   "DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral
RT   sclerosis complex.";
RL   Ann. Neurol. 58:803-807(2005).
RN   [44]
RP   CHARACTERIZATION OF VARIANT PARK7 PRO-166.
RX   PubMed=17846173; DOI=10.1083/jcb.200611128;
RA   Olzmann J.A., Li L., Chudaev M.V., Chen J., Perez F.A., Palmiter R.D.,
RA   Chin L.S.;
RT   "Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1
RT   to aggresomes via binding to HDAC6.";
RL   J. Cell Biol. 178:1025-1038(2007).
RN   [45]
RP   VARIANT ASP-64.
RX   PubMed=20186336; DOI=10.1371/journal.pone.0009367;
RA   Krebiehl G., Ruckerbauer S., Burbulla L.F., Kieper N., Maurer B.,
RA   Waak J., Wolburg H., Gizatullina Z., Gellerich F.N., Woitalla D.,
RA   Riess O., Kahle P.J., Proikas-Cezanne T., Kruger R.;
RT   "Reduced basal autophagy and impaired mitochondrial dynamics due to
RT   loss of Parkinson's disease-associated protein DJ-1.";
RL   PLoS ONE 5:E9367-E9367(2010).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive
CC       chaperone.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=173.4 uM for casein;
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-
CC       terminus) with OTUD7B. Interacts with BBS1, HIPK1, CLCF1 and
CC       MTERF.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=6; IntAct=EBI-1164361, EBI-608057;
CC       Q9UER7:DAXX; NbExp=3; IntAct=EBI-1164361, EBI-77321;
CC       Q13158:FADD; NbExp=9; IntAct=EBI-1164361, EBI-494804;
CC       O94776:MTA2; NbExp=3; IntAct=EBI-1164361, EBI-1783035;
CC       Q6GQQ9:OTUD7B; NbExp=3; IntAct=EBI-1164361, EBI-527784;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion.
CC       Note=Under normal conditions, located predominantly in the
CC       cytoplasm and, to a lesser extent, in the nucleus and
CC       mitochondrion. Translocates to the mitochondrion and subsequently
CC       to the nucleus in response to oxidative stress and exerts an
CC       increased cytoprotective effect against oxidative damage. Detected
CC       in tau inclusions in brains from neurodegenerative disease
CC       patients.
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, kidney, skeletal
CC       muscle, liver, testis and heart. Detected at slightly lower levels
CC       in placenta and brain. Detected in astrocytes, Sertoli cells,
CC       spermatogonia, spermatids and spermatozoa.
CC   -!- INDUCTION: By hydrogen peroxide and UV irradiation.
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is enhanced
CC       after ultraviolet irradiation and essential for cell-growth
CC       promoting activity and transforming activity.
CC   -!- PTM: Cys-106 is easily oxidized to sulfinic acid.
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress.
CC   -!- DISEASE: Defects in PARK7 are the cause of Parkinson disease type
CC       7 (PARK7) [MIM:606324]. A neurodegenerative disorder characterized
CC       by resting tremor, postural tremor, bradykinesia, muscular
CC       rigidity, anxiety and psychotic episodes. PARK7 has onset before
CC       40 years, slow progression and initial good response to levodopa.
CC       Some patients may show traits reminiscent of amyotrophic lateral
CC       sclerosis-parkinsonism/dementia complex (Guam disease).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PARK7";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=P&genename=PARK7+%40+DJ-1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D61380; BAA09603.2; -; mRNA.
DR   EMBL; AF021819; AAC12806.1; -; mRNA.
DR   EMBL; AB073864; BAB71782.1; -; mRNA.
DR   EMBL; AK312000; BAG34938.1; -; mRNA.
DR   EMBL; AL034417; CAB52550.1; -; Genomic_DNA.
DR   EMBL; CH471130; EAW71591.1; -; Genomic_DNA.
DR   EMBL; BC008188; AAH08188.1; -; mRNA.
DR   EMBL; AB045294; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY648999; AAT68961.1; -; Genomic_DNA.
DR   IPI; IPI00298547; -.
DR   PIR; JC5394; JC5394.
DR   RefSeq; NP_001116849.1; NM_001123377.1.
DR   RefSeq; NP_009193.2; NM_007262.4.
DR   UniGene; Hs.419640; -.
DR   PDB; 1J42; X-ray; 2.50 A; A=1-189.
DR   PDB; 1P5F; X-ray; 1.10 A; A=1-189.
DR   PDB; 1PDV; X-ray; 1.80 A; A=1-189.
DR   PDB; 1PDW; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-189.
DR   PDB; 1PE0; X-ray; 1.70 A; A/B=1-189.
DR   PDB; 1Q2U; X-ray; 1.60 A; A=1-189.
DR   PDB; 1SOA; X-ray; 1.20 A; A=1-189.
DR   PDB; 1UCF; X-ray; 1.95 A; A/B=1-189.
DR   PDB; 2OR3; X-ray; 1.20 A; A/B=1-189.
DR   PDB; 2R1T; X-ray; 1.70 A; A/B=2-188.
DR   PDB; 2R1U; X-ray; 1.50 A; A/B=2-188.
DR   PDB; 2R1V; X-ray; 1.70 A; A/B=2-188.
DR   PDB; 2RK3; X-ray; 1.05 A; A=1-189.
DR   PDB; 2RK4; X-ray; 1.15 A; A=1-189.
DR   PDB; 2RK6; X-ray; 1.15 A; A=1-189.
DR   PDB; 3B36; X-ray; 1.50 A; A=1-189.
DR   PDB; 3B38; X-ray; 1.85 A; A=1-189.
DR   PDB; 3B3A; X-ray; 1.50 A; A=1-189.
DR   PDB; 3BWE; X-ray; 2.40 A; A/B/C/D/E/F/G=1-189.
DR   PDB; 3CY6; X-ray; 1.35 A; A=1-189.
DR   PDB; 3CYF; X-ray; 1.60 A; A=1-189.
DR   PDB; 3CZ9; X-ray; 1.15 A; A=1-189.
DR   PDB; 3CZA; X-ray; 1.20 A; A=1-189.
DR   PDB; 3EZG; X-ray; 1.15 A; A=1-189.
DR   PDB; 3F71; X-ray; 1.20 A; A=1-189.
DR   PDB; 3SF8; X-ray; 1.56 A; A/B=1-189.
DR   PDBsum; 1J42; -.
DR   PDBsum; 1P5F; -.
DR   PDBsum; 1PDV; -.
DR   PDBsum; 1PDW; -.
DR   PDBsum; 1PE0; -.
DR   PDBsum; 1Q2U; -.
DR   PDBsum; 1SOA; -.
DR   PDBsum; 1UCF; -.
DR   PDBsum; 2OR3; -.
DR   PDBsum; 2R1T; -.
DR   PDBsum; 2R1U; -.
DR   PDBsum; 2R1V; -.
DR   PDBsum; 2RK3; -.
DR   PDBsum; 2RK4; -.
DR   PDBsum; 2RK6; -.
DR   PDBsum; 3B36; -.
DR   PDBsum; 3B38; -.
DR   PDBsum; 3B3A; -.
DR   PDBsum; 3BWE; -.
DR   PDBsum; 3CY6; -.
DR   PDBsum; 3CYF; -.
DR   PDBsum; 3CZ9; -.
DR   PDBsum; 3CZA; -.
DR   PDBsum; 3EZG; -.
DR   PDBsum; 3F71; -.
DR   PDBsum; 3SF8; -.
DR   ProteinModelPortal; Q99497; -.
DR   SMR; Q99497; 3-188.
DR   DIP; DIP-35515N; -.
DR   IntAct; Q99497; 28.
DR   STRING; Q99497; -.
DR   MEROPS; C56.002; -.
DR   PhosphoSite; Q99497; -.
DR   DMDM; 56404943; -.
DR   Cornea-2DPAGE; Q99497; -.
DR   OGP; Q99497; -.
DR   REPRODUCTION-2DPAGE; IPI00298547; -.
DR   UCD-2DPAGE; O14805; -.
DR   UCD-2DPAGE; Q99497; -.
DR   PaxDb; Q99497; -.
DR   PeptideAtlas; Q99497; -.
DR   PRIDE; Q99497; -.
DR   DNASU; 11315; -.
DR   Ensembl; ENST00000338639; ENSP00000340278; ENSG00000116288.
DR   Ensembl; ENST00000377488; ENSP00000366708; ENSG00000116288.
DR   Ensembl; ENST00000377491; ENSP00000366711; ENSG00000116288.
DR   Ensembl; ENST00000493678; ENSP00000418770; ENSG00000116288.
DR   GeneID; 11315; -.
DR   KEGG; hsa:11315; -.
DR   UCSC; uc001aou.4; human.
DR   CTD; 11315; -.
DR   GeneCards; GC01P007944; -.
DR   HGNC; HGNC:16369; PARK7.
DR   HPA; CAB005870; -.
DR   HPA; HPA004190; -.
DR   MIM; 168600; phenotype.
DR   MIM; 602533; gene.
DR   MIM; 606324; phenotype.
DR   neXtProt; NX_Q99497; -.
DR   Orphanet; 90020; Amyotrophic lateral sclerosis-parkinsonism-dementia complex.
DR   Orphanet; 2828; Young adult-onset Parkinsonism.
DR   PharmGKB; PA32946; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   InParanoid; Q99497; -.
DR   KO; K05687; -.
DR   OMA; GDHYKYS; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   PhylomeDB; Q99497; -.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   EvolutionaryTrace; Q99497; -.
DR   GenomeRNAi; 11315; -.
DR   NextBio; 42983; -.
DR   PMAP-CutDB; Q99497; -.
DR   ArrayExpress; Q99497; -.
DR   Bgee; Q99497; -.
DR   CleanEx; HS_PARK7; -.
DR   Genevestigator; Q99497; -.
DR   GO; GO:0030424; C:axon; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; IEA:Compara.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IDA:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:Compara.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Compara.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0008219; P:cell death; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IEA:Compara.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; IEA:Compara.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Compara.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Compara.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; IEA:Compara.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Compara.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Autophagy; Chaperone; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disease mutation; Fertilization;
KW   Hydrolase; Inflammatory response; Isopeptide bond; Mitochondrion;
KW   Neurodegeneration; Nucleus; Oxidation; Parkinson disease;
KW   Parkinsonism; Phosphoprotein; Polymorphism; Protease;
KW   Reference proteome; RNA-binding; Stress response; Tumor suppressor;
KW   Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000157849.
FT   PROPEP        ?    189       Removed in mature form.
FT                                /FTId=PRO_0000405558.
FT   ACT_SITE    106    106       Probable.
FT   ACT_SITE    126    126       Probable.
FT   MOD_RES      67     67       Phosphotyrosine.
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H).
FT   MOD_RES     148    148       N6-acetyllysine.
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   VARIANT      26     26       M -> I (in PARK7; does not affect protein
FT                                stability and degradation; does not
FT                                interfere with homodimerization).
FT                                /FTId=VAR_020492.
FT   VARIANT      64     64       E -> D (in PARK7; no apparent effect on
FT                                protein stability; impaired mitochondrial
FT                                morphology).
FT                                /FTId=VAR_020493.
FT   VARIANT      98     98       R -> Q.
FT                                /FTId=VAR_020494.
FT   VARIANT     104    104       A -> T (in PARK7).
FT                                /FTId=VAR_020495.
FT   VARIANT     149    149       D -> A (in PARK7).
FT                                /FTId=VAR_020496.
FT   VARIANT     150    150       G -> S.
FT                                /FTId=VAR_020497.
FT   VARIANT     163    163       E -> K.
FT                                /FTId=VAR_034801.
FT   VARIANT     166    166       L -> P (in PARK7; reduces protein
FT                                stability and leads to increased
FT                                degradation; interferes with
FT                                homodimerization; abolishes interaction
FT                                with PIAS2; strongly reduces chaperone
FT                                activity; ubiquitinated by PARK2, leading
FT                                to its recognition by HDAC6 and targeting
FT                                to aggresome where is degraded;
FT                                dbSNP:rs28938172).
FT                                /FTId=VAR_020498.
FT   VARIANT     171    171       A -> S.
FT                                /FTId=VAR_020499.
FT   MUTAGEN      46     46       C->A: Reduces protein stability. No
FT                                effect on oxidation.
FT   MUTAGEN      46     46       C->S: No effect on mitochondrial
FT                                translocation.
FT   MUTAGEN      51     51       V->A: Disrupts dimer formation and
FT                                strongly reduces ability to eliminate
FT                                hydrogen peroxide.
FT   MUTAGEN      53     53       C->A: Strongly reduces chaperone activity
FT                                and ability to eliminate hydrogen
FT                                peroxide.
FT   MUTAGEN      53     53       C->S: No effect on mitochondrial
FT                                translocation.
FT   MUTAGEN     106    106       C->A: Abolishes oxidation, association
FT                                with mitochondria and protease activity.
FT                                No effect on chaperone activity. Reduced
FT                                binding to OTUD7B.
FT   MUTAGEN     106    106       C->D: Abolishes oxidation and association
FT                                with mitochondria. No effect on chaperone
FT                                activity.
FT   MUTAGEN     106    106       C->S: No effect on mitochondrial
FT                                translocation. Reduced protease activity.
FT   MUTAGEN     126    126       H->A: Abolishes protease activity.
FT   MUTAGEN     130    130       K->R: Partially compensates for loss of
FT                                stability; when associated with P-166.
FT   CONFLICT    119    119       F -> C (in Ref. 3; BAB71782).
FT   STRAND        5     10
FT   HELIX        16     28
FT   STRAND       32     37
FT   TURN         38     41
FT   STRAND       51     53
FT   STRAND       55     57
FT   HELIX        58     62
FT   STRAND       68     72
FT   HELIX        76     84
FT   HELIX        86     97
FT   STRAND      101    105
FT   TURN        106    108
FT   HELIX       109    114
FT   HELIX       127    129
FT   HELIX       130    133
FT   TURN        134    136
FT   STRAND      139    141
FT   STRAND      145    149
FT   STRAND      152    155
FT   HELIX       158    160
FT   HELIX       161    173
FT   HELIX       175    182
FT   HELIX       183    185
SQ   SEQUENCE   189 AA;  19891 MW;  4B21661B3A76BC67 CRC64;
     MASKRALVIL AKGAEEMETV IPVDVMRRAG IKVTVAGLAG KDPVQCSRDV VICPDASLED
     AKKEGPYDVV VLPGGNLGAQ NLSESAAVKE ILKEQENRKG LIAAICAGPT ALLAHEIGFG
     SKVTTHPLAK DKMMNGGHYT YSENRVEKDG LILTSRGPGT SFEFALAIVE ALNGKEVAAQ
     VKAPLVLKD
//
ID   PARK7_MESAU             Reviewed;         189 AA.
AC   Q7TQ35;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   09-JAN-2013, entry version 44.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Contraception-associated protein 1;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=PARK7; Synonyms=CAP1;
OS   Mesocricetus auratus (Golden hamster).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Cricetidae; Cricetinae; Mesocricetus.
OX   NCBI_TaxID=10036;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-15, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15112332; DOI=10.1002/mrd.20085;
RA   Siva A.B., Sundareswaran V.R., Yeung C.-H., Cooper T.G., Shivaji S.;
RT   "Hamster contraception associated protein 1 (CAP1).";
RL   Mol. Reprod. Dev. 68:373-383(2004).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20400973; DOI=10.1038/aja.2010.19;
RA   Kameshwari D.B., Bhande S., Sundaram C.S., Kota V., Siva A.B.,
RA   Shivaji S.;
RT   "Glucose-regulated protein precursor (GRP78) and tumor rejection
RT   antigen (GP96) are unique to hamster caput epididymal spermatozoa.";
RL   Asian J. Androl. 12:344-355(2010).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity).
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-
CC       terminus) with OTUD7B. Interacts with HIPK1, BBS1, CLCF1 and MTERF
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- TISSUE SPECIFICITY: Detected in liver, heart, spleen and testis
CC       (at protein level). Detected in liver, heart, spleen, kidney,
CC       epididymidis, vas deferens, sperm cells and testis.
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ431372; CAD24072.2; -; mRNA.
DR   HSSP; Q99497; 1PS4.
DR   ProteinModelPortal; Q7TQ35; -.
DR   SMR; Q7TQ35; 1-189.
DR   MEROPS; C56.002; -.
DR   PRIDE; Q7TQ35; -.
DR   HOVERGEN; HBG053511; -.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Autophagy; Chaperone; Cytoplasm;
KW   Direct protein sequencing; Fertilization; Hydrolase;
KW   Inflammatory response; Isopeptide bond; Mitochondrion; Nucleus;
KW   Oxidation; Phosphoprotein; Protease; RNA-binding; Stress response;
KW   Tumor suppressor; Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000252487.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405559.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   MOD_RES     148    148       N6-acetyllysine (By similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  19915 MW;  D9106615AEDD9ABE CRC64;
     MASKRALVIL AKGAEEMETV IPVDIMRRAG IKVTVAGLAG KDPVQCSRDV MICPDTSLED
     AKKQGPYDVV VLPGGNLGAQ NLSESPVVKE ILKEQESRKG LIAAICAGPT ALLAHEIGFG
     SKVTTHPGAK DKMMNGSHYS YSESRVEKDG LILTSRGPGT SFEFALAIVE ALSGKEAADQ
     VKAPLVLKD
//
ID   PARK7_MOUSE             Reviewed;         189 AA.
AC   Q99LX0; O88306; Q3THB9; Q3U509;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   09-JAN-2013, entry version 91.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=Park7;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   MEDLINE=21125241; PubMed=11223268; DOI=10.1016/S0378-1119(00)00590-4;
RA   Taira T., Takahashi K., Kitagawa R., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Molecular cloning of human and mouse DJ-1 genes and identification of
RT   Sp1-dependent activation of the human DJ-1 promoter.";
RL   Gene 263:285-292(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=BALB/c, and NOD; TISSUE=Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 13-27; 63-89 AND 99-122, AND MASS SPECTROMETRY.
RC   TISSUE=Hippocampus;
RA   Lubec G., Klug S.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [6]
RP   INDUCTION.
RX   PubMed=14749723; DOI=10.1038/sj.embor.7400074;
RA   Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K.,
RA   Ariga H.;
RT   "DJ-1 has a role in antioxidative stress to prevent cell death.";
RL   EMBO Rep. 5:213-218(2004).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15784737; DOI=10.1073/pnas.0501282102;
RA   Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S.,
RA   Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D.,
RA   Lozano A.M., Anisman H., Park D.S., Mak T.W.;
RT   "Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-
RT   tetrahydropyrindine (MPTP) and oxidative stress.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:5215-5220(2005).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17015834; DOI=10.1073/pnas.0607260103;
RA   Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P.;
RT   "DJ-1, a cancer- and Parkinson's disease-associated protein,
RT   stabilizes the antioxidant transcriptional master regulator Nrf2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15091-15096(2006).
RN   [9]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF CYS-46; CYS-53 AND
RP   CYS-106.
RX   PubMed=17766438; DOI=10.1073/pnas.0703219104;
RA   Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B.,
RA   Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H.,
RA   Przedborski S., Dawson T.M., Dawson V.L.;
RT   "DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-
RT   like peroxidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14807-14812(2007).
RN   [10]
RP   FUNCTION.
RX   PubMed=19276172; DOI=10.1096/fj.08-125153;
RA   Waak J., Weber S.S., Waldenmaier A., Gorner K., Alunni-Fabbroni M.,
RA   Schell H., Vogt-Weisenhorn D., Pham T.T., Reumers V., Baekelandt V.,
RA   Wurst W., Kahle P.J.;
RT   "Regulation of astrocyte inflammatory responses by the Parkinson's
RT   disease-associated gene DJ-1.";
RL   FASEB J. 23:2478-2489(2009).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=20800516; DOI=10.1016/j.bcmd.2010.07.014;
RA   Xu X., Martin F., Friedman J.S.;
RT   "The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in
RT   red cells and plays a role in protection against oxidative damage.";
RL   Blood Cells Mol. Dis. 45:227-232(2010).
RN   [12]
RP   INTERACTION WITH BBS1; CLCF1; MTERF AND OTUD7B.
RX   PubMed=21097510; DOI=10.1074/jbc.M110.147371;
RA   McNally R.S., Davis B.K., Clements C.M., Accavitti-Loper M.A.,
RA   Mak T.W., Ting J.P.;
RT   "DJ-1 enhances cell survival through the binding of cezanne, a
RT   negative regulator of NF-{kappa}B.";
RL   J. Biol. Chem. 286:4098-4106(2011).
RN   [13]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21068725; DOI=10.1038/nature09536;
RA   Guzman J.N., Sanchez-Padilla J., Wokosin D., Kondapalli J., Ilijic E.,
RA   Schumacker P.T., Surmeier D.J.;
RT   "Oxidant stress evoked by pacemaking in dopaminergic neurons is
RT   attenuated by DJ-1.";
RL   Nature 468:696-700(2010).
RN   [14]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20186336; DOI=10.1371/journal.pone.0009367;
RA   Krebiehl G., Ruckerbauer S., Burbulla L.F., Kieper N., Maurer B.,
RA   Waak J., Wolburg H., Gizatullina Z., Gellerich F.N., Woitalla D.,
RA   Riess O., Kahle P.J., Proikas-Cezanne T., Kruger R.;
RT   "Reduced basal autophagy and impaired mitochondrial dynamics due to
RT   loss of Parkinson's disease-associated protein DJ-1.";
RL   PLoS ONE 5:E9367-E9367(2010).
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive
CC       chaperone.
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR (By similarity).
CC       Interacts (via N-terminus) with OTUD7B. Interacts with BBS1, CLCF1
CC       and MTERF. Binds to HIPK1 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Mitochondrion (By similarity). Note=Under normal
CC       conditions, located predominantly in the cytoplasm and, to a
CC       lesser extent, in the nucleus and mitochondrion. Translocates to
CC       the mitochondrion and subsequently to the nucleus in response to
CC       oxidative stress and exerts an increased cytoprotective effect
CC       against oxidative damage (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed in erythroblasts and in mature red
CC       blood cells from peripheral blood (at protein level).
CC   -!- DEVELOPMENTAL STAGE: Expression increases during erythroid
CC       development (at protein level).
CC   -!- INDUCTION: By hydrogen peroxide.
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- DISRUPTION PHENOTYPE: Increased sensitivity of embryonic cortical
CC       neurons to oxidative stress. Age-dependent increase in
CC       mitochondrial hydrogen peroxide production and reduced
CC       mitochondrial aconitase activity. Down-regulation of Slc25a14 and
CC       Slc25a27, compromised calcium-induced uncoupling and increased
CC       oxidation of mitochondrial matrix proteins specifically in the
CC       dopaminergic neurons of the substantia nigra pars compacta.
CC       Reduced N2el2 protein expression. Impaired mitochondrial function
CC       and morphology with reduced autophagy leading to accumulation of
CC       defective mitochondria.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB015652; BAA29063.2; -; mRNA.
DR   EMBL; AK146368; BAE27118.1; -; mRNA.
DR   EMBL; AK153948; BAE32271.1; -; mRNA.
DR   EMBL; AK168341; BAE40278.1; -; mRNA.
DR   EMBL; AL607084; CAM19230.1; -; Genomic_DNA.
DR   EMBL; BC002187; AAH02187.1; -; mRNA.
DR   IPI; IPI00117264; -.
DR   RefSeq; NP_065594.2; NM_020569.3.
DR   UniGene; Mm.277349; -.
DR   ProteinModelPortal; Q99LX0; -.
DR   SMR; Q99LX0; 1-189.
DR   IntAct; Q99LX0; 2.
DR   STRING; Q99LX0; -.
DR   MEROPS; C56.002; -.
DR   PhosphoSite; Q99LX0; -.
DR   REPRODUCTION-2DPAGE; Q99LX0; -.
DR   UCD-2DPAGE; Q99LX0; -.
DR   PaxDb; Q99LX0; -.
DR   PRIDE; Q99LX0; -.
DR   Ensembl; ENSMUST00000030805; ENSMUSP00000030805; ENSMUSG00000028964.
DR   Ensembl; ENSMUST00000105673; ENSMUSP00000101298; ENSMUSG00000028964.
DR   Ensembl; ENSMUST00000105674; ENSMUSP00000101299; ENSMUSG00000028964.
DR   Ensembl; ENSMUST00000105675; ENSMUSP00000101300; ENSMUSG00000028964.
DR   GeneID; 57320; -.
DR   KEGG; mmu:57320; -.
DR   UCSC; uc008vxz.2; mouse.
DR   CTD; 11315; -.
DR   MGI; MGI:2135637; Park7.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000001231; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   InParanoid; Q99LX0; -.
DR   KO; K05687; -.
DR   OMA; GDHYKYS; -.
DR   OrthoDB; EOG4DJJXJ; -.
DR   NextBio; 313682; -.
DR   ArrayExpress; Q99LX0; -.
DR   Bgee; Q99LX0; -.
DR   Genevestigator; Q99LX0; -.
DR   GermOnline; ENSMUSG00000028964; Mus musculus.
DR   GO; GO:0030424; C:axon; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; IEA:Compara.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; IMP:UniProtKB.
DR   GO; GO:0051920; F:peroxiredoxin activity; IMP:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:MGI.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; TAS:MGI.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:UniProtKB.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IMP:MGI.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; IMP:MGI.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0051899; P:membrane depolarization; IMP:MGI.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:MGI.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IMP:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Compara.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Compara.
DR   GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IEA:Compara.
DR   GO; GO:0050727; P:regulation of inflammatory response; IMP:UniProtKB.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Compara.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Autophagy; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Fertilization; Hydrolase;
KW   Inflammatory response; Isopeptide bond; Mitochondrion; Nucleus;
KW   Oxidation; Phosphoprotein; Protease; Reference proteome; RNA-binding;
KW   Stress response; Tumor suppressor; Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000157850.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405560.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   MOD_RES     148    148       N6-acetyllysine (By similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
FT   MUTAGEN      46     46       C->A: Sulfinic acid detected following
FT                                treatment with hydrogen peroxide.
FT   MUTAGEN      53     53       C->A: Sulfinic acid detected following
FT                                treatment with hydrogen peroxide.
FT   MUTAGEN     106    106       C->A: No sulfinic acid detected following
FT                                treatment with hydrogen peroxide.
FT   CONFLICT    127    127       P -> T (in Ref. 2; BAE40278).
SQ   SEQUENCE   189 AA;  20021 MW;  877C825CCA07468F CRC64;
     MASKRALVIL AKGAEEMETV IPVDVMRRAG IKVTVAGLAG KDPVQCSRDV MICPDTSLED
     AKTQGPYDVV VLPGGNLGAQ NLSESPMVKE ILKEQESRKG LIAAICAGPT ALLAHEVGFG
     CKVTTHPLAK DKMMNGSHYS YSESRVEKDG LILTSRGPGT SFEFALAIVE ALVGKDMANQ
     VKAPLVLKD
//
ID   PARK7_RAT               Reviewed;         189 AA.
AC   O88767;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   09-JAN-2013, entry version 92.
DE   RecName: Full=Protein DJ-1;
DE            EC=3.4.-.-;
DE   AltName: Full=Contraception-associated protein 1;
DE            Short=Protein CAP1;
DE   AltName: Full=Fertility protein SP22;
DE   AltName: Full=Parkinson disease protein 7 homolog;
DE   Flags: Precursor;
GN   Name=Park7; Synonyms=Cap1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 13-29 AND 65-74, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   MEDLINE=99011415; PubMed=9792810; DOI=10.1006/bbrc.1998.9512;
RA   Wagenfeld A., Gromoll J., Cooper T.G.;
RT   "Molecular cloning and expression of rat contraception associated
RT   protein 1 (CAP1), a protein putatively involved in fertilization.";
RL   Biochem. Biophys. Res. Commun. 251:545-549(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   MEDLINE=98401975; PubMed=9733139;
RA   Welch J.E., Barbee R.R., Roberts N.L., Suarez J.D., Klinefelter G.R.;
RT   "SP22: a novel fertility protein from a highly conserved gene
RT   family.";
RL   J. Androl. 19:385-393(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RA   Welch J.E., Barbee R.R., Roberts N.L., Suarez J.D., Klinefelter G.R.;
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 27-45, ASSOCIATION WITH AN RNA-BINDING COMPLEX,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=10022524;
RX   DOI=10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8;
RA   Hod Y., Pentyala S.N., Whyard T.C., El-Maghrabi M.R.;
RT   "Identification and characterization of a novel protein that regulates
RT   RNA-protein interaction.";
RL   J. Cell. Biochem. 72:435-444(1999).
RN   [5]
RP   PROTEIN SEQUENCE OF 33-48; 63-89; 100-122; 133-145 AND 157-175, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
CC   -!- FUNCTION: Protects cells against oxidative stress and cell death.
CC       Plays a role in regulating expression or stability of the
CC       mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
CC       dopaminergic neurons of the substantia nigra pars compacta and
CC       attenuates the oxidative stress induced by calcium entry into the
CC       neurons via L-type channels during pacemaking. Eliminates hydrogen
CC       peroxide and protects cells against hydrogen peroxide-induced cell
CC       death. May act as an atypical peroxiredoxin-like peroxidase that
CC       scavenges hydrogen peroxide. Following removal of a C-terminal
CC       peptide, displays protease activity and enhanced cytoprotective
CC       action against oxidative stress-induced apoptosis. Stabilizes
CC       NFE2L2 by preventing its association with KEAP1 and its subsequent
CC       ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating
CC       activity. Enhances RELA nuclear translocation. Binds to a number
CC       of mRNAs containing multiple copies of GG or CC motifs and
CC       partially inhibits their translation but dissociates following
CC       oxidative stress. Required for correct mitochondrial morphology
CC       and function and for autophagy of dysfunctional mitochondria.
CC       Regulates astrocyte inflammatory responses. Acts as a positive
CC       regulator of androgen receptor-dependent transcription. Prevents
CC       aggregation of SNCA. Plays a role in fertilization. Has no
CC       proteolytic activity. Has cell-growth promoting activity and
CC       transforming activity. May function as a redox-sensitive chaperone
CC       (By similarity).
CC   -!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
CC       complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-
CC       terminus) with OTUD7B. Interacts with HIPK1, BBS1, CLCF1 and MTERF
CC       (By similarity). Part of a ternary RNA-binding complex.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion (By
CC       similarity). Note=Under normal conditions, located predominantly
CC       in the cytoplasm and, to a lesser extent, in the nucleus and
CC       mitochondrion. Translocates to the mitochondrion and subsequently
CC       to the nucleus in response to oxidative stress and exerts an
CC       increased cytoprotective effect against oxidative damage (By
CC       similarity).
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected on epididymal sperm.
CC       Highly expressed in testis and prostate. Detected at lower levels
CC       in heart, lung, brain, liver, kidney, seminal vesicle, caput and
CC       corpus epididymis.
CC   -!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
CC       for cell-growth promoting activity and transforming activity (By
CC       similarity).
CC   -!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
CC       activation of protease activity in response to oxidative stress
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ007291; CAA07434.1; -; mRNA.
DR   EMBL; AF157511; AAD43956.1; -; mRNA.
DR   EMBL; AF157512; AAD43957.1; -; mRNA.
DR   IPI; IPI00212523; -.
DR   PIR; JE0344; JE0344.
DR   RefSeq; NP_476484.1; NM_057143.1.
DR   UniGene; Rn.30105; -.
DR   ProteinModelPortal; O88767; -.
DR   SMR; O88767; 1-189.
DR   IntAct; O88767; 1.
DR   STRING; O88767; -.
DR   MEROPS; C56.002; -.
DR   PhosphoSite; O88767; -.
DR   World-2DPAGE; 0004:O88767; -.
DR   PRIDE; O88767; -.
DR   Ensembl; ENSRNOT00000024711; ENSRNOP00000024711; ENSRNOG00000018289.
DR   GeneID; 117287; -.
DR   KEGG; rno:117287; -.
DR   UCSC; RGD:621808; rat.
DR   CTD; 11315; -.
DR   RGD; 621808; Park7.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000001231; -.
DR   HOGENOM; HOG000063194; -.
DR   HOVERGEN; HBG053511; -.
DR   KO; K05687; -.
DR   OMA; GDHYKYS; -.
DR   NextBio; 620247; -.
DR   ArrayExpress; O88767; -.
DR   Genevestigator; O88767; -.
DR   GermOnline; ENSRNOG00000018289; Rattus norvegicus.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
DR   GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Autophagy; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Fertilization; Hydrolase;
KW   Inflammatory response; Isopeptide bond; Mitochondrion; Nucleus;
KW   Oxidation; Phosphoprotein; Protease; Reference proteome; RNA-binding;
KW   Stress response; Tumor suppressor; Ubl conjugation; Zymogen.
FT   CHAIN         1      ?       Protein DJ-1.
FT                                /FTId=PRO_0000157851.
FT   PROPEP        ?    189       Removed in mature form (By similarity).
FT                                /FTId=PRO_0000405561.
FT   ACT_SITE    106    106       By similarity.
FT   ACT_SITE    126    126       By similarity.
FT   MOD_RES      67     67       Phosphotyrosine (By similarity).
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
FT   MOD_RES     148    148       N6-acetyllysine (By similarity).
FT   CROSSLNK    130    130       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
SQ   SEQUENCE   189 AA;  19974 MW;  08AC2C37D62A9455 CRC64;
     MASKRALVIL AKGAEEMETV IPVDIMRRAG IKVTVAGLAG KDPVQCSRDV VICPDTSLEE
     AKTQGPYDVV VLPGGNLGAQ NLSESALVKE ILKEQENRKG LIAAICAGPT ALLAHEVGFG
     CKVTSHPLAK DKMMNGSHYS YSESRVEKDG LILTSRGPGT SFEFALAIVE ALSGKDMANQ
     VKAPLVLKD
//
ID   PDDC1_BOVIN             Reviewed;         220 AA.
AC   Q29RZ1;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 1.
DT   03-OCT-2012, entry version 36.
DE   RecName: Full=Parkinson disease 7 domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=PDDC1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Uterus;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC113324; AAI13325.1; -; mRNA.
DR   IPI; IPI00709628; -.
DR   RefSeq; NP_001039612.1; NM_001046147.1.
DR   UniGene; Bt.37556; -.
DR   ProteinModelPortal; Q29RZ1; -.
DR   Ensembl; ENSBTAT00000013662; ENSBTAP00000013662; ENSBTAG00000010348.
DR   GeneID; 513454; -.
DR   KEGG; bta:513454; -.
DR   CTD; 347862; -.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000010778; -.
DR   HOGENOM; HOG000067792; -.
DR   HOVERGEN; HBG106581; -.
DR   InParanoid; Q29RZ1; -.
DR   OMA; TICAVSH; -.
DR   OrthoDB; EOG4QC16D; -.
DR   NextBio; 20870861; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     35       Potential.
FT   CHAIN        36    220       Parkinson disease 7 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000305093.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    201    201       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   220 AA;  23263 MW;  35ABD0F8F941D876 CRC64;
     MASERLPSRP ACLLVASGAA EGVSAQSFLH CFTLASAAFN LQVATPGGKT MDFVDVNESN
     ARWVQDFRLK AYASPAKLES IDGARYHALL IPSCPGALVD LASSGSLARI LQHFHSESKP
     ICAVGHGVAA LCCATSEDRS WVFQGYSVTG PSVYELVRAP GFAHLPLIVE DFVKDAGACF
     SASEPDAMHV VLDRHLVTGQ NASSTVPAVQ NLLFLCGSRK
//
ID   PDDC1_DANRE             Reviewed;         213 AA.
AC   Q3B7H1;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 1.
DT   16-MAY-2012, entry version 39.
DE   RecName: Full=Parkinson disease 7 domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=pddc1; ORFNames=zgc:123196;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC107609; AAI07610.1; -; mRNA.
DR   IPI; IPI00656522; -.
DR   RefSeq; NP_001032195.1; NM_001037118.1.
DR   UniGene; Dr.1836; -.
DR   ProteinModelPortal; Q3B7H1; -.
DR   PRIDE; Q3B7H1; -.
DR   GeneID; 100148360; -.
DR   KEGG; dre:100148360; -.
DR   CTD; 347862; -.
DR   ZFIN; ZDB-GENE-051030-96; pddc1.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000067792; -.
DR   HOVERGEN; HBG106581; -.
DR   InParanoid; Q3B7H1; -.
DR   OrthoDB; EOG4QC16D; -.
DR   NextBio; 20791988; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       Potential.
FT   CHAIN        21    213       Parkinson disease 7 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000305096.
SQ   SEQUENCE   213 AA;  22861 MW;  CA5D89770A53FD98 CRC64;
     MTSKPTCLIV ASAASAGVSA RSFQQCFNLC NPVFNLQTAT PGGKSIDFTG VDDSTGRWVQ
     EFSIKPYANP AKLESIDGAR YQALLIPDCP GAMNDLAHSG SLARILSHFI SQQKPVCAVG
     QGVAALCCAT EDQKWIFSRY SMTGPSVFEL VRSSEFANLP LIVEDFIKDN GGSYTASIED
     AVHVVLDRHL ITGQNIQSTT AAVNNLILLC NNR
//
ID   PDDC1_HUMAN             Reviewed;         220 AA.
AC   Q8NB37; B7ZKW5; Q2NL76; Q6ZQY0; Q8NAE0;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-NOV-2012, entry version 69.
DE   RecName: Full=Parkinson disease 7 domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=PDDC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Small intestine, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NB37-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NB37-2; Sequence=VSP_028233;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q8NB37-3; Sequence=VSP_028231;
CC       Name=4;
CC         IsoId=Q8NB37-4; Sequence=VSP_028231, VSP_028232;
CC         Note=No experimental confirmation available;
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK091602; BAC03706.1; -; mRNA.
DR   EMBL; AK092816; BAC03983.1; -; mRNA.
DR   EMBL; AK128653; BAC87551.1; -; mRNA.
DR   EMBL; BC110868; AAI10869.1; -; mRNA.
DR   EMBL; BC112145; AAI12146.1; -; mRNA.
DR   EMBL; BC143420; AAI43421.1; -; mRNA.
DR   IPI; IPI00167976; -.
DR   IPI; IPI00168112; -.
DR   IPI; IPI00443655; -.
DR   IPI; IPI00719079; -.
DR   RefSeq; NP_872418.1; NM_182612.2.
DR   UniGene; Hs.218362; -.
DR   ProteinModelPortal; Q8NB37; -.
DR   IntAct; Q8NB37; 1.
DR   MINT; MINT-1397454; -.
DR   MEROPS; C56.974; -.
DR   DMDM; 74730065; -.
DR   PaxDb; Q8NB37; -.
DR   PRIDE; Q8NB37; -.
DR   Ensembl; ENST00000319863; ENSP00000321691; ENSG00000177225.
DR   Ensembl; ENST00000354286; ENSP00000346239; ENSG00000177225.
DR   Ensembl; ENST00000397472; ENSP00000380612; ENSG00000177225.
DR   Ensembl; ENST00000479959; ENSP00000436204; ENSG00000177225.
DR   Ensembl; ENST00000524550; ENSP00000431183; ENSG00000177225.
DR   GeneID; 347862; -.
DR   KEGG; hsa:347862; -.
DR   UCSC; uc001lrc.3; human.
DR   UCSC; uc001lrd.3; human.
DR   UCSC; uc001lrf.1; human.
DR   CTD; 347862; -.
DR   GeneCards; GC11M000759; -.
DR   HGNC; HGNC:26616; PDDC1.
DR   HPA; HPA008812; -.
DR   neXtProt; NX_Q8NB37; -.
DR   PharmGKB; PA142671193; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000067792; -.
DR   HOVERGEN; HBG106581; -.
DR   OMA; TICAVSH; -.
DR   OrthoDB; EOG4QC16D; -.
DR   PhylomeDB; Q8NB37; -.
DR   GenomeRNAi; 347862; -.
DR   NextBio; 99299; -.
DR   ArrayExpress; Q8NB37; -.
DR   Bgee; Q8NB37; -.
DR   CleanEx; HS_PDDC1; -.
DR   Genevestigator; Q8NB37; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     38       Potential.
FT   CHAIN        39    220       Parkinson disease 7 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000305094.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ      83    119       GARYHALLIPSCPGALTDLASSGSLARILQHFHSESK ->
FT                                E (in isoform 3 and isoform 4).
FT                                /FTId=VSP_028231.
FT   VAR_SEQ     151    220       PSVCELVRAPGFARLPLVVEDFVKDSGACFSASEPDAVHVV
FT                                LDRHLVTGQNASSTVPAVQNLLFLCGSRK -> GLGLSQEP
FT                                PPRSRSPLCVSSSGPPASPACRSWWRTS (in isoform
FT                                4).
FT                                /FTId=VSP_028232.
FT   VAR_SEQ     182    220       ASEPDAVHVVLDRHLVTGQNASSTVPAVQNLLFLCGSRK
FT                                -> GAAASCPKADRHWQHFPVEEIFLACGFKVAGLGAAPGW
FT                                GRGGKQEDRPPEEQRRAGEDFPIYQCVFIYP (in
FT                                isoform 2).
FT                                /FTId=VSP_028233.
SQ   SEQUENCE   220 AA;  23298 MW;  73A49DD9C551D6BD CRC64;
     MASERLPNRP ACLLVASGAA EGVSAQSFLH CFTMASTAFN LQVATPGGKA MEFVDVTESN
     ARWVQDFRLK AYASPAKLES IDGARYHALL IPSCPGALTD LASSGSLARI LQHFHSESKP
     ICAVGHGVAA LCCATNEDRS WVFDSYSLTG PSVCELVRAP GFARLPLVVE DFVKDSGACF
     SASEPDAVHV VLDRHLVTGQ NASSTVPAVQ NLLFLCGSRK
//
ID   PDDC1_MOUSE             Reviewed;         220 AA.
AC   Q8BFQ8; Q8C2Q9;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-NOV-2012, entry version 61.
DE   RecName: Full=Parkinson disease 7 domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=Pddc1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Cerebellum, Eye, Head, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC40181.1; Type=Frameshift; Positions=219;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK081187; BAC38160.1; -; mRNA.
DR   EMBL; AK084273; BAC39152.1; -; mRNA.
DR   EMBL; AK088159; BAC40181.1; ALT_FRAME; mRNA.
DR   EMBL; AK140975; BAE24535.1; -; mRNA.
DR   EMBL; BC023835; AAH23835.1; -; mRNA.
DR   IPI; IPI00224733; -.
DR   RefSeq; NP_742114.3; NM_172116.4.
DR   UniGene; Mm.290953; -.
DR   ProteinModelPortal; Q8BFQ8; -.
DR   SMR; Q8BFQ8; 5-218.
DR   UCD-2DPAGE; Q8BFQ8; -.
DR   PaxDb; Q8BFQ8; -.
DR   PRIDE; Q8BFQ8; -.
DR   Ensembl; ENSMUST00000106008; ENSMUSP00000101630; ENSMUSG00000051007.
DR   GeneID; 213350; -.
DR   KEGG; mmu:213350; -.
DR   UCSC; uc012fwy.1; mouse.
DR   CTD; 347862; -.
DR   MGI; MGI:2387178; Pddc1.
DR   eggNOG; COG0693; -.
DR   GeneTree; ENSGT00390000010778; -.
DR   HOGENOM; HOG000067792; -.
DR   HOVERGEN; HBG106581; -.
DR   OrthoDB; EOG4QC16D; -.
DR   NextBio; 373923; -.
DR   ArrayExpress; Q8BFQ8; -.
DR   Bgee; Q8BFQ8; -.
DR   CleanEx; MM_PDDC1; -.
DR   Genevestigator; Q8BFQ8; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     35       Potential.
FT   CHAIN        36    220       Parkinson disease 7 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000305095.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) (Potential).
FT   CONFLICT      9      9       R -> G (in Ref. 1; BAC40181).
FT   CONFLICT     22     22       G -> D (in Ref. 1; BAC40181).
FT   CONFLICT    141    141       W -> R (in Ref. 1; BAC40181).
SQ   SEQUENCE   220 AA;  23277 MW;  FB0615AF7204CB23 CRC64;
     MASERLPSRP ACLLVASGAS EGVSAQSFVH CFTLASAAFN LQVATPGGKA IDFVDVTESN
     ARWVQDFRLK AYASPAKLES IDGARYHALL IPSCPGALTD LASSGSLARI LQHFRSESKP
     ICAIGHGVAA LCCATNEDRS WVFQGYSLTG PSVYELIRAP GFARLPLIVE DFVKDSGAGF
     SASEPDAVHV VLDRHLVTGQ NANSTVPAVQ NLLFLCGSRK
//
ID   PDDC1_XENLA             Reviewed;         229 AA.
AC   Q32NG4;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 1.
DT   11-JUL-2012, entry version 22.
DE   RecName: Full=Parkinson disease 7 domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=pddc1;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC108639; AAI08640.1; -; mRNA.
DR   RefSeq; NP_001089896.1; NM_001096427.1.
DR   UniGene; Xl.46985; -.
DR   ProteinModelPortal; Q32NG4; -.
DR   GeneID; 734963; -.
DR   KEGG; xla:734963; -.
DR   CTD; 347862; -.
DR   Xenbase; XB-GENE-1005355; pddc1.
DR   HOVERGEN; HBG106581; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Glycoprotein; Secreted; Signal.
FT   SIGNAL        1     34       Potential.
FT   CHAIN        35    229       Parkinson disease 7 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000305097.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    212    212       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   229 AA;  24657 MW;  98A66F269EF36053 CRC64;
     MKKQGAPVSG GGTERLTKPS CLMVGSAVAE GVSAQSFLHS FTLASSAFNL QVATPGGKAL
     DFVGISETDS RWFQDFQLKP YSNPARLESI DGSRYHALLI PHCPGALTDL ANSGYLARIL
     QHFTAEKKPI CAIGHGVTAL CCATNQDKSW VFQNYSLTGP SVYELVRRPE YASLPLILED
     YAKDSGATFS ASEPDAIHVV LDRHLITGQN DNSTMPAVQN LILLCNGRK
//
ID   PFPI_PYRAB              Reviewed;         166 AA.
AC   Q9V1F8; G8ZGH3;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-NOV-2012, entry version 74.
DE   RecName: Full=Intracellular protease 1;
DE            EC=3.2.-.-;
DE   AltName: Full=Intracellular protease I;
GN   Name=pfpI; OrderedLocusNames=PYRAB04690; ORFNames=PAB0311;
OS   Pyrococcus abyssi (strain GE5 / Orsay).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=272844;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=GE5 / Orsay;
RX   MEDLINE=22511545; PubMed=12622808;
RX   DOI=10.1046/j.1365-2958.2003.03381.x;
RA   Cohen G.N., Barbe V., Flament D., Galperin M., Heilig R., Lecompte O.,
RA   Poch O., Prieur D., Querellou J., Ripp R., Thierry J.-C.,
RA   Van der Oost J., Weissenbach J., Zivanovic Y., Forterre P.;
RT   "An integrated analysis of the genome of the hyperthermophilic
RT   archaeon Pyrococcus abyssi.";
RL   Mol. Microbiol. 47:1495-1512(2003).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=GE5 / Orsay;
RX   PubMed=22057919; DOI=10.1007/s00284-011-0035-x;
RA   Gao J., Wang J.;
RT   "Re-annotation of two hyperthermophilic archaea Pyrococcus abyssi GE5
RT   and Pyrococcus furiosus DSM 3638.";
RL   Curr. Microbiol. 64:118-129(2012).
CC   -!- SUBUNIT: Homohexamer formed by a dimer of trimers that assemble
CC       into a hollow ring structure (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ248284; CAB49391.1; -; Genomic_DNA.
DR   EMBL; HE613800; CCE69852.1; -; Genomic_DNA.
DR   PIR; H75163; H75163.
DR   RefSeq; NP_126160.1; NC_000868.1.
DR   ProteinModelPortal; Q9V1F8; -.
DR   SMR; Q9V1F8; 1-166.
DR   MEROPS; C56.001; -.
DR   EnsemblBacteria; EBPYRT00000002953; EBPYRP00000002884; EBPYRG00000002953.
DR   GeneID; 1495365; -.
DR   GenomeReviews; AL096836_GR; PYRAB04690.
DR   KEGG; pab:PAB0311; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; GSMSKKI; -.
DR   ProtClustDB; CLSK253649; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Cytoplasm; Hydrolase; Protease.
FT   CHAIN         1    166       Intracellular protease 1.
FT                                /FTId=PRO_0000157825.
FT   DOMAIN        1    166       PfpI endopeptidase.
FT   ACT_SITE    101    101       Potential.
SQ   SEQUENCE   166 AA;  18522 MW;  C38832E1C1DC0718 CRC64;
     MRVLILSADQ FEDVELIYPY HRLKEEGHEV LVASFKRGVI TGKHGYTVNV DLAFEEVNPD
     EFDALVLPGG RAPERVRLNE KAVEIAKKMF SEGKPVASIC HGPQILISAG VLRGRRGTSY
     PGIKDDMINA GVDWVDAEVV VDGNWVSSRV PGDLYAWMRE FVKLLK
//
ID   PFPI_PYRFU              Reviewed;         166 AA.
AC   Q51732;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   31-OCT-2012, entry version 81.
DE   RecName: Full=Intracellular protease 1;
DE            EC=3.2.-.-;
DE   AltName: Full=Intracellular protease I;
GN   Name=pfpI; OrderedLocusNames=PF1719;
OS   Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=186497;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-28; 128-157
RP   AND 159-166, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION.
RC   STRAIN=ATCC 43587 / DSM 3638 / JCM 8422 / Vc1;
RX   MEDLINE=96196168; PubMed=8626329;
RA   Halio S.B., Blumentals I.I., Short S.A., Merrill B.M., Kelly R.M.;
RT   "Sequence, expression in Escherichia coli, and analysis of the gene
RT   encoding a novel intracellular protease (PfpI) from the
RT   hyperthermophilic archaeon Pyrococcus furiosus.";
RL   J. Bacteriol. 178:2605-2612(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43587 / DSM 3638 / JCM 8422 / Vc1;
RX   MEDLINE=99359404; PubMed=10430560;
RA   Maeder D.L., Weiss R.B., Dunn D.M., Cherry J.L., Gonzalez J.M.,
RA   DiRuggiero J., Robb F.T.;
RT   "Divergence of the hyperthermophilic archaea Pyrococcus furiosus and
RT   P. horikoshii inferred from complete genomic sequences.";
RL   Genetics 152:1299-1305(1999).
CC   -!- FUNCTION: Highly stable protease. Although the physiological
CC       function is unclear it is the dominant protease in P.furiosus.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Temperature dependence:
CC         Highly thermostable (a half-life of over 30 hours at 98 degrees
CC         Celsius);
CC   -!- SUBUNIT: Homooligomer. Two active complexes, a 86 and a 66 kDa,
CC       have been found. They probably contain four and three subunits
CC       respectively.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: Is resistant to several denaturants.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U57642; AAB04694.1; -; Genomic_DNA.
DR   EMBL; AE009950; AAL81843.1; -; Genomic_DNA.
DR   PIR; JC6003; JC6003.
DR   RefSeq; NP_579448.1; NC_003413.1.
DR   ProteinModelPortal; Q51732; -.
DR   SMR; Q51732; 1-166.
DR   MEROPS; C56.001; -.
DR   PRIDE; Q51732; -.
DR   EnsemblBacteria; EBPYRT00000004875; EBPYRP00000004736; EBPYRG00000004874.
DR   GeneID; 1469596; -.
DR   GenomeReviews; AE009950_GR; PF1719.
DR   KEGG; pfu:PF1719; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; MINAGVE; -.
DR   ProtClustDB; CLSK253649; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Protease; Reference proteome.
FT   CHAIN         1    166       Intracellular protease 1.
FT                                /FTId=PRO_0000157826.
FT   DOMAIN        1    166       PfpI endopeptidase.
FT   ACT_SITE    100    100       Nucleophile (By similarity).
FT   ACT_SITE    101    101       Potential.
SQ   SEQUENCE   166 AA;  18791 MW;  B4AA6FFB83FBE52F CRC64;
     MKILFLSANE FEDVELIYPY HRLKEEGHEV YIASFEKGVI TGKHGYSVKV DLTFDEVNPD
     EFDALVLPGG RAPERVRLNE KAVEIARKMF TEGKPVATIC HGPQILISAG VLKGRKGTSY
     IGIRDDMINA GVEWIDREVV VDGNWVSSRH PGDLYAWMRE FVKLLK
//
ID   PFPI_PYRHO              Reviewed;         166 AA.
AC   O59413;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   06-FEB-2013, entry version 82.
DE   RecName: Full=Intracellular protease 1;
DE            EC=3.2.-.-;
DE   AltName: Full=Intracellular protease I;
GN   Name=pfpI; OrderedLocusNames=PH1704;
OS   Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 /
OS   NBRC 100139 / OT-3).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=70601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3;
RX   MEDLINE=98344137; PubMed=9679194; DOI=10.1093/dnares/5.2.55;
RA   Kawarabayasi Y., Sawada M., Horikawa H., Haikawa Y., Hino Y.,
RA   Yamamoto S., Sekine M., Baba S., Kosugi H., Hosoyama A., Nagai Y.,
RA   Sakai M., Ogura K., Otsuka R., Nakazawa H., Takamiya M., Ohfuku Y.,
RA   Funahashi T., Tanaka T., Kudoh Y., Yamazaki J., Kushida N., Oguchi A.,
RA   Aoki K., Yoshizawa T., Nakamura Y., Robb F.T., Horikoshi K.,
RA   Masuchi Y., Shizuya H., Kikuchi H.;
RT   "Complete sequence and gene organization of the genome of a hyper-
RT   thermophilic archaebacterium, Pyrococcus horikoshii OT3.";
RL   DNA Res. 5:55-76(1998).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND SUBUNIT.
RX   PubMed=11114201; DOI=10.1073/pnas.260503597;
RA   Du X., Choi I.-G., Kim R., Wang W., Jancarik J., Yokota H., Kim S.-H.;
RT   "Crystal structure of an intracellular protease from Pyrococcus
RT   horikoshii at 2-A resolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14079-14084(2000).
CC   -!- SUBUNIT: Homohexamer formed by a dimer of trimers that assemble
CC       into a hollow ring structure.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000001; BAA30818.1; -; Genomic_DNA.
DR   PIR; C71178; C71178.
DR   RefSeq; NP_143548.1; NC_000961.1.
DR   PDB; 1G2I; X-ray; 2.00 A; A/B/C=1-166.
DR   PDBsum; 1G2I; -.
DR   ProteinModelPortal; O59413; -.
DR   SMR; O59413; 1-166.
DR   MEROPS; C56.001; -.
DR   EnsemblBacteria; EBPYRT00000000722; EBPYRP00000000722; EBPYRG00000000722.
DR   GeneID; 1442551; -.
DR   GenomeReviews; BA000001_GR; PH1704.
DR   KEGG; pho:PH1704; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; MINAGVE; -.
DR   ProtClustDB; CLSK253649; -.
DR   BioCyc; PHOR70601:GJWR-1704-MONOMER; -.
DR   EvolutionaryTrace; O59413; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Hydrolase; Protease.
FT   CHAIN         1    166       Intracellular protease 1.
FT                                /FTId=PRO_0000157827.
FT   DOMAIN        1    166       PfpI endopeptidase.
FT   ACT_SITE    100    100       Nucleophile.
FT   ACT_SITE    101    101       Potential.
FT   STRAND        2      6
FT   HELIX        13     25
FT   STRAND       29     41
FT   STRAND       47     50
FT   HELIX        54     56
FT   HELIX        59     61
FT   STRAND       63     67
FT   HELIX        72     76
FT   HELIX        80     91
FT   STRAND       96     99
FT   TURN        100    103
FT   HELIX       104    109
FT   HELIX       121    123
FT   HELIX       124    129
FT   STRAND      140    142
FT   STRAND      145    148
FT   HELIX       151    153
FT   HELIX       154    165
SQ   SEQUENCE   166 AA;  18624 MW;  CED046ED1789808C CRC64;
     MKVLFLTANE FEDVELIYPY HRLKEEGHEV YIASFERGTI TGKHGYSVKV DLTFDKVNPE
     EFDALVLPGG RAPERVRLNE KAVSIARKMF SEGKPVASIC HGPQILISAG VLRGRKGTSY
     PGIKDDMINA GVEWVDAEVV VDGNWVSSRV PADLYAWMRE FVKLLK
//
ID   PFPI_PYRKO              Reviewed;         166 AA.
AC   Q5JGM7;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   06-FEB-2013, entry version 52.
DE   RecName: Full=Intracellular protease 1;
DE            EC=3.2.-.-;
DE   AltName: Full=Intracellular protease I;
GN   Name=pfpI; OrderedLocusNames=TK1284;
OS   Pyrococcus kodakaraensis (strain ATCC BAA-918 / JCM 12380 / KOD1)
OS   (Thermococcus kodakaraensis (strain KOD1)).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Thermococcus.
OX   NCBI_TaxID=69014;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-918 / JCM 12380 / KOD1;
RX   PubMed=15710748; DOI=10.1101/gr.3003105;
RA   Fukui T., Atomi H., Kanai T., Matsumi R., Fujiwara S., Imanaka T.;
RT   "Complete genome sequence of the hyperthermophilic archaeon
RT   Thermococcus kodakaraensis KOD1 and comparison with Pyrococcus
RT   genomes.";
RL   Genome Res. 15:352-363(2005).
CC   -!- SUBUNIT: Homohexamer formed by a dimer of trimers that assemble
CC       into a hollow ring structure (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP006878; BAD85473.1; -; Genomic_DNA.
DR   RefSeq; YP_183697.1; NC_006624.1.
DR   ProteinModelPortal; Q5JGM7; -.
DR   SMR; Q5JGM7; 1-166.
DR   MEROPS; C56.001; -.
DR   EnsemblBacteria; EBPYRT00000007522; EBPYRP00000007303; EBPYRG00000007521.
DR   GeneID; 3235476; -.
DR   GenomeReviews; AP006878_GR; TK1284.
DR   KEGG; tko:TK1284; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; MINAGVE; -.
DR   ProtClustDB; CLSK253649; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Cytoplasm; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    166       Intracellular protease 1.
FT                                /FTId=PRO_0000157828.
FT   DOMAIN        1    166       PfpI endopeptidase.
FT   ACT_SITE    101    101       Potential.
SQ   SEQUENCE   166 AA;  18415 MW;  F6FC25F20B228316 CRC64;
     MKVLILSADG FEDLELIYPL HRIKEEGHEV YVASFQRGKI TGKHGYTVNV DLAFDEVDPD
     EFDALVLPGG RAPEIVRLNE KAVAITKKMF EDGKPVASIC HGPQILISAG VLKGRKGTST
     VTIRDDVKNA GAEWIDAEVV VDGNWVSSRH PGDLYAWMRE FVKLLR
//
ID   PIAS2_HUMAN             Reviewed;         621 AA.
AC   O75928; O75927; Q96BT5; Q96KE3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   06-FEB-2013, entry version 121.
DE   RecName: Full=E3 SUMO-protein ligase PIAS2;
DE            EC=6.3.2.-;
DE   AltName: Full=Androgen receptor-interacting protein 3;
DE            Short=ARIP3;
DE   AltName: Full=DAB2-interacting protein;
DE            Short=DIP;
DE   AltName: Full=Msx-interacting zinc finger protein;
DE            Short=Miz1;
DE   AltName: Full=PIAS-NY protein;
DE   AltName: Full=Protein inhibitor of activated STAT x;
DE   AltName: Full=Protein inhibitor of activated STAT2;
GN   Name=PIAS2; Synonyms=PIASX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PIAS2-ALPHA AND PIAS2-BETA).
RC   TISSUE=B-cell;
RX   MEDLINE=98393695; PubMed=9724754; DOI=10.1073/pnas.95.18.10626;
RA   Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D.,
RA   Shuai K.;
RT   "Inhibition of Stat1-mediated gene activation by PIAS1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10626-10631(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Testis;
RX   PubMed=15301740;
RA   Zheng Y., Zhou Z.-M., Yin L.-L., Li J.-M., Sha J.-H.;
RT   "Molecular cloning and characterization of a novel splicing variant of
RT   PIASx.";
RL   Acta Pharmacol. Sin. 25:1058-1064(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PIAS2-ALPHA).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=99121113; PubMed=9920921; DOI=10.1074/jbc.274.6.3700;
RA   Moilanen A.-M., Karvonen U., Poukka H., Yan W., Toppari J.,
RA   Jaenne O.A., Palvimo J.J.;
RT   "A testis-specific androgen receptor coregulator that belongs to a
RT   novel family of nuclear proteins.";
RL   J. Biol. Chem. 274:3700-3704(1999).
RN   [6]
RP   INTERACTION WITH SUMO1; TP73 AND TP53.
RX   MEDLINE=20549653; PubMed=10961991; DOI=10.1074/jbc.M004293200;
RA   Minty A., Dumont X., Kaghad M., Caput D.;
RT   "Covalent modification of p73alpha by SUMO-1. Two-hybrid screening
RT   with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1
RT   interaction motif.";
RL   J. Biol. Chem. 275:36316-36323(2000).
RN   [7]
RP   INTERACTION WITH PARK7, AND SUBCELLULAR LOCATION.
RX   MEDLINE=21463059; PubMed=11477070; DOI=10.1074/jbc.M101730200;
RA   Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M.M.,
RA   Ariga H.;
RT   "DJ-1 positively regulates the androgen receptor by impairing the
RT   binding of PIASx alpha to the receptor.";
RL   J. Biol. Chem. 276:37556-37563(2001).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=21332840; PubMed=11439351; DOI=10.1038/sj.onc.1204489;
RA   Gross M., Liu B., Tan J.-A., French F.S., Carey M., Shuai K.;
RT   "Distinct effects of PIAS proteins on androgen-mediated gene
RT   activation in prostate cancer cells.";
RL   Oncogene 20:3880-3887(2001).
RN   [9]
RP   INTERACTION WITH AXIN1.
RX   PubMed=12223491; DOI=10.1074/jbc.M208099200;
RA   Rui H.L., Fan E., Zhou H.M., Xu Z., Zhang Y., Lin S.C.;
RT   "SUMO-1 modification of the C-terminal KVEKVD of Axin is required for
RT   JNK activation but has no effect on Wnt signaling.";
RL   J. Biol. Chem. 277:42981-42986(2002).
RN   [10]
RP   SUMOYLATION OF MDM2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-362.
RX   MEDLINE=22371046; PubMed=12393906; DOI=10.1074/jbc.M208319200;
RA   Miyauchi Y., Yogosawa S., Honda R., Nishida T., Yasuda H.;
RT   "Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and
RT   RanBP2 enzymes.";
RL   J. Biol. Chem. 277:50131-50136(2002).
RN   [11]
RP   INTERACTION WITH JUN; TP53 AND UBE2I, SUMOYLATION, AND MUTAGENESIS OF
RP   CYS-362.
RX   MEDLINE=21874110; PubMed=11867732; DOI=10.1073/pnas.052559499;
RA   Schmidt D., Mueller S.;
RT   "Members of the PIAS family act as SUMO ligases for c-Jun and p53 and
RT   repress p53 activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:2872-2877(2002).
RN   [12]
RP   INTERACTION WITH STAT4, AND SUBCELLULAR LOCATION.
RX   MEDLINE=22679218; PubMed=12716907; DOI=10.1074/jbc.C300119200;
RA   Arora T., Liu B., He H., Kim J., Murphy T.L., Murphy K.M.,
RA   Modlin R.L., Shuai K.;
RT   "PIASx is a transcriptional co-repressor of signal transducer and
RT   activator of transcription 4.";
RL   J. Biol. Chem. 278:21327-21330(2003).
RN   [13]
RP   INTERACTION WITH PLAG1.
RX   PubMed=15208321; DOI=10.1074/jbc.M401753200;
RA   Van Dyck F., Delvaux E.L.D., Van de Ven W.J.M., Chavez M.V.;
RT   "Repression of the transactivating capacity of the oncoprotein PLAG1
RT   by SUMOylation.";
RL   J. Biol. Chem. 279:36121-36131(2004).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH ELK1.
RX   PubMed=15920481; DOI=10.1038/sj.emboj.7600690;
RA   Yang S.-H., Sharrocks A.D.;
RT   "PIASx acts as an Elk-1 coactivator by facilitating derepression.";
RL   EMBO J. 24:2161-2171(2005).
RN   [15]
RP   FUNCTION IN PARK7 SUMOYLATION.
RX   PubMed=15976810; DOI=10.1038/sj.cdd.4401704;
RA   Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,
RA   Seino C., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Proper SUMO-1 conjugation is essential to DJ-1 to exert its full
RT   activities.";
RL   Cell Death Differ. 13:96-108(2006).
RN   [16]
RP   INTERACTION WITH KLF8.
RX   PubMed=16617055; DOI=10.1074/jbc.M513135200;
RA   Wei H., Wang X., Gan B., Urvalek A.M., Melkoumian Z.K., Guan J.-L.,
RA   Zhao J.;
RT   "Sumoylation delimits KLF8 transcriptional activity associated with
RT   the cell cycle regulation.";
RL   J. Biol. Chem. 281:16664-16671(2006).
RN   [17]
RP   INTERACTION WITH IFIH1/MDA5.
RX   PubMed=21156324; DOI=10.1016/j.molimm.2010.09.003;
RA   Fu J., Xiong Y., Xu Y., Cheng G., Tang H.;
RT   "MDA5 is SUMOylated by PIAS2? in the upregulation of type I interferon
RT   signaling.";
RL   Mol. Immunol. 48:415-422(2011).
RN   [18]
RP   STRUCTURE BY NMR OF 466-488 IN COMPLEX WITH SUMO1, AND MUTAGENESIS OF
RP   VAL-467; VAL-469; ILE-470; LEU-472 AND THR-473.
RX   PubMed=16204249; DOI=10.1074/jbc.M507059200;
RA   Song J., Zhang Z., Hu W., Chen Y.;
RT   "Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding
RT   motif: a reversal of the bound orientation.";
RL   J. Biol. Chem. 280:40122-40129(2005).
CC   -!- FUNCTION: Functions as an E3-type small ubiquitin-like modifier
CC       (SUMO) ligase, stabilizing the interaction between UBE2I and the
CC       substrate, and as a SUMO-tethering factor. Plays a crucial role as
CC       a transcriptional coregulator in various cellular pathways,
CC       including the STAT pathway, the p53 pathway and the steroid
CC       hormone signaling pathway. The effects of this transcriptional
CC       coregulation, transactivation or silencing may vary depending upon
CC       the biological context and the PIAS2 isoform studied. However, it
CC       seems to be mostly involved in gene silencing. Binds to sumoylated
CC       ELK1 and enhances its transcriptional activity by preventing
CC       recruitment of HDAC2 by ELK1, thus reversing SUMO-mediated
CC       repression of ELK1 transactivation activity. Isoform PIAS2-beta,
CC       but not isoform PIAS2-alpha, promotes MDM2 sumoylation. Isoform
CC       PIAS2-alpha promotes PARK7 sumoylation. Isoform PIAS2-beta
CC       promotes NCOA2 sumoylation more efficiently than isoform PIAS2-
CC       alpha.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Binds SUMO1 and UBE2I. Interacts with AXIN1, JUN, MDM2,
CC       PARK7, TP53 and TP73 isoform alpha, but not TP73 isoform beta.
CC       Interacts with STAT4 following IL12 and IFN-alpha stimulation of
CC       T-cells. Interacts also with GTF2I, GTF2IRD1, IKFZ1, DAB2 and
CC       MSX2, as well as with several steroid receptors, including ESR1,
CC       ESR2, NR3C1, PGR, AR, and with NCOA2 (By similarity). Sumoylation
CC       of a target protein seems to enhance the interaction. Binds to
CC       sumoylated ELK1. Binds DNA, such as CDKN1A promoter, in a
CC       sequence-specific manner. Interacts with PLAG1. Interacts with
CC       KLF8; the interaction results in SUMO ligation and repression of
CC       KLF8 transcriptional activity and of its cell cycle progression
CC       into G(1) phase. PIAS2-beta interacts with IFIH1/MDA5.
CC   -!- INTERACTION:
CC       P01106:MYC; NbExp=4; IntAct=EBI-348555, EBI-447544;
CC       Q96T51:RUFY1; NbExp=3; IntAct=EBI-348555, EBI-3941207;
CC       P63279:UBE2I; NbExp=5; IntAct=EBI-348555, EBI-80168;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle. Nucleus, PML body.
CC       Note=Colocalizes at least partially with promyelocytic leukemia
CC       nuclear bodies (PML NBs).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=PIAS2-beta; Synonyms=PIASx-beta, Miz1;
CC         IsoId=O75928-1; Sequence=Displayed;
CC       Name=PIAS2-alpha; Synonyms=PIASx-alpha, ARIP3;
CC         IsoId=O75928-2; Sequence=VSP_050008, VSP_050009;
CC       Name=3;
CC         IsoId=O75928-3; Sequence=VSP_012196, VSP_012197;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis. Isoform 3 is
CC       expressed predominantly in adult testis, weakly in pancreas,
CC       embryonic testis and sperm, and at very low levels in other
CC       organs.
CC   -!- DEVELOPMENTAL STAGE: Isoform 3 expression in adult testis is 14.2-
CC       fold stronger than in embryonic testis.
CC   -!- INDUCTION: Up-regulated transiently during myeloid differentiation
CC       in various cells lines, such as HL-60, U-937, K-562, induced by
CC       either phorbol ester (TPA) or retinoic acid.
CC   -!- DOMAIN: The LXXLL motif is a transcriptional coregulator
CC       signature.
CC   -!- PTM: Sumoylated.
CC   -!- SIMILARITY: Belongs to the PIAS family.
CC   -!- SIMILARITY: Contains 1 PINIT domain.
CC   -!- SIMILARITY: Contains 1 SAP domain.
CC   -!- SIMILARITY: Contains 1 SP-RING-type zinc finger.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077953; AAC36704.1; -; mRNA.
DR   EMBL; AF077954; AAC36705.1; -; mRNA.
DR   EMBL; AF361054; AAK48938.1; -; mRNA.
DR   EMBL; AC090241; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015190; AAH15190.1; -; mRNA.
DR   IPI; IPI00005836; -.
DR   IPI; IPI00244407; -.
DR   IPI; IPI00477352; -.
DR   RefSeq; NP_004662.2; NM_004671.3.
DR   RefSeq; NP_775298.1; NM_173206.3.
DR   UniGene; Hs.657844; -.
DR   PDB; 2ASQ; NMR; -; B=466-488.
DR   PDB; 4FO9; X-ray; 2.39 A; A=147-488.
DR   PDBsum; 2ASQ; -.
DR   PDBsum; 4FO9; -.
DR   ProteinModelPortal; O75928; -.
DR   SMR; O75928; 1-65, 147-426.
DR   IntAct; O75928; 15.
DR   MINT; MINT-1455373; -.
DR   STRING; O75928; -.
DR   PhosphoSite; O75928; -.
DR   PaxDb; O75928; -.
DR   PRIDE; O75928; -.
DR   DNASU; 9063; -.
DR   Ensembl; ENST00000324794; ENSP00000317163; ENSG00000078043.
DR   Ensembl; ENST00000398654; ENSP00000381648; ENSG00000078043.
DR   GeneID; 9063; -.
DR   KEGG; hsa:9063; -.
DR   UCSC; uc002lck.3; human.
DR   UCSC; uc002lcl.3; human.
DR   UCSC; uc002lcn.1; human.
DR   CTD; 9063; -.
DR   GeneCards; GC18M044392; -.
DR   HGNC; HGNC:17311; PIAS2.
DR   MIM; 603567; gene.
DR   neXtProt; NX_O75928; -.
DR   PharmGKB; PA134933292; -.
DR   eggNOG; NOG125513; -.
DR   HOGENOM; HOG000230594; -.
DR   HOVERGEN; HBG053598; -.
DR   InParanoid; O75928; -.
DR   KO; K16063; -.
DR   OrthoDB; EOG4RNB85; -.
DR   PhylomeDB; O75928; -.
DR   Pathway_Interaction_DB; il12_stat4pathway; IL12 signaling mediated by STAT4.
DR   Pathway_Interaction_DB; ranbp2pathway; Sumoylation by RanBP2 regulates transcriptional repression.
DR   UniPathway; UPA00886; -.
DR   EvolutionaryTrace; O75928; -.
DR   GenomeRNAi; 9063; -.
DR   NextBio; 33959; -.
DR   ArrayExpress; O75928; -.
DR   Bgee; O75928; -.
DR   CleanEx; HS_PIAS2; -.
DR   Genevestigator; O75928; -.
DR   GermOnline; ENSG00000078043; Homo sapiens.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO ligase activity; IDA:BHF-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-dependent; NAS:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.720.30; G3DSA:1.10.720.30; 1.
DR   InterPro; IPR023321; PINIT.
DR   InterPro; IPR003034; SAP_DNA-bd.
DR   InterPro; IPR004181; Znf_MIZ.
DR   Pfam; PF14324; PINIT; 1.
DR   Pfam; PF02891; zf-MIZ; 1.
DR   SMART; SM00513; SAP; 1.
DR   PROSITE; PS51466; PINIT; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS51044; ZF_SP_RING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Ligase; Metal-binding; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    621       E3 SUMO-protein ligase PIAS2.
FT                                /FTId=PRO_0000218976.
FT   DOMAIN       11     45       SAP.
FT   DOMAIN      134    299       PINIT.
FT   ZN_FING     331    408       SP-RING-type.
FT   REGION      467    473       SUMO1-binding.
FT   MOTIF        19     23       LXXLL motif.
FT   MOTIF       484    492       Nuclear localization signal (By
FT                                similarity).
FT   COMPBIAS    571    612       Ser-rich.
FT   COMPBIAS    596    602       Poly-Ser.
FT   VAR_SEQ       1      8       MADFEELR -> MNAGKQLQRTLH (in isoform 3).
FT                                /FTId=VSP_012196.
FT   VAR_SEQ     402    621       Missing (in isoform 3).
FT                                /FTId=VSP_012197.
FT   VAR_SEQ     551    572       LDFLSLIPVDPQYCPPMFLDSL -> EQRRNDINNELKLGT
FT                                SSDTVQQ (in isoform PIAS2-alpha).
FT                                /FTId=VSP_050008.
FT   VAR_SEQ     573    621       Missing (in isoform PIAS2-alpha).
FT                                /FTId=VSP_050009.
FT   VARIANT     207    207       V -> A (in dbSNP:rs16940108).
FT                                /FTId=VAR_056693.
FT   MUTAGEN     362    362       C->S,A: Loss of MDM2 and TP53 sumoylation
FT                                and of autosumoylation; no loss of JUN-
FT                                and TP53-binding.
FT   MUTAGEN     467    467       V->A: Reduces affinity for SUMO1.
FT   MUTAGEN     469    469       V->A: Abolishes binding to SUMO1.
FT   MUTAGEN     470    470       I->A: Abolishes binding to SUMO1.
FT   MUTAGEN     472    472       L->A: Abolishes binding to SUMO1.
FT   MUTAGEN     473    473       T->A: Reduces affinity for SUMO1.
FT   CONFLICT    144    144       P -> L (in Ref. 2; AAK48938).
FT   CONFLICT    616    616       D -> E (in Ref. 1; AAC36705).
FT   STRAND      154    165
FT   STRAND      173    181
FT   HELIX       185    192
FT   STRAND      195    197
FT   STRAND      203    215
FT   STRAND      231    234
FT   STRAND      237    239
FT   HELIX       264    266
FT   STRAND      271    273
FT   STRAND      275    282
FT   STRAND      289    298
FT   HELIX       301    309
FT   HELIX       316    327
FT   STRAND      340    345
FT   TURN        347    349
FT   STRAND      354    359
FT   HELIX       370    379
FT   TURN        386    388
FT   HELIX       394    396
FT   STRAND      397    400
FT   HELIX       401    407
FT   STRAND      415    418
FT   STRAND      469    471
SQ   SEQUENCE   621 AA;  68240 MW;  6422B383345AD883 CRC64;
     MADFEELRNM VSSFRVSELQ VLLGFAGRNK SGRKHDLLMR ALHLLKSGCS PAVQIKIREL
     YRRRYPRTLE GLSDLSTIKS SVFSLDGGSS PVEPDLAVAG IHSLPSTSVT PHSPSSPVGS
     VLLQDTKPTF EMQQPSPPIP PVHPDVQLKN LPFYDVLDVL IKPTSLVQSS IQRFQEKFFI
     FALTPQQVRE ICISRDFLPG GRRDYTVQVQ LRLCLAETSC PQEDNYPNSL CIKVNGKLFP
     LPGYAPPPKN GIEQKRPGRP LNITSLVRLS SAVPNQISIS WASEIGKNYS MSVYLVRQLT
     SAMLLQRLKM KGIRNPDHSR ALIKEKLTAD PDSEIATTSL RVSLMCPLGK MRLTIPCRAV
     TCTHLQCFDA ALYLQMNEKK PTWICPVCDK KAAYESLILD GLFMEILNDC SDVDEIKFQE
     DGSWCPMRPK KEAMKVSSQP CTKIESSSVL SKPCSVTVAS EASKKKVDVI DLTIESSSDE
     EEDPPAKRKC IFMSETQSSP TKGVLMYQPS SVRVPSVTSV DPAAIPPSLT DYSVPFHHTP
     ISSMSSDLPG LDFLSLIPVD PQYCPPMFLD SLTSPLTASS TSVTTTSSHE SSTHVSSSSS
     RSETGVITSS GSNIPDIISL D
//
ID   PIAS4_HUMAN             Reviewed;         510 AA.
AC   Q8N2W9; O75926; Q96G19; Q9UN16;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   06-FEB-2013, entry version 109.
DE   RecName: Full=E3 SUMO-protein ligase PIAS4;
DE            EC=6.3.2.-;
DE   AltName: Full=PIASy;
DE   AltName: Full=Protein inhibitor of activated STAT protein 4;
DE   AltName: Full=Protein inhibitor of activated STAT protein gamma;
DE            Short=PIAS-gamma;
GN   Name=PIAS4; Synonyms=PIASG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=B-cell;
RX   MEDLINE=98393695; PubMed=9724754; DOI=10.1073/pnas.95.18.10626;
RA   Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D.,
RA   Shuai K.;
RT   "Inhibition of Stat1-mediated gene activation by PIAS1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10626-10631(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-510, AND INTERACTION WITH TP53.
RX   MEDLINE=21281852; PubMed=11388671; DOI=10.1023/A:1011392811628;
RA   Nelson V., Davis G.E., Maxwell S.A.;
RT   "A putative protein inhibitor of activated STAT (PIASy) interacts with
RT   p53 and inhibits p53-mediated transactivation but not apoptosis.";
RL   Apoptosis 6:221-234(2001).
RN   [4]
RP   INTERACTION WITH STAT1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   23-LEU-LEU-24.
RX   MEDLINE=21145822; PubMed=11248056; DOI=10.1073/pnas.051489598;
RA   Liu B., Gross M., ten Hoeve J., Shuai K.;
RT   "A transcriptional corepressor of Stat1 with an essential LXXLL
RT   signature motif.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3203-3207(2001).
RN   [5]
RP   INTERACTION WITH AR, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   23-LEU-LEU-24.
RX   MEDLINE=21332840; PubMed=11439351; DOI=10.1038/sj.onc.1204489;
RA   Gross M., Liu B., Tan J.-A., French F.S., Carey M., Shuai K.;
RT   "Distinct effects of PIAS proteins on androgen-mediated gene
RT   activation in prostate cancer cells.";
RL   Oncogene 20:3880-3887(2001).
RN   [6]
RP   INTERACTION WITH AXIN1.
RX   PubMed=12223491; DOI=10.1074/jbc.M208099200;
RA   Rui H.L., Fan E., Zhou H.M., Xu Z., Zhang Y., Lin S.C.;
RT   "SUMO-1 modification of the C-terminal KVEKVD of Axin is required for
RT   JNK activation but has no effect on Wnt signaling.";
RL   J. Biol. Chem. 277:42981-42986(2002).
RN   [7]
RP   INTERACTION WITH GATA2.
RX   PubMed=12750312; DOI=10.1161/01.RES.0000076893.70898.36;
RA   Chun T.-H., Itoh H., Subramanian L., Iniguez-Lluhi J.A., Nakao K.;
RT   "Modification of GATA-2 transcriptional activity in endothelial cells
RT   by the SUMO E3 ligase PIASy.";
RL   Circ. Res. 92:1201-1208(2003).
RN   [8]
RP   FUNCTION IN TCF4 SUMOYLATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LYS-35 AND LYS-128.
RX   PubMed=12727872; DOI=10.1093/emboj/cdg204;
RA   Yamamoto H., Ihara M., Matsuura Y., Kikuchi A.;
RT   "Sumoylation is involved in beta-catenin-dependent activation of Tcf-
RT   4.";
RL   EMBO J. 22:2047-2059(2003).
RN   [9]
RP   FUNCTION IN MYB SUMOYLATION.
RX   PubMed=12631292; DOI=10.1046/j.1432-1033.2003.03504.x;
RA   Dahle O., Andersen T.O., Nordgaard O., Matre V., Del Sal G.,
RA   Gabrielsen O.S.;
RT   "Transactivation properties of c-Myb are critically dependent on two
RT   SUMO-1 acceptor sites that are conjugated in a PIASy enhanced
RT   manner.";
RL   Eur. J. Biochem. 270:1338-1348(2003).
RN   [10]
RP   FUNCTION IN CEBPA SUMOYLATION.
RX   PubMed=12511558; DOI=10.1074/jbc.M210440200;
RA   Subramanian L., Benson M.D., Iniguez-Lluhi J.A.;
RT   "A synergy control motif within the attenuator domain of
RT   CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy
RT   through its PIASy-enhanced modification by SUMO-1 or SUMO-3.";
RL   J. Biol. Chem. 278:9134-9141(2003).
RN   [11]
RP   INTERACTION WITH TICAM1.
RX   PubMed=15251447; DOI=10.1016/j.febslet.2004.05.081;
RA   Zhang J., Xu L.G., Han K.J., Wei X., Shu H.B.;
RT   "PIASy represses TRIF-induced ISRE and NF-kappaB activation but not
RT   apoptosis.";
RL   FEBS Lett. 570:97-101(2004).
RN   [12]
RP   SUMOYLATION AT LYS-35 AND LYS-128, FUNCTION IN TCF4 SUMOYLATION,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-35 AND LYS-128.
RX   PubMed=15831457; DOI=10.1128/MCB.25.9.3506-3518.2005;
RA   Ihara M., Yamamoto H., Kikuchi A.;
RT   "SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-
RT   dependent activation of Tcf-4.";
RL   Mol. Cell. Biol. 25:3506-3518(2005).
RN   [13]
RP   FUNCTION IN PARK7 SUMOYLATION.
RX   PubMed=15976810; DOI=10.1038/sj.cdd.4401704;
RA   Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C.,
RA   Seino C., Iguchi-Ariga S.M.M., Ariga H.;
RT   "Proper SUMO-1 conjugation is essential to DJ-1 to exert its full
RT   activities.";
RL   Cell Death Differ. 13:96-108(2006).
RN   [14]
RP   INTERACTION WITH KLF8.
RX   PubMed=16617055; DOI=10.1074/jbc.M513135200;
RA   Wei H., Wang X., Gan B., Urvalek A.M., Melkoumian Z.K., Guan J.-L.,
RA   Zhao J.;
RT   "Sumoylation delimits KLF8 transcriptional activity associated with
RT   the cell cycle regulation.";
RL   J. Biol. Chem. 281:16664-16671(2006).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-114 AND LYS-125, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   FUNCTION IN SUMOYLATION OF HERC2 AND RNF168.
RX   PubMed=22508508; DOI=10.1083/jcb.201106152;
RA   Danielsen J.R., Povlsen L.K., Villumsen B.H., Streicher W.,
RA   Nilsson J., Wikstrom M., Bekker-Jensen S., Mailand N.;
RT   "DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a
RT   novel SUMO-binding Zinc finger.";
RL   J. Cell Biol. 197:179-187(2012).
CC   -!- FUNCTION: Functions as an E3-type small ubiquitin-like modifier
CC       (SUMO) ligase, stabilizing the interaction between UBE2I and the
CC       substrate, and as a SUMO-tethering factor. Plays a crucial role as
CC       a transcriptional coregulation in various cellular pathways,
CC       including the STAT pathway, the p53/TP53 pathway, the Wnt pathway
CC       and the steroid hormone signaling pathway. Involved in gene
CC       silencing. Mediates sumoylation of CEBPA, PARK7, HERC2, MYB, TCF4
CC       and RNF168. In Wnt signaling, represses LEF1 and enhances TCF4
CC       transcriptional activities through promoting their sumoylations.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Interacts with AR, AXIN1, GATA2, LEF1, TP53 and STAT1
CC       (IFNG-induced). Binds to AT-rich DNA sequences, known as matrix or
CC       scaffold attachment regions (MARs/SARs) (By similarity). Interacts
CC       with TICAM1. Interacts with KLF8; the interaction results in SUMO
CC       ligation and repression of KLF8 transcriptional activity and of
CC       its cell cycle progression into G(1) phase.
CC   -!- INTERACTION:
CC       Q16665:HIF1A; NbExp=3; IntAct=EBI-473160, EBI-447269;
CC       P42858:HTT; NbExp=3; IntAct=EBI-473160, EBI-466029;
CC       P61956:SUMO2; NbExp=3; IntAct=EBI-473160, EBI-473220;
CC       O75528:TADA3; NbExp=2; IntAct=EBI-473160, EBI-473249;
CC       P04637:TP53; NbExp=2; IntAct=EBI-473160, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus, PML body. Note=Colocalizes with
CC       SUMO1 and TCF7L2/TCF4 and LEF1 in a subset of PML (promyelocytic
CC       leukemia) nuclear bodies.
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and, at lower
CC       levels, in spleen, prostate, ovary, colon and peripheral blood
CC       leukocytes.
CC   -!- DOMAIN: The LXXLL motif is a coregulator signature that is
CC       essential for transcriptional corepression.
CC   -!- PTM: Sumoylated. Lys-35 is the main site of sumoylation.
CC       Sumoylation is required for TCF4 sumoylation and transcriptional
CC       activitation. Represses LEF1 transcriptional activity. SUMO1 is
CC       the preferred conjugate.
CC   -!- SIMILARITY: Belongs to the PIAS family.
CC   -!- SIMILARITY: Contains 1 PINIT domain.
CC   -!- SIMILARITY: Contains 1 SAP domain.
CC   -!- SIMILARITY: Contains 1 SP-RING-type zinc finger.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD45155.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077952; AAC36703.1; -; mRNA.
DR   EMBL; BC010047; AAH10047.2; -; mRNA.
DR   EMBL; BC029874; AAH29874.1; -; mRNA.
DR   EMBL; BC066895; AAH66895.1; -; mRNA.
DR   EMBL; AF164437; AAD45155.1; ALT_INIT; mRNA.
DR   IPI; IPI00166500; -.
DR   RefSeq; NP_056981.2; NM_015897.2.
DR   UniGene; Hs.105779; -.
DR   ProteinModelPortal; Q8N2W9; -.
DR   SMR; Q8N2W9; 3-66, 131-406.
DR   IntAct; Q8N2W9; 45.
DR   MINT; MINT-1181821; -.
DR   STRING; Q8N2W9; -.
DR   PhosphoSite; Q8N2W9; -.
DR   DMDM; 34922831; -.
DR   PRIDE; Q8N2W9; -.
DR   DNASU; 51588; -.
DR   Ensembl; ENST00000262971; ENSP00000262971; ENSG00000105229.
DR   GeneID; 51588; -.
DR   KEGG; hsa:51588; -.
DR   UCSC; uc002lzg.3; human.
DR   CTD; 51588; -.
DR   GeneCards; GC19P004007; -.
DR   HGNC; HGNC:17002; PIAS4.
DR   HPA; HPA010598; -.
DR   MIM; 605989; gene.
DR   neXtProt; NX_Q8N2W9; -.
DR   PharmGKB; PA134945903; -.
DR   eggNOG; NOG125513; -.
DR   HOGENOM; HOG000230594; -.
DR   HOVERGEN; HBG053598; -.
DR   InParanoid; Q8N2W9; -.
DR   KO; K16065; -.
DR   OMA; LVPQNNE; -.
DR   OrthoDB; EOG4THVT3; -.
DR   PhylomeDB; Q8N2W9; -.
DR   Pathway_Interaction_DB; ar_pathway; Coregulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; ifngpathway; IFN-gamma pathway.
DR   Pathway_Interaction_DB; smad2_3pathway; Regulation of cytoplasmic and nuclear SMAD2/3 signaling.
DR   Pathway_Interaction_DB; smad2_3nuclearpathway; Regulation of nuclear SMAD2/3 signaling.
DR   UniPathway; UPA00886; -.
DR   GenomeRNAi; 51588; -.
DR   NextBio; 55429; -.
DR   ArrayExpress; Q8N2W9; -.
DR   Bgee; Q8N2W9; -.
DR   CleanEx; HS_PIAS4; -.
DR   Genevestigator; Q8N2W9; -.
DR   GermOnline; ENSG00000105229; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IEA:Compara.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO ligase activity; IMP:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Compara.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Compara.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Compara.
DR   GO; GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.720.30; G3DSA:1.10.720.30; 1.
DR   Gene3D; 3.30.40.10; Znf_RING/FYVE/PHD; 1.
DR   InterPro; IPR023321; PINIT.
DR   InterPro; IPR003034; SAP_DNA-bd.
DR   InterPro; IPR004181; Znf_MIZ.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF14324; PINIT; 1.
DR   Pfam; PF02891; zf-MIZ; 1.
DR   SMART; SM00513; SAP; 1.
DR   PROSITE; PS51466; PINIT; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS51044; ZF_SP_RING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; DNA-binding; Isopeptide bond; Ligase;
KW   Metal-binding; Nucleus; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Ubl conjugation pathway;
KW   Wnt signaling pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    510       E3 SUMO-protein ligase PIAS4.
FT                                /FTId=PRO_0000218982.
FT   DOMAIN       12     46       SAP.
FT   DOMAIN      119    279       PINIT.
FT   ZN_FING     311    388       SP-RING-type.
FT   MOTIF        20     24       LXXLL motif.
FT   COMPBIAS    464    492       Asp/Glu-rich (acidic).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     114    114       N6-acetyllysine.
FT   MOD_RES     125    125       N6-acetyllysine.
FT   CROSSLNK     35     35       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK    128    128       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   MUTAGEN      23     24       LL->AA: Loss of repression of AR- and
FT                                STAT1-induced transcription; no effect on
FT                                AR- and STAT1-binding.
FT   MUTAGEN      35     35       K->R: Complete loss of sumoylation. No
FT                                enhancement of TCF4 sumoylation. No
FT                                effect on interaction with TCF4.
FT                                Colocalizes with SUMO1 in nucleus but
FT                                concentrated into nuclear granules.
FT   MUTAGEN     128    128       K->R: Some loss of sumoylation.
FT   MUTAGEN     342    342       C->A: Inhibits TCF4 sumoylation. Inhibits
FT                                beta-catenin-mediated TCF7L2/TCF4
FT                                activity. No colocalization with
FT                                TCF7L2/TCF4 in nuclear punctate
FT                                structures; when associated with A-347.
FT   MUTAGEN     347    347       C->A: Inhibits TCF4 sumoylation. Inhibits
FT                                beta-catenin-mediated TCF7L2/TCF4
FT                                activity. No colocalization with
FT                                TCF7L2/TCF4 in nuclear punctate
FT                                structures; when associated with A-342.
FT                                AR- and STAT1-binding.
FT   CONFLICT    178    178       N -> K (in Ref. 1).
FT   CONFLICT    179    182       SREL -> FQGM (in Ref. 1 and 3).
FT   CONFLICT    482    482       E -> G (in Ref. 2; AAH66895).
SQ   SEQUENCE   510 AA;  56504 MW;  26AAA18246E1ACE3 CRC64;
     MAAELVEAKN MVMSFRVSDL QMLLGFVGRS KSGLKHELVT RALQLVQFDC SPELFKKIKE
     LYETRYAKKN SEPAPQPHRP LDPLTMHSTY DRAGAVPRTP LAGPNIDYPV LYGKYLNGLG
     RLPAKTLKPE VRLVKLPFFN MLDELLKPTE LVPQNNEKLQ ESPCIFALTP RQVELIRNSR
     ELQPGVKAVQ VVLRICYSDT SCPQEDQYPP NIAVKVNHSY CSVPGYYPSN KPGVEPKRPC
     RPINLTHLMY LSSATNRITV TWGNYGKSYS VALYLVRQLT SSELLQRLKT IGVKHPELCK
     ALVKEKLRLD PDSEIATTGV RVSLICPLVK MRLSVPCRAE TCAHLQCFDA VFYLQMNEKK
     PTWMCPVCDK PAPYDQLIID GLLSKILSEC EDADEIEYLV DGSWCPIRAE KERSCSPQGA
     ILVLGPSDAN GLLPAPSVNG SGALGSTGGG GPVGSMENGK PGADVVDLTL DSSSSSEDEE
     EEEEEEEDED EEGPRPKRRC PFQKGLVPAC
//
ID   PINK1_HUMAN             Reviewed;         581 AA.
AC   Q9BXM7; Q8N6T9; Q8NBU3; Q96DE4;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   09-JAN-2013, entry version 113.
DE   RecName: Full=Serine/threonine-protein kinase PINK1, mitochondrial;
DE            EC=2.7.11.1;
DE   AltName: Full=BRPK;
DE   AltName: Full=PTEN-induced putative kinase protein 1;
DE   Flags: Precursor;
GN   Name=PINK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Endometrium;
RX   MEDLINE=21385714; PubMed=11494141; DOI=10.1038/sj.onc.1204608;
RA   Unoki M., Nakamura Y.;
RT   "Growth-suppressive effects of BPOZ and EGR2, two genes involved in
RT   the PTEN signaling pathway.";
RL   Oncogene 20:4457-4465(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND
RP   AUTOPHOSPHORYLATION.
RC   TISSUE=Placenta;
RX   PubMed=14607334; DOI=10.1016/S0304-3835(03)00443-9;
RA   Nakajima A., Kataoka K., Hong M., Sakaguchi M., Huh N.-H.;
RT   "BRPK, a novel protein kinase showing increased expression in mouse
RT   cancer cell lines with higher metastatic potential.";
RL   Cancer Lett. 201:195-201(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   THR-340 AND THR-521.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Leukocyte, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY.
RX   PubMed=18687899; DOI=10.1073/pnas.0802814105;
RA   Zhou C., Huang Y., Shao Y., May J., Prou D., Perier C., Dauer W.,
RA   Schon E.A., Przedborski S.;
RT   "The kinase domain of mitochondrial PINK1 faces the cytoplasm.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12022-12027(2008).
RN   [7]
RP   FUNCTION IN MITOCHONDRIAL AUTOPHAGY, SUBCELLULAR LOCATION, INTERACTION
RP   WITH PARK2, AND CHARACTERIZATION OF VARIANTS PARK6 PRO-126; ASP-309
RP   AND PRO-347.
RX   PubMed=20798600; DOI=10.4161/auto.6.7.13286;
RA   Geisler S., Holmstrom K.M., Treis A., Skujat D., Weber S.S.,
RA   Fiesel F.C., Kahle P.J., Springer W.;
RT   "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated
RT   mutations.";
RL   Autophagy 6:871-878(2010).
RN   [8]
RP   FUNCTION IN MITOCHONDRIAL AUTOPHAGY.
RX   PubMed=20404107; DOI=10.1083/jcb.200910140;
RA   Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A.,
RA   Sou Y.S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M.,
RA   Hattori N., Tanaka K.;
RT   "PINK1 stabilized by mitochondrial depolarization recruits Parkin to
RT   damaged mitochondria and activates latent Parkin for mitophagy.";
RL   J. Cell Biol. 189:211-221(2010).
RN   [9]
RP   FUNCTION IN MITOCHONDRIAL AUTOPHAGY, AND INTERACTION WITH PARK2.
RX   PubMed=19966284; DOI=10.1073/pnas.0911187107;
RA   Vives-Bauza C., Zhou C., Huang Y., Cui M., de Vries R.L., Kim J.,
RA   May J., Tocilescu M.A., Liu W., Ko H.S., Magrane J., Moore D.J.,
RA   Dawson V.L., Grailhe R., Dawson T.M., Li C., Tieu K., Przedborski S.;
RT   "PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:378-383(2010).
RN   [10]
RP   PHOSPHORYLATION AT SER-228 AND SER-402.
RX   PubMed=22910362; DOI=10.1038/ncomms2016;
RA   Okatsu K., Oka T., Iguchi M., Imamura K., Kosako H., Tani N.,
RA   Kimura M., Go E., Koyano F., Funayama M., Shiba-Fukushima K., Sato S.,
RA   Shimizu H., Fukunaga Y., Taniguchi H., Komatsu M., Hattori N.,
RA   Mihara K., Tanaka K., Matsuda N.;
RT   "PINK1 autophosphorylation upon membrane potential dissipation is
RT   essential for Parkin recruitment to damaged mitochondria.";
RL   Nat. Commun. 3:1016-1016(2012).
RN   [11]
RP   VARIANTS PARK6 PHE-92; PRO-168 AND HIS-464, AND VARIANTS LEU-296;
RP   THR-340; THR-442; LYS-476; THR-521 AND ASN-525.
RX   PubMed=15349860; DOI=10.1002/ana.20256;
RA   Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V.,
RA   Romito L., Albanese A., Dallapiccola B., Bentivoglio A.R.;
RT   "PINK1 mutations are associated with sporadic early-onset
RT   parkinsonism.";
RL   Ann. Neurol. 56:336-341(2004).
RN   [12]
RP   VARIANTS PARK6 GLN-271; PRO-347 AND GLY-417.
RX   PubMed=15349870; DOI=10.1002/ana.20251;
RA   Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H.,
RA   Yoshino H., Asahina M., Kobayashi S., Hassin-Baer S., Lu C.-S.,
RA   Ng A.R., Rosales R.L., Shimizu N., Toda T., Mizuno Y., Hattori N.;
RT   "Novel PINK1 mutations in early-onset parkinsonism.";
RL   Ann. Neurol. 56:424-427(2004).
RN   [13]
RP   ERRATUM.
RA   Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H.,
RA   Yoshino H., Asahina M., Kobayashi S., Hassin-Baer S., Lu C.-S.,
RA   Ng A.R., Rosales R.L., Shimizu N., Toda T., Mizuno Y., Hattori N.;
RL   Ann. Neurol. 56:603-603(2004).
RN   [14]
RP   VARIANTS PARK6 LYS-240; PRO-347 AND PRO-489, AND VARIANTS GLY-231;
RP   ILE-235; GLY-263; LEU-318; THR-339; THR-340; HIS-362; SER-425; LYS-476
RP   AND THR-521.
RX   PubMed=15596610; DOI=10.1001/archneur.61.12.1898;
RA   Rogaeva E., Johnson J., Lang A.E., Gulick C., Gwinn-Hardy K.,
RA   Kawarai T., Sato C., Morgan A., Werner J., Nussbaum R., Petit A.,
RA   Okun M.S., McInerney A., Mandel R., Groen J.L., Fernandez H.H.,
RA   Postuma R., Foote K.D., Salehi-Rad S., Liang Y., Reimsnider S.,
RA   Tandon A., Hardy J., St George-Hyslop P., Singleton A.B.;
RT   "Analysis of the PINK1 gene in a large cohort of cases with Parkinson
RT   disease.";
RL   Arch. Neurol. 61:1898-1904(2004).
RN   [15]
RP   VARIANT PARK6 HIS-147.
RX   PubMed=15505171;
RA   Healy D.G., Abou-Sleiman P.M., Gibson J.M., Ross O.A., Jain S.,
RA   Gandhi S., Gosal D., Muqit M.M.K., Wood N.W., Lynch T.;
RT   "PINK1 (PARK6) associated Parkinson disease in Ireland.";
RL   Neurology 63:1486-1488(2004).
RN   [16]
RP   VARIANT PARK6 ASP-309, CHARACTERIZATION OF VARIANT PARK6 ASP-309,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15087508; DOI=10.1126/science.1096284;
RA   Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M.K., Harvey K.,
RA   Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G.,
RA   Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S.,
RA   Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B.,
RA   Auburger G., Wood N.W.;
RT   "Hereditary early-onset Parkinson's disease caused by mutations in
RT   PINK1.";
RL   Science 304:1158-1160(2004).
RN   [17]
RP   VARIANT PARK6 VAL-268.
RX   PubMed=16207217; DOI=10.1111/j.1399-0004.2005.00500.x;
RA   Tan E.K., Yew K., Chua E., Shen H., Jamora R.D., Lee E., Puong K.Y.,
RA   Zhao Y., Pavanni R., Wong M.C., Puvan K., Yih Y., Tan L.C.S.;
RT   "Analysis of PINK1 in Asian patients with familial parkinsonism.";
RL   Clin. Genet. 68:468-470(2005).
RN   [18]
RP   VARIANTS PARK6 HIS-279 AND GLN-534 INS, AND VARIANT LEU-115.
RX   PubMed=15970950; DOI=10.1038/sj.ejhg.5201455;
RA   Klein C., Djarmati A., Hedrich K., Schaefer N., Scaglione C.,
RA   Marchese R., Kock N., Schuele B., Hiller A., Lohnau T., Winkler S.,
RA   Wiegers K., Hering R., Bauer P., Riess O., Abbruzzese G.,
RA   Martinelli P., Pramstaller P.P.;
RT   "PINK1, Parkin, and DJ-1 mutations in Italian patients with early-
RT   onset parkinsonism.";
RL   Eur. J. Hum. Genet. 13:1086-1093(2005).
RN   [19]
RP   CHARACTERIZATION OF VARIANTS PARK6 PRO-168 AND ASP-309.
RX   PubMed=16207731; DOI=10.1093/hmg/ddi377;
RA   Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B.,
RA   Valente E.M., Casari G.;
RT   "Mitochondrial import and enzymatic activity of PINK1 mutants
RT   associated to recessive parkinsonism.";
RL   Hum. Mol. Genet. 14:3477-3492(2005).
RN   [20]
RP   VARIANT PARK6 ARG-388.
RX   PubMed=15955953; DOI=10.1212/01.WNL.0000164009.36740.4E;
RA   Li Y., Tomiyama H., Sato K., Hatano Y., Yoshino H., Atsumi M.,
RA   Kitaguchi M., Sasaki S., Kawaguchi S., Miyajima H., Toda T.,
RA   Mizuno Y., Hattori N.;
RT   "Clinicogenetic study of PINK1 mutations in autosomal recessive early-
RT   onset parkinsonism.";
RL   Neurology 64:1955-1957(2005).
RN   [21]
RP   VARIANTS PARK6 PRO-168 AND LEU-196, AND VARIANTS LEU-115; THR-340;
RP   LYS-476 AND THR-521.
RX   PubMed=16009891; DOI=10.1212/01.wnl.0000167546.39375.82;
RG   The Italian Parkinson genetics network;
RA   Bonifati V., Rohe C.F., Breedveld G.J., Fabrizio E., De Mari M.,
RA   Tassorelli C., Tavella A., Marconi R., Nicholl D.J., Chien H.F.,
RA   Fincati E., Abbruzzese G., Marini P., De Gaetano A., Horstink M.W.,
RA   Maat-Kievit J.A., Sampaio C., Antonini A., Stocchi F., Montagna P.,
RA   Toni V., Guidi M., Dalla Libera A., Tinazzi M., De Pandis F.,
RA   Fabbrini G., Goldwurm S., de Klein A., Barbosa E., Lopiano L.,
RA   Martignoni E., Lamberti P., Vanacore N., Meco G., Oostra B.A.;
RT   "Early-onset parkinsonism associated with PINK1 mutations: frequency,
RT   genotypes, and phenotypes.";
RL   Neurology 65:87-95(2005).
RN   [22]
RP   VARIANTS ILE-317; THR-339; THR-383; SER-411; HIS-431; SER-451;
RP   SER-461; LYS-476; PRO-501 AND ARG-575, AND CHARACTERIZATION OF
RP   VARIANTS HIS-431; SER-451; LYS-476; PRO-501 AND ARG-575.
RX   PubMed=16969854; DOI=10.1002/ana.20960;
RA   Abou-Sleiman P.M., Muqit M.M.K., McDonald N.Q., Yang Y.X., Gandhi S.,
RA   Healy D.G., Harvey K., Harvey R.J., Deas E., Bhatia K., Quinn N.,
RA   Lees A., Latchman D.S., Wood N.W.;
RT   "A heterozygous effect for PINK1 mutations in Parkinson's disease?";
RL   Ann. Neurol. 60:414-419(2006).
RN   [23]
RP   VARIANT PARK6 ASP-217.
RX   PubMed=16966503; DOI=10.1001/archneur.63.9.1257;
RA   Leutenegger A.-L., Salih M.A.M., Ibanez P., Mukhtar M.M., Lesage S.,
RA   Arabi A., Lohmann E., Duerr A., Ahmed A.E.M., Brice A.;
RT   "Juvenile-onset Parkinsonism as a result of the first mutation in the
RT   adenosine triphosphate orientation domain of PINK1.";
RL   Arch. Neurol. 63:1257-1261(2006).
RN   [24]
RP   VARIANT PARK6 MET-313.
RX   PubMed=17030667; DOI=10.1001/archneur.63.10.1483;
RA   Chishti M.A., Bohlega S., Ahmed M., Loualich A., Carroll P., Sato C.,
RA   St George-Hyslop P., Westaway D., Rogaeva E.;
RT   "T313M PINK1 mutation in an extended highly consanguineous Saudi
RT   family with early-onset Parkinson disease.";
RL   Arch. Neurol. 63:1483-1485(2006).
RN   [25]
RP   VARIANTS PARK6 GLY-125; LYS-240; PRO-369; ALA-386 AND VAL-409.
RX   PubMed=16401616; DOI=10.1093/brain/awl005;
RG   The French Parkinson's disease genetics study group;
RA   Ibanez P., Lesage S., Lohmann E., Thobois S., De Michele G., Borg M.,
RA   Agid Y., Durr A., Brice A.;
RT   "Mutational analysis of the PINK1 gene in early-onset parkinsonism in
RT   Europe and North Africa.";
RL   Brain 129:686-694(2006).
RN   [26]
RP   VARIANT PARK6 LEU-399.
RX   PubMed=16632486; DOI=10.1093/hmg/ddl104;
RA   Tang B., Xiong H., Sun P., Zhang Y., Wang D., Hu Z., Zhu Z., Ma H.,
RA   Pan Q., Xia J.-H., Xia K., Zhang Z.;
RT   "Association of PINK1 and DJ-1 confers digenic inheritance of early-
RT   onset Parkinson's disease.";
RL   Hum. Mol. Genet. 15:1816-1825(2006).
RN   [27]
RP   VARIANT PARK6 THR-280, AND VARIANTS THR-340 AND THR-521.
RX   PubMed=16482571; DOI=10.1002/mds.20810;
RA   Tan E.-K., Yew K., Chua E., Puvan K., Shen H., Lee E., Puong K.-Y.,
RA   Zhao Y., Pavanni R., Wong M.-C., Jamora D., de Silva D., Moe K.-T.,
RA   Woon F.-P., Yuen Y., Tan L.;
RT   "PINK1 mutations in sporadic early-onset Parkinson's disease.";
RL   Mov. Disord. 21:789-793(2006).
RN   [28]
RP   VARIANT PARK6 GLN-407, AND VARIANTS THR-340 AND THR-521.
RX   PubMed=16257123; DOI=10.1016/j.neulet.2005.10.005;
RA   Fung H.-C., Chen C.-M., Hardy J., Singleton A.B., Lee-Chen G.-J.,
RA   Wu Y.-R.;
RT   "Analysis of the PINK1 gene in a cohort of patients with sporadic
RT   early-onset parkinsonism in Taiwan.";
RL   Neurosci. Lett. 394:33-36(2006).
RN   [29]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-148; SER-196; LEU-209; LEU-215;
RP   THR-339; THR-340; ILE-341; PHE-377; THR-477 AND THR-521.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [30]
RP   VARIANTS PHE-67; PRO-68; TRP-98; SER-111; VAL-124; MET-145; ASN-186;
RP   ILE-257 VAL-268; GLN-276; LEU-296; ILE-317; LEU-322; THR-339; THR-383;
RP   VAL-395; THR-442; LYS-476; ASN-525 AND THR-537.
RX   PubMed=18330912; DOI=10.1002/humu.20719;
RG   The Italian PD study group;
RA   Marongiu R., Ferraris A., Ialongo T., Michiorri S., Soleti F.,
RA   Ferrari F., Elia A.E., Ghezzi D., Albanese A., Altavista M.C.,
RA   Antonini A., Barone P., Brusa L., Cortelli P., Martinelli P.,
RA   Pellecchia M.T., Pezzoli G., Scaglione C., Stanzione P., Tinazzi M.,
RA   Zecchinelli A., Zeviani M., Cassetta E., Garavaglia B.,
RA   Dallapiccola B., Bentivoglio A.R., Valente E.M.;
RT   "PINK1 heterozygous rare variants: prevalence, significance and
RT   phenotypic spectrum.";
RL   Hum. Mutat. 29:565-565(2008).
RN   [31]
RP   VARIANT PARK6 PRO-126.
RX   PubMed=18286320; DOI=10.1007/s00415-008-0763-4;
RA   Prestel J., Gempel K., Hauser T.K., Schweitzer K., Prokisch H.,
RA   Ahting U., Freudenstein D., Bueltmann E., Naegele T., Berg D.,
RA   Klopstock T., Gasser T.;
RT   "Clinical and molecular characterisation of a Parkinson family with a
RT   novel PINK1 mutation.";
RL   J. Neurol. 255:643-648(2008).
CC   -!- FUNCTION: Protects against mitochondrial dysfunction during
CC       cellular stress, potentially by phosphorylating mitochondrial
CC       proteins. Involved in the clearance of damaged mitochondria via
CC       selective autophagy (mitophagy). It is necessary for PARK2
CC       recruitment to dysfunctional mitochondria to initiate their
CC       degradation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Interacts with PARK2.
CC   -!- INTERACTION:
CC       Q8IXI2:RHOT1; NbExp=3; IntAct=EBI-2846068, EBI-1396430;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass
CC       membrane protein. Cytoplasm, cytosol.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BXM7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXM7-2; Sequence=VSP_050754, VSP_050755;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle and
CC       testis, and at lower levels in brain, placenta, liver, kidney,
CC       pancreas, prostate, ovary and small intestine. Present in the
CC       embryonic testis from an early stage of development.
CC   -!- PTM: Autophosphorylation at Ser-228 and Ser-402 is essential for
CC       Parkin/PARK2 recruitment to depolarized mitochondria.
CC   -!- DISEASE: Defects in PINK1 are the cause of Parkinson disease type
CC       6 (PARK6) [MIM:605909]. A neurodegenerative disorder characterized
CC       by parkinsonian signs such as rigidity, resting tremor and
CC       bradykinesia. A subset of patients manifest additional symptoms
CC       including hyperreflexia, autonomic instability, dementia and
CC       psychiatric disturbances. Symptoms show diurnal fluctuation and
CC       can improve after sleep.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PINK1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB053323; BAB55647.1; -; mRNA.
DR   EMBL; AF316873; AAK28062.1; -; mRNA.
DR   EMBL; AK075225; BAC11484.1; -; mRNA.
DR   EMBL; AL391357; CAH73475.1; -; Genomic_DNA.
DR   EMBL; BC009534; AAH09534.1; -; mRNA.
DR   EMBL; BC028215; AAH28215.1; -; mRNA.
DR   IPI; IPI00307065; -.
DR   IPI; IPI00411562; -.
DR   RefSeq; NP_115785.1; NM_032409.2.
DR   UniGene; Hs.389171; -.
DR   ProteinModelPortal; Q9BXM7; -.
DR   SMR; Q9BXM7; 262-514.
DR   DIP; DIP-29427N; -.
DR   IntAct; Q9BXM7; 3.
DR   STRING; Q9BXM7; -.
DR   PhosphoSite; Q9BXM7; -.
DR   DMDM; 48428484; -.
DR   PaxDb; Q9BXM7; -.
DR   PRIDE; Q9BXM7; -.
DR   DNASU; 65018; -.
DR   Ensembl; ENST00000321556; ENSP00000364204; ENSG00000158828.
DR   GeneID; 65018; -.
DR   KEGG; hsa:65018; -.
DR   UCSC; uc001bdm.3; human.
DR   UCSC; uc001bdn.3; human.
DR   CTD; 65018; -.
DR   GeneCards; GC01P020959; -.
DR   HGNC; HGNC:14581; PINK1.
DR   HPA; CAB026191; -.
DR   HPA; HPA001931; -.
DR   MIM; 168600; phenotype.
DR   MIM; 605909; phenotype.
DR   MIM; 608309; gene.
DR   neXtProt; NX_Q9BXM7; -.
DR   Orphanet; 2828; Young adult-onset Parkinsonism.
DR   PharmGKB; PA33325; -.
DR   eggNOG; COG0515; -.
DR   HOGENOM; HOG000231649; -.
DR   HOVERGEN; HBG053601; -.
DR   InParanoid; Q9BXM7; -.
DR   KO; K05688; -.
DR   OMA; WNISAGS; -.
DR   OrthoDB; EOG480HW9; -.
DR   PhylomeDB; Q9BXM7; -.
DR   GenomeRNAi; 65018; -.
DR   NextBio; 67218; -.
DR   ArrayExpress; Q9BXM7; -.
DR   Bgee; Q9BXM7; -.
DR   CleanEx; HS_PINK1; -.
DR   Genevestigator; Q9BXM7; -.
DR   GermOnline; ENSG00000158828; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0010857; F:calcium-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008219; P:cell death; IEA:UniProtKB-KW.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0000422; P:mitochondrion degradation; IMP:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0033603; P:positive regulation of dopamine secretion; IEA:Compara.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; IDA:BHF-UCL.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:BHF-UCL.
DR   GO; GO:0032226; P:positive regulation of synaptic transmission, dopaminergic; IEA:Compara.
DR   GO; GO:0043254; P:regulation of protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Autophagy; Complete proteome;
KW   Cytoplasm; Disease mutation; Kinase; Magnesium; Membrane;
KW   Metal-binding; Mitochondrion; Mitochondrion outer membrane;
KW   Neurodegeneration; Nucleotide-binding; Parkinsonism; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Transit peptide; Transmembrane; Transmembrane helix.
FT   TRANSIT       1     77       Mitochondrion (Potential).
FT   CHAIN        78    581       Serine/threonine-protein kinase PINK1,
FT                                mitochondrial.
FT                                /FTId=PRO_0000024369.
FT   TOPO_DOM     78     93       Mitochondrial intermembrane (Potential).
FT   TRANSMEM     94    110       Helical; (Potential).
FT   TOPO_DOM    111    581       Cytoplasmic (Potential).
FT   DOMAIN      156    511       Protein kinase.
FT   NP_BIND     162    170       ATP (By similarity).
FT   ACT_SITE    362    362       Proton acceptor (By similarity).
FT   BINDING     186    186       ATP (By similarity).
FT   MOD_RES     228    228       Phosphoserine; by autocatalysis.
FT   MOD_RES     402    402       Phosphoserine; by autocatalysis.
FT   VAR_SEQ       1    307       Missing (in isoform 2).
FT                                /FTId=VSP_050754.
FT   VAR_SEQ     308    320       LGHGRTLFLVMKN -> MCGSQRPSPLSTS (in
FT                                isoform 2).
FT                                /FTId=VSP_050755.
FT   VARIANT      67     67       L -> F.
FT                                /FTId=VAR_046566.
FT   VARIANT      68     68       R -> P.
FT                                /FTId=VAR_046567.
FT   VARIANT      92     92       C -> F (in PARK6).
FT                                /FTId=VAR_046568.
FT   VARIANT      98     98       R -> W.
FT                                /FTId=VAR_046569.
FT   VARIANT     111    111       I -> S.
FT                                /FTId=VAR_046570.
FT   VARIANT     115    115       Q -> L.
FT                                /FTId=VAR_046571.
FT   VARIANT     124    124       A -> V.
FT                                /FTId=VAR_046572.
FT   VARIANT     125    125       C -> G (in PARK6).
FT                                /FTId=VAR_062773.
FT   VARIANT     126    126       Q -> P (in PARK6; strongly reduces
FT                                interaction with PARK2).
FT                                /FTId=VAR_064344.
FT   VARIANT     145    145       T -> M (in dbSNP:rs45604240).
FT                                /FTId=VAR_046573.
FT   VARIANT     147    147       R -> H (in PARK6; uncertain
FT                                pathogenicity).
FT                                /FTId=VAR_046574.
FT   VARIANT     148    148       L -> W (in dbSNP:rs56297806).
FT                                /FTId=VAR_041010.
FT   VARIANT     168    168       A -> P (in PARK6; has reduced
FT                                autophosphorylation activity compared to
FT                                wild-type; localizes to the mitochondria
FT                                and immunogold experiments reveal that
FT                                both wild-type and mutant proteins face
FT                                the mitochondrial intermembrane space).
FT                                /FTId=VAR_046575.
FT   VARIANT     186    186       K -> N.
FT                                /FTId=VAR_046576.
FT   VARIANT     196    196       P -> L (in PARK6).
FT                                /FTId=VAR_046577.
FT   VARIANT     196    196       P -> S (in dbSNP:rs35802484).
FT                                /FTId=VAR_041011.
FT   VARIANT     209    209       P -> L (in dbSNP:rs34677717).
FT                                /FTId=VAR_041012.
FT   VARIANT     215    215       P -> L (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041013.
FT   VARIANT     217    217       A -> D (in PARK6).
FT                                /FTId=VAR_046578.
FT   VARIANT     231    231       E -> G.
FT                                /FTId=VAR_046579.
FT   VARIANT     235    235       N -> I.
FT                                /FTId=VAR_046580.
FT   VARIANT     240    240       E -> K (in PARK6).
FT                                /FTId=VAR_046581.
FT   VARIANT     257    257       T -> I.
FT                                /FTId=VAR_046582.
FT   VARIANT     263    263       R -> G.
FT                                /FTId=VAR_046583.
FT   VARIANT     268    268       L -> V (in PARK6).
FT                                /FTId=VAR_046584.
FT   VARIANT     271    271       H -> Q (in PARK6).
FT                                /FTId=VAR_046585.
FT   VARIANT     276    276       R -> Q.
FT                                /FTId=VAR_046586.
FT   VARIANT     279    279       R -> H (in PARK6).
FT                                /FTId=VAR_046587.
FT   VARIANT     280    280       A -> T (in PARK6; early-onset).
FT                                /FTId=VAR_062774.
FT   VARIANT     296    296       P -> L.
FT                                /FTId=VAR_046588.
FT   VARIANT     305    305       P -> L (in dbSNP:rs7349186).
FT                                /FTId=VAR_018993.
FT   VARIANT     309    309       G -> D (in PARK6; fails to maintain
FT                                mitochondrial membrane potential; has
FT                                reduced autophosphorylation activity
FT                                compared to wild-type; strongly reduces
FT                                interaction with PARK2).
FT                                /FTId=VAR_018994.
FT   VARIANT     313    313       T -> M (in PARK6).
FT                                /FTId=VAR_046589.
FT   VARIANT     317    317       V -> I.
FT                                /FTId=VAR_046590.
FT   VARIANT     318    318       M -> L.
FT                                /FTId=VAR_046591.
FT   VARIANT     322    322       P -> L.
FT                                /FTId=VAR_046592.
FT   VARIANT     339    339       A -> T (in dbSNP:rs55831733).
FT                                /FTId=VAR_041014.
FT   VARIANT     340    340       A -> T (in dbSNP:rs3738136).
FT                                /FTId=VAR_018995.
FT   VARIANT     341    341       M -> I (in dbSNP:rs35813094).
FT                                /FTId=VAR_041015.
FT   VARIANT     347    347       L -> P (in PARK6; strongly reduces
FT                                interaction with PARK2).
FT                                /FTId=VAR_046593.
FT   VARIANT     362    362       D -> H.
FT                                /FTId=VAR_046594.
FT   VARIANT     369    369       L -> P (in PARK6).
FT                                /FTId=VAR_062775.
FT   VARIANT     377    377       C -> F (in dbSNP:rs34203620).
FT                                /FTId=VAR_041016.
FT   VARIANT     383    383       A -> T (in dbSNP:rs45515602).
FT                                /FTId=VAR_046595.
FT   VARIANT     386    386       G -> A (in PARK6).
FT                                /FTId=VAR_062776.
FT   VARIANT     388    388       C -> R (in PARK6).
FT                                /FTId=VAR_046596.
FT   VARIANT     395    395       G -> V.
FT                                /FTId=VAR_046597.
FT   VARIANT     399    399       P -> L (in PARK6; digenic inheritance;
FT                                associated with Ser-39 mutation in PARK7
FT                                gene).
FT                                /FTId=VAR_062777.
FT   VARIANT     407    407       R -> Q (in PARK6; early-onset).
FT                                /FTId=VAR_062778.
FT   VARIANT     409    409       G -> V (in PARK6).
FT                                /FTId=VAR_062779.
FT   VARIANT     411    411       G -> S (in dbSNP:rs45478900).
FT                                /FTId=VAR_046598.
FT   VARIANT     417    417       E -> G (in PARK6).
FT                                /FTId=VAR_046599.
FT   VARIANT     425    425       P -> S.
FT                                /FTId=VAR_046600.
FT   VARIANT     431    431       Y -> H (may predispose to Parkinson
FT                                disease development; shows decreased
FT                                mitochondrial membrane potential under
FT                                stress conditions).
FT                                /FTId=VAR_046601.
FT   VARIANT     442    442       I -> T.
FT                                /FTId=VAR_046602.
FT   VARIANT     451    451       N -> S (may predispose to Parkinson
FT                                disease development; shows decreased
FT                                mitochondrial membrane potential under
FT                                stress conditions).
FT                                /FTId=VAR_046603.
FT   VARIANT     461    461       L -> S.
FT                                /FTId=VAR_046604.
FT   VARIANT     464    464       R -> H (in PARK6).
FT                                /FTId=VAR_046605.
FT   VARIANT     476    476       E -> K (may predispose to Parkinson
FT                                disease development; shows decreased
FT                                mitochondrial membrane potential under
FT                                stress conditions).
FT                                /FTId=VAR_046606.
FT   VARIANT     477    477       S -> T (in dbSNP:rs34416410).
FT                                /FTId=VAR_041017.
FT   VARIANT     489    489       L -> P (in PARK6).
FT                                /FTId=VAR_046607.
FT   VARIANT     501    501       R -> P (may predispose to Parkinson
FT                                disease development; shows decreased
FT                                mitochondrial membrane potential under
FT                                stress conditions).
FT                                /FTId=VAR_046608.
FT   VARIANT     521    521       N -> T (in dbSNP:rs1043424).
FT                                /FTId=VAR_018996.
FT   VARIANT     525    525       D -> N.
FT                                /FTId=VAR_046609.
FT   VARIANT     534    534       Q -> QQ (in PARK6).
FT                                /FTId=VAR_046610.
FT   VARIANT     537    537       A -> T.
FT                                /FTId=VAR_046611.
FT   VARIANT     575    575       C -> R (may predispose to Parkinson
FT                                disease development; shows decreased
FT                                mitochondrial membrane potential under
FT                                stress conditions).
FT                                /FTId=VAR_046612.
FT   CONFLICT    209    209       P -> A (in Ref. 5; AAH28215).
FT   CONFLICT    419    419       S -> P (in Ref. 3; BAC11484).
SQ   SEQUENCE   581 AA;  62769 MW;  721FE01F63263A64 CRC64;
     MAVRQALGRG LQLGRALLLR FTGKPGRAYG LGRPGPAAGC VRGERPGWAA GPGAEPRRVG
     LGLPNRLRFF RQSVAGLAAR LQRQFVVRAW GCAGPCGRAV FLAFGLGLGL IEEKQAESRR
     AVSACQEIQA IFTQKSKPGP DPLDTRRLQG FRLEEYLIGQ SIGKGCSAAV YEATMPTLPQ
     NLEVTKSTGL LPGRGPGTSA PGEGQERAPG APAFPLAIKM MWNISAGSSS EAILNTMSQE
     LVPASRVALA GEYGAVTYRK SKRGPKQLAP HPNIIRVLRA FTSSVPLLPG ALVDYPDVLP
     SRLHPEGLGH GRTLFLVMKN YPCTLRQYLC VNTPSPRLAA MMLLQLLEGV DHLVQQGIAH
     RDLKSDNILV ELDPDGCPWL VIADFGCCLA DESIGLQLPF SSWYVDRGGN GCLMAPEVST
     ARPGPRAVID YSKADAWAVG AIAYEIFGLV NPFYGQGKAH LESRSYQEAQ LPALPESVPP
     DVRQLVRALL QREASKRPSA RVAANVLHLS LWGEHILALK NLKLDKMVGW LLQQSAATLL
     ANRLTEKCCV ETKMKMLFLA NLECETLCQA ALLLCSWRAA L
//
ID   PRKN2_HUMAN             Reviewed;         465 AA.
AC   O60260; A3FG77; A8K975; Q5TFV8; Q6Q2I6; Q8NI41; Q8NI43; Q8NI44;
AC   Q8WW07;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   06-FEB-2013, entry version 129.
DE   RecName: Full=E3 ubiquitin-protein ligase parkin;
DE            EC=6.3.2.-;
DE   AltName: Full=Parkinson juvenile disease protein 2;
DE            Short=Parkinson disease protein 2;
GN   Name=PARK2; Synonyms=PRKN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND INVOLVEMENT IN
RP   PARK2.
RC   TISSUE=Fetal brain, and Skeletal muscle;
RX   MEDLINE=98219084; PubMed=9560156; DOI=10.1038/33416;
RA   Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y.,
RA   Minoshima S., Yokochi M., Mizuno Y., Shimizu N.;
RT   "Mutations in the parkin gene cause autosomal recessive juvenile
RT   parkinsonism.";
RL   Nature 392:605-608(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   VARIANTS ARG-311 AND THR-371, AND MASS SPECTROMETRY.
RX   PubMed=19501131; DOI=10.1016/j.neulet.2009.05.079;
RA   Kasap M., Akpinar G., Sazci A., Idrisoglu H.A., Vahaboglu H.;
RT   "Evidence for the presence of full-length PARK2 mRNA and Parkin
RT   protein in human blood.";
RL   Neurosci. Lett. 460:196-200(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RA   D'Agata V., Scapagnini G., Cavallaro S.;
RT   "Functional and molecular diversity of parkin.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 312-361.
RA   Zou H.Q., Chan P.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10319893;
RX   DOI=10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z;
RA   Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T.,
RA   Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N.,
RA   Mizuno Y.;
RT   "Immunohistochemical and subcellular localization of Parkin protein:
RT   absence of protein in autosomal recessive juvenile parkinsonism
RT   patients.";
RL   Ann. Neurol. 45:668-672(1999).
RN   [10]
RP   FUNCTION IN UBIQUITINATION.
RX   MEDLINE=20549560; PubMed=10973942; DOI=10.1074/jbc.C000447200;
RA   Imai Y., Soda M., Takahashi R.;
RT   "Parkin suppresses unfolded protein stress-induced cell death through
RT   its E3 ubiquitin-protein ligase activity.";
RL   J. Biol. Chem. 275:35661-35664(2000).
RN   [11]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANTS PARK PRO-42 AND ARG-240.
RX   MEDLINE=20347715; PubMed=10888878; DOI=10.1038/77060;
RA   Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S.,
RA   Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T.;
RT   "Familial Parkinson disease gene product, parkin, is a ubiquitin-
RT   protein ligase.";
RL   Nat. Genet. 25:302-305(2000).
RN   [12]
RP   INTERACTION WITH UBE2L6 AND SEPT5, AND UBIQUITINATION OF SEPT5.
RX   MEDLINE=20542129; PubMed=11078524; DOI=10.1073/pnas.240347797;
RA   Zhang Y., Gao J., Chung K.K.K., Huang H., Dawson V.L., Dawson T.M.;
RT   "Parkin functions as an E2-dependent ubiquitin-protein ligase and
RT   promotes the degradation of the synaptic vesicle-associated protein,
RT   CDCrel-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:13354-13359(2000).
RN   [13]
RP   UBIQUITINATION OF GPR37.
RX   MEDLINE=21332586; PubMed=11439185; DOI=10.1016/S0092-8674(01)00407-X;
RA   Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., Takahashi R.;
RT   "An unfolded putative transmembrane polypeptide, which can lead to
RT   endoplasmic reticulum stress, is a substrate of Parkin.";
RL   Cell 105:891-902(2001).
RN   [14]
RP   INTERACTION, UBIQUITINATION OF SNCAIP, CHARACTERIZATION OF VARIANTS
RP   PARK2 ARG-240; CYS-256; TRP-275 AND ASN-415, AND MUTAGENESIS OF
RP   CYS-337; CYS-421 AND CYS-431.
RX   MEDLINE=21474644; PubMed=11590439; DOI=10.1038/nm1001-1144;
RA   Chung K.K.K., Zhang Y., Lim K.L., Tanaka Y., Huang H., Gao J.,
RA   Ross C.A., Dawson V.L., Dawson T.M.;
RT   "Parkin ubiquitinates the alpha-synuclein-interacting protein,
RT   synphilin-1: implications for Lewy-body formation in Parkinson
RT   disease.";
RL   Nat. Med. 7:1144-1150(2001).
RN   [15]
RP   UBIQUITINATION OF AN O-GLYCOSYLATED ISOFORM OF SNCAIP, SUBCELLULAR
RP   LOCATION, AND CHARACTERIZATION OF VARIANTS PARK PRO-42 AND ARG-240.
RX   MEDLINE=21345366; PubMed=11431533; DOI=10.1126/science.1060627;
RA   Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P.,
RA   Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., Selkoe D.J.;
RT   "Ubiquitination of a new form of alpha-synuclein by parkin from human
RT   brain: implications for Parkinson's disease.";
RL   Science 293:263-269(2001).
RN   [16]
RP   PRESENCE OF ATYPICAL RING FINGER DOMAINS.
RX   PubMed=12446796;
RA   Marin I., Ferrus A.;
RT   "Comparative genomics of the RBR family, including the Parkinson's
RT   disease-related gene parkin and the genes of the ariadne subfamily.";
RL   Mol. Biol. Evol. 19:2039-2050(2002).
RN   [17]
RP   INTERACTION WITH STUB1 AND HSP70, AND UBIQUITINATION OF STUB1.
RX   MEDLINE=22146551; PubMed=12150907; DOI=10.1016/S1097-2765(02)00583-X;
RA   Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.,
RA   Takahashi R.;
RT   "CHIP is associated with Parkin, a gene responsible for familial
RT   Parkinson's disease, and enhances its ubiquitin ligase activity.";
RL   Mol. Cell 10:55-67(2002).
RN   [18]
RP   INTERACTION WITH SYT11, CHARACTERIZATION OF VARIANT PARK GLY-289, AND
RP   MUTAGENESIS OF CYS-418.
RX   MEDLINE=22887331; PubMed=12925569; DOI=10.1093/hmg/ddg269;
RA   Huynh D.P., Scoles D.R., Nguyen D., Pulst S.M.;
RT   "The autosomal recessive juvenile Parkinson disease gene product,
RT   parkin, interacts with and ubiquitinates synaptotagmin XI.";
RL   Hum. Mol. Genet. 12:2587-2597(2003).
RN   [19]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.M309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [20]
RP   FUNCTION, INTERACTION WITH FBXW7 AND CUL1, AND UBIQUITINATION OF
RP   CYCLIN E.
RX   MEDLINE=22516607; PubMed=12628165; DOI=10.1016/S0896-6273(03)00084-9;
RA   Staropoli J.F., McDermott C., Martinat C., Schulman B., Demireva E.,
RA   Abeliovich A.;
RT   "Parkin is a component of an SCF-like ubiquitin ligase complex and
RT   protects postmitotic neurons from kainate excitotoxicity.";
RL   Neuron 37:735-749(2003).
RN   [21]
RP   INVOLVEMENT IN CANCER.
RX   MEDLINE=22979425; PubMed=14614460; DOI=10.1038/sj.onc.1207072;
RA   Denison S.R., Wang F., Becker N.A., Schuele B., Kock N.,
RA   Phillips L.A., Klein C., Smith D.I.;
RT   "Alterations in the common fragile site gene Parkin in ovarian and
RT   other cancers.";
RL   Oncogene 22:8370-8378(2003).
RN   [22]
RP   FUNCTION, AND INVOLVEMENT IN CANCER.
RX   MEDLINE=22631680; PubMed=12719539; DOI=10.1073/pnas.0931262100;
RA   Cesari R., Martin E.S., Calin G.A., Pentimalli F., Bichi R.,
RA   McAdams H., Trapasso F., Drusco A., Shimizu M., Masciullo V.,
RA   D'Andrilli G., Scambia G., Picchio M.C., Alder H., Godwin A.K.,
RA   Croce C.M.;
RT   "Parkin, a gene implicated in autosomal recessive juvenile
RT   parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-
RT   q27.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5956-5961(2003).
RN   [23]
RP   REVIEW.
RX   PubMed=15229644; DOI=10.1038/sj.embor.7400188;
RA   Kahle P.J., Haass C.;
RT   "How does parkin ligate ubiquitin to Parkinson's disease?";
RL   EMBO Rep. 5:681-685(2004).
RN   [24]
RP   FUNCTION, UBIQUITINATION, AND S-NITROSYLATION.
RX   PubMed=15105460; DOI=10.1126/science.1093891;
RA   Chung K.K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C.,
RA   Marsh L., Dawson V.L., Dawson T.M.;
RT   "S-nitrosylation of parkin regulates ubiquitination and compromises
RT   parkin's protective function.";
RL   Science 304:1328-1331(2004).
RN   [25]
RP   INTERACTION WITH PSMA7.
RX   PubMed=15987638; DOI=10.1016/j.febslet.2005.06.003;
RA   Dachsel J.C., Lucking C.B., Deeg S., Schultz E., Lalowski M.,
RA   Casademunt E., Corti O., Hampe C., Patenge N., Vaupel K., Yamamoto A.,
RA   Dichgans M., Brice A., Wanker E.E., Kahle P.J., Gasser T.;
RT   "Parkin interacts with the proteasome subunit alpha4.";
RL   FEBS Lett. 579:3913-3919(2005).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH SNCAIP.
RX   PubMed=15728840; DOI=10.1523/JNEUROSCI.4474-04.2005;
RA   Lim K.L., Chew K.C., Tan J.M., Wang C., Chung K.K., Zhang Y.,
RA   Tanaka Y., Smith W., Engelender S., Ross C.A., Dawson V.L.,
RA   Dawson T.M.;
RT   "Parkin mediates nonclassical, proteasomal-independent ubiquitination
RT   of synphilin-1: implications for Lewy body formation.";
RL   J. Neurosci. 25:2002-2009(2005).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH AIMP2.
RX   PubMed=16135753; DOI=10.1523/JNEUROSCI.2172-05.2005;
RA   Ko H.S., von Coelln R., Sriram S.R., Kim S.W., Chung K.K.K.,
RA   Pletnikova O., Troncoso J., Johnson B., Saffary R., Goh E.L., Song H.,
RA   Park B.-J., Kim M.J., Kim S., Dawson V.L., Dawson T.M.;
RT   "Accumulation of the authentic parkin substrate aminoacyl-tRNA
RT   synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell
RT   death.";
RL   J. Neurosci. 25:7968-7978(2005).
RN   [28]
RP   INTERACTION WITH LRRK2.
RX   PubMed=16352719; DOI=10.1073/pnas.0508052102;
RA   Smith W.W., Pei Z., Jiang H., Moore D.J., Liang Y., West A.B.,
RA   Dawson V.L., Dawson T.M., Ross C.A.;
RT   "Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin and mutant
RT   LRRK2 induces neuronal degeneration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:18676-18681(2005).
RN   [29]
RP   INTERACTION WITH RANBP2.
RX   PubMed=16332688; DOI=10.1074/jbc.M504994200;
RA   Um J.W., Min D.S., Rhim H., Kim J., Paik S.R., Chung K.C.;
RT   "Parkin ubiquitinates and promotes the degradation of RanBP2.";
RL   J. Biol. Chem. 281:3595-3603(2006).
RN   [30]
RP   INTERACTION WITH SUMO1, AND SUBCELLULAR LOCATION.
RX   PubMed=16955485; DOI=10.1002/jnr.21041;
RA   Um J.W., Chung K.C.;
RT   "Functional modulation of parkin through physical interaction with
RT   SUMO-1.";
RL   J. Neurosci. Res. 84:1543-1554(2006).
RN   [31]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17846173; DOI=10.1083/jcb.200611128;
RA   Olzmann J.A., Li L., Chudaev M.V., Chen J., Perez F.A., Palmiter R.D.,
RA   Chin L.S.;
RT   "Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1
RT   to aggresomes via binding to HDAC6.";
RL   J. Cell Biol. 178:1025-1038(2007).
RN   [32]
RP   FUNCTION IN MITOCHONDRIAL AUTOPHAGY, AND SUBCELLULAR LOCATION.
RX   PubMed=19029340; DOI=10.1083/jcb.200809125;
RA   Narendra D., Tanaka A., Suen D.F., Youle R.J.;
RT   "Parkin is recruited selectively to impaired mitochondria and promotes
RT   their autophagy.";
RL   J. Cell Biol. 183:795-803(2008).
RN   [33]
RP   INTERACTION WITH RNF41, UBIQUITINATION, MUTAGENESIS OF CYS-421, AND
RP   FUNCTION.
RX   PubMed=18541373; DOI=10.1016/j.neulet.2008.05.052;
RA   Yu F., Zhou J.;
RT   "Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced
RT   oxidative stress.";
RL   Neurosci. Lett. 440:4-8(2008).
RN   [34]
RP   INTERACTION WITH PINK1.
RX   PubMed=20798600; DOI=10.4161/auto.6.7.13286;
RA   Geisler S., Holmstrom K.M., Treis A., Skujat D., Weber S.S.,
RA   Fiesel F.C., Kahle P.J., Springer W.;
RT   "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated
RT   mutations.";
RL   Autophagy 6:871-878(2010).
RN   [35]
RP   FUNCTION, INTERACTION WITH BCL2, SUBCELLULAR LOCATION,
RP   CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ARG-240 AND PHE-431, AND
RP   CHARACTERIZATION OF VARIANT PARK LEU-437.
RX   PubMed=20889974; DOI=10.1074/jbc.M110.101469;
RA   Chen D., Gao F., Li B., Wang H., Xu Y., Zhu C., Wang G.;
RT   "Parkin mono-ubiquitinates Bcl-2 and regulates autophagy.";
RL   J. Biol. Chem. 285:38214-38223(2010).
RN   [36]
RP   FUNCTION IN MITOCHONDRIAL AUTOPHAGY, SUBCELLULAR LOCATION, INTERACTION
RP   WITH PINK1, AND CHARACTERIZATION OF VARIANTS PARK ASN-415 AND ASP-430.
RX   PubMed=19966284; DOI=10.1073/pnas.0911187107;
RA   Vives-Bauza C., Zhou C., Huang Y., Cui M., de Vries R.L., Kim J.,
RA   May J., Tocilescu M.A., Liu W., Ko H.S., Magrane J., Moore D.J.,
RA   Dawson V.L., Grailhe R., Dawson T.M., Li C., Tieu K., Przedborski S.;
RT   "PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:378-383(2010).
RN   [37]
RP   FUNCTION, INTERACTION WITH ZNF746, AND CHARACTERIZATION OF VARIANTS
RP   PARK TRP-275; ASP-430 AND PHE-431.
RX   PubMed=21376232; DOI=10.1016/j.cell.2011.02.010;
RA   Shin J.H., Ko H.S., Kang H., Lee Y., Lee Y.I., Pletinkova O.,
RA   Troconso J.C., Dawson V.L., Dawson T.M.;
RT   "PARIS (ZNF746) repression of PGC-1alpha contributes to
RT   neurodegeneration in Parkinson's disease.";
RL   Cell 144:689-702(2011).
RN   [38]
RP   FUNCTION, REACTION MECHANISM, AND INTERACTION WITH UBE2L3.
RX   PubMed=21532592; DOI=10.1038/nature09966;
RA   Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E.;
RT   "UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT
RT   hybrids.";
RL   Nature 474:105-108(2011).
RN   [39]
RP   STRUCTURE BY NMR OF 1-76, AND INTERACTION WITH PSMD4.
RX   MEDLINE=22520692; PubMed=12634850; DOI=10.1038/sj.embor.embor764;
RA   Sakata E., Yamaguchi Y., Kurimoto E., Kikuchi J., Yokoyama S.,
RA   Yamada S., Kawahara H., Yokosawa H., Hattori N., Mizuno Y., Tanaka K.,
RA   Kato K.;
RT   "Parkin binds the Rpn10 subunit of 26S proteasomes through its
RT   ubiquitin-like domain.";
RL   EMBO Rep. 4:301-306(2003).
RN   [40]
RP   STRUCTURE BY NMR OF 307-384 IN COMPLEX WITH ZINC IONS,
RP   CHARACTERIZATION OF VARIANT PARK2 PRO-351, MUTAGENESIS OF CYS-332 AND
RP   CYS-365, AND MASS SPECTROMETRY.
RX   PubMed=17360614; DOI=10.1073/pnas.0610548104;
RA   Beasley S.A., Hristova V.A., Shaw G.S.;
RT   "Structure of the Parkin in-between-ring domain provides insights for
RT   E3-ligase dysfunction in autosomal recessive Parkinson's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:3095-3100(2007).
RN   [41]
RP   REVIEW ON VARIANTS.
RX   PubMed=14976155; DOI=10.1093/hmg/ddh089;
RA   Mata I.F., Lockhart P.J., Farrer M.J.;
RT   "Parkin genetics: one model for Parkinson's disease.";
RL   Hum. Mol. Genet. 13:R127-R133(2004).
RN   [42]
RP   VARIANT PARK2 ARG-240.
RX   MEDLINE=98401162; PubMed=9731209; DOI=10.1006/bbrc.1998.9134;
RA   Hattori N., Matsumine H., Asakawa S., Kitada T., Yoshino H.,
RA   Elibol B., Brookes A.J., Yamamura Y., Kobayashi T., Wang M.,
RA   Yoritaka A., Minoshima S., Shimizu N., Mizuno Y.;
RT   "Point mutations (Thr240Arg and Gln311Stop) in the Parkin gene.";
RL   Biochem. Biophys. Res. Commun. 249:754-758(1998).
RN   [43]
RP   ERRATUM.
RA   Hattori N., Matsumine H., Asakawa S., Kitada T., Yoshino H.,
RA   Elibol B., Brookes A.J., Yamamura Y., Kobayashi T., Wang M.,
RA   Yoritaka A., Minoshima S., Shimizu N., Mizuno Y.;
RL   Biochem. Biophys. Res. Commun. 251:666-666(1998).
RN   [44]
RP   VARIANTS PARK2 ASN-161; CYS-256; TRP-275 AND ASN-415, AND VARIANTS
RP   ASN-167; LEU-380 AND ASN-394.
RX   MEDLINE=99172064; PubMed=10072423; DOI=10.1093/hmg/8.4.567;
RA   Abbas N., Luecking C.B., Ricard S., Duerr A., Bonifati V.,
RA   De Michele G., Bouley S., Vaughan J.R., Gasser T., Marconi R.,
RA   Broussolle E., Brefel-Courbon C., Harhangi B.S., Oostra B.A.,
RA   Fabrizio E., Bohme G.A., Pradier L., Wood N.W., Filla A., Meco G.,
RA   Denefle P., Agid Y., Brice A.;
RT   "A wide variety of mutations in the parkin gene are responsible for
RT   autosomal recessive parkinsonism in Europe.";
RL   Hum. Mol. Genet. 8:567-574(1999).
RN   [45]
RP   VARIANT ASN-167.
RX   MEDLINE=99439450; PubMed=10511432;
RA   Satoh J., Kuroda Y.;
RT   "Association of codon 167 Ser/Asn heterozygosity in the parkin gene
RT   with sporadic Parkinson's disease.";
RL   NeuroReport 10:2735-2739(1999).
RN   [46]
RP   VARIANT PARK2 PHE-431.
RX   PubMed=10939576;
RX   DOI=10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.3.CO;2-U;
RA   Maruyama M., Ikeuchi T., Saito M., Ishikawa A., Yuasa T., Tanaka H.,
RA   Hayashi S., Wakabayashi K., Takahashi H., Tsuji S.;
RT   "Novel mutations, pseudo-dominant inheritance, and possible familial
RT   affects in patients with autosomal recessive juvenile parkinsonism.";
RL   Ann. Neurol. 48:245-250(2000).
RN   [47]
RP   VARIANTS ASN-167; TRP-366 AND LEU-380.
RX   MEDLINE=20422559; PubMed=10965160; DOI=10.1159/000008203;
RA   Hu C.-J., Sung S.-M., Liu H.-C., Lee C.-C., Tsai C.-H., Chang J.-G.;
RT   "Polymorphisms of the parkin gene in sporadic Parkinson's disease
RT   among Chinese in Taiwan.";
RL   Eur. Neurol. 44:90-93(2000).
RN   [48]
RP   VARIANTS PARK ASN-161; ASN-211; CYS-256; TRP-275; ASN-280; GLY-289;
RP   GLU-328; CYS-334; ASN-415 AND ASP-430.
RX   MEDLINE=20267489; PubMed=10824074; DOI=10.1056/NEJM200005253422103;
RA   Luecking C.B., Duerr A., Bonifati V., Vaughan J.R., De Michele G.,
RA   Gasser T., Harhangi B.S., Meco G., Denefle P., Wood N.W., Agid Y.,
RA   Brice A.;
RT   "Association between early-onset Parkinson's disease and mutations in
RT   the parkin gene.";
RL   N. Engl. J. Med. 342:1560-1567(2000).
RN   [49]
RP   VARIANTS PARK ARG-211; TRP-275 AND ASP-430.
RX   MEDLINE=21090533; PubMed=11179010; DOI=10.1086/318791;
RA   Periquet M., Luecking C.B., Vaughan J.R., Bonifati V., Duerr A.,
RA   De Michele G., Horstink M., Farrer M., Illarioshkin S.N., Pollak P.,
RA   Borg M., Brefel-Courbon C., Denefle P., Meco G., Gasser T.,
RA   Breteler M.M., Wood N.W., Agid Y., Brice A.;
RT   "Origin of the mutations in the parkin gene in Europe: exon
RT   rearrangements are independent recurrent events, whereas point
RT   mutations may result from founder effects.";
RL   Am. J. Hum. Genet. 68:617-626(2001).
RN   [50]
RP   VARIANT PARK2 GLU-82.
RX   MEDLINE=21380005; PubMed=11487568; DOI=10.1093/hmg/10.16.1649;
RA   Hedrich K., Kann M., Lanthaler A.J., Dalski A., Eskelson C., Landt O.,
RA   Schwinger E., Vieregge P., Lang A.E., Breakefield X.O., Ozelius L.J.,
RA   Pramstaller P.P., Klein C.;
RT   "The importance of gene dosage studies: mutational analysis of the
RT   parkin gene in early-onset parkinsonism.";
RL   Hum. Mol. Genet. 10:1649-1656(2001).
RN   [51]
RP   VARIANT PARK2 TYR-212.
RX   MEDLINE=21106127; PubMed=11163284; DOI=10.1016/S0304-3940(00)01733-X;
RA   Pineda-Trujillo N., Carvajal-Carmona L.G., Buritica O., Moreno S.,
RA   Uribe C., Pineda D., Toro M., Garcia F., Arias W., Bedoya G.,
RA   Lopera F., Ruiz-Linares A.;
RT   "A novel Cys212Tyr founder mutation in parkin and allelic
RT   heterogeneity of juvenile parkinsonism in a population from North West
RT   Colombia.";
RL   Neurosci. Lett. 298:87-90(2001).
RN   [52]
RP   VARIANTS PARK GLU-82; CYS-256; TRP-275; GLU-328 AND 441-ARG.
RX   MEDLINE=22108846; PubMed=12116199; DOI=10.1002/ajmg.10525;
RG   French Parkinson's disease genetics study group;
RG   European consortium on genetic susceptibility on Parkinson's disease;
RA   West A., Periquet M., Lincoln S., Luecking C.B., Nicholl D.,
RA   Bonifati V., Rawal N., Gasser T., Lohmann E., Deleuze J.-F.,
RA   Maraganore D., Levey A., Wood N.W., Duerr A., Hardy J., Brice A.,
RA   Farrer M.;
RT   "Complex relationship between parkin mutations and Parkinson
RT   disease.";
RL   Am. J. Med. Genet. 114:584-591(2002).
RN   [53]
RP   ERRATUM.
RG   French Parkinson's disease genetics study group;
RG   European consortium on genetic susceptibility on Parkinson's disease;
RA   West A., Periquet M., Lincoln S., Luecking C.B., Nicholl D.,
RA   Bonifati V., Rawal N., Gasser T., Lohmann E., Deleuze J.-F.,
RA   Maraganore D., Levey A., Wood N.W., Duerr A., Hardy J., Brice A.,
RA   Farrer M.J.;
RL   Am. J. Med. Genet. 114:992-992(2002).
RN   [54]
RP   VARIANTS PARK2 LEU-37 AND PRO-351.
RX   MEDLINE=22104975; PubMed=12112109; DOI=10.1002/ana.10179;
RA   Kann M., Jacobs H., Mohrmann K., Schumacher K., Hedrich K.,
RA   Garrels J., Wiegers K., Schwinger E., Pramstaller P.P.,
RA   Breakefield X.O., Ozelius L.J., Vieregge P., Klein C.;
RT   "Role of parkin mutations in 111 community-based patients with early-
RT   onset parkinsonism.";
RL   Ann. Neurol. 51:621-625(2002).
RN   [55]
RP   VARIANTS PARK ASN-211; TRP-275; ASP-430 AND LEU-437.
RX   MEDLINE=22110646; PubMed=12114481; DOI=10.1136/jmg.39.7.489;
RA   Nichols W.C., Pankratz N., Uniacke S.K., Pauciulo M.W., Halter C.,
RA   Rudolph A., Conneally P.M., Foroud T.;
RT   "Linkage stratification and mutation analysis at the parkin locus
RT   identifies mutation positive Parkinson's disease families.";
RL   J. Med. Genet. 39:489-492(2002).
RN   [56]
RP   VARIANT PARK MET-15, AND VARIANTS LEU-380 AND ASN-394.
RX   MEDLINE=22284235; PubMed=12397156; DOI=10.1136/jnnp.73.5.582;
RA   Munoz E., Tolosa E., Pastor P., Marti M.J., Valldeoriola F.,
RA   Campdelacreu J., Oliva R.;
RT   "Relative high frequency of the c.255delA parkin gene mutation in
RT   Spanish patients with autosomal recessive parkinsonism.";
RL   J. Neurol. Neurosurg. Psych. 73:582-584(2002).
RN   [57]
RP   VARIANTS PARK PRO-42; VAL-192; CYS-256; TRP-275; ASP-430 AND LEU-437.
RX   MEDLINE=21966393; PubMed=11971093;
RA   Hedrich K., Marder K., Harris J., Kann M., Lynch T., Meija-Santana H.,
RA   Pramstaller P.P., Schwinger E., Bressman S.B., Fahn S., Klein C.;
RT   "Evaluation of 50 probands with early-onset Parkinson's disease for
RT   parkin mutations.";
RL   Neurology 58:1239-1246(2002).
RN   [58]
RP   VARIANT PARK PRO-46.
RX   MEDLINE=22249643; PubMed=12362318;
RA   Xu Y., Liu Z., Wang Y., Tao E., Chen G., Chen B.;
RT   "A new point mutation on exon 2 of parkin gene in Parkinson's
RT   disease.";
RL   Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19:409-411(2002).
RN   [59]
RP   VARIANTS PARK GLN-33; TYR-253; CYS-256; TRP-275; ASN-280; ASP-430 AND
RP   LEU-437, AND VARIANTS GLU-82; LEU-380 AND ASN-394.
RX   MEDLINE=22615149; PubMed=12730996; DOI=10.1002/ana.10524;
RA   Oliveira S.A., Scott W.K., Martin E.R., Nance M.A., Watts R.L.,
RA   Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Ondo W.G.,
RA   Allen F.H. Jr., Scott B.L., Goetz C.G., Small G.W., Mastaglia F.,
RA   Stajich J.M., Zhang F., Booze M.W., Winn M.P., Middleton L.T.,
RA   Haines J.L., Pericak-Vance M.A., Vance J.M.;
RT   "Parkin mutations and susceptibility alleles in late-onset Parkinson's
RT   disease.";
RL   Ann. Neurol. 53:624-629(2003).
RN   [60]
RP   VARIANTS PARK VAL-192; ASN-211; MET-240 AND LEU-437, AND VARIANT
RP   ASN-167.
RX   MEDLINE=22516579; PubMed=12629236;
RA   Foroud T., Uniacke S.K., Liu L., Pankratz N., Rudolph A., Halter C.,
RA   Shults C., Marder K., Conneally P.M., Nichols W.C.;
RT   "Heterozygosity for a mutation in the parkin gene leads to later onset
RT   Parkinson disease.";
RL   Neurology 60:796-801(2003).
RN   [61]
RP   VARIANTS HIS-100; SER-271 AND SER-339.
RX   MEDLINE=22667519; PubMed=12781599;
RA   Chen R., Gosavi N.S., Langston J.W., Chan P.;
RT   "Parkin mutations are rare in patients with young-onset parkinsonism
RT   in a US population.";
RL   Parkinsonism Relat. Disord. 9:309-312(2003).
RN   [62]
RP   CHARACTERIZATION OF VARIANTS PARK ASN-161; ASN-211; ARG-240; ASN-280
RP   AND GLU-328.
RX   PubMed=20404107; DOI=10.1083/jcb.200910140;
RA   Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A.,
RA   Sou Y.S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M.,
RA   Hattori N., Tanaka K.;
RT   "PINK1 stabilized by mitochondrial depolarization recruits Parkin to
RT   damaged mitochondria and activates latent Parkin for mitophagy.";
RL   J. Cell Biol. 189:211-221(2010).
CC   -!- FUNCTION: Functions within a multiprotein E3 ubiquitin ligase
CC       complex, catalyzing the covalent attachment of ubiquitin moieties
CC       onto substrate proteins, such as BCL2, SYT11, CCNE1, GPR37, STUB1,
CC       a 22 kDa O-linked glycosylated isoform of SNCAIP, SEPT5, ZNF746
CC       and AIMP2. Mediates monoubiquitination as well as 'Lys-48'-linked
CC       and 'Lys-63'-linked polyubiquitination of substrates depending on
CC       the context. Participates in the removal and/or detoxification of
CC       abnormally folded or damaged protein by mediating 'Lys-63'-linked
CC       polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-
CC       linked polyubiquitinated misfolded proteins are then recognized by
CC       HDAC6, leading to their recruitment to aggresomes, followed by
CC       degradation. Mediates 'Lys-63'-linked polyubiquitination of
CC       SNCAIP, possibly playing a role in Lewy-body formation. Mediates
CC       monoubiquitination of BCL2, thereby acting as a positive regulator
CC       of autophagy. Promotes the autophagic degradation of dysfunctional
CC       depolarized mitochondria. Mediates 'Lys-48'-linked
CC       polyubiquitination of ZNF746, followed by degradation of ZNF746 by
CC       the proteasome; possibly playing a role in role in regulation of
CC       neuron death. Limits the production of reactive oxygen species
CC       (ROS). Loss of this ubiquitin ligase activity appears to be the
CC       mechanism underlying pathogenesis of PARK2. May protect neurons
CC       against alpha synuclein toxicity, proteasomal dysfunction, GPR37
CC       accumulation, and kainate-induced excitotoxicity. May play a role
CC       in controlling neurotransmitter trafficking at the presynaptic
CC       terminal and in calcium-dependent exocytosis. Regulates cyclin-E
CC       during neuronal apoptosis. May represent a tumor suppressor gene.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Forms an E3 ubiquitin ligase complex with UBE2L3 or
CC       UBE2L6. Mediates 'Lys-63'-linked polyubiquitination by associating
CC       with UBE2V1. Part of a SCF-like complex, consisting of PARK2, CUL1
CC       and FBXW7. Interacts with SNCAIP. Binds to the C2A and C2B domains
CC       of SYT11. Interacts and regulates the turnover of SEPT5. Part of a
CC       complex, including STUB1, HSP70 and GPR37. The amount of STUB1 in
CC       the complex increases during ER stress. STUB1 promotes the
CC       dissociation of HSP70 from PARK2 and GPR37, thus facilitating
CC       PARK2-mediated GPR37 ubiquitination. HSP70 transiently associates
CC       with unfolded GPR37 and inhibits the E3 activity of PARK2,
CC       whereas, STUB1 enhances the E3 activity of PARK2 through promotion
CC       of dissociation of HSP70 from PARK2-GPR37 complexes. Interacts
CC       with PSMD4 and PACRG. Interacts with LRRK2. Interacts with RANBP2.
CC       Interacts with SUMO1 but not SUMO2, which promotes nuclear
CC       localization and autoubiquitination. Interacts (via first RING-
CC       type domain) with AIMP2 (via N-terminus). Interacts with PSMA7 and
CC       RNF41. Interacts with PINK1.
CC   -!- INTERACTION:
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-716346, EBI-5323863;
CC       P49792:RANBP2; NbExp=11; IntAct=EBI-716346, EBI-973138;
CC       Q8IXI2:RHOT1; NbExp=3; IntAct=EBI-716346, EBI-1396430;
CC       Q9Z2Q6:Sept5 (xeno); NbExp=2; IntAct=EBI-716346, EBI-772125;
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-716346, EBI-358993;
CC       Q6NUN9:ZNF746; NbExp=6; IntAct=EBI-716346, EBI-3862525;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Nucleus. Endoplasmic
CC       reticulum. Mitochondrion. Note=Mainly localizes in the cytosol.
CC       Co-localizes with SYT11 in neutrites. Co-localizes with SNCAIP in
CC       brainstem Lewy bodies. Relocates to dysfunctional mitochondria
CC       that have lost the mitochondrial membrane potential; recruitment
CC       to mitochondria is PINK1-dependent.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=O60260-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60260-2; Sequence=VSP_011707;
CC       Name=3;
CC         IsoId=O60260-3; Sequence=VSP_011706, VSP_011709, VSP_011710;
CC       Name=4;
CC         IsoId=O60260-4; Sequence=VSP_011705;
CC       Name=5;
CC         IsoId=O60260-5; Sequence=VSP_011708, VSP_011711, VSP_011712;
CC       Name=6;
CC         IsoId=O60260-6; Sequence=VSP_041563;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the brain including the
CC       substantia nigra. Expressed in heart, testis and skeletal muscle.
CC       Expression is down-regulated or absent in tumor biopsies, and
CC       absent in the brain of PARK2 patients. Overexpression protects
CC       dopamine neurons from kainate-mediated apoptosis. Found in serum
CC       (at protein level).
CC   -!- DOMAIN: The ubiquitin-like domain binds the PSMD4 subunit of 26S
CC       proteasomes.
CC   -!- PTM: Auto-ubiquitinates in an E2-dependent manner leading to its
CC       own degradation. Also polyubiquitinated by RNF41 for proteasomal
CC       degradation.
CC   -!- PTM: S-nitrosylated. The inhibition of PARK2 ubiquitin E3 ligase
CC       activity by S-nitrosylation could contribute to the degenerative
CC       process in PD by impairing the ubiquitination of PARK2 substrates.
CC   -!- DISEASE: Defects in PARK2 are a cause of Parkinson disease (PARK)
CC       [MIM:168600]. A complex neurodegenerative disorder characterized
CC       by bradykinesia, resting tremor, muscular rigidity and postural
CC       instability. Additional features are characteristic postural
CC       abnormalities, dysautonomia, dystonic cramps, and dementia. The
CC       pathology of Parkinson disease involves the loss of dopaminergic
CC       neurons in the substantia nigra and the presence of Lewy bodies
CC       (intraneuronal accumulations of aggregated proteins), in surviving
CC       neurons in various areas of the brain. The disease is progressive
CC       and usually manifests after the age of 50 years, although early-
CC       onset cases (before 50 years) are known. The majority of the cases
CC       are sporadic suggesting a multifactorial etiology based on
CC       environmental and genetic factors. However, some patients present
CC       with a positive family history for the disease. Familial forms of
CC       the disease usually begin at earlier ages and are associated with
CC       atypical clinical features.
CC   -!- DISEASE: Defects in PARK2 are the cause of Parkinson disease type
CC       2 (PARK2) [MIM:600116]; also known as early-onset parkinsonism
CC       with diurnal fluctuation (EPDF) or autosomal recessive juvenile
CC       Parkinson disease (PDJ). A neurodegenerative disorder
CC       characterized by bradykinesia, rigidity, postural instability,
CC       tremor, and onset usually befor 40. It differs from classic
CC       Parkinson disease by early DOPA-induced dyskinesia, diurnal
CC       fluctuation of the symptoms, sleep benefit, dystonia and hyper-
CC       reflexia. Dementia is absent. Pathologically, patients show loss
CC       of dopaminergic neurons in the substantia nigra, similar to that
CC       seen in Parkinson disease; however, Lewy bodies (intraneuronal
CC       accumulations of aggregated proteins) are absent.
CC   -!- DISEASE: Note=Defects in PARK2 may be involved in the development
CC       and/or progression of ovarian cancer.
CC   -!- MISCELLANEOUS: The parkin locus (PRKN), adjacent to the 6q
CC       telomere is hyper-recombinable and lies within FRA6E, the third
CC       most common fragile site in tumor tissue.
CC   -!- MISCELLANEOUS: Members of the RBR family are atypical E3 ligases.
CC       They interact with the E2 conjugating enzyme UBE2L3 and function
CC       like HECT-type E3 enzymes: they bind E2s via the first RING
CC       domain, but require an obligate trans-thiolation step during the
CC       ubiquitin transfer, requiring a conserved cysteine residue in the
CC       second RING domain (PubMed:21532592).
CC   -!- SIMILARITY: Belongs to the RBR family. Parkin subfamily.
CC   -!- SIMILARITY: Contains 1 IBR-type zinc finger.
CC   -!- SIMILARITY: Contains 2 RING-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 ubiquitin-like domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PARK2";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Life's tremors - Issue
CC       131 of September 2011;
CC       URL="http://web.expasy.org/spotlight/back_issues/sptlt131.shtml";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB009973; BAA25751.1; -; mRNA.
DR   EMBL; EF375726; ABN46990.1; -; mRNA.
DR   EMBL; AF381282; AAM21457.1; -; mRNA.
DR   EMBL; AF381283; AAM21458.1; -; mRNA.
DR   EMBL; AF381286; AAM21461.1; -; mRNA.
DR   EMBL; AK292590; BAF85279.1; -; mRNA.
DR   EMBL; AL445215; CAH73681.1; -; Genomic_DNA.
DR   EMBL; AL035697; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AL132982; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP000886; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP000887; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP001576; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP001577; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP001578; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AP003699; CAH73681.1; JOINED; Genomic_DNA.
DR   EMBL; AL035697; CAI21385.1; -; Genomic_DNA.
DR   EMBL; AL132982; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AL445215; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP000886; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP000887; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP001576; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP001577; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP001578; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AP003699; CAI21385.1; JOINED; Genomic_DNA.
DR   EMBL; AL132982; CAI23601.1; -; Genomic_DNA.
DR   EMBL; AL035697; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AL445215; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP000886; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP000887; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP001576; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP001577; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP001578; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; AP003699; CAI23601.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW47573.1; -; Genomic_DNA.
DR   EMBL; BC022014; AAH22014.1; -; mRNA.
DR   EMBL; AY564225; AAS88422.1; -; Genomic_DNA.
DR   IPI; IPI00005254; -.
DR   IPI; IPI00332282; -.
DR   IPI; IPI00332283; -.
DR   IPI; IPI00470428; -.
DR   IPI; IPI00470429; -.
DR   IPI; IPI00984693; -.
DR   RefSeq; NP_004553.2; NM_004562.2.
DR   RefSeq; NP_054642.2; NM_013987.2.
DR   RefSeq; NP_054643.2; NM_013988.2.
DR   UniGene; Hs.132954; -.
DR   PDB; 1IYF; NMR; -; A=1-76.
DR   PDB; 2JMO; NMR; -; A=308-384.
DR   PDBsum; 1IYF; -.
DR   PDBsum; 2JMO; -.
DR   ProteinModelPortal; O60260; -.
DR   SMR; O60260; 1-76, 307-384, 410-464.
DR   DIP; DIP-37655N; -.
DR   IntAct; O60260; 13.
DR   MINT; MINT-1351124; -.
DR   STRING; O60260; -.
DR   PhosphoSite; O60260; -.
DR   PaxDb; O60260; -.
DR   PRIDE; O60260; -.
DR   DNASU; 5071; -.
DR   Ensembl; ENST00000338468; ENSP00000343589; ENSG00000185345.
DR   Ensembl; ENST00000366894; ENSP00000355860; ENSG00000185345.
DR   Ensembl; ENST00000366896; ENSP00000355862; ENSG00000185345.
DR   Ensembl; ENST00000366897; ENSP00000355863; ENSG00000185345.
DR   Ensembl; ENST00000366898; ENSP00000355865; ENSG00000185345.
DR   Ensembl; ENST00000479615; ENSP00000434414; ENSG00000185345.
DR   GeneID; 5071; -.
DR   KEGG; hsa:5071; -.
DR   UCSC; uc003qtx.4; human.
DR   UCSC; uc010kke.1; human.
DR   CTD; 5071; -.
DR   GeneCards; GC06M161740; -.
DR   HGNC; HGNC:8607; PARK2.
DR   HPA; CAB016257; -.
DR   MIM; 168600; phenotype.
DR   MIM; 600116; phenotype.
DR   MIM; 602544; gene.
DR   neXtProt; NX_O60260; -.
DR   Orphanet; 2828; Young adult-onset Parkinsonism.
DR   PharmGKB; PA32942; -.
DR   eggNOG; NOG278133; -.
DR   HOVERGEN; HBG053682; -.
DR   InParanoid; O60260; -.
DR   KO; K04556; -.
DR   OMA; GGEKDFA; -.
DR   OrthoDB; EOG4HHP2G; -.
DR   PhylomeDB; O60260; -.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Reactome; REACT_6900; Immune System.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; O60260; -.
DR   GenomeRNAi; 5071; -.
DR   NextBio; 19538; -.
DR   ArrayExpress; O60260; -.
DR   Bgee; O60260; -.
DR   CleanEx; HS_PARK2; -.
DR   Genevestigator; O60260; -.
DR   GermOnline; ENSG00000185345; Homo sapiens.
DR   GO; GO:0016235; C:aggresome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0070842; P:aggresome assembly; IMP:BHF-UCL.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0000422; P:mitochondrion degradation; IMP:UniProtKB.
DR   GO; GO:0032232; P:negative regulation of actin filament bundle assembly; IDA:BHF-UCL.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL.
DR   GO; GO:0070997; P:neuron death; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; IDA:BHF-UCL.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:UniProtKB.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB.
DR   InterPro; IPR003977; Parkin.
DR   InterPro; IPR000626; Ubiquitin.
DR   InterPro; IPR019955; Ubiquitin_supergroup.
DR   InterPro; IPR002867; Znf_C6HC.
DR   PANTHER; PTHR11685:SF2; PTHR11685:SF2; 1.
DR   Pfam; PF01485; IBR; 2.
DR   Pfam; PF00240; ubiquitin; 1.
DR   PIRSF; PIRSF037880; Parkin; 1.
DR   PRINTS; PR01475; PARKIN.
DR   SMART; SM00647; IBR; 2.
DR   SMART; SM00213; UBQ; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; FALSE_NEG.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
DR   PROSITE; PS00518; ZF_RING_1; FALSE_NEG.
DR   PROSITE; PS50089; ZF_RING_2; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autophagy; Complete proteome;
KW   Cytoplasm; Disease mutation; Endoplasmic reticulum; Ligase;
KW   Metal-binding; Mitochondrion; Neurodegeneration; Nucleus;
KW   Parkinson disease; Parkinsonism; Polymorphism; Reference proteome;
KW   Repeat; S-nitrosylation; Ubl conjugation; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    465       E3 ubiquitin-protein ligase parkin.
FT                                /FTId=PRO_0000058576.
FT   DOMAIN        1     76       Ubiquitin-like.
FT   ZN_FING     238    293       RING-type 1; atypical.
FT   ZN_FING     313    377       IBR-type.
FT   ZN_FING     418    449       RING-type 2.
FT   REGION      204    238       SYT11 binding 1.
FT   REGION      257    293       SYT11 binding 2.
FT   VAR_SEQ       1    191       Missing (in isoform 4).
FT                                /FTId=VSP_011705.
FT   VAR_SEQ       1     79       Missing (in isoform 3).
FT                                /FTId=VSP_011706.
FT   VAR_SEQ      58    206       Missing (in isoform 6).
FT                                /FTId=VSP_041563.
FT   VAR_SEQ     179    206       Missing (in isoform 2).
FT                                /FTId=VSP_011707.
FT   VAR_SEQ     290    290       V -> VGTGDTVVLRGALGGFRRGV (in isoform 5).
FT                                /FTId=VSP_011708.
FT   VAR_SEQ     291    297       AGCPNSL -> VCLLPGM (in isoform 3).
FT                                /FTId=VSP_011709.
FT   VAR_SEQ     298    465       Missing (in isoform 3).
FT                                /FTId=VSP_011710.
FT   VAR_SEQ     362    368       FAFCREC -> YGQRRTK (in isoform 5).
FT                                /FTId=VSP_011711.
FT   VAR_SEQ     369    465       Missing (in isoform 5).
FT                                /FTId=VSP_011712.
FT   VARIANT      15     15       V -> M (in PARK).
FT                                /FTId=VAR_019733.
FT   VARIANT      33     33       R -> Q (in PARK).
FT                                /FTId=VAR_019734.
FT   VARIANT      37     37       P -> L (in PARK2).
FT                                /FTId=VAR_019735.
FT   VARIANT      42     42       R -> P (in PARK; early-onset; induces a
FT                                conformational change in the PSMD4-
FT                                binding site of Ubl resulting in impaired
FT                                proteasomal binding).
FT                                /FTId=VAR_019736.
FT   VARIANT      46     46       A -> P (in PARK; early-onset; sporadic).
FT                                /FTId=VAR_019737.
FT   VARIANT      82     82       A -> E (in PARK2 and PARK;
FT                                dbSNP:rs55774500).
FT                                /FTId=VAR_019738.
FT   VARIANT      92     92       A -> V (in PARK2).
FT                                /FTId=VAR_019739.
FT   VARIANT     100    100       Q -> H.
FT                                /FTId=VAR_019740.
FT   VARIANT     161    161       K -> N (in PARK2 and PARK; severely
FT                                compromises the mitochondrial
FT                                localization and fails to stabilize
FT                                BCL2).
FT                                /FTId=VAR_019741.
FT   VARIANT     167    167       S -> N (in dbSNP:rs1801474).
FT                                /FTId=VAR_019742.
FT   VARIANT     192    192       M -> L (in dbSNP:rs9456735).
FT                                /FTId=VAR_054107.
FT   VARIANT     192    192       M -> V (in PARK; early and late onset;
FT                                dbSNP:rs9456735).
FT                                /FTId=VAR_019743.
FT   VARIANT     211    211       K -> N (in PARK; early and late onset;
FT                                severely compromises the mitochondrial
FT                                localization).
FT                                /FTId=VAR_019744.
FT   VARIANT     211    211       K -> R (in PARK; early onset).
FT                                /FTId=VAR_019745.
FT   VARIANT     212    212       C -> Y (in PARK2).
FT                                /FTId=VAR_019746.
FT   VARIANT     240    240       T -> M (in PARK; late onset).
FT                                /FTId=VAR_019747.
FT   VARIANT     240    240       T -> R (in PARK2; impairs the ability to
FT                                ubiquitinate SNCAIP and BCL2; loss of
FT                                UBE2L3 binding; severely compromises the
FT                                mitochondrial localization).
FT                                /FTId=VAR_019748.
FT   VARIANT     253    253       C -> Y (in PARK; late onset).
FT                                /FTId=VAR_019749.
FT   VARIANT     256    256       R -> C (in PARK2 and PARK; early and late
FT                                onset; impairs the ability to
FT                                ubiquitinate SNCAIP and ZNF746;
FT                                dbSNP:rs34424986).
FT                                /FTId=VAR_019750.
FT   VARIANT     271    271       R -> S.
FT                                /FTId=VAR_019751.
FT   VARIANT     275    275       R -> W (in PARK2 and PARK; early and late
FT                                onset; impairs the ability to
FT                                ubiquitinate SNCAIP; dbSNP:rs34424986).
FT                                /FTId=VAR_019752.
FT   VARIANT     280    280       D -> N (in PARK; does not affect PINK-1
FT                                dependent localization to depolarized
FT                                mitochondria).
FT                                /FTId=VAR_019753.
FT   VARIANT     284    284       G -> R (in PARK2).
FT                                /FTId=VAR_019754.
FT   VARIANT     289    289       C -> G (in PARK; fails to ubiquitinate
FT                                SYT11; loses ability to bind SYT11;
FT                                dbSNP:rs55961220).
FT                                /FTId=VAR_019755.
FT   VARIANT     311    311       Q -> R (in a patient with Parkinson
FT                                disease; unknown pathological
FT                                significance).
FT                                /FTId=VAR_062672.
FT   VARIANT     328    328       G -> E (in PARK; does not affect PINK-1
FT                                dependent localization to depolarized
FT                                mitochondria).
FT                                /FTId=VAR_019756.
FT   VARIANT     334    334       R -> C (in PARK).
FT                                /FTId=VAR_019757.
FT   VARIANT     339    339       A -> S.
FT                                /FTId=VAR_019758.
FT   VARIANT     351    351       T -> P (in PARK2; impairs folding of IBR
FT                                domain).
FT                                /FTId=VAR_019759.
FT   VARIANT     366    366       R -> W (in dbSNP:rs56092260).
FT                                /FTId=VAR_019760.
FT   VARIANT     371    371       A -> T (in a patient with Parkinson
FT                                disease; unknown pathological
FT                                significance).
FT                                /FTId=VAR_062673.
FT   VARIANT     380    380       V -> L (in dbSNP:rs1801582).
FT                                /FTId=VAR_019761.
FT   VARIANT     394    394       D -> N (in dbSNP:rs1801334).
FT                                /FTId=VAR_019762.
FT   VARIANT     415    415       T -> N (in PARK2 and PARK; impairs the
FT                                ability to ubiquitinate SNCAIP; does not
FT                                affect turnover of CDCRE1; impairs PINK1-
FT                                dependent localization to dysfunctional
FT                                depolarized mitochondria).
FT                                /FTId=VAR_019763.
FT   VARIANT     430    430       G -> D (in PARK; early onset; impairs
FT                                PINK1-dependent localization to
FT                                dysfunctional depolarized mitochondria;
FT                                impaired E3 ubiquitin-protein ligase
FT                                toward ZNF746).
FT                                /FTId=VAR_019764.
FT   VARIANT     431    431       C -> F (in PARK2; impaired E3 ubiquitin-
FT                                protein ligase toward ZNF746 and BCL2).
FT                                /FTId=VAR_019765.
FT   VARIANT     437    437       P -> L (in PARK; early and late onset and
FT                                impaired E3 ubiquitin-protein ligase
FT                                toward BCL2).
FT                                /FTId=VAR_019766.
FT   VARIANT     441    441       C -> R (in PARK).
FT                                /FTId=VAR_019767.
FT   MUTAGEN     332    332       C->S: Impairs folding of IBR domain.
FT   MUTAGEN     337    337       C->A: Impairs the ability to ubiquitinate
FT                                SNCAIP.
FT   MUTAGEN     365    365       C->S: Impairs protein folding.
FT   MUTAGEN     418    418       C->R: Fails to ubiquitinate SYT11. Does
FT                                not loose ability to bind SYT11.
FT   MUTAGEN     421    421       C->A: Impairs the ability of self-
FT                                ubiquitination and to ubiquitinate
FT                                SNCAIP.
FT   MUTAGEN     431    431       C->A: Impairs the ability to ubiquitinate
FT                                SNCAIP.
FT   CONFLICT    223    223       S -> P (in Ref. 1; BAA25751 and 3;
FT                                AAM21458/AAM21457).
FT   CONFLICT    289    290       CV -> MI (in Ref. 2; AAM21461).
FT   CONFLICT    339    339       A -> V (in Ref. 8; AAS88422).
FT   STRAND        2      7
FT   TURN          8     10
FT   STRAND       11     17
FT   STRAND       19     21
FT   HELIX        23     33
FT   STRAND       38     45
FT   STRAND       48     50
FT   TURN         52     55
FT   HELIX        57     60
FT   STRAND       63     70
FT   STRAND      318    320
FT   STRAND      334    336
FT   STRAND      354    356
FT   TURN        366    369
FT   STRAND      377    379
SQ   SEQUENCE   465 AA;  51641 MW;  9A8BB802A3FC84C3 CRC64;
     MIVFVRFNSS HGFPVEVDSD TSIFQLKEVV AKRQGVPADQ LRVIFAGKEL RNDWTVQNCD
     LDQQSIVHIV QRPWRKGQEM NATGGDDPRN AAGGCEREPQ SLTRVDLSSS VLPGDSVGLA
     VILHTDSRKD SPPAGSPAGR SIYNSFYVYC KGPCQRVQPG KLRVQCSTCR QATLTLTQGP
     SCWDDVLIPN RMSGECQSPH CPGTSAEFFF KCGAHPTSDK ETSVALHLIA TNSRNITCIT
     CTDVRSPVLV FQCNSRHVIC LDCFHLYCVT RLNDRQFVHD PQLGYSLPCV AGCPNSLIKE
     LHHFRILGEE QYNRYQQYGA EECVLQMGGV LCPRPGCGAG LLPEPDQRKV TCEGGNGLGC
     GFAFCRECKE AYHEGECSAV FEASGTTTQA YRVDERAAEQ ARWEAASKET IKKTTKPCPR
     CHVPVEKNGG CMHMKCPQPQ CRLEWCWNCG CEWNRVCMGD HWFDV
//
ID   SNO4_YEAST              Reviewed;         237 AA.
AC   Q04902; D6W0E9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   09-JAN-2013, entry version 83.
DE   RecName: Full=Protein SNO4;
DE            EC=3.2.-.-;
GN   Name=SNO4; OrderedLocusNames=YMR322C; ORFNames=YM9924.14C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204511 / S288c / AB972;
RX   MEDLINE=97313268; PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S.,
RA   Jagels K., Lye G., Moule S., Odell C., Pearson D., Rajandream M.A.,
RA   Rice P., Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RG   Saccharomyces Genome Database;
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May act as a chaperone.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z54141; CAA90840.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10223.1; -; Genomic_DNA.
DR   RefSeq; NP_014055.1; NM_001182835.1.
DR   ProteinModelPortal; Q04902; -.
DR   SMR; Q04902; 4-237.
DR   DIP; DIP-1968N; -.
DR   IntAct; Q04902; 8.
DR   MINT; MINT-386922; -.
DR   STRING; Q04902; -.
DR   MEROPS; C56.A04; -.
DR   EnsemblFungi; YMR322C; YMR322C; YMR322C.
DR   GeneID; 855372; -.
DR   KEGG; sce:YMR322C; -.
DR   CYGD; YMR322c; -.
DR   SGD; S000004941; SNO4.
DR   GeneTree; ENSGT00390000013431; -.
DR   HOGENOM; HOG000181653; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   NextBio; 979157; -.
DR   Genevestigator; Q04902; -.
DR   GermOnline; YMR322C; Saccharomyces cerevisiae.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; ISS:SGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    237       Protein SNO4.
FT                                /FTId=PRO_0000157853.
FT   ACT_SITE    138    138       Potential.
FT   ACT_SITE    139    139       Potential.
FT   ACT_SITE    170    170       Potential.
SQ   SEQUENCE   237 AA;  26040 MW;  004EA3E702332905 CRC64;
     MTPKRALISL TSYHGPFYKD GAKTGVFVVE ILRSFDTFEK HGFEVDFVSE TGGFGWDEHY
     LPKSFIGGED KMNFETKNSA FNKALARIKT ANEVNASDYK IFFASAGHGA LFDYPKAKNL
     QDIASKIYAN GGVIAAICHG PLLFDGLIDI KTTRPLIEGK AITGFPLEGE IALGVDDILR
     SRKLTTVERV ANKNRAKYLA PIHPWDDYSI TDGKLVTGVN ANSSYSTTIR AINALYS
//
ID   TOPRS_HUMAN             Reviewed;        1045 AA.
AC   Q9NS56; O43273; Q6P987; Q9NS55; Q9UNR9;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   06-FEB-2013, entry version 100.
DE   RecName: Full=E3 ubiquitin-protein ligase Topors;
DE            EC=6.3.2.-;
DE   AltName: Full=SUMO1-protein E3 ligase Topors;
DE   AltName: Full=Topoisomerase I-binding RING finger protein;
DE   AltName: Full=Topoisomerase I-binding arginine/serine-rich protein;
DE   AltName: Full=Tumor suppressor p53-binding protein 3;
DE            Short=p53-binding protein 3;
DE            Short=p53BP3;
GN   Name=TOPORS; Synonyms=LUN, TP53BPL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH TOP1, AND
RP   SUBCELLULAR LOCATION.
RX   MEDLINE=99289498; PubMed=10352183; DOI=10.1093/nar/27.12.2538;
RA   Haluska P. Jr., Saleem A., Rasheed Z., Ahmed F., Su E.W., Liu L.F.,
RA   Rubin E.H.;
RT   "Interaction between human topoisomerase I and a novel RING
RT   finger/arginine-serine protein.";
RL   Nucleic Acids Res. 27:2538-2544(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PUTATIVE DNA-BINDING,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   MEDLINE=21216701; PubMed=11278651; DOI=10.1074/jbc.M010262200;
RA   Chu D., Kakazu N., Gorrin-Rivas M.J., Lu H.P., Kawata M., Abe T.,
RA   Ueda K., Adachi Y.;
RT   "Cloning and characterization of LUN, a novel RING-finger protein that
RT   is highly expressed in lung and specifically binds to a palindromic
RT   sequence.";
RL   J. Biol. Chem. 276:14004-14013(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   THR-154; LYS-517 AND ASP-749.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 51-1045 (ISOFORM 1), INTERACTION WITH
RP   TP53, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   MEDLINE=99346144; PubMed=10415337; DOI=10.1016/S0378-1119(99)00203-6;
RA   Zhou R., Wen H., Ao S.-Z.;
RT   "Identification of a novel gene encoding a p53-associated protein.";
RL   Gene 235:93-101(1999).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12083797; DOI=10.1006/excr.2002.5550;
RA   Rasheed Z.A., Saleem A., Ravee Y., Pandolfi P.P., Rubin E.H.;
RT   "The topoisomerase I-binding RING protein, topors, is associated with
RT   promyelocytic leukemia nuclear bodies.";
RL   Exp. Cell Res. 277:152-160(2002).
RN   [7]
RP   INTERACTION WITH SUMO1 AND UBE2I, SUBCELLULAR LOCATION, SUMOYLATION,
RP   AND MUTAGENESIS OF LYS-76; LYS-301; LYS-485; LYS-560 AND LYS-921.
RX   PubMed=14516784; DOI=10.1016/S0014-4827(03)00292-1;
RA   Weger S., Hammer E., Engstler M.;
RT   "The DNA topoisomerase I binding protein topors as a novel cellular
RT   target for SUMO-1 modification: characterization of domains necessary
RT   for subcellular localization and sumolation.";
RL   Exp. Cell Res. 290:13-27(2003).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF TRP-131.
RX   PubMed=15247280; DOI=10.1074/jbc.C400300200;
RA   Rajendra R., Malegaonkar D., Pungaliya P., Marshall H., Rasheed Z.,
RA   Brownell J., Liu L.F., Lutzker S., Saleem A., Rubin E.H.;
RT   "Topors functions as an E3 ubiquitin ligase with specific E2 enzymes
RT   and ubiquitinates p53.";
RL   J. Biol. Chem. 279:36440-36444(2004).
RN   [9]
RP   REDUCED EXPRESSION IN LUNG CANCERS.
RX   PubMed=15364129; DOI=10.1016/j.lungcan.2004.03.009;
RA   Oyanagi H., Takenaka K., Ishikawa S., Kawano Y., Adachi Y., Ueda K.,
RA   Wada H., Tanaka F.;
RT   "Expression of LUN gene that encodes a novel RING finger protein is
RT   correlated with development and progression of non-small cell lung
RT   cancer.";
RL   Lung Cancer 46:21-28(2004).
RN   [10]
RP   TISSUE SPECIFICITY, AND REDUCED EXPRESSION IN COLON CANCERS.
RX   PubMed=15107820; DOI=10.1038/sj.onc.1207700;
RA   Saleem A., Dutta J., Malegaonkar D., Rasheed F., Rasheed Z.,
RA   Rajendra R., Marshall H., Luo M., Li H., Rubin E.H.;
RT   "The topoisomerase I- and p53-binding protein topors is differentially
RT   expressed in normal and malignant human tissues and may function as a
RT   tumor suppressor.";
RL   Oncogene 23:5293-5300(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [12]
RP   FUNCTION, AND SUMOYLATION.
RX   PubMed=16122737; DOI=10.1016/j.febslet.2005.07.088;
RA   Weger S., Hammer E., Heilbronn R.;
RT   "Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.";
RL   FEBS Lett. 579:5007-5012(2005).
RN   [13]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=15735665; DOI=10.1038/sj.onc.1208554;
RA   Lin L., Ozaki T., Takada Y., Kageyama H., Nakamura Y., Hata A.,
RA   Zhang J.H., Simonds W.F., Nakagawara A., Koseki H.;
RT   "Topors, a p53 and topoisomerase I-binding RING finger protein, is a
RT   coactivator of p53 in growth suppression induced by DNA damage.";
RL   Oncogene 24:3385-3396(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-902; SER-912 AND
RP   SER-914, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   INVOLVEMENT IN RP31.
RX   PubMed=17924349; DOI=10.1086/521953;
RA   Chakarova C.F., Papaioannou M.G., Khanna H., Lopez I., Waseem N.,
RA   Shah A., Theis T., Friedman J., Maubaret C., Bujakowska K.,
RA   Veraitch B., El-Aziz M.M.A., Prescott de Q., Parapuram S.K.,
RA   Bickmore W.A., Munro P.M.G., Gal A., Hamel C.P., Marigo V.,
RA   Ponting C.P., Wissinger B., Zrenner E., Matter K., Swaroop A.,
RA   Koenekoop R.K., Bhattacharya S.S.;
RT   "Mutations in TOPORS cause autosomal dominant retinitis pigmentosa
RT   with perivascular retinal pigment epithelium atrophy.";
RL   Am. J. Hum. Genet. 81:1098-1103(2007).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SIN3A.
RX   PubMed=17803295; DOI=10.1021/pr0703674;
RA   Pungaliya P., Kulkarni D., Park H.J., Marshall H., Zheng H.,
RA   Lackland H., Saleem A., Rubin E.H.;
RT   "TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying
RT   proteins.";
RL   J. Proteome Res. 6:3918-3923(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [18]
RP   PHOSPHORYLATION AT SER-98; SER-499; SER-585 AND SER-866, MASS
RP   SPECTROMETRY, AND MUTAGENESIS OF SER-98.
RX   PubMed=19053840; DOI=10.1021/bi801904q;
RA   Park H.J., Zheng H., Kulkarni D., Kerrigan J., Pungaliya P.,
RA   Saleem A., Rubin E.H.;
RT   "Identification of phosphorylation sites of TOPORS and a role for
RT   serine 98 in the regulation of ubiquitin but not SUMO E3 ligase
RT   activity.";
RL   Biochemistry 47:13887-13896(2008).
RN   [19]
RP   FUNCTION, INTERACTION WITH NKX3-1, AND SUBCELLULAR LOCATION.
RX   PubMed=18077445; DOI=10.1074/jbc.M708630200;
RA   Guan B., Pungaliya P., Li X., Uquillas C., Mutton L.N., Rubin E.H.,
RA   Bieberich C.J.;
RT   "Ubiquitination by TOPORS regulates the prostate tumor suppressor
RT   NKX3.1.";
RL   J. Biol. Chem. 283:4834-4840(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   FUNCTION, INTERACTION WITH PLK1, PHOSPHORYLATION AT SER-718 BY PLK1,
RP   MUTAGENESIS OF SER-718, AND SUBCELLULAR LOCATION.
RX   PubMed=19473992; DOI=10.1074/jbc.C109.001560;
RA   Yang X., Li H., Zhou Z., Wang W.H., Deng A., Andrisani O., Liu X.;
RT   "Plk1-mediated phosphorylation of Topors regulates p53 stability.";
RL   J. Biol. Chem. 284:18588-18592(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-864 AND SER-866,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   FUNCTION, INTERACTION WITH IKBKE, AND SUBCELLULAR LOCATION.
RX   PubMed=20188669; DOI=10.1016/j.molcel.2010.01.018;
RA   Renner F., Moreno R., Schmitz M.L.;
RT   "SUMOylation-dependent localization of IKKepsilon in PML nuclear
RT   bodies is essential for protection against DNA-damage-triggered cell
RT   death.";
RL   Mol. Cell 37:503-515(2010).
CC   -!- FUNCTION: Functions as an E3 ubiquitin-protein ligase and as an E3
CC       SUMO1-protein ligase. Probable tumor suppressor involved in cell
CC       growth, cell proliferation and apoptosis that regulates p53/TP53
CC       stability through ubiquitin-dependent degradation. May regulate
CC       chromatin modification through sumoylation of several chromatin
CC       modification-associated proteins. May be involved in DNA damage-
CC       induced cell death through IKBKE sumoylation.
CC   -!- SUBUNIT: Interacts with PARK7/DJ-1 (By similarity). Interacts with
CC       TOP1. Interacts with p53/TP53; can both ubiquitinate and sumoylate
CC       p53/TP53. Interacts with the SUMO1 conjugating enzyme UBE2I.
CC       Interacts with SUMO1. Interacts with NKX3-1; polyubiquitinates
CC       NKX3-1 and induces its proteasomal degradation. Interacts with
CC       SIN3A; sumoylates SIN3A. Interacts with IKBKE; induced by DNA
CC       damage.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body. Note=Localizes
CC       to discrete nuclear foci which partly overlap with PML nuclear
CC       bodies. Targeted to PML nuclear bodies upon DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=LUN-1;
CC         IsoId=Q9NS56-1; Sequence=Displayed;
CC       Name=2; Synonyms=LUN-2;
CC         IsoId=Q9NS56-2; Sequence=VSP_017916, VSP_017917;
CC   -!- TISSUE SPECIFICITY: Expressed at highest levels in testis and at
CC       lower levels in adrenal gland, bone marrow, brain, colon, heart,
CC       kidney, liver, muscle, ovary, pancreas, placenta, prostate,
CC       skeletal muscle, skin, small intestine, spleen, stomach, testis,
CC       thymus, thyroid and uterus. Expressed in the alveolar epithelium
CC       of the lung. Expression is commonly decreased in colon
CC       adenocarcinomas and lung cancers.
CC   -!- INDUCTION: By genotoxic agents such as cisplatin and camptothecin.
CC   -!- PTM: Phosphorylation at Ser-98 regulates the E3 ubiquitin-protein
CC       ligase activity but not the SUMO1-protein ligase activity.
CC       Phosphorylation at Ser-718 increases the E3 ubiquitin-protein
CC       ligase activity versus the SUMO1-protein ligase activity resulting
CC       in increased p53/TP53 ubiquitination and degradation.
CC   -!- PTM: Sumoylated.
CC   -!- DISEASE: Defects in TOPORS are the cause of retinitis pigmentosa
CC       type 31 (RP31) [MIM:609923]. RP leads to degeneration of retinal
CC       photoreceptor cells. Patients typically have night vision
CC       blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field
CC       and eventually central vision as well. RP31 inheritance is
CC       autosomal dominant.
CC   -!- SIMILARITY: Contains 1 RING-type zinc finger.
CC   -!- CAUTION: Was originally (PubMed:11278651) thought to bind to the
CC       palindromic consensus sequence 5'-TCCCAGCACTTTGGGA-3' and to
CC       regulate the transcription of numerous genes in the lung.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC98530.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF098300; AAD23379.1; -; mRNA.
DR   EMBL; AB045732; BAB03714.1; -; mRNA.
DR   EMBL; AB045733; BAB03715.1; -; mRNA.
DR   EMBL; AL353671; CAH71253.1; -; Genomic_DNA.
DR   EMBL; AL353671; CAH71254.1; -; Genomic_DNA.
DR   EMBL; BC060884; AAH60884.1; -; mRNA.
DR   EMBL; U82939; AAC98530.1; ALT_INIT; mRNA.
DR   IPI; IPI00396077; -.
DR   IPI; IPI00643426; -.
DR   RefSeq; NP_001182551.1; NM_001195622.1.
DR   RefSeq; NP_005793.2; NM_005802.4.
DR   UniGene; Hs.589962; -.
DR   ProteinModelPortal; Q9NS56; -.
DR   SMR; Q9NS56; 99-147.
DR   IntAct; Q9NS56; 11.
DR   MINT; MINT-94004; -.
DR   STRING; Q9NS56; -.
DR   PhosphoSite; Q9NS56; -.
DR   DMDM; 74752935; -.
DR   PaxDb; Q9NS56; -.
DR   PRIDE; Q9NS56; -.
DR   Ensembl; ENST00000360538; ENSP00000353735; ENSG00000197579.
DR   Ensembl; ENST00000379858; ENSP00000369187; ENSG00000197579.
DR   GeneID; 10210; -.
DR   KEGG; hsa:10210; -.
DR   UCSC; uc003zrb.3; human.
DR   UCSC; uc003zrc.3; human.
DR   CTD; 10210; -.
DR   GeneCards; GC09M032496; -.
DR   HGNC; HGNC:21653; TOPORS.
DR   MIM; 609507; gene.
DR   MIM; 609923; phenotype.
DR   neXtProt; NX_Q9NS56; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA134979531; -.
DR   eggNOG; NOG244178; -.
DR   HOGENOM; HOG000231723; -.
DR   HOVERGEN; HBG080410; -.
DR   InParanoid; Q9NS56; -.
DR   KO; K10631; -.
DR   OMA; DIINFRR; -.
DR   OrthoDB; EOG47H5PC; -.
DR   PhylomeDB; Q9NS56; -.
DR   GenomeRNAi; 10210; -.
DR   NextBio; 38656; -.
DR   ArrayExpress; Q9NS56; -.
DR   Bgee; Q9NS56; -.
DR   CleanEx; HS_TOPORS; -.
DR   Genevestigator; Q9NS56; -.
DR   GermOnline; ENSG00000197579; Homo sapiens.
DR   GO; GO:0005814; C:centriole; IDA:BHF-UCL.
DR   GO; GO:0036064; C:cilium basal body; IDA:BHF-UCL.
DR   GO; GO:0000930; C:gamma-tubulin complex; IDA:BHF-UCL.
DR   GO; GO:0030496; C:midbody; TAS:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; IDA:BHF-UCL.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:BHF-UCL.
DR   GO; GO:0003823; F:antigen binding; IPI:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0035845; P:photoreceptor cell outer segment organization; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-dependent; IEA:Compara.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IDA:BHF-UCL.
DR   GO; GO:0043161; P:proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:BHF-UCL.
DR   GO; GO:0016925; P:protein sumoylation; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Compara.
DR   GO; GO:0010842; P:retina layer formation; ISS:BHF-UCL.
DR   GO; GO:0046549; P:retinal cone cell development; ISS:BHF-UCL.
DR   GO; GO:0046548; P:retinal rod cell development; ISS:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-dependent; NAS:UniProtKB.
DR   Gene3D; 3.30.40.10; Znf_RING/FYVE/PHD; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA damage; Isopeptide bond;
KW   Ligase; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Retinitis pigmentosa; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1045       E3 ubiquitin-protein ligase Topors.
FT                                /FTId=PRO_0000232626.
FT   ZN_FING     103    142       RING-type.
FT   REGION        1    195       E3 ubiquitin-protein ligase activity.
FT   REGION       51    374       Required for DNA-binding.
FT   REGION      437    654       Interaction with SUMO1.
FT   REGION      437    574       Required for sumoylation and localization
FT                                to discrete nuclear foci.
FT   REGION      456    882       Interaction with TOP1.
FT   REGION      456    731       Interaction with p53/TP53.
FT   REGION      854    917       Interaction with UBE2I.
FT   COMPBIAS    579    788       Arg-rich.
FT   COMPBIAS    854    895       Lys-rich.
FT   MOD_RES      98     98       Phosphoserine.
FT   MOD_RES     194    194       Phosphoserine.
FT   MOD_RES     499    499       Phosphoserine.
FT   MOD_RES     585    585       Phosphoserine.
FT   MOD_RES     718    718       Phosphoserine; by PLK1.
FT   MOD_RES     864    864       Phosphoserine.
FT   MOD_RES     866    866       Phosphoserine.
FT   MOD_RES     902    902       Phosphoserine.
FT   MOD_RES     912    912       Phosphoserine.
FT   MOD_RES     914    914       Phosphoserine.
FT   CROSSLNK    560    560       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   VAR_SEQ       1     65       Missing (in isoform 2).
FT                                /FTId=VSP_017916.
FT   VAR_SEQ      66     66       E -> M (in isoform 2).
FT                                /FTId=VSP_017917.
FT   VARIANT     154    154       A -> T (in dbSNP:rs17855104).
FT                                /FTId=VAR_037629.
FT   VARIANT     517    517       E -> K (in dbSNP:rs17855103).
FT                                /FTId=VAR_037630.
FT   VARIANT     749    749       N -> D (in dbSNP:rs17857515).
FT                                /FTId=VAR_037631.
FT   VARIANT     812    812       P -> R (in dbSNP:rs36034138).
FT                                /FTId=VAR_037632.
FT   MUTAGEN      76     76       K->R: No effect on sumoylation.
FT   MUTAGEN      98     98       S->A: Loss of phosphorylation but no
FT                                effect on E3 ubiquitin-protein ligase
FT                                activity.
FT   MUTAGEN      98     98       S->D: Increase in E3 ubiquitin-protein
FT                                ligase activity and increased binding to
FT                                UBE2D1. No effect on SUMO1-protein ligase
FT                                activity.
FT   MUTAGEN     131    131       W->A: Abrogates E3 ubiquitin-protein
FT                                ligase activity.
FT   MUTAGEN     301    301       K->R: No effect on sumoylation.
FT   MUTAGEN     485    485       K->R: No effect on sumoylation.
FT   MUTAGEN     560    560       K->R: Strongly reduces sumoylation.
FT   MUTAGEN     718    718       S->A: Loss of phosphorylation by PLK1 and
FT                                increases in p53/TP53 stability.
FT   MUTAGEN     921    921       K->R: No effect on sumoylation.
FT   CONFLICT    124    125       CF -> K (in Ref. 5; AAC98530).
FT   CONFLICT    257    257       N -> S (in Ref. 1; AAD23379).
FT   CONFLICT    308    308       F -> S (in Ref. 1; AAD23379).
FT   CONFLICT    922    922       E -> G (in Ref. 1; AAD23379).
FT   CONFLICT   1040   1040       R -> K (in Ref. 1; AAD23379).
SQ   SEQUENCE   1045 AA;  119198 MW;  3DA635FDB5C83B77 CRC64;
     MGSQPPLGSP LSREEGEAPP PAPASEGRRR SRRVRLRGSC RHRPSFLGCR ELAASAPARP
     APASSEIMAS AAKEFKMDNF SPKAGTSKLQ QTVPADASPD SKCPICLDRF DNVSYLDRCL
     HKFCFRCVQE WSKNKAECPL CKQPFDSIFH SVRAEDDFKE YVLRPSYNGS FVTPDRRFRY
     RTTLTRERNA SVYSPSGPVN RRTTTPPDSG VLFEGLGIST RPRDVEIPQF MRQIAVRRPT
     TADERSLRKI QEQDIINFRR TLYRAGARVR NIEDGGRYRD ISAEFFRRNP ACLHRLVPWL
     KRELTVLFGA HGSLVNIVQH IIMSNVTRYD LESQAFVSDL RPFLLNRTEH FIHEFISFAR
     SPFNMAAFDQ HANYDCPAPS YEEGSHSDSS VITISPDEAE TQELDINVAT VSQAPWDDET
     PGPSYSSSEQ VHVTMSSLLN TSDSSDEELV TGGATSQIQG VQTNDDLNND SDDSSDNCVI
     VGFVKPLAER TPELVELSSD SEDLGSYEKM ETVKTQEQEQ SYSSGDSDVS RCSSPHSVLG
     KDEQINKGHC DSSTRIKSKK EEKRSTSLSS PRNLNSSVRG DRVYSPYNHR HRKRGRSRSS
     DSRSQSRSGH DQKNHRKHHG KKRMKSKRSR SRESSRPRGR RDKKRSRTRD SSWSRRSQTL
     SLSSESTSRS RSRSSDHGKR RSRSRNRDRY YLRNNYGSRY KWEYTYYSRN KDRDGYESSY
     RRRTLSRAHY SRQSSSPEFR VQSFSERTNA RKKNNHSERK YYYYERHRSR SLSSNRSRTA
     STGTDRVRNE KPGGKRKYKT RHLEGTNEVA QPSREFASKA KDSHYQKSSS KLDGNYKNES
     DTFSDSRSSD RETKHKRRKR KTRSLSVEIV YEGKATDTTK HHKKKKKKHK KKHKKHHGDN
     ASRSPVVITI DSDSDKDSEV KEDTECDNSG PQDPLQNEFL APSLEPFETK DVVTIEAEFG
     VLDKECDIAT LSNNLNNANK TVDNIPPLAA SVEQTLDVRE ESTFVSDLEN QPSNIVSLQT
     EPSRQLPSPR TSLMSVCLGR DCDMS
//
ID   TOPRS_MOUSE             Reviewed;        1033 AA.
AC   Q80Z37; Q3U5B5; Q3UPZ1; Q3USN3; Q3UZ55; Q8BXP2; Q8CFF5; Q8CGC8;
AC   Q920L3;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   06-FEB-2013, entry version 80.
DE   RecName: Full=E3 ubiquitin-protein ligase Topors;
DE            EC=6.3.2.-;
DE   AltName: Full=SUMO1-protein E3 ligase Topors;
DE   AltName: Full=Topoisomerase I-binding RING finger protein;
DE   AltName: Full=Topoisomerase I-binding arginine/serine-rich protein;
DE   AltName: Full=Tumor suppressor p53-binding protein 3;
DE            Short=p53-binding protein 3;
DE            Short=p53BP3;
GN   Name=Topors;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH PARK7 AND TP53,
RP   AND SUBCELLULAR LOCATION.
RC   STRAIN=C57BL/6;
RX   PubMed=15703819;
RA   Shinbo Y., Taira T., Niki T., Iguchi-Ariga S.M.M., Ariga H.;
RT   "DJ-1 restores p53 transcription activity inhibited by
RT   Topors/p53BP3.";
RL   Int. J. Oncol. 26:641-648(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH TP53,
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=15735665; DOI=10.1038/sj.onc.1208554;
RA   Lin L., Ozaki T., Takada Y., Kageyama H., Nakamura Y., Hata A.,
RA   Zhang J.H., Simonds W.F., Nakagawara A., Koseki H.;
RT   "Topors, a p53 and topoisomerase I-binding RING finger protein, is a
RT   coactivator of p53 in growth suppression induced by DNA damage.";
RL   Oncogene 24:3385-3396(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-824.
RC   STRAIN=C57BL/6J;
RC   TISSUE=Corpora quadrigemina, Lung, Retina, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-911 AND SER-1025, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
CC   -!- FUNCTION: Functions as an E3 ubiquitin-protein ligase and as a E3
CC       SUMO1-protein ligase. Probable tumor suppressor involved in cell
CC       growth, cell proliferation and apoptosis that regulates p53/TP53
CC       stability through ubiquitin-dependent degradation. May regulate
CC       chromatin modification through sumoylation of several chromatin
CC       modification-associated proteins. May be involved in DNA-damage-
CC       induced cell death through IKBKE sumoylation.
CC   -!- SUBUNIT: Interacts with TOP1. Interacts with the SUMO1 conjugating
CC       enzyme UBE2I. Interacts with SUMO1. Interacts with NKX3-1;
CC       polyubiquitinates NKX3-1 and induces its proteasomal degradation.
CC       Interacts with SIN3A; sumoylates SIN3A. Interacts with IKBKE;
CC       induced by DNA damage (By similarity). Interacts with p53/TP53.
CC       Interacts with PARK7/DJ-1.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body (By similarity).
CC       Note=Localizes to discrete nuclear foci which partly overlap with
CC       PML nuclear bodies. Targeted to PML nuclear bodies upon DNA damage
CC       (By similarity).
CC   -!- INDUCTION: By genotoxic agents such as cisplatin and camptothecin.
CC   -!- PTM: Phosphorylation at Ser-99 regulates the E3 ubiquitin-protein
CC       ligase activity but not the SUMO1-protein ligase activity.
CC       Phosphorylation at Ser-718 increases the E3 ubiquitin-protein
CC       ligase activity versus the E3 SUMO1-protein ligase activity
CC       resulting in increased p53/TP53 ubiquitination and degradation (By
CC       similarity).
CC   -!- PTM: Sumoylated (By similarity).
CC   -!- SIMILARITY: Contains 1 RING-type zinc finger.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37141.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB072395; BAB69457.1; -; mRNA.
DR   EMBL; AB104865; BAC65157.1; -; mRNA.
DR   EMBL; BC037141; AAH37141.1; ALT_SEQ; mRNA.
DR   EMBL; BC040797; AAH40797.1; -; mRNA.
DR   EMBL; AK044564; BAC31981.2; -; mRNA.
DR   EMBL; AK134075; BAE22003.1; -; mRNA.
DR   EMBL; AK140250; BAE24298.1; -; mRNA.
DR   EMBL; AK143025; BAE25253.1; -; mRNA.
DR   EMBL; AK153743; BAE32164.1; -; mRNA.
DR   IPI; IPI00330897; -.
DR   RefSeq; NP_598858.2; NM_134097.3.
DR   UniGene; Mm.251548; -.
DR   ProteinModelPortal; Q80Z37; -.
DR   SMR; Q80Z37; 100-148.
DR   MINT; MINT-1789728; -.
DR   STRING; Q80Z37; -.
DR   PhosphoSite; Q80Z37; -.
DR   PRIDE; Q80Z37; -.
DR   Ensembl; ENSMUST00000042575; ENSMUSP00000046843; ENSMUSG00000036822.
DR   GeneID; 106021; -.
DR   KEGG; mmu:106021; -.
DR   CTD; 10210; -.
DR   MGI; MGI:2146189; Topors.
DR   eggNOG; NOG244178; -.
DR   GeneTree; ENSGT00530000064170; -.
DR   HOVERGEN; HBG080410; -.
DR   InParanoid; Q80Z37; -.
DR   KO; K10631; -.
DR   OMA; DIINFRR; -.
DR   OrthoDB; EOG47H5PC; -.
DR   NextBio; 358016; -.
DR   ArrayExpress; Q80Z37; -.
DR   Bgee; Q80Z37; -.
DR   CleanEx; MM_TOPORS; -.
DR   Genevestigator; Q80Z37; -.
DR   GermOnline; ENSMUSG00000036822; Mus musculus.
DR   GO; GO:0005814; C:centriole; IEA:Compara.
DR   GO; GO:0036064; C:cilium basal body; IDA:BHF-UCL.
DR   GO; GO:0000930; C:gamma-tubulin complex; IEA:Compara.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; IDA:BHF-UCL.
DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IEA:Compara.
DR   GO; GO:0003823; F:antigen binding; IEA:Compara.
DR   GO; GO:0003677; F:DNA binding; IEA:Compara.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO ligase activity; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISS:UniProtKB.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; IEA:Compara.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-dependent; IGI:MGI.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IEA:Compara.
DR   GO; GO:0043161; P:proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IEA:Compara.
DR   GO; GO:0034504; P:protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IEA:Compara.
DR   GO; GO:0016925; P:protein sumoylation; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IDA:MGI.
DR   Gene3D; 3.30.40.10; Znf_RING/FYVE/PHD; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA damage; Isopeptide bond; Ligase; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1033       E3 ubiquitin-protein ligase Topors.
FT                                /FTId=PRO_0000232627.
FT   ZN_FING     104    143       RING-type.
FT   REGION       52    376       Required for DNA-binding (By similarity).
FT   REGION      438    654       Interaction with SUMO1 (By similarity).
FT   REGION      438    574       Sumoylation and localization to discrete
FT                                nuclear foci (By similarity).
FT   REGION      457    879       Interaction with TOP1 (By similarity).
FT   REGION      457    731       Interaction with p53/TP53 (By
FT                                similarity).
FT   REGION      851    914       Interaction with UBE2I (By similarity).
FT   COMPBIAS    579    787       Arg-rich.
FT   COMPBIAS    877    892       Lys-rich.
FT   MOD_RES      99     99       Phosphoserine (By similarity).
FT   MOD_RES     196    196       Phosphoserine (By similarity).
FT   MOD_RES     500    500       Phosphoserine (By similarity).
FT   MOD_RES     585    585       Phosphoserine (By similarity).
FT   MOD_RES     718    718       Phosphoserine; by PLK1 (By similarity).
FT   MOD_RES     861    861       Phosphoserine (By similarity).
FT   MOD_RES     863    863       Phosphoserine (By similarity).
FT   MOD_RES     899    899       Phosphoserine (By similarity).
FT   MOD_RES     909    909       Phosphoserine (By similarity).
FT   MOD_RES     911    911       Phosphoserine.
FT   MOD_RES    1025   1025       Phosphoserine.
FT   CROSSLNK    561    561       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO) (By
FT                                similarity).
FT   CONFLICT     40     40       S -> F (in Ref. 1; BAB69457).
FT   CONFLICT    623    623       L -> P (in Ref. 3; AAH40797).
FT   CONFLICT    657    657       S -> A (in Ref. 1; BAB69457).
FT   CONFLICT    682    682       S -> A (in Ref. 3; AAH40797).
SQ   SEQUENCE   1033 AA;  117082 MW;  3A99C00491D7EFD2 CRC64;
     MGSQPPPPGS PLSREEGEAP PLVPAEEGRR RSRRVRLRGS CRHRPSLLSR RELASNGPAV
     PATASSEIMA SAAKEFKMDN FSPKAGTSKL QQTVPADASP DSKCPICLDR FDNVSYLDRC
     LHKFCFRCVQ EWSKNKAECP LCKQPFDSIF HSVRAEDDFK EYVLRPSYNG SFTNPEVRRF
     RYRTTMTRER SASLYSPSST VSRRTTTPPD SGVLFEGLGI STRPRDVDIP QFMRQMALRG
     PTTTDERSLR KIQEQDIINF RRTLYRAGVR VRSIEDGGRY RDISAEFFRR NPACLHRLVP
     WLKRELTVLF GAHGSLVNIV QHIIMSNVTR YDLESQAFVS DLRPFLLNRT EHFIHEFISF
     ARSPFNMAAF DQHANYDCPP SSEEGSRSDS SVITISPDEA ETQELDMNAS TVRQAPWDDE
     TPGPSYSSSE QVHVGVSSLL NSSDSSDEEL VSGGTTSQIQ GVQTNDDVNN DSDSSSDNCV
     IVGFVKPLAE RTPELVELSS DSEELGPYEK VETVKTQEQE QSYSSGDSDV SRASSPRSVL
     GKDEQMSKSH CDSDTRISSK KEEKRSTSLP APRDSSSTRG DRVCSPYNHR HRKGGRSRSS
     DSRSQSRSGH DPRNHRKHGK KRLRNKRSRS RESSSRPRAR KDKKRSRTRD SSWSRRSQTL
     SLSSGSTSRS RSRSSDHGKR RSRSRNRDRY YLRNNYGSKY KWEYTYYSRN KDRDGYESSY
     RRRTLSRAHY SRQSSSPEFR IQSFSERTNA RKKNHSERKY YYYERRRSRS VSSNRSRTTS
     AGPDRVRNEK PGGKRKYKTR HLEGTSEEAQ PAREFTSKGK DSHYQKSKLD GSYKNESDSF
     SDSRSSDRET KHKRRRRRTR SLSVEIVYEG KATDTSKHHK KKKKKHKKKH KKHHGDNTSR
     SPVVITIDSD SDGESEVKAG IECSNGSLPQ PIQDGAFETK DVVTIEDELG VLDKDCDVTA
     LADDLSTSQT VENCDSPAVP VEQTLDVREE STFASDLESQ SSNVSIQAEP SRPVPSPRTS
     LSSVSPGRDC DVS
//
ID   Y029_MYCGE              Reviewed;         186 AA.
AC   P47275; Q49223;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-NOV-2012, entry version 59.
DE   RecName: Full=Uncharacterized protein MG029;
GN   OrderedLocusNames=MG029;
OS   Mycoplasma genitalium (strain ATCC 33530 / G-37 / NCTC 10195).
OC   Bacteria; Tenericutes; Mollicutes; Mycoplasmataceae; Mycoplasma.
OX   NCBI_TaxID=243273;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33530 / G-37 / NCTC 10195;
RX   MEDLINE=96026346; PubMed=7569993; DOI=10.1126/science.270.5235.397;
RA   Fraser C.M., Gocayne J.D., White O., Adams M.D., Clayton R.A.,
RA   Fleischmann R.D., Bult C.J., Kerlavage A.R., Sutton G.G., Kelley J.M.,
RA   Fritchman J.L., Weidman J.F., Small K.V., Sandusky M., Fuhrmann J.L.,
RA   Nguyen D.T., Utterback T.R., Saudek D.M., Phillips C.A., Merrick J.M.,
RA   Tomb J.-F., Dougherty B.A., Bott K.F., Hu P.-C., Lucier T.S.,
RA   Peterson S.N., Smith H.O., Hutchison C.A. III, Venter J.C.;
RT   "The minimal gene complement of Mycoplasma genitalium.";
RL   Science 270:397-403(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-31.
RC   STRAIN=ATCC 33530 / G-37 / NCTC 10195;
RX   MEDLINE=94075230; PubMed=8253680;
RA   Peterson S.N., Hu P.-C., Bott K.F., Hutchison C.A. III;
RT   "A survey of the Mycoplasma genitalium genome by using random
RT   sequencing.";
RL   J. Bacteriol. 175:7918-7930(1993).
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD10593.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L43967; AAC71245.1; -; Genomic_DNA.
DR   EMBL; U01773; AAD10593.1; ALT_INIT; Genomic_DNA.
DR   PIR; B64203; B64203.
DR   RefSeq; NP_072689.1; NC_000908.2.
DR   ProteinModelPortal; P47275; -.
DR   GeneID; 875348; -.
DR   GenomeReviews; L43967_GR; MG029.
DR   KEGG; mge:MG_029; -.
DR   PATRIC; 20009434; VBIMycGen98045_0027.
DR   eggNOG; COG0693; -.
DR   BioCyc; MGEN243273:GH2R-68-MONOMER; -.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   4: Predicted;
KW   Complete proteome.
FT   CHAIN         1    186       Uncharacterized protein MG029.
FT                                /FTId=PRO_0000210393.
SQ   SEQUENCE   186 AA;  20884 MW;  A60F7B32027DC80E CRC64;
     MKKILVIVYP EMNDVEYTNV MVVFSFIKTI QTTCYHHSLK KITASNGVVE VNNIVNTINL
     SEFDAVYIPG GIGATKHLDK DEKLLKTINY FKVNNLYLFA ICDTPNVLFK HGIITKDEIY
     SSFPNPNLVM SENRSTAKVT VANKLITARS AGCALEFATV IVCTFLKDNT LNELVHKRLF
     GSEIKD
//
ID   Y032_MYCPN              Reviewed;         108 AA.
AC   P75082;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   28-NOV-2012, entry version 55.
DE   RecName: Full=Uncharacterized protein MG029 homolog;
GN   OrderedLocusNames=MPN_032; ORFNames=B01_orf108, MP122;
OS   Mycoplasma pneumoniae (strain ATCC 29342 / M129).
OC   Bacteria; Tenericutes; Mollicutes; Mycoplasmataceae; Mycoplasma.
OX   NCBI_TaxID=272634;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29342 / M129;
RX   MEDLINE=97105885; PubMed=8948633; DOI=10.1093/nar/24.22.4420;
RA   Himmelreich R., Hilbert H., Plagens H., Pirkl E., Li B.-C.,
RA   Herrmann R.;
RT   "Complete sequence analysis of the genome of the bacterium Mycoplasma
RT   pneumoniae.";
RL   Nucleic Acids Res. 24:4420-4449(1996).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00089; AAB95770.1; -; Genomic_DNA.
DR   PIR; S73448; S73448.
DR   RefSeq; NP_109720.1; NC_000912.1.
DR   ProteinModelPortal; P75082; -.
DR   IntAct; P75082; 3.
DR   GeneID; 876894; -.
DR   GenomeReviews; U00089_GR; MPN_032.
DR   KEGG; mpn:MPN032; -.
DR   PATRIC; 20021339; VBIMycPne110_0031.
DR   eggNOG; COG0693; -.
DR   BioCyc; MPNE272634:GJ6Z-34-MONOMER; -.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   4: Predicted;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    108       Uncharacterized protein MG029 homolog.
FT                                /FTId=PRO_0000210394.
SQ   SEQUENCE   108 AA;  12200 MW;  6C0D6FDA546E8B2C CRC64;
     MKKLLVIVYP DMNDVEYTNT MVVFGFVKEL QTVIYHPNLS TVKGSNGVTL VNQITSKVNL
     EEFDGVFIPG GMGATKVLDH DQQLLDTIRY FKDHDKYVFA ICDTPNVL
//
ID   Y1084_STAHJ             Reviewed;         172 AA.
AC   Q4L7I2;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   06-FEB-2013, entry version 47.
DE   RecName: Full=Uncharacterized protein SH1084;
GN   OrderedLocusNames=SH1084;
OS   Staphylococcus haemolyticus (strain JCSC1435).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=279808;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JCSC1435;
RX   PubMed=16237012; DOI=10.1128/JB.187.21.7292-7308.2005;
RA   Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y.,
RA   Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S.,
RA   Lee J.C., Hiramatsu K.;
RT   "Whole-genome sequencing of Staphylococcus haemolyticus uncovers the
RT   extreme plasticity of its genome and the evolution of human-colonizing
RT   staphylococcal species.";
RL   J. Bacteriol. 187:7292-7308(2005).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP006716; BAE04393.1; -; Genomic_DNA.
DR   RefSeq; YP_252999.1; NC_007168.1.
DR   ProteinModelPortal; Q4L7I2; -.
DR   STRING; Q4L7I2; -.
DR   EnsemblBacteria; EBSTAT00000044614; EBSTAP00000043065; EBSTAG00000044612.
DR   GeneID; 3483605; -.
DR   GenomeReviews; AP006716_GR; SH1084.
DR   KEGG; sha:SH1084; -.
DR   PATRIC; 19618215; VBIStaHae67511_1069.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; WVDEQVV; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SHAE279808:GJX7-1100-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    172       Uncharacterized protein SH1084.
FT                                /FTId=PRO_0000157843.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   172 AA;  18674 MW;  003B57F6BDB3A570 CRC64;
     MTKKVAIILS NEFEDIELTS PKEAIEEAGF ETEIIGDTAN AEVVGKHGEK VIVDVSIADA
     KPEDYDGLLI PGGFSPDHLR GDAEGRYGTF AKYFTKNDVP AFAICHGPQI LIDTDDLNGR
     TLTAVLNVRK DLSNAGANVV DESVVVDKNI VTSRTPDDLD DFNREIVKQL QA
//
ID   Y1281_ARCFU             Reviewed;         168 AA.
AC   O28987;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   28-NOV-2012, entry version 73.
DE   RecName: Full=Uncharacterized protein AF_1281;
GN   OrderedLocusNames=AF_1281;
OS   Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM
OS   9628 / NBRC 100126).
OC   Archaea; Euryarchaeota; Archaeoglobi; Archaeoglobales;
OC   Archaeoglobaceae; Archaeoglobus.
OX   NCBI_TaxID=224325;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126;
RX   MEDLINE=98049343; PubMed=9389475; DOI=10.1038/37052;
RA   Klenk H.-P., Clayton R.A., Tomb J.-F., White O., Nelson K.E.,
RA   Ketchum K.A., Dodson R.J., Gwinn M.L., Hickey E.K., Peterson J.D.,
RA   Richardson D.L., Kerlavage A.R., Graham D.E., Kyrpides N.C.,
RA   Fleischmann R.D., Quackenbush J., Lee N.H., Sutton G.G., Gill S.R.,
RA   Kirkness E.F., Dougherty B.A., McKenney K., Adams M.D., Loftus B.J.,
RA   Peterson S.N., Reich C.I., McNeil L.K., Badger J.H., Glodek A.,
RA   Zhou L., Overbeek R., Gocayne J.D., Weidman J.F., McDonald L.A.,
RA   Utterback T.R., Cotton M.D., Spriggs T., Artiach P., Kaine B.P.,
RA   Sykes S.M., Sadow P.W., D'Andrea K.P., Bowman C., Fujii C.,
RA   Garland S.A., Mason T.M., Olsen G.J., Fraser C.M., Smith H.O.,
RA   Woese C.R., Venter J.C.;
RT   "The complete genome sequence of the hyperthermophilic, sulphate-
RT   reducing archaeon Archaeoglobus fulgidus.";
RL   Nature 390:364-370(1997).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE000782; AAB89965.1; -; Genomic_DNA.
DR   PIR; H69409; H69409.
DR   RefSeq; NP_070109.1; NC_000917.1.
DR   ProteinModelPortal; O28987; -.
DR   MEROPS; C56.001; -.
DR   GeneID; 1484506; -.
DR   GenomeReviews; AE000782_GR; AF_1281.
DR   KEGG; afu:AF1281; -.
DR   eggNOG; COG0693; -.
DR   KO; K05520; -.
DR   OMA; GRKATCW; -.
DR   BioCyc; AFUL224325:GJBC-1307-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    168       Uncharacterized protein AF_1281.
FT                                /FTId=PRO_0000157846.
FT   DOMAIN        1    166       PfpI endopeptidase.
SQ   SEQUENCE   168 AA;  18968 MW;  D4B7D253A5AF4C8F CRC64;
     MRVLILAENE FEDLELFYPL YRLREEGLEV KVASSSLEVR VGKKGYQVRP DLTYEDVKVE
     DYAGLVIPGG KSPERVRINE RAVEIVKDFL ELGKPVAAIC HGPQLLISAM AVKGRRMTSW
     IGIRDDLIAA GALYEDRPVV VDGNVITSRM PDDLPYFCGE LIKILKRY
//
ID   Y1413_STAEQ             Reviewed;         172 AA.
AC   Q5HN59;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   06-FEB-2013, entry version 48.
DE   RecName: Full=Uncharacterized protein SERP1413;
GN   OrderedLocusNames=SERP1413;
OS   Staphylococcus epidermidis (strain ATCC 35984 / RP62A).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=176279;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 35984 / RP62A;
RX   PubMed=15774886; DOI=10.1128/JB.187.7.2426-2438.2005;
RA   Gill S.R., Fouts D.E., Archer G.L., Mongodin E.F., DeBoy R.T.,
RA   Ravel J., Paulsen I.T., Kolonay J.F., Brinkac L.M., Beanan M.J.,
RA   Dodson R.J., Daugherty S.C., Madupu R., Angiuoli S.V., Durkin A.S.,
RA   Haft D.H., Vamathevan J.J., Khouri H., Utterback T.R., Lee C.,
RA   Dimitrov G., Jiang L., Qin H., Weidman J., Tran K., Kang K.H.,
RA   Hance I.R., Nelson K.E., Fraser C.M.;
RT   "Insights on evolution of virulence and resistance from the complete
RT   genome analysis of an early methicillin-resistant Staphylococcus
RT   aureus strain and a biofilm-producing methicillin-resistant
RT   Staphylococcus epidermidis strain.";
RL   J. Bacteriol. 187:2426-2438(2005).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000029; AAW54770.1; -; Genomic_DNA.
DR   RefSeq; YP_188982.1; NC_002976.3.
DR   ProteinModelPortal; Q5HN59; -.
DR   STRING; Q5HN59; -.
DR   EnsemblBacteria; EBSTAT00000042501; EBSTAP00000041044; EBSTAG00000042499.
DR   GeneID; 3242876; -.
DR   GenomeReviews; CP000029_GR; SERP1413.
DR   KEGG; ser:SERP1413; -.
DR   PATRIC; 19613755; VBIStaEpi130894_1381.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   OMA; VCHAPWL; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SEPI176279:GJJB-1477-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    172       Uncharacterized protein SERP1413.
FT                                /FTId=PRO_0000157842.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   172 AA;  18697 MW;  9E516F85BEC1AAF7 CRC64;
     MAKKVAIILA DEFEDIELTS PKEALENAGF ETEVIGDTAN HEVVGKHGEK VTVDVSIADA
     KPENYDALLI PGGFSPDHLR GDEEGRYGTF AKYFTKNDVP TFAICHGPLV LVDTDDLKGR
     TITGVINVRK DLSNAGANVV DESVVVDNNI VTSRVPDDLD DFNREIVKKL EA
//
ID   Y1560_STAES             Reviewed;         172 AA.
AC   Q8CRV8;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   09-JAN-2013, entry version 57.
DE   RecName: Full=Uncharacterized protein SE_1560;
GN   OrderedLocusNames=SE_1560;
OS   Staphylococcus epidermidis (strain ATCC 12228).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=176280;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 12228;
RX   MEDLINE=22832016; PubMed=12950922;
RX   DOI=10.1046/j.1365-2958.2003.03671.x;
RA   Zhang Y.-Q., Ren S.-X., Li H.-L., Wang Y.-X., Fu G., Yang J.,
RA   Qin Z.-Q., Miao Y.-G., Wang W.-Y., Chen R.-S., Shen Y., Chen Z.,
RA   Yuan Z.-H., Zhao G.-P., Qu D., Danchin A., Wen Y.-M.;
RT   "Genome-based analysis of virulence genes in a non-biofilm-forming
RT   Staphylococcus epidermidis strain (ATCC 12228).";
RL   Mol. Microbiol. 49:1577-1593(2003).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE015929; AAO05159.1; -; Genomic_DNA.
DR   RefSeq; NP_765115.1; NC_004461.1.
DR   ProteinModelPortal; Q8CRV8; -.
DR   STRING; Q8CRV8; -.
DR   EnsemblBacteria; EBSTAT00000039526; EBSTAP00000038159; EBSTAG00000039524.
DR   GeneID; 1057286; -.
DR   GenomeReviews; AE015929_GR; SE_1560.
DR   KEGG; sep:SE1560; -.
DR   PATRIC; 19608980; VBIStaEpi113981_1524.
DR   eggNOG; COG0693; -.
DR   KO; K05520; -.
DR   OMA; VCHAPWL; -.
DR   ProtClustDB; CLSK885618; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    172       Uncharacterized protein SE_1560.
FT                                /FTId=PRO_0000157841.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   172 AA;  18697 MW;  9E516F85BEC1AAF7 CRC64;
     MAKKVAIILA DEFEDIELTS PKEALENAGF ETEVIGDTAN HEVVGKHGEK VTVDVSIADA
     KPENYDALLI PGGFSPDHLR GDEEGRYGTF AKYFTKNDVP TFAICHGPLV LVDTDDLKGR
     TITGVINVRK DLSNAGANVV DESVVVDNNI VTSRVPDDLD DFNREIVKKL EA
//
ID   Y1625_STAS1             Reviewed;         172 AA.
AC   Q49WT1;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   09-JAN-2013, entry version 47.
DE   RecName: Full=Uncharacterized protein SSP1625;
GN   OrderedLocusNames=SSP1625;
OS   Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 /
OS   DSM 20229).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=342451;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15305 / DSM 20229;
RX   PubMed=16135568; DOI=10.1073/pnas.0502950102;
RA   Kuroda M., Yamashita A., Hirakawa H., Kumano M., Morikawa K.,
RA   Higashide M., Maruyama A., Inose Y., Matoba K., Toh H., Kuhara S.,
RA   Hattori M., Ohta T.;
RT   "Whole genome sequence of Staphylococcus saprophyticus reveals the
RT   pathogenesis of uncomplicated urinary tract infection.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13272-13277(2005).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP008934; BAE18770.1; -; Genomic_DNA.
DR   RefSeq; YP_301715.1; NC_007350.1.
DR   ProteinModelPortal; Q49WT1; -.
DR   STRING; Q49WT1; -.
DR   EnsemblBacteria; EBSTAT00000047940; EBSTAP00000046309; EBSTAG00000047937.
DR   GeneID; 3615232; -.
DR   GenomeReviews; AP008934_GR; SSP1625.
DR   KEGG; ssp:SSP1625; -.
DR   PATRIC; 19624834; VBIStaSap90642_1624.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; VCHAPWL; -.
DR   ProtClustDB; CLSK885618; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    172       Uncharacterized protein SSP1625.
FT                                /FTId=PRO_0000157845.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   172 AA;  18907 MW;  3854C634EFAE0033 CRC64;
     MTKKVAIILA DEFEDIELTS PKEALENAGF ETEVIGDTEK HELVGKHGEK VTVDVSIADA
     KPENYDALLI PGGFSPDHLR GDEEGRYGTF TKYFTQNDVP TFAICHGPLL LVDTDDLKGR
     TITGVINVRK DLSNAGAHVV DESVVIDNNI VTSRVPDDLD DFNREIIKKL KA
//
ID   Y1692_STAAN             Reviewed;         171 AA.
AC   P0A0K1; Q53719;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   09-JAN-2013, entry version 46.
DE   RecName: Full=Uncharacterized protein SA1692;
GN   OrderedLocusNames=SA1692;
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=N315;
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000018; BAB42961.1; -; Genomic_DNA.
DR   PIR; B89975; B89975.
DR   RefSeq; NP_374982.1; NC_002745.2.
DR   ProteinModelPortal; P0A0K1; -.
DR   SMR; P0A0K1; 1-170.
DR   STRING; P0A0K1; -.
DR   EnsemblBacteria; EBSTAT00000001682; EBSTAP00000001682; EBSTAG00000001682.
DR   GeneID; 1124575; -.
DR   GenomeReviews; BA000018_GR; SA1692.
DR   KEGG; sau:SA1692; -.
DR   PATRIC; 19575782; VBIStaAur116463_1822.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SAUR158879:GJCB-1803-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein SA1692.
FT                                /FTId=PRO_0000157836.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y1797_STAAS             Reviewed;         171 AA.
AC   Q6G859;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 48.
DE   RecName: Full=Uncharacterized protein SAS1797;
GN   OrderedLocusNames=SAS1797;
OS   Staphylococcus aureus (strain MSSA476).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282459;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MSSA476;
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571857; CAG43602.1; -; Genomic_DNA.
DR   RefSeq; YP_043914.1; NC_002953.3.
DR   ProteinModelPortal; Q6G859; -.
DR   SMR; Q6G859; 1-170.
DR   STRING; Q6G859; -.
DR   EnsemblBacteria; EBSTAT00000023620; EBSTAP00000022787; EBSTAG00000023619.
DR   GeneID; 2862559; -.
DR   GenomeReviews; BX571857_GR; SAS1797.
DR   KEGG; sas:SAS1797; -.
DR   PATRIC; 19553177; VBIStaAur96780_1869.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein SAS1797.
FT                                /FTId=PRO_0000157838.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y1815_STAAW             Reviewed;         171 AA.
AC   P0A0K2; Q53719;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   09-JAN-2013, entry version 46.
DE   RecName: Full=Uncharacterized protein MW1815;
GN   OrderedLocusNames=MW1815;
OS   Staphylococcus aureus (strain MW2).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=196620;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MW2;
RX   MEDLINE=22040717; PubMed=12044378; DOI=10.1016/S0140-6736(02)08713-5;
RA   Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A.,
RA   Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L.,
RA   Yamamoto K., Hiramatsu K.;
RT   "Genome and virulence determinants of high virulence community-
RT   acquired MRSA.";
RL   Lancet 359:1819-1827(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000033; BAB95680.1; -; Genomic_DNA.
DR   RefSeq; NP_646632.1; NC_003923.1.
DR   ProteinModelPortal; P0A0K2; -.
DR   SMR; P0A0K2; 1-170.
DR   STRING; P0A0K2; -.
DR   EnsemblBacteria; EBSTAT00000027383; EBSTAP00000026422; EBSTAG00000027382.
DR   GeneID; 1003930; -.
DR   GenomeReviews; BA000033_GR; MW1815.
DR   KEGG; sam:MW1815; -.
DR   PATRIC; 19570328; VBIStaAur44266_1886.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SAUR196620:GJ9Z-1877-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein MW1815.
FT                                /FTId=PRO_0000157839.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y1875_STAAM             Reviewed;         171 AA.
AC   P0A0K0; Q53719;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   06-FEB-2013, entry version 47.
DE   RecName: Full=Uncharacterized protein SAV1875;
GN   OrderedLocusNames=SAV1875;
OS   Staphylococcus aureus (strain Mu50 / ATCC 700699).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158878;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Mu50 / ATCC 700699;
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000017; BAB58037.1; -; Genomic_DNA.
DR   RefSeq; NP_372399.1; NC_002758.2.
DR   ProteinModelPortal; P0A0K0; -.
DR   SMR; P0A0K0; 1-170.
DR   STRING; P0A0K0; -.
DR   EnsemblBacteria; EBSTAT00000007170; EBSTAP00000006988; EBSTAG00000007169.
DR   GeneID; 1121888; -.
DR   GenomeReviews; BA000017_GR; SAV1875.
DR   KEGG; sav:SAV1875; -.
DR   PATRIC; 19564596; VBIStaAur52173_1937.
DR   eggNOG; COG0693; -.
DR   KO; K05520; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SAUR158878:GJJ5-1930-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein SAV1875.
FT                                /FTId=PRO_0000157834.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y1933_STAAC             Reviewed;         171 AA.
AC   Q5HEP9;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   09-JAN-2013, entry version 49.
DE   RecName: Full=Uncharacterized protein SACOL1933;
GN   OrderedLocusNames=SACOL1933;
OS   Staphylococcus aureus (strain COL).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=93062;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=COL;
RX   PubMed=15774886; DOI=10.1128/JB.187.7.2426-2438.2005;
RA   Gill S.R., Fouts D.E., Archer G.L., Mongodin E.F., DeBoy R.T.,
RA   Ravel J., Paulsen I.T., Kolonay J.F., Brinkac L.M., Beanan M.J.,
RA   Dodson R.J., Daugherty S.C., Madupu R., Angiuoli S.V., Durkin A.S.,
RA   Haft D.H., Vamathevan J.J., Khouri H., Utterback T.R., Lee C.,
RA   Dimitrov G., Jiang L., Qin H., Weidman J., Tran K., Kang K.H.,
RA   Hance I.R., Nelson K.E., Fraser C.M.;
RT   "Insights on evolution of virulence and resistance from the complete
RT   genome analysis of an early methicillin-resistant Staphylococcus
RT   aureus strain and a biofilm-producing methicillin-resistant
RT   Staphylococcus epidermidis strain.";
RL   J. Bacteriol. 187:2426-2438(2005).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000046; AAW38374.1; -; Genomic_DNA.
DR   RefSeq; YP_186758.1; NC_002951.2.
DR   ProteinModelPortal; Q5HEP9; -.
DR   SMR; Q5HEP9; 1-170.
DR   STRING; Q5HEP9; -.
DR   EnsemblBacteria; EBSTAT00000009357; EBSTAP00000009092; EBSTAG00000009356.
DR   GeneID; 3237519; -.
DR   GenomeReviews; CP000046_GR; SACOL1933.
DR   KEGG; sac:SACOL1933; -.
DR   PATRIC; 19530143; VBIStaAur112458_1888.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein SACOL1933.
FT                                /FTId=PRO_0000157835.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y1965_STAAR             Reviewed;         171 AA.
AC   Q6GFI2;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 48.
DE   RecName: Full=Uncharacterized protein SAR1965;
GN   OrderedLocusNames=SAR1965;
OS   Staphylococcus aureus (strain MRSA252).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282458;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MRSA252;
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571856; CAG40952.1; -; Genomic_DNA.
DR   RefSeq; YP_041340.1; NC_002952.2.
DR   ProteinModelPortal; Q6GFI2; -.
DR   STRING; Q6GFI2; -.
DR   EnsemblBacteria; EBSTAT00000021863; EBSTAP00000021199; EBSTAG00000021862.
DR   GeneID; 2861207; -.
DR   GenomeReviews; BX571856_GR; SAR1965.
DR   KEGG; sar:SAR1965; -.
DR   PATRIC; 19547565; VBIStaAur71814_1972.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   OMA; VCHAPWL; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SAUR282458:GJA5-1999-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    171       Uncharacterized protein SAR1965.
FT                                /FTId=PRO_0000157837.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18680 MW;  A56AA08B0FCBD712 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVFGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y2013_STAA8             Reviewed;         171 AA.
AC   P0A0K3; Q2G2H2; Q53719;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   09-JAN-2013, entry version 46.
DE   RecName: Full=Uncharacterized protein SAOUHSC_02013;
DE   AltName: Full=ORF1;
GN   OrderedLocusNames=SAOUHSC_02013;
OS   Staphylococcus aureus (strain NCTC 8325).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=94131293; PubMed=7905453; DOI=10.1016/0378-1119(93)90016-V;
RA   Borchardt S.A., Babwah A.V., Jayaswal R.K.;
RT   "Sequence analysis of the region downstream from a peptidoglycan
RT   hydrolase-encoding gene from Staphylococcus aureus NCTC8325.";
RL   Gene 137:253-258(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W.,
RA   Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC8325 genome.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L19300; AAA18514.1; -; Unassigned_DNA.
DR   EMBL; CP000253; ABD31069.1; -; Genomic_DNA.
DR   RefSeq; YP_500510.1; NC_007795.1.
DR   ProteinModelPortal; P0A0K3; -.
DR   SMR; P0A0K3; 1-170.
DR   STRING; P0A0K3; -.
DR   EnsemblBacteria; EBSTAT00000028969; EBSTAP00000027920; EBSTAG00000028967.
DR   GeneID; 3920467; -.
DR   GenomeReviews; CP000253_GR; SAOUHSC_02013.
DR   KEGG; sao:SAOUHSC_02013; -.
DR   PATRIC; 19581413; VBIStaAur99865_1828.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; RQAGHET; -.
DR   ProtClustDB; CLSK885618; -.
DR   BioCyc; SAUR93061:GIWJ-1963-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    171       Uncharacterized protein SAOUHSC_02013.
FT                                /FTId=PRO_0000157840.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   171 AA;  18632 MW;  A571A08B0FD0D719 CRC64;
     MTKKVAIILA NEFEDIEYSS PKEALENAGF NTVVIGDTAN SEVVGKHGEK VTVDVGIAEA
     KPEDYDALLI PGGFSPDHLR GDTEGRYGTF AKYFTKNDVP TFAICHGPQI LIDTDDLKGR
     TLTAVLNVRK DLSNAGAHVV DESVVVDNNI VTSRVPDDLD DFNREIVKQL Q
//
ID   Y294_MYCPN              Reviewed;         206 AA.
AC   P75483;
DT   08-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   28-NOV-2012, entry version 56.
DE   RecName: Full=Uncharacterized protein MPN_294;
GN   OrderedLocusNames=MPN_294; ORFNames=H10_orf206, MP541;
OS   Mycoplasma pneumoniae (strain ATCC 29342 / M129).
OC   Bacteria; Tenericutes; Mollicutes; Mycoplasmataceae; Mycoplasma.
OX   NCBI_TaxID=272634;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29342 / M129;
RX   MEDLINE=97105885; PubMed=8948633; DOI=10.1093/nar/24.22.4420;
RA   Himmelreich R., Hilbert H., Plagens H., Pirkl E., Li B.-C.,
RA   Herrmann R.;
RT   "Complete sequence analysis of the genome of the bacterium Mycoplasma
RT   pneumoniae.";
RL   Nucleic Acids Res. 24:4420-4449(1996).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00089; AAB96189.1; -; Genomic_DNA.
DR   PIR; S73867; S73867.
DR   RefSeq; NP_109982.1; NC_000912.1.
DR   ProteinModelPortal; P75483; -.
DR   IntAct; P75483; 1.
DR   PaxDb; P75483; -.
DR   DNASU; 877198; -.
DR   GeneID; 877198; -.
DR   GenomeReviews; U00089_GR; MPN_294.
DR   KEGG; mpn:MPN294; -.
DR   PATRIC; 20021923; VBIMycPne110_0318.
DR   eggNOG; COG0693; -.
DR   OMA; ATNIAND; -.
DR   BioCyc; MPNE272634:GJ6Z-301-MONOMER; -.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   4: Predicted;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    206       Uncharacterized protein MPN_294.
FT                                /FTId=PRO_0000210658.
SQ   SEQUENCE   206 AA;  23219 MW;  0C8504A5C45BD85D CRC64;
     MDLLTTANKT PRIAKSRPVR IAIIITQKTN DLHATVPCFL WRKARYAVDL ISAEAKASIM
     LEMGIHVRCD NTLSKTNFNQ YTAAFIPHGN TTRLVEIDKL RKDLEKFVYK PKGPMRWLFS
     SGNGACVLKE FDLIAPDQLV TVQNEKEMVK LLGKNFIKQP VHVDKNIISC ANSCGLTKFS
     FKVIEELSGI ELARKTANLV DHIYKG
//
ID   Y918_STAS1              Reviewed;         172 AA.
AC   Q49YS0;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   09-JAN-2013, entry version 45.
DE   RecName: Full=Uncharacterized protein SSP0918;
GN   OrderedLocusNames=SSP0918;
OS   Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 /
OS   DSM 20229).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=342451;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15305 / DSM 20229;
RX   PubMed=16135568; DOI=10.1073/pnas.0502950102;
RA   Kuroda M., Yamashita A., Hirakawa H., Kumano M., Morikawa K.,
RA   Higashide M., Maruyama A., Inose Y., Matoba K., Toh H., Kuhara S.,
RA   Hattori M., Ohta T.;
RT   "Whole genome sequence of Staphylococcus saprophyticus reveals the
RT   pathogenesis of uncomplicated urinary tract infection.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13272-13277(2005).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP008934; BAE18063.1; -; Genomic_DNA.
DR   RefSeq; YP_301008.1; NC_007350.1.
DR   ProteinModelPortal; Q49YS0; -.
DR   STRING; Q49YS0; -.
DR   EnsemblBacteria; EBSTAT00000047551; EBSTAP00000045920; EBSTAG00000047548.
DR   GeneID; 3616821; -.
DR   GenomeReviews; AP008934_GR; SSP0918.
DR   KEGG; ssp:SSP0918; -.
DR   PATRIC; 19623342; VBIStaSap90642_0917.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; GSMSKKI; -.
DR   ProtClustDB; CLSK885618; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   3: Inferred from homology;
KW   Complete proteome.
FT   CHAIN         1    172       Uncharacterized protein SSP0918.
FT                                /FTId=PRO_0000157844.
FT   DOMAIN        3    171       PfpI endopeptidase.
SQ   SEQUENCE   172 AA;  18575 MW;  B8E6CBF302842B5D CRC64;
     MAKKVAIILT NEFEDIELTS PKEAIEEAGH ETVVIGDQAN SEVVGKHGTK VAVDVSIADA
     KPEDFDGLLI PGGFSPDHLR GDAEGRYGTF AKYFTKNDVP AFAICHGPQI LIDTDDLNGR
     TLTAVLNVRK DLANAGAQVV DESVVVDKNI VTSRTPDDLD DFNREIVNQL ND
//
ID   Y967_METJA              Reviewed;         205 AA.
AC   Q58377;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-NOV-2012, entry version 72.
DE   RecName: Full=Uncharacterized protein MJ0967;
GN   OrderedLocusNames=MJ0967;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   MEDLINE=96337999; PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L77117; AAB98972.1; -; Genomic_DNA.
DR   PIR; G64420; G64420.
DR   RefSeq; NP_247962.1; NC_000909.1.
DR   ProteinModelPortal; Q58377; -.
DR   GeneID; 1451865; -.
DR   GenomeReviews; L77117_GR; MJ0967.
DR   KEGG; mja:MJ_0967; -.
DR   eggNOG; COG0693; -.
DR   KO; K05520; -.
DR   OMA; ICISPAV; -.
DR   ProtClustDB; CLSK2517675; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    205       Uncharacterized protein MJ0967.
FT                                /FTId=PRO_0000157847.
FT   COMPBIAS    174    180       Val-rich.
SQ   SEQUENCE   205 AA;  22542 MW;  E60E6AD066ECCFB5 CRC64;
     MKRLAVILIT LALVSSMCIT NSNEKRENMK NAKVLMVIAP KDFRDEELFE PMAVFESNGL
     KVDVVSTTKG ECVGMLGNKI TVEKTIYDVN PDDYVAIVIV GGIGSKEYLW NNTKLIELVK
     EFYNKNKVVS AICLSPVVLA RAGILKGKKA TVYPAPEAIE ELKKAGAIYE DRGVVVDGNV
     ITAKSPDYAR LFGLEVLKAI EKNNE
//
ID   YA02_SCHPO              Reviewed;         240 AA.
AC   Q09675;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   28-NOV-2012, entry version 75.
DE   RecName: Full=Uncharacterized protein C5H10.02c;
DE            EC=3.2.-.-;
GN   ORFNames=SPAC5H10.02c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAA89952.1; -; Genomic_DNA.
DR   PIR; S55480; S55480.
DR   RefSeq; NP_592815.1; NM_001018215.1.
DR   ProteinModelPortal; Q09675; -.
DR   EnsemblFungi; SPAC5H10.02c.1; SPAC5H10.02c.1:pep; SPAC5H10.02c.
DR   GeneID; 2541799; -.
DR   KEGG; spo:SPAC5H10.02c; -.
DR   PomBase; SPAC5H10.02c; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; MHEHELM; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   NextBio; 20802887; -.
DR   ArrayExpress; Q09675; -.
DR   GO; GO:0005829; C:cytosol; IDA:PomBase.
DR   GO; GO:0005634; C:nucleus; IDA:PomBase.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEP:PomBase.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    240       Uncharacterized protein C5H10.02c.
FT                                /FTId=PRO_0000157854.
FT   ACT_SITE    141    141       Potential.
FT   ACT_SITE    142    142       Potential.
FT   ACT_SITE    175    175       Potential.
SQ   SEQUENCE   240 AA;  26117 MW;  22C5614F06D56296 CRC64;
     MSIAKGKNAL LVASSYYGPF YPDGKNTGVH FSELLIPYNV FKKAGFNVQF VSENGSYKFD
     DHSIEESKLG DFERKVFNDK NDDFWTNLNN MKKASDIVGK DYQLLFVAGG HAAMFDLPKA
     TNLQAVAREV FTNGGVLSAV CHGPVLLANV KNPQSVEGKT VVYHKHVTAF NKAGEEKMGV
     MDELKKRGMK SLNEIFAEAG ATFIDPPNPN VNFTQIDGKI VTGVNPQSAK STAEAAVSAL
//
ID   YAJL_ECOLI              Reviewed;         196 AA.
AC   Q46948; Q2MC02;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   28-NOV-2012, entry version 94.
DE   RecName: Full=Chaperone protein YajL;
GN   Name=yajL; Synonyms=thiJ; OrderedLocusNames=b0424, JW5057;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Backstrom A.D.;
RT   "The biosynthesis of thiamin in Escherichia coli K-12: structural
RT   genes for thiamin biosynthetic enzymes (thiCEFGH and thiJ) and
RT   function of the thiE gene product (thiamin phosphate synthase [E.C.
RT   2.5.1.3]).";
RL   Thesis (1996), Cornell University, United States.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   MEDLINE=97426617; PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1474(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   ABSENCE OF FUNCTION IN THIAMINE BIOSYNTHESIS.
RX   MEDLINE=98256429; PubMed=9592144; DOI=10.1093/nar/26.11.2606;
RA   Mueller E.G., Buck C.J., Palenchar P.M., Barnhart L.E., Paulson J.L.;
RT   "Identification of a gene involved in the generation of 4-thiouridine
RT   in tRNA.";
RL   Nucleic Acids Res. 26:2606-2610(1998).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / BW25113;
RX   PubMed=20889753; DOI=10.1128/JB.01077-10;
RA   Kthiri F., Gautier V., Le H.T., Prere M.F., Fayet O., Malki A.,
RA   Landoulsi A., Richarme G.;
RT   "Translational defects in a mutant deficient in YajL, the bacterial
RT   homolog of the parkinsonism-associated protein DJ-1.";
RL   J. Bacteriol. 192:6302-6306(2010).
RN   [7]
RP   FUNCTION AS A CHAPERONE, ENZYME REGULATION, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF CYS-106.
RC   STRAIN=K12 / BW25113;
RX   PubMed=20124404; DOI=10.1074/jbc.M109.077529;
RA   Kthiri F., Le H.T., Gautier V., Caldas T., Malki A., Landoulsi A.,
RA   Bohn C., Bouloc P., Richarme G.;
RT   "Protein aggregation in a mutant deficient in yajL, the bacterial
RT   homolog of the Parkinsonism-associated protein DJ-1.";
RL   J. Biol. Chem. 285:10328-10336(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS), AND SUBUNIT.
RX   PubMed=16181642; DOI=10.1016/j.jmb.2005.08.033;
RA   Wilson M.A., Ringe D., Petsko G.A.;
RT   "The atomic resolution crystal structure of the YajL (ThiJ) protein
RT   from Escherichia coli: a close prokaryotic homologue of the
RT   Parkinsonism-associated protein DJ-1.";
RL   J. Mol. Biol. 353:678-691(2005).
CC   -!- FUNCTION: Involved in biogenesis of ribosomal proteins, probably
CC       as a ribosomal protein-folding chaperone. Interacts with ribosomal
CC       subunits, ribosomes and polysomes. Confers resistance to oxidative
CC       stress.
CC   -!- ENZYME REGULATION: Active in both its reduced and oxidized states,
CC       and is more active in its oxidized form.
CC   -!- SUBUNIT: Homodimer.
CC   -!- PTM: Cys-106 is easily oxidized to sulfinic acid.
CC   -!- DISRUPTION PHENOTYPE: In aerobiosis, mutants show a protein
CC       aggregation phenotype, which is increased by oxidative stress.
CC       Mutants show also altered gene expression and display decreased
CC       translation accuracy.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- CAUTION: Was originally (Ref.1) thought to be involved in thiamine
CC       biosynthesis. However, this phenotype was probably due to an
CC       artifactual recombination event involving a portion of the
CC       adjacent thiI gene.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA82704.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC       Sequence=AAB40180.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34923; AAA82704.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U82664; AAB40180.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC73527.2; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76204.1; -; Genomic_DNA.
DR   PIR; H64771; H64771.
DR   RefSeq; NP_414958.4; NC_000913.2.
DR   RefSeq; YP_488716.1; NC_007779.1.
DR   PDB; 2AB0; X-ray; 1.10 A; A/B=1-196.
DR   PDBsum; 2AB0; -.
DR   ProteinModelPortal; Q46948; -.
DR   SMR; Q46948; 2-196.
DR   PRIDE; Q46948; -.
DR   EnsemblBacteria; EBESCT00000003934; EBESCP00000003934; EBESCG00000003219.
DR   EnsemblBacteria; EBESCT00000016140; EBESCP00000015431; EBESCG00000015200.
DR   GeneID; 12934351; -.
DR   GeneID; 945066; -.
DR   GenomeReviews; AP009048_GR; JW5057.
DR   GenomeReviews; U00096_GR; b0424.
DR   KEGG; ecj:Y75_p0412; -.
DR   KEGG; eco:b0424; -.
DR   PATRIC; 32115999; VBIEscCol129921_0441.
DR   EchoBASE; EB3057; -.
DR   EcoGene; EG13272; yajL.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063194; -.
DR   KO; K03152; -.
DR   OMA; GDHYKYS; -.
DR   ProtClustDB; PRK11574; -.
DR   BioCyc; EcoCyc:HMP-KIN-MONOMER; -.
DR   BioCyc; ECOL316407:JW5057-MONOMER; -.
DR   EvolutionaryTrace; Q46948; -.
DR   Genevestigator; Q46948; -.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IMP:UniProtKB.
DR   GO; GO:0042254; P:ribosome biogenesis; IMP:UniProtKB.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chaperone; Complete proteome; Oxidation;
KW   Reference proteome; Ribosome biogenesis; Stress response.
FT   CHAIN         1    196       Chaperone protein YajL.
FT                                /FTId=PRO_0000157829.
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H).
FT   MUTAGEN     106    106       C->A,D: Does not complement a disruption
FT                                mutant.
FT   STRAND        4      9
FT   HELIX        15     27
FT   STRAND       31     36
FT   STRAND       44     46
FT   STRAND       52     54
FT   STRAND       56     58
FT   HELIX        59     62
FT   STRAND       68     72
FT   HELIX        76     84
FT   HELIX        86     97
FT   STRAND      101    105
FT   HELIX       108    112
FT   TURN        113    117
FT   STRAND      118    122
FT   HELIX       128    133
FT   TURN        136    138
FT   STRAND      143    147
FT   TURN        148    151
FT   STRAND      152    155
FT   HELIX       158    160
FT   HELIX       161    172
FT   HELIX       175    182
FT   TURN        183    186
SQ   SEQUENCE   196 AA;  20777 MW;  15282395CCF2CE75 CRC64;
     MSASALVCLA PGSEETEAVT TIDLLVRGGI KVTTASVASD GNLAITCSRG VKLLADAPLV
     EVADGEYDVI VLPGGIKGAE CFRDSTLLVE TVKQFHRSGR IVAAICAAPA TVLVPHDIFP
     IGNMTGFPTL KDKIPAEQWL DKRVVWDARV KLLTSQGPGT AIDFGLKIID LLVGREKAHE
     VASQLVMAAG IYNYYE
//
ID   YAJL_SALTY              Reviewed;         196 AA.
AC   P55880;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-DEC-2001, sequence version 2.
DT   28-NOV-2012, entry version 74.
DE   RecName: Full=Chaperone protein YajL;
GN   Name=yajL; OrderedLocusNames=STM0433;
OS   Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Salmonella.
OX   NCBI_TaxID=99287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LT2 / SGSC1412 / ATCC 700720;
RX   MEDLINE=21534948; PubMed=11677609; DOI=10.1038/35101614;
RA   McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P.,
RA   Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D.,
RA   Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E.,
RA   Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M.,
RA   Waterston R., Wilson R.K.;
RT   "Complete genome sequence of Salmonella enterica serovar Typhimurium
RT   LT2.";
RL   Nature 413:852-856(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 153-196.
RA   Metcalf W.W., Jiang W., Wanner B.L.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in biogenesis of ribosomal proteins, probably
CC       as a ribosomal protein-folding chaperone (By similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE006468; AAL19387.1; -; Genomic_DNA.
DR   EMBL; U69493; AAB39640.1; -; Genomic_DNA.
DR   PIR; T46945; T46945.
DR   RefSeq; NP_459428.1; NC_003197.1.
DR   ProteinModelPortal; P55880; -.
DR   SMR; P55880; 2-196.
DR   PRIDE; P55880; -.
DR   GeneID; 1251952; -.
DR   GenomeReviews; AE006468_GR; STM0433.
DR   KEGG; stm:STM0433; -.
DR   PATRIC; 32379201; VBISalEnt20916_0462.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063194; -.
DR   KO; K03152; -.
DR   OMA; TCDKVVD; -.
DR   ProtClustDB; PRK11574; -.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   GO; GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR006287; DJ1.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01383; not_thiJ; 1.
PE   3: Inferred from homology;
KW   Chaperone; Complete proteome; Oxidation; Reference proteome;
KW   Ribosome biogenesis; Stress response.
FT   CHAIN         1    196       Chaperone protein YajL.
FT                                /FTId=PRO_0000157830.
FT   MOD_RES     106    106       Cysteine sulfinic acid (-SO2H) (By
FT                                similarity).
SQ   SEQUENCE   196 AA;  20767 MW;  C4B239015257E176 CRC64;
     MSAQALVCLA PGSEETEAVT TIDLLVRGGI HVTTASVASD GNLTIVCSRG VKLLADAPLV
     EVADGDYDII VLPGGIKGAE CFRDSPLLVE TVKQFHRSGR IVAAICAAAA TVLVPHDIFP
     IGNMTGFPAL KDKIPAEQWL DKRVVWDARV KLLTSQGPGT AIDFGLKIID LLAGREKAHE
     VASQLVMAAG IYNYYE
//
ID   YAK6_SCHPO              Reviewed;         251 AA.
AC   Q09918;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   28-NOV-2012, entry version 65.
DE   RecName: Full=Uncharacterized protein C1F7.06;
GN   ORFNames=SPAC1F7.06;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAA91953.1; -; Genomic_DNA.
DR   PIR; S62578; S62578.
DR   RefSeq; NP_594492.1; NM_001019921.1.
DR   ProteinModelPortal; Q09918; -.
DR   EnsemblFungi; SPAC1F7.06.1; SPAC1F7.06.1:pep; SPAC1F7.06.
DR   GeneID; 2541687; -.
DR   KEGG; spo:SPAC1F7.06; -.
DR   PomBase; SPAC1F7.06; -.
DR   eggNOG; COG0693; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   NextBio; 20802780; -.
DR   ArrayExpress; Q09918; -.
DR   GO; GO:0005829; C:cytosol; IDA:PomBase.
DR   GO; GO:0005634; C:nucleus; IDA:PomBase.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    251       Uncharacterized protein C1F7.06.
FT                                /FTId=PRO_0000157855.
SQ   SEQUENCE   251 AA;  27907 MW;  B5A60207D035BB34 CRC64;
     MDERHEAAGE TSEKPKVLFL LNSYYGPFYD DGDNTGVNVV DLYEAFKVFE ENGFDIVIAS
     DTGDYGFDDK SFRDPAIVDE TQSIFSNPDC SLMKKLKNIA RLDRLNPSDY VIVYIPGGYG
     CSFDFPHAKV VQDFLYRFYE TKGIICAVAQ ANIALAYTTN SDGQALCTNR RVTGCTWKDE
     VQNGVLNVMN RLNFYSFGHI AENIGAIFES PPVYVEDPFI VEDGQLFTGS NTNSAKGVAM
     EAVRAVLNYD G
//
ID   YAOD_SCHPO              Reviewed;         222 AA.
AC   Q10092;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   28-NOV-2012, entry version 73.
DE   RecName: Full=Uncharacterized protein C11D3.13;
DE            EC=3.2.-.-;
GN   ORFNames=SPAC11D3.13;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAA92314.1; -; Genomic_DNA.
DR   PIR; T37522; T37522.
DR   RefSeq; NP_592808.1; NM_001018208.1.
DR   ProteinModelPortal; Q10092; -.
DR   EnsemblFungi; SPAC11D3.13.1; SPAC11D3.13.1:pep; SPAC11D3.13.
DR   GeneID; 2542927; -.
DR   KEGG; spo:SPAC11D3.13; -.
DR   PomBase; SPAC11D3.13; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; YDDGAKT; -.
DR   NextBio; 20803963; -.
DR   ArrayExpress; Q10092; -.
DR   GO; GO:0005829; C:cytosol; IDA:PomBase.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0033554; P:cellular response to stress; IEP:PomBase.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    222       Uncharacterized protein C11D3.13.
FT                                /FTId=PRO_0000157856.
FT   ACT_SITE    124    124       Potential.
FT   ACT_SITE    125    125       Potential.
FT   ACT_SITE    155    155       Potential.
SQ   SEQUENCE   222 AA;  24226 MW;  9A466BE06AF17AD6 CRC64;
     MVLFMKTVQR PEHISLKSCI PFKSLQRQGI VFRLSVRMVM LADDHSISDS ALSDSDKNAF
     KDKNNDFWKA IKNAKNASDI NFSDYSIFFA AGGHGTLFDF PSATNLHKGA AKIYSMGGVI
     AAVCHGPVIL PCIKDSTGFS IVKGKTVTAF NEIAEQQMNL MPTFEKYHFK TLNKLFQEAG
     SNFVDPQEPF DDFVKTDGKL VTGANPASAA STAKAALNSL NS
//
ID   YCP1_STRLI              Reviewed;         141 AA.
AC   P49322;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   18-APR-2012, entry version 35.
DE   RecName: Full=Uncharacterized protein in cpoL 5'region;
DE   AltName: Full=ORF1;
DE   Flags: Fragment;
OS   Streptomyces lividans.
OC   Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales;
OC   Streptomycineae; Streptomycetaceae; Streptomyces.
OX   NCBI_TaxID=1916;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=TK64;
RX   MEDLINE=94209235; PubMed=8157602;
RA   Bantleon R., Altenbuchner J., van Pee K.-H.;
RT   "Chloroperoxidase from Streptomyces lividans: isolation and
RT   characterization of the enzyme and the corresponding gene.";
RL   J. Bacteriol. 176:2339-2347(1994).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U02635; -; NOT_ANNOTATED_CDS; Unassigned_DNA.
DR   PIR; B55211; B55211.
DR   ProteinModelPortal; P49322; -.
DR   InterPro; IPR025628; DJ-1_InhA.
DR   Pfam; PF13278; DUF4066; 1.
PE   3: Inferred from homology;
FT   CHAIN         1   >141       Uncharacterized protein in cpoL 5'region.
FT                                /FTId=PRO_0000157848.
FT   NON_TER     141    141
SQ   SEQUENCE   141 AA;  14359 MW;  26C72B6C9ACD414E CRC64;
     MTAGPHRVVV LVFDGMKLLD LSGPAEVFSE ANRFGADYRL SIVSADGSPV RSSIGMLVPA
     DTDARAAAAH DTLVVVGGDA LPGSPVGPVL GAAAKELAER AGRVASVCTG AFVLGAAGLL
     EGRRATTHWQ HTATLARRCP S
//
ID   YDB3_SCHPO              Reviewed;         191 AA.
AC   Q10356;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-NOV-2012, entry version 73.
DE   RecName: Full=Uncharacterized protein C22E12.03c;
GN   ORFNames=SPAC22E12.03c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329670; CAA93890.1; -; Genomic_DNA.
DR   PIR; T38160; T38160.
DR   RefSeq; NP_594829.1; NM_001020258.1.
DR   PDB; 4GDH; X-ray; 1.05 A; A/B/C/D=1-191.
DR   PDB; 4GE0; X-ray; 1.45 A; A/B/C/D=1-191.
DR   PDB; 4GE3; X-ray; 1.50 A; A/B/C/D=1-191.
DR   PDBsum; 4GDH; -.
DR   PDBsum; 4GE0; -.
DR   PDBsum; 4GE3; -.
DR   ProteinModelPortal; Q10356; -.
DR   STRING; Q10356; -.
DR   MEROPS; C56.002; -.
DR   EnsemblFungi; SPAC22E12.03c.1; SPAC22E12.03c.1:pep; SPAC22E12.03c.
DR   GeneID; 2541772; -.
DR   KEGG; spo:SPAC22E12.03c; -.
DR   PomBase; SPAC22E12.03c; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063194; -.
DR   OMA; EGGYKYL; -.
DR   OrthoDB; EOG4GXJX9; -.
DR   NextBio; 20802863; -.
DR   ArrayExpress; Q10356; -.
DR   GO; GO:0005829; C:cytosol; IDA:PomBase.
DR   GO; GO:0005634; C:nucleus; IDA:PomBase.
DR   GO; GO:0033554; P:cellular response to stress; IEP:PomBase.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Reference proteome.
FT   CHAIN         1    191       Uncharacterized protein C22E12.03c.
FT                                /FTId=PRO_0000157857.
FT   STRAND        4      9
FT   HELIX        14     26
FT   STRAND       31     38
FT   STRAND       43     45
FT   STRAND       51     53
FT   STRAND       55     57
FT   HELIX        58     60
FT   HELIX        64     70
FT   STRAND       72     76
FT   HELIX        80     87
FT   HELIX        90     99
FT   STRAND      106    110
FT   HELIX       111    114
FT   HELIX       115    119
FT   STRAND      125    127
FT   HELIX       131    133
FT   HELIX       134    139
FT   STRAND      147    152
FT   STRAND      155    158
FT   HELIX       161    163
FT   HELIX       164    175
FT   HELIX       178    187
SQ   SEQUENCE   191 AA;  21078 MW;  909817B8D554AB2E CRC64;
     MVKVCLFVAD GTDEIEFSAP WGIFKRAEIP IDSVYVGENK DRLVKMSRDV EMYANRSYKE
     IPSADDFAKQ YDIAIIPGGG LGAKTLSTTP FVQQVVKEFY KKPNKWIGMI CAGTLTAKTS
     GLPNKQITGH PSVRGQLEEG GYKYLDQPVV LEENLITSQG PGTAMLFGLK LLEQVASKDK
     YNAVYKSLSM P
//
ID   YDEA_BACSU              Reviewed;         197 AA.
AC   P96658; Q797I9;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   09-JAN-2013, entry version 61.
DE   RecName: Full=Uncharacterized protease YdeA;
DE            EC=3.2.-.-;
GN   Name=ydeA; OrderedLocusNames=BSU05110;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RA   Kasahara Y., Nakai S., Lee S., Sadaie Y., Ogasawara N.;
RT   "A 148 kbp sequence of the region between 35 and 47 degree of the
RT   Bacillus subtilis genome.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   MEDLINE=98044033; PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.06 ANGSTROMS) OF 2-196.
RG   New York structural genomics research consortium (NYSGRC);
RT   "Crystal structure of a protein of unknown function from Bacillus
RT   subtilis.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001488; BAA19347.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB12318.1; -; Genomic_DNA.
DR   PIR; C69777; C69777.
DR   RefSeq; NP_388392.1; NC_000964.3.
DR   PDB; 3F5D; X-ray; 2.06 A; A=2-196.
DR   PDBsum; 3F5D; -.
DR   ProteinModelPortal; P96658; -.
DR   SMR; P96658; 1-193.
DR   DNASU; 939914; -.
DR   EnsemblBacteria; EBBACT00000002065; EBBACP00000002065; EBBACG00000002062.
DR   GeneID; 939914; -.
DR   GenomeReviews; AL009126_GR; BSU05110.
DR   KEGG; bsu:BSU05110; -.
DR   PATRIC; 18972624; VBIBacSub10457_0533.
DR   GenoList; BSU05110; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000015209; -.
DR   OMA; AICGAVD; -.
DR   ProtClustDB; CLSK561009; -.
DR   BioCyc; BSUB:BSU05110-MONOMER; -.
DR   EvolutionaryTrace; P96658; -.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Hydrolase; Protease;
KW   Reference proteome.
FT   CHAIN         1    197       Uncharacterized protease YdeA.
FT                                /FTId=PRO_0000388349.
FT   DOMAIN      ?29   ?166       PfpI endopeptidase.
FT   ACT_SITE     98     98       Nucleophile (By similarity).
FT   STRAND        2      7
FT   STRAND       10     12
FT   HELIX        18     25
FT   STRAND       30     43
FT   STRAND       48     50
FT   STRAND       52     54
FT   STRAND       63     67
FT   HELIX        78     89
FT   STRAND       94     97
FT   HELIX        99    106
FT   TURN        107    112
FT   HELIX       120    123
FT   STRAND      138    143
FT   STRAND      146    149
FT   HELIX       154    164
FT   HELIX       170    182
FT   HELIX       184    191
SQ   SEQUENCE   197 AA;  22454 MW;  952181570C6209DA CRC64;
     MKKALFLILD QYADWEGVYL ASALNQREDW SVHTVSLDPI VSSIGGFKTS VDYIIGLEPA
     NFNLLVMIGG DSWSNDNKKL LHFVKTAFQK NIPIAAICGA VDFLAKNGLL NNHSHTGNFV
     YLWKDYKQYK PISSFVEKQA VRDKNLVTAN GTAPIEFTNL ILEMIDFDTP ENIEKMMYMN
     RYGFYHFCDK YGNPFVD
//
ID   YHBO_ECOLI              Reviewed;         172 AA.
AC   P45470; Q2M957;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   28-NOV-2012, entry version 95.
DE   RecName: Full=Protein YhbO;
GN   Name=yhbO; OrderedLocusNames=b3153, JW5529;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   MEDLINE=97426617; PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1474(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 2-172, AND SUBUNIT.
RX   PubMed=14649299; DOI=10.1023/A:1026177202925;
RA   Abergel C., Coutard B., Byrne D., Chenivesse S., Claude J.-B.,
RA   Deregnaucourt C., Fricaux T., Gianesini-Boutreux C., Jeudy S.,
RA   Lebrun R., Maza C., Notredame C., Poirot O., Suhre K., Varagnol M.,
RA   Claverie J.-M.;
RT   "Structural genomics of highly conserved microbial genes of unknown
RT   function in search of new antibacterial targets.";
RL   J. Struct. Funct. Genomics 4:141-157(2003).
CC   -!- SUBUNIT: Homodimer.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA57956.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18997; AAA57956.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC76187.2; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77199.1; -; Genomic_DNA.
DR   RefSeq; NP_417622.2; NC_000913.2.
DR   RefSeq; YP_491340.1; NC_007779.1.
DR   PDB; 1OI4; X-ray; 2.03 A; A/B=2-172.
DR   PDBsum; 1OI4; -.
DR   ProteinModelPortal; P45470; -.
DR   SMR; P45470; 1-171.
DR   DIP; DIP-12263N; -.
DR   EnsemblBacteria; EBESCT00000004111; EBESCP00000004111; EBESCG00000003358.
DR   EnsemblBacteria; EBESCT00000015749; EBESCP00000015040; EBESCG00000014809.
DR   GeneID; 12930276; -.
DR   GeneID; 947666; -.
DR   GenomeReviews; AP009048_GR; JW5529.
DR   GenomeReviews; U00096_GR; b3153.
DR   KEGG; ecj:Y75_p3075; -.
DR   KEGG; eco:b3153; -.
DR   PATRIC; 32121724; VBIEscCol129921_3248.
DR   EchoBASE; EB2637; -.
DR   EcoGene; EG12784; yhbO.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; GSMSKKI; -.
DR   ProtClustDB; CLSK880610; -.
DR   BioCyc; EcoCyc:G7647-MONOMER; -.
DR   BioCyc; ECOL316407:JW5529-MONOMER; -.
DR   EvolutionaryTrace; P45470; -.
DR   Genevestigator; P45470; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0009408; P:response to heat; IMP:EcoCyc.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:EcoCyc.
DR   GO; GO:0009268; P:response to pH; IMP:EcoCyc.
DR   GO; GO:0009411; P:response to UV; IMP:EcoCyc.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Reference proteome.
FT   CHAIN         1    172       Protein YhbO.
FT                                /FTId=PRO_0000157831.
FT   DOMAIN        3    171       PfpI endopeptidase.
FT   STRAND        4      8
FT   HELIX        16     27
FT   STRAND       31     38
FT   STRAND       42     44
FT   STRAND       51     53
FT   HELIX        58     60
FT   HELIX        63     65
FT   STRAND       67     71
FT   HELIX        76     80
FT   HELIX        84     95
FT   STRAND      100    103
FT   TURN        104    106
FT   HELIX       107    113
FT   HELIX       125    127
FT   HELIX       128    133
FT   STRAND      144    146
FT   TURN        147    149
FT   STRAND      150    155
FT   HELIX       156    158
FT   HELIX       159    170
SQ   SEQUENCE   172 AA;  18858 MW;  CF9E2E405788125E CRC64;
     MSKKIAVLIT DEFEDSEFTS PADEFRKAGH EVITIEKQAG KTVKGKKGEA SVTIDKSIDE
     VTPAEFDALL LPGGHSPDYL RGDNRFVTFT RDFVNSGKPV FAICHGPQLL ISADVIRGRK
     LTAVKPIIID VKNAGAEFYD QEVVVDKDQL VTSRTPDDLP AFNREALRLL GA
//
ID   YHS9_SCHPO              Reviewed;         261 AA.
AC   O43084;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   31-OCT-2012, entry version 58.
DE   RecName: Full=Uncharacterized protein C947.09;
DE            EC=3.2.-.-;
GN   ORFNames=SPBC947.09;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329671; CAA17037.1; -; Genomic_DNA.
DR   PIR; T40773; T40773.
DR   RefSeq; NP_595267.1; NM_001021174.1.
DR   HSSP; Q04432; 1RW7.
DR   ProteinModelPortal; O43084; -.
DR   EnsemblFungi; SPBC947.09.1; SPBC947.09.1:pep; SPBC947.09.
DR   GeneID; 2541295; -.
DR   KEGG; spo:SPBC947.09; -.
DR   PomBase; SPBC947.09; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; NDAGANF; -.
DR   OrthoDB; EOG4KD9W5; -.
DR   NextBio; 20802405; -.
DR   ArrayExpress; O43084; -.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEP:PomBase.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    261       Uncharacterized protein C947.09.
FT                                /FTId=PRO_0000317305.
FT   ACT_SITE    162    162       Potential.
FT   ACT_SITE    163    163       Potential.
FT   ACT_SITE    196    196       Potential.
SQ   SEQUENCE   261 AA;  28534 MW;  32C7801A9A5BA49A CRC64;
     MPAKTRNVLI ACSDYYGPFY KDGENTGAFF LELLHPYLVF RDACFNVDIV TESGKIQFDD
     HSVAGPAIDK GSKGEEFLSY DDHIASGPEL SKAEKYVLEN KDDMFWRIVQ NSKTADEVNP
     DKYDIFFVAG GHATLFDFPK ATNLQKLGTS IYENGGVVAA VCHGPTLLPF MKRQTSDGSV
     SIVCGKDVTA FDRVAEDKSK LMEALKKYNL EVLDDMLNDA GANFIKSPNP FGDFVIADGR
     LVTGSNPASA TSTAKTALRV L
//
ID   YJ73_SCHPO              Reviewed;         244 AA.
AC   O74914;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   31-OCT-2012, entry version 55.
DE   RecName: Full=Uncharacterized protein C757.03c;
DE            EC=3.2.-.-;
GN   ORFNames=SPCC757.03c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=16823372; DOI=10.1038/nbt1222;
RA   Matsuyama A., Arai R., Yashiroda Y., Shirai A., Kamata A., Sekido S.,
RA   Kobayashi Y., Hashimoto A., Hamamoto M., Hiraoka Y., Horinouchi S.,
RA   Yoshida M.;
RT   "ORFeome cloning and global analysis of protein localization in the
RT   fission yeast Schizosaccharomyces pombe.";
RL   Nat. Biotechnol. 24:841-847(2006).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329672; CAA21228.1; -; Genomic_DNA.
DR   PIR; T41594; T41594.
DR   RefSeq; NP_587678.1; NM_001022673.1.
DR   HSSP; Q04432; 1QVW.
DR   ProteinModelPortal; O74914; -.
DR   EnsemblFungi; SPCC757.03c.1; SPCC757.03c.1:pep; SPCC757.03c.
DR   GeneID; 2539466; -.
DR   KEGG; spo:SPCC757.03c; -.
DR   PomBase; SPCC757.03c; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000181653; -.
DR   OMA; EPWGEKV; -.
DR   OrthoDB; EOG4M3DJN; -.
DR   NextBio; 20800628; -.
DR   ArrayExpress; O74914; -.
DR   GO; GO:0005829; C:cytosol; IDA:PomBase.
DR   GO; GO:0005634; C:nucleus; IDA:PomBase.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEP:PomBase.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Cytoplasm; Hydrolase; Nucleus; Protease;
KW   Reference proteome.
FT   CHAIN         1    244       Uncharacterized protein C757.03c.
FT                                /FTId=PRO_0000317306.
FT   ACT_SITE    139    139       Potential.
FT   ACT_SITE    140    140       Potential.
FT   ACT_SITE    173    173       Potential.
SQ   SEQUENCE   244 AA;  26743 MW;  297E24AB85765EE0 CRC64;
     MASEGKVLLV ASSYYGPFYP DGMNTGVHFA ELLIPYQVFR EAGYEVQLTS ETGKCKFDDH
     SIKKSALGEV ERDAFDNKDN EFWYALKDIK PADKINYKEF CIMFIAGGHA AMFDLPHATN
     LQTLAQQIYA SNGVLAAVCH GPVMLPFVDD TKSPEGRSVV YGKKVTAFNS TGELVMGVSS
     ALRERNMQDL NSLFREAGAE FVDPPTPMSD FTQVDGRIVT GVNPMSAKST AEAAIKVSQS
     LRKT
//
ID   YOAZ_BACSU              Reviewed;         210 AA.
AC   O34947; Q796E9;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   09-JAN-2013, entry version 56.
DE   RecName: Full=Uncharacterized protease YoaZ;
DE            EC=3.2.-.-;
GN   Name=yoaZ; OrderedLocusNames=BSU18790;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Lapidus A., Galleron N., Sorokin A., Ehrlich D.;
RT   "Sequence analysis of the Bacillus subtilis chromosome region between
RT   the terC and odhAB loci cloned in a yeast artificial chromosome.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   MEDLINE=98044033; PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF027868; AAB84456.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB13771.1; -; Genomic_DNA.
DR   PIR; A69898; A69898.
DR   RefSeq; NP_389760.1; NC_000964.3.
DR   HSSP; Q8UGZ9; 2FEX.
DR   ProteinModelPortal; O34947; -.
DR   SMR; O34947; 3-209.
DR   EnsemblBacteria; EBBACT00000000534; EBBACP00000000534; EBBACG00000000532.
DR   GeneID; 940031; -.
DR   GenomeReviews; AL009126_GR; BSU18790.
DR   KEGG; bsu:BSU18790; -.
DR   PATRIC; 18975599; VBIBacSub10457_1990.
DR   GenoList; BSU18790; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000015209; -.
DR   OMA; LPGGNTW; -.
DR   ProtClustDB; CLSK887391; -.
DR   BioCyc; BSUB:BSU18790-MONOMER; -.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; FALSE_NEG.
PE   3: Inferred from homology;
KW   Complete proteome; Hydrolase; Protease; Reference proteome.
FT   CHAIN         1    210       Uncharacterized protease YoaZ.
FT                                /FTId=PRO_0000388350.
FT   DOMAIN        4    180       PfpI endopeptidase.
FT   ACT_SITE    110    110       Nucleophile (By similarity).
SQ   SEQUENCE   210 AA;  23420 MW;  18A8BA915AAEF745 CRC64;
     MQTRKVYLYV FHTMSDWEYG YLIAELNSGR YFKQDAASLK VVTVGVNKEM ITTLGGLSIK
     PDISLDECTL GSQDLIILPG GNTWGEDIHQ PILKKVGDAL KLGTTIAAIC GATLGLANEG
     YLNSRKHTSN DLDYMNMVCP NYKGETFYEK GPAVSDENLV TASGIAPLEF AVEVLKKLDV
     FAPDTLRSWY KLNKTQKPEY FFELMNTINR
//
ID   YRAA_BACSU              Reviewed;         169 AA.
AC   O06006;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   24-OCT-2003, sequence version 2.
DT   09-JAN-2013, entry version 85.
DE   RecName: Full=Putative cysteine protease YraA;
DE            EC=3.2.-.-;
GN   Name=yraA; OrderedLocusNames=BSU27020;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   MEDLINE=97286548; PubMed=9141695;
RA   Parro V., San Roman M., Galindo I., Purnelle B., Bolotin A.,
RA   Sorokin A., Mellado R.P.;
RT   "A 23911 bp region of the Bacillus subtilis genome comprising genes
RT   located upstream and downstream of the lev operon.";
RL   Microbiology 143:1321-1326(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   MEDLINE=98044033; PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   SEQUENCE REVISION TO C-TERMINUS.
RX   MEDLINE=20036940; PubMed=10568751; DOI=10.1101/gr.9.11.1116;
RA   Medigue C., Rose M., Viari A., Danchin A.;
RT   "Detecting and analyzing DNA sequencing errors: toward a higher
RT   quality of the Bacillus subtilis genome sequence.";
RL   Genome Res. 9:1116-1127(1999).
RN   [4]
RP   FUNCTION, INDUCTION, OPERON STRUCTURE, AND DISRUPTION PHENOTYPE.
RC   STRAIN=168;
RX   PubMed=19170879; DOI=10.1111/j.1365-2958.2008.06568.x;
RA   Nguyen T.T.H., Eiamphungporn W., Maeder U., Liebeke M., Lalk M.,
RA   Hecker M., Helmann J.D., Antelmann H.;
RT   "Genome-wide responses to carbonyl electrophiles in Bacillus subtilis:
RT   control of the thiol-dependent formaldehyde dehydrogenase AdhA and
RT   cysteine proteinase YraA by the MerR-family regulator YraB (AdhR).";
RL   Mol. Microbiol. 71:876-894(2009).
CC   -!- FUNCTION: Functions in the protection against aldehyde-stress,
CC       possibly by degrading damaged proteins.
CC   -!- INDUCTION: The adhR-yraA operon is induced by formaldehyde and
CC       methylgloxal, under the control of AdhR. A second yraA-specific
CC       transcription unit is not induced by formaldehyde or methylglyoxal
CC       and is not controlled by AdhR.
CC   -!- DISRUPTION PHENOTYPE: No aldehyde-stress related phenotype; when
CC       combined with a yfkM disruption shows significantly reduced growth
CC       in the presence of formaldehye and methylglyoxal.
CC   -!- SIMILARITY: Belongs to the peptidase C56 family.
CC   -!- SIMILARITY: Contains 1 PfpI endopeptidase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA63466.1; Type=Frameshift; Positions=150;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92868; CAA63466.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AL009126; CAB14644.2; -; Genomic_DNA.
DR   PIR; A69970; A69970.
DR   RefSeq; NP_390580.2; NC_000964.3.
DR   ProteinModelPortal; O06006; -.
DR   SMR; O06006; 1-168.
DR   EnsemblBacteria; EBBACT00000002560; EBBACP00000002560; EBBACG00000002555.
DR   GeneID; 937603; -.
DR   GenomeReviews; AL009126_GR; BSU27020.
DR   KEGG; bsu:BSU27020; -.
DR   PATRIC; 18977258; VBIBacSub10457_2818.
DR   GenoList; BSU27020; -.
DR   eggNOG; COG0693; -.
DR   HOGENOM; HOG000063195; -.
DR   KO; K05520; -.
DR   OMA; VCHAPWL; -.
DR   ProtClustDB; CLSK904612; -.
DR   BioCyc; BSUB:BSU27020-MONOMER; -.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:InterPro.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:UniProtKB-KW.
DR   InterPro; IPR006286; Peptidase_C56.
DR   InterPro; IPR002818; ThiJ/PfpI.
DR   Pfam; PF01965; DJ-1_PfpI; 1.
DR   TIGRFAMs; TIGR01382; PfpI; 1.
DR   PROSITE; PS51276; PEPTIDASE_C56_PFPI; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Hydrolase; Protease; Reference proteome;
KW   Stress response.
FT   CHAIN         1    169       Putative cysteine protease YraA.
FT                                /FTId=PRO_0000157833.
FT   DOMAIN        3    169       PfpI endopeptidase.
FT   ACT_SITE    103    103       Nucleophile (By similarity).
FT   ACT_SITE    104    104       Potential.
SQ   SEQUENCE   169 AA;  18512 MW;  1AB077EC1536BE71 CRC64;
     MSKKIAVLVT DQFEDIEYTS PVKAYEEAGY SVVAIDLEAG KEVTGKHGEK VKIDKAISDV
     DASDFDALLI PGGFSPDLLR ADDRPGEFAK AFVENKKPVF AICHGPQVLI DTDLLKGKDI
     TGYRSIRKDL INAGANYKDA EVVVSHNIVT SRTPDDLEAF NRESLNLLK
//